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ABSTRACT 
 
End stage alcoholic liver disease (ESALD) is a leading yet controversial indication for 
orthotopic liver transplantation (OLT). Around one third of these patients will return to 
harmful alcohol use after transplantation, against medical advice. Relapse to harmful 
drinking contributes to mortality, morbidity and poor quality of life for the individual and 
impacts on the reputation of the program. Despite the availability of established alcohol 
treatment, ESALD transplant patients avoid such services. The current research investigated 
the barriers to and reasons for treatment resistance amongst ESALD transplant patients. A 
mixed method approach was utilized, consisting of a quantitative prospective case control 
study and a qualitative in-depth interview study.  
The case control study compared 40 ESALD transplant patients (cases) matched for age and 
sex with 40 alcohol treatment seekers without liver disease (controls). The aim of the study 
was to identify barriers and reasons for treatment resistance by ESALD transplant patients 
in comparison with alcohol treatment seekers. The qualitative in-depth interview study 
involved semi-structured interviews amongst 42 ESALD transplant candidates. The aim 
was to illuminate the cognitive processes, experiences and understandings of ESALD 
transplant participants regarding abstinence, alcohol relapse, and alcohol treatment seeking 
in the context of liver transplantation.  
The results of the case control study showed that ESALD transplant patients perceive no 
need for treatment due to their lengthy abstinence and high motivation for change. Standard 
alcohol interventions are not tailored to the ESALD transplant population as they differ 
from ATS on alcohol severity, health beliefs, psychiatric co-morbidity and quality of life. 
No differences were found between the two groups with regard to HCV, co-morbid 
substance abuse and education levels. Barriers to help seeking amongst ESALD transplant 
subjects consisted of possible fear of stigma and limited access to alcohol services.  
The in-depth interview study found 62% of ESALD transplant participants reporting stigma 
to be a major deterrent to utilizing specialty alcohol treatment because of its association 
with the label ‘alcoholic’ and its inconsistency with the criteria for membership of a group 
prototype of ideal transplant candidates. Self-management by ESALD transplant 
participants to achieve substantial abstinence removed the necessity for professional 
support services. Abstainers were strongly supported by intimate partners, social networks 
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and a moral obligation inherent in ‘the contract’ with the liver team, none of which they 
acknowledged as significant in their capacity to remain abstinent. A major barrier to alcohol 
treatment seeking was the lack of an appropriate and suitable alcohol treatment service 
which was medically justified, integrated with the transplant program and actively 
incorporating the social and interpersonal dimensions of transplantation. 
The findings of the research provide significant therapeutic implications to tailoring a more 
suitable and efficacious approach to the management of alcohol relapse within the liver 
transplant context.  
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CHAPTER 1 
Introduction 
 
  
Carlo DiClemente (2007), a leading author and researcher in the field of the 
psychology of change and addictive behaviours wrote  
 
Natural or self-directed change is the fundamental process where we should 
be looking for mechanisms of change. It is the change process that interacts 
with any efforts to assist individuals to change drinking behavior. 
Treatment is not a powerful force meeting an immovable object. ....From 
this perspective it is the change processes or mechanisms located in the 
person and person-environmental interactions that are the critical 
mechanisms for creating change....Treatments then are viewed as an 
extension of the person’s process of self-change and not as a unique and 
critical mechanism for change. [1] (p.19S) 
 
People needing to change after facing personal problems or life setbacks may prefer 
to solve their own problems rather than pursue professional help. Such people will 
seriously consider professional treatment only when all efforts at self-help have been 
exhausted. The preference for self-directed change in place of seeking professional 
help, can also apply to individuals who have developed a problem of excessive 
alcohol use [2]. While a large number of people in society drink safely, a substantial 
number can experience alcohol use problems resulting in issues such as alcoholic 
liver disease and yet do not seek professional treatment [3-4]. 
 
Alcoholic liver disease (ALD) due to excessive alcohol consumption is a major health 
problem in the western world [5]. ALD involves a spectrum of disease severity 
ranging from fatty liver to a more severe form of the condition termed alcoholic 
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cirrhosis, which is one of the leading causes of morbidity and mortality [6]. The 
progression of the disease involves scar tissue increasingly replacing normal liver 
tissue, thus preventing healthy liver function. For patients with end-stage alcoholic 
liver disease (ESALD) abstaining from alcohol use is imperative to preserve life [7]. 
However liver damage may still progress despite months or years of abstinence and 
the only effective treatment option to staying alive is a liver transplant.  
 
Liver transplantation is a surgical procedure in which the diseased liver is removed 
and replaced by a healthy liver in the original anatomic location. This treatment was 
pioneered by Thomas Starzl in 1963 in Denver, Colorado with the first successful one 
year human survival transplant occurring in 1967 [8]. Improvements in survival rates 
after transplantation continued thereafter. Over the following two decades a number 
of medical and surgical advancements has resulted in a dramatic increase in the 
number of transplants performed worldwide [9-10]. The goal of liver transplantation 
is the treatment of irreversible life-threatening liver disease which has not responded 
to alternative medical and surgical interventions. The success of liver transplantation 
has resulted in an ever increasing demand for donor organs but there is an inadequate 
rate of organ donation causing a deficit between the number of donor organs and the 
number of patients requiring a transplant [11]. After almost a half century of liver 
transplant experience, one of the key issues facing transplant programs is less related 
to scientific medical advances and more concerned with access and equity around the 
provision of a life saving treatment [12].  
 
One of the leading indications for transplantation is ESALD, second only to liver 
disease as a result of chronic HCV infection [13]. The provision of liver 
transplantation for those with ESALD is problematic. Michael Lucey, Professor of 
Medicine Chief, Section of Gastroenterology and Hepatology, recently stated that 
‘..the apparent success of LT for ALD masks a more complex reality. There are still 
unresolved controversies about LT for patient with ALD’ [14] (p.751).  
 
Central to the controversy, is the issue of alcohol relapse during the pre- and post- 
transplant period [13, 15]. Firstly, relapse to harmful drinking has been found to 
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contribute to mortality and morbidity, mental health problems and poor quality of life. 
Secondly, transplant programs are concerned that relapse to any alcohol use by 
ESALD transplant recipients may affect the readiness of the public to donate 
affecting access to transplantation for all diseases [16]. Relapse occurs despite 
transplant programs carefully selecting and evaluating potential candidates and a 
mandatory period of sustained abstinence before being listed.  
 
Transplant research literature to date continues to highlight the need for an effective 
alcohol treatment approach in order to reduce the risk of relapse but identifying the 
most acceptable and effective intervention for ESALD transplant patients continues to 
remain a problem. There are conflicting views within the transplant field about the 
model behind the provision of alcohol treatment. Transplant physicians and 
hepatologists consider relapse a failure of transplantation because their goal is 
lifelong abstinence even after the patient has positively recovered from transplant 
surgery. This approach contrasts with that of addiction specialists where alcohol use 
disorders are understood as a separate medical condition to ALD characterised by 
remission and relapses and where open disclosure of alcohol use during the course of 
treatment is encouraged. It has been argued that the policy requiring strict abstinence 
inhibits the lack of candour by patients for fear of being penalised. This becomes 
counter-therapeutic as it inhibit treatment seeking and re-establishing sobriety [17] 
[14].  
 
Controlled studies have attempted to attend to the risk of relapse by providing 
established alcohol interventions within the liver transplant setting [18-19] but 
ESALD transplant patients did not perceive a need for alcohol treatment and these 
interventions were not successful.  
 
Focus and aim of the study 
 
In order to understand the barriers, and reasons for, resistance to alcohol treatment by 
ESALD patients within the context of liver transplantation, this research draws on 
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five fundamental areas: liver transplantation and ESALD, alcohol use disorders and 
relapse, alcohol treatment seeking, cognitive behavioural change and the sociology of 
alcohol use disorders. As discussed earlier the majority of people with alcohol use 
disorders will not seek treatment despite its effectiveness. The resistance to treatment 
by ESALD transplant patients presented an interesting and challenging research 
project.  
 
Alcohol treatment seeking often entails a complex and multi-factorial process 
dependent on the interaction of psychological, social, biological but also 
organisational factors [20-22]. Liver transplantation for those with ESALD involves a 
number of issues including: medical, political, economic, moral and ethical, adding to 
the complexity surrounding treatment resistance by this client population.  
 
This study proceeded from the concern regarding alcohol relapse amongst ESALD 
transplant patients and their rejection of alcohol treatment considering their history of 
alcohol dependence or abuse and the negative outcomes associated with relapse. This 
study will investigate factors contributing to treatment resistance and barriers 
amongst ESALD transplant patients to guide design of effective treatment 
approaches.  
 
Research question 
 
The primary research question for this project is: 
 
What are the barriers to, and reasons for, resistance to specialty alcohol treatment 
amongst ESALD transplant candidates before and after liver transplantation? 
 
Sub-questions include: 
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1. Do ESALD transplant patients need alcohol treatment? 
2. How are ESALD transplant patients different from those who actively pursue 
specialist alcohol services? The difference here will be identified by 
establishing the correlates of alcohol treatment seeking. 
3. What is the experience of help seeking for ESALD transplant patients 
considering the medical and social factors surrounding liver transplantation?  
4. Can ESALD transplant relapsers and abstainers inform us about what treatment 
approach may be more suitable and effective within a transplant setting? 
5. How do we identify those amongst the ESALD transplant population who may 
need or benefit from treatment? 
6. How do we set up treatment services that engage ESALD transplant patients 
towards alcohol treatment?  
 
Overview of the research approach 
 
The present study is the first systematic attempt to investigate reasons for treatment 
resistance and barriers to alcohol dependency treatment amongst ESALD transplant 
patients. As treatment seeking is a complex process and in order to identify the most salient 
variables, processes or themes behind treatment resistance and barriers to treatment, two 
research paradigms were chosen to optimally address the research question. A mixed 
method research design involving both quantitative and qualitative data collection 
techniques was adopted and is illustrated in Figure 1.  
The advantages of combining the qualitative and quantitative approaches is that the 
different data sets can be both illuminating in terms of similarity and differences of 
findings yielding a unitary picture providing breadth and depth to the problem.  
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Figure 1.1. Flowchart of the study design 
 
 
Study 1 
 
Study one utilized the empirico-analytical paradigm research approach (commonly referred 
to as quantitative research). Its epistemological and ontological position means the 
researcher is able to isolate and define variables and variable categories framed in the 
hypothesis and allows that to be tested against the data. The use of instruments or measures 
which are pre-determined and specifically selected allows the researcher to effectively prove 
or disapprove the hypothesis. From the range of research approaches in this paradigm, the 
case control study was the most suitable in order to investigate factors contributing to 
treatment resistance. This enabled a comparison to be made between those who actively 
participate in professional alcohol treatment services and ESALD transplant patients who are 
non-treatment seekers, while controlling for liver disease as a primary motivator for 
treatment.  
 
 
 
ESALD transplant patients 
 (n=40) 
Alcohol treatment seekers 
(n= 40) 
Study 1 
Case control study 
(n=80) 
 Study 2 
In-depth interview-based 
study 
(n=42) 
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Study 2  
 
The interpretive paradigm was chosen for Study 2 as it focuses on accessing and 
understanding the meanings of participants’ experiences rather than testing a theoretical 
assumption. This approach was utilized as it is the most direct method to extract and uncover 
the beliefs, meanings and experiences of ESALD transplant candidates in the social world of 
the transplant setting. Thematic approach to analysis of interview data was chosen as this 
enables the research to develop a substantive theory.  
 
Significance of the research 
 
This study addresses an important gap in the literature as there are no empirical findings 
to explain the lack of treatment seeking or resistance amongst ESALD transplant patients 
to find the most effective alcohol approach considering the clinical characteristics and 
experiences of this population.  
 
Organisation of the thesis  
 
Three extensive bodies of literature relevant to the topic under investigation were 
critically reviewed. Chapters 2 and 3 provide an introduction and background to key 
issues surrounding liver transplantation and ESALD transplant patients for the two 
research studies. Chapter 2 discusses alcoholic liver disease, selection, evaluation and 
stages of liver transplantation. ESALD as an indication of transplantation is discussed 
attending to key issues including: historical factors, the medical and ethical 
controversy, selection and evaluation procedures, liver transplant outcomes and 
alcohol relapse. Chapter 3 contains a critical review of the current management of 
alcohol problems by liver transplant programs. This chapter pays special attention to 
four studies which have attempted to treat alcohol use disorders within the context of 
the liver transplantation exploring findings and methodological limitations. The 
chapter ends by presenting the current research examining the demographics and 
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clinical characteristics of the ESALD transplant population to alcohol treatment 
seekers.  
 
The thesis is then divided into two parts. Part 1 contains the literature review, method, 
results and discussion for the case control study. Part 2 presents the in-depth 
interview study similarly.  
 
Part 1 commences with Chapter 4 which provides the literature review for the case 
control study. A number of factors are known to keep people from seeking 
professional help and are outlined in this chapter. A brief review of the general 
psychotherapy literature explaining treatment resistance is provided. This is followed 
by the theoretical models conceptualising the alcohol treatment seeking process along 
with the research findings concerning the correlates and barriers to alcohol treatment 
seeking.  
 
Chapters 5, 6, 7 discuss the case control study. Chapter 5 details the methodology 
utilized including subjects, study procedures, measures, data management and 
statistical analysis. Chapter 6 presents the results. Chapter 7 discusses the research 
findings in relation to the hypotheses and wider research literature.  
 
Part 2 commences with Chapter 8 which draws on sociological theories of alcohol use 
with attention to alcoholism and stigma to develop a conceptual framework that 
locates excessive alcohol use and transplant policies and practices within a medical 
and social context. Chapter 9 presents the qualitative research paradigm and 
approach, methodology; and quality management. Chapter 10 presents the 
characteristics of the participants, the results of the thematic analysis highlighting the 
key themes and key quotes. Discussions of the findings are presented in Chapter 11. 
 
Chapter 12 consists of a conclusion drawing the findings of both the case control and 
qualitative study in relation to the research question. Recommendations for the 
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management of problematic alcohol use within the liver transplant setting are 
presented.  
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CHAPTER 2 
Orthotopic Liver Transplantation and end stage Alcoholic Liver 
Disease 
 
 
End Stage Alcoholic Liver Disease (ESALD) is a leading indication for Orthotopic Liver 
Transplantation (OLT). Before directly addressing the topic of the research investigation 
pertaining to the lack of voluntary participation in specialty alcohol treatment by ESALD 
transplant candidates it is important to present the background, practices and key issues 
surrounding liver transplantation, especially as it relates to those with ESALD. This chapter 
commences with a brief overview of alcoholic liver disease (ALD) followed by discussion 
about current practices, procedures and research findings concerning OLT. A key issue 
facing transplant programs worldwide which will be discussed is the provision of a 
medically intensive life saving procedure in the climate of organ shortage and growing 
patient demand. Furthermore ESALD is the most controversial indication for OLT and one 
which is subject to more intensive evaluation and monitoring than other conditions causing 
end stage liver disease. At the centre of this debate is relapse to alcohol use after liver 
transplantation and the latest research findings and understandings about alcohol relapse 
amongst ESALD transplant candidates are reported including: relapse rates, the medical and 
psychosocial consequences and predictors of relapse. 
  
Alcoholic Liver Disease  
 
Alcohol remains a major cause of liver disease worldwide especially in established market 
economies and accounts for 50% of cirrhosis deaths in the western world [1-2]. Alcoholic 
Liver Disease (ALD) accounts for a conservative estimate of 3% (1.8 million) of the global 
burden of death [3]. In the United States in 2007, liver cirrhosis was the 12th most common 
cause of death accounting for 29,165 deaths, of these 14,406 (49%) were alcohol-related [4]. 
Similarly in 1996 Australian mortality figures showed ALD as the 13
th
 leading cause of 
death [5]. Between 1992 and 2001, 31,133 Australians died from alcohol related disease and 
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injury with alcoholic cirrhosis accounting for 6,825 deaths (22%) [6].  
 
ALD is defined as acute or chronic liver disease in the presence of regular alcohol 
consumption where no other cause of liver injury can account for the disease [7]. To be more 
confident of the role of alcohol in an individual case, a history of sustained excessive alcohol 
use (normally ≥ 20g ethanol/day in women; ≥ 60g ethanol/day in men) is typically found [8]. 
ALD involves a disease spectrum that ranges from fatty liver or simple steatosis, alcoholic 
hepatitis and eventually alcoholic cirrhosis [9]. Alcoholic cirrhosis is the most serious form 
of ALD causes most deaths and morbidity from this disorder. In cirrhosis scar tissue replaces 
normal liver tissue, disrupting blood flow through the liver thus preventing healthy liver 
function. ALD develops over a long period and during the early years of the disease patients 
with cirrhosis may only present mild and non-specific symptoms [10]. ALD at the end stage 
of the spectrum manifests usually in the older patient who starts showing signs of liver 
failure which can eventuate in the end of life. Once cirrhosis has developed, the prognosis is 
dictated by the evolution of complications such as encephalopathy, bleeding, fluid retention, 
cachexia (generalised wasting) and hepatocellular carcinoma (liver cancer).  
The amount of alcohol ingested is the most potent risk factor for the development of ALD. 
Epidemiological data shows a strong correlation between levels of alcohol consumption with 
numbers of cases of ALD [11-13]. In the United States cirrhosis mortality increased steadily 
following the end of Prohibition in 1933 until 1973 where it peaked at 18.1 deaths per 
100,000 population followed by a steady decline in the last four decades (Figure 2.1). 
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Figure 2.1 Age-adjusted death rates from liver cirrhosis by sex (death registration States, 
1910–1932, and United States, 1933–2007) [14] 
 
One study estimated that for every additional litre per capita in alcohol consumption there 
was a corresponding 14% increase in cirrhosis in men and 8% increase in women [15]. 
Higher rates of cirrhosis death are seen in countries where people traditionally consume 
more alcohol (such as Spain, France and Italy) and lower rates in countries where alcohol 
consumption is lower (such as Iceland, NZ and Norway) while countries such as the United 
States are in the middle range along with Belgium and Canada [2, 11] (WHO, 2000). 
Mortality from ALD has been steadily declining in most countries worldwide including 
Australia, European countries and the USA since the mid or late 1970s, mainly as a result of 
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reduction in alcohol consumption [10, 16]. By contrast, steady upward trends have been seen 
more recently in the United Kingdom and central and eastern European countries, and 
ascribed to the continual increase in alcohol consumption [16]. A striking increase in 
hospital admissions and mortality in England from chronic liver disease with mortality rates 
doubled between 1979 and 2005 [17]. Hospital admission rates for ALD doubled between 
1989/1990 and 2002/2003 and in 2005 ALD contributed to two thirds of chronic liver 
disease deaths. Alarmingly, increases in ALD were reported amongst those in the 25-34 age 
groups along with increased incidence in females between the ages of 35 to 54.  
According to Thomson a number of significant factors play a role in the increase mortality 
and morbidity due to ALD. These include: increased availability of alcohol due to increase 
in the number of licensed premises and broader licensing laws; drop in the cost of alcohol; 
media and advertising portraying binge drinking and popular celebrity culture, public health 
ignorance especially around addiction; and modern life stressors. Thomson noted that many 
will perceive cirrhosis as a disease of people who are ‘alcoholic’ or ‘addicted’ despite the 
fact that many patients with chronic liver disease do not fit profile of those who are severely 
dependent [18]. In Australia between 1993 and 2005, Liang and colleagues reported 
significant decreases in the mortality rate of ALD coinciding with a gradual increase in 
hospital admissions for alcoholic hepatic failure and alcoholic cirrhosis especially among 
younger age groups. The increase in admissions and reduction in mortality was believed to 
be due to an increase in screening of alcohol-related and improvements in disease 
management in primary care settings [10].  
 
Epidemiological data suggest that a threshold of 80g of daily alcohol in a male and 20g in a 
female for an average of 10-12 years is necessary for alcoholic injury to develop [19-21]. 
Fatty liver develops in about 90% of individuals who drink more than 60g/day of alcohol but 
can occur in those who drink less [13]. However there are data showing lifetime risk of 
death from alcohol use increases with consumption and not necessarily within the threshold 
[22]. In Australia 44% of Australians were drinking amounts which exceeded the 2001 
National Health and Medical Research Council (NHMRC) guidelines for minimising 
problems from the chronic effects of alcohol (an average of no more than 2 drinks per day 
for women and 4 drinks per day for men ) [6].  
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Cirrhosis mortality rates are substantially lower among the young but increase considerably 
in middle age reaching a peak in the 45-54 age group, making it the fourth leading cause of 
death in this age group [11]. Cirrhosis mortality rates are two times higher in men than in 
women despite the higher risk for developing cirrhosis in women at an individual level due 
to physiological factors. The higher rate of cirrhosis mortality amongst men is probably due 
to a greater alcohol consumption and a higher rates of alcohol use disorders amongst men 
compared to women [11].  
 
Not all patients who drink excessively develop life threatening alcoholic liver disease as the 
severity of liver damage is not consistently related to the amount and years of alcohol 
consumption. While 90% - 100% of heavy drinkers will develop fatty liver, only 10% to 
35% develop alcohol hepatitis and 8% to 20% develop alcohol related cirrhosis [23]. A 
number of other risk factors have been associated with the development and progression of 
liver disease including: the type of alcohol consumed, pattern of drinking, sex, ethnicity, 
malnutrition, obesity, iron overload and chronic hepatitis virus infection [13]. Genetic 
factors involving polymorphisms of hepatic alcohol-metabolizing enzymes play a central 
role in the tissue tropism of alcohol injury [24]. Also a large proportion of patients with ALD 
have coexisting chronic Hepatitis C Virus (HCV) infection suggesting that the virus may 
accelerate the development of cirrhosis and the progression to end stage liver failure [9].  
 
A diagnosis of end-stage ALD is determined medically based on a history of significant 
alcohol consumption, physical examination, laboratory and pathologic evaluations. Other 
causes for liver disease are excluded by appropriate medical evaluation. Abstinence is the 
cornerstone of therapy in the management of the condition along with nutrition, diet and 
certain medications [9]. However despite months or years of abstinence some patients with 
end stage ALD will require liver transplantation due to signs of far advanced hepatic damage 
or complications such as bleeding varices or the hepatorenal syndrome [9, 25]. Without liver 
transplantation the 5 year patient survival rate for those with ESALD has been reported to be 
as low as 23% [1] whereas with OLT the survival rate is increased to 88% [26].  
 
In conclusion ALD is a leading cause of death especially in industrialised western countries 
with high levels of alcohol consumption. While ALD can be attributed to heavy alcohol 
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consumption there are a number of other aetiological factors leading to the development of 
the disease. ALD can be perceived as a diagnosis associated with the stereotype of 
alcoholism or found only amongst those with severe alcohol dependence syndrome. This 
review reveals that ALD can affect individuals in the wider community with a range of 
alcohol consumption patterns and co-existing aetiologies.  
 
Orthotopic Liver Transplantation  
 
Background to OLT  
 
Orthotopic Liver Transplantation (OLT) is the most effective treatment for patients with 
irreversible liver disease, who have not responded to alternative medical and surgical 
interventions and who are approaching the terminal phase of their illness [27-28]. This 
surgical technique has extended the survival and improved the quality of life of patients with 
end-stage liver disease who previously would have died within a few months to a few years 
[29-30]. 
 
OLT is the most commonly used technique for liver transplantation which involves removal 
of the recipient native liver and replacement with the transplanted donor liver in the same 
anatomic location as the original liver. The majority of liver transplants use the whole liver 
from a heart beating brain-dead donor. Further developments in OLT include: split liver 
transplantation, in which a single donor liver is used to provide transplants for two 
recipients, living donor liver transplantation, in which a portion of a healthy person’s liver is 
removed and used as the allograft; and auxiliary liver transplantation in which a portion of 
the diseased liver is removed and the reduced-size graft is implanted alongside the native 
organ [28]. 
 
 In 1983 a consensus conference held in the United States under the auspices of the National 
Institutes of Health (NIH p.110S) formally announced that liver transplantation had become 
a ‘therapeutic modality for end stage liver disease that deserved broader application’ as 
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opposed to it being considered an experimental procedure[32]. By 1988 over 1,700 
transplants were conducted in the United States alone with an overall 5 year survival rate of 
70% [33]. Continuing advances over the next two decades in surgical and anaesthetic 
techniques, availability of new immunosuppressive agents for rejection, more reliable 
technology for organ preservation, advances in microbiology and critical care medicine 
resulted in a dramatic increase in the number of transplants performed [7, 29, 34].  
Liver transplantation is now available worldwide and is offered in the United States, Europe, 
Great Britain, Australia, Asia, Africa and South America. Transplant registry figures show 
that in Europe between 1968 to 2009, 93,634 liver transplants were performed [35], in the 
United States between 1999 and 2008, 54,446 patients received OLT [36], and in Australia 
between 1985-2008, 3305 transplants were conducted [37]. In addition survival rates after 
OLT have continued to improve compared to the survival rates of the 1980s. Current 
survival data for the United States, Europe and Australia are provided in Table 2.1. Overall 
OLT has contributed substantially to a significant decrease in cirrhosis mortality worldwide 
[38].  
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The number of medical conditions considered as suitable indications for OLT has also 
expanded. These include: cholestatic liver disorders, metabolic disorders causing cirrhosis, 
metabolic disorders causing severe extrahepatic morbidity, primary malignancies of the 
liver, fulminant hepatic failure, retransplantation and chronic noncholestatic liver disorders 
comprising of chronic hepatitis C, chronic hepatitis B, autoimmune hepatitis and alcoholic 
liver disease [30].  
 
 Selection criteria  
 
The principles and practice behind the selection and allocation of donor organs varies 
between continents, countries and even states with different models for selection and listing 
being introduced in America, Europe and Australia [41]. According to Neuberger [34] in 
1991 the World Health Organisation stated that donated organs should be allocated based on 
medical need and not financial or other considerations [42]. This was followed by the United 
Network for Organ Sharing (UNOS) stating that donated organs should balance medical 
usefulness and justice (equity in distribution of the benefits and burdens among all transplant 
patients). Thus in 1997 the American Medical Association Committee on Ethical Issues 
developed acceptable selection criteria for OLT which included: the likelihood of benefit for 
the patient, importance of the treatment in improving the patient’s quality of life, duration of 
Table 2.1 Patient survival rates after OLT for United States, Europe,  Australia  for  1, 5 and 
10 years post-transplant 
 
Country                            Time period                 1 year         5 years            10 years 
 
United States [39]                  1998- 2007                   87%               67.6%            52.9% 
Europe [40]                            1988- 2009                   82-70%         71-58%          61-45% 
Australia [37]                         1986-2007                     85%             78%                67.5% 
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benefit, urgency of treatment and the amount of resources likely to be required. 
Unacceptable criteria for OLT included: ability to pay, the patient’s contribution to society, 
perceived obstacles to treatment (e.g. antisocial behaviour), past use of medical resources 
and the patient’s contribution to the medical disorder (e.g. drug or alcohol abuse). However 
these may not be actually followed in practice [34].  
 
In 2002, UNOS for the United States, introduced standardized minimal criteria or system for 
allocating organs based on a disease severity score called the model for end-stage liver 
disease (MELD). MELD is an objective method of predicting liver disease mortality without 
transplantation by calculating a score based on three blood test parameters: serum creatinine, 
serum total bilirubin and international normalized ratio (INR) [43]. Other countries such as 
France, Israel and Eurotransplant countries and Brazil have followed this system of selection 
establishing nationally agreed selection criteria with the graft being offered to identified 
patients, selected according to MELD scores, body size and blood group [41].  
 
In Australia the Transplantation Society of Australia and New Zealand (TSANZ) [44] 
developed nationally uniform allocation protocols outlining the eligibility criteria for 
patients to be listed for OLT. The eligibility criteria and allocation protocols are followed by 
all Australian and New Zealand transplant units. Decisions regarding eligibility and 
allocation include: relative urgency of need, medical factors which affect likelihood of 
success (e.g. tissue matching); relative severity of illness and disability; relative length of 
time on the waiting list; likelihood that the recipient will (be able to) comply with the 
necessary ongoing treatment after transplantation. The general recipient suitability criteria 
for OLT according to the Transplantation Society of Australia and New Zealand (TSANZ) 
are outlined in Table 2.2.  
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Table 2.2 General Recipient Suitability Criteria by the Transplantation Society of Australia 
and New Zealand [44] 
 
1) Accepted indication for listing 
a) Life threatening acute or chronic liver disease not amenable to alternative therapy 
b) Extrahepatic manifestations of inborn error of metabolism (FAP, GSD, hyperlipidaemia). 
 
2) Transplant to improve quality of life but not life expectancy (i.e. palliative transplant) is 
accepted indication. 
 
3) Accepted onto the waiting list by a recognised liver transplant unit. 
 
4) Absence of contra-indications e.g.: 
a) Life threatening non-hepatic illness considered to preclude successful liver transplantation 
b) Persisting alcohol or substance abuse 
c) Inability to co-operative with lifelong medical supervision 
d) The presence of significant malignancy (except for hepatocellular cancer) 
e) Severe neurologic or development impairment. 
 
 
 
The stages of liver transplantation  
 
Liver transplantation can be viewed as a continuum involving five stages: referral and 
review of clinical history by the transplant unit, the liver transplant evaluation process, the 
waiting list period, the peri-operative period and finally post-operative recovery period [45]. 
Stage 2, the liver transplant evaluation process, is especially important in order to yield 
successful transplant outcomes and for the patient to be placed on the waiting list for OLT.  
 
According to Murray [30] there are three steps in the evaluation process. The first step 
entails determining a need for liver transplantation which involves a medical assessment 
which carefully examines the natural history of the patient’s disease with the expected 
survival after the operation. A number of clinical tools involving disease-specific models are 
utilized to score the relative risk of mortality amongst patients with chronic liver diseases, 
such as the Child-Turcotte-Pugh (CTP) and the prognostic model for end-stage liver disease 
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(MELD). The second step is to ensure that every alternative form of medical or surgical 
treatments for chronic liver disease have been attempted before committing a patient to OLT. 
The final step is determining the potential for successful liver transplantation involving a 
comprehensive medical and psychosocial evaluation.  
 
The objective of the evaluation is to identify indications and exclude contraindications as 
listed in Table 1.2 to discern whether the patient is able to survive the operation and post-
operative period, their medical compliance and the impact of co-morbid conditions such as 
psychiatric disorders or drug and alcohol dependence. Positive OLT outcomes are dependent 
not only the high degree of medical and nursing expertise but also patient compliance with 
the treatment regimen throughout the pre and post- transplantation process. The treatment 
regimen involves taking immunosuppressive and other medication, regular outpatient 
follow-up appointments and lifestyle changes involving diet, nutritional supplementation, 
exercise, smoking and drug and alcohol use.  
 
The evaluation by the transplant unit usually takes a few days to a few weeks. It may extend 
for months or more in some cases particularly those where substance use issues are 
uncertain. Patients may be refused OLT due to medical contraindications and/or active 
alcohol or substance abuse or other factors. In Australia the decision to select a patient for 
OLT is usually made by a transplant committee consisting of transplant physicians, 
transplant surgeons, hepatologists, psychiatrists, nurses and allied health professionals [27]. 
Once the decision is made to place the patient on the liver transplant waiting list patients 
may wait a year or more for a suitable liver to be available. For all transplant candidates this 
can be a stressful period where they may experience complications of their disease and/or 
return to alcohol or drug use. Patients with alcohol-induced liver disease have the longest 
waiting time and highest risk of death on the waiting list followed by viral hepatitis [46].  
 
An era of donor organ shortage  
  
The success and effectiveness of OLT resulted in the revision of medical management 
guidelines recommending that patients with end-stage liver disease be considered or referred 
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for liver transplant evaluation. This contributed to an ever growing number of potential 
transplant recipients on waiting lists which became increasingly disproportionate to the 
supply of cadaveric donor organs [29, 41]. In the United States in 2007 there were 12,213 
patients on the waiting list of whom 6489 (53%) received a transplant. 11,081 new patients 
for candidacy were registered that year [47]. In Australia from 1985 to 2007, a total of 1946 
patients were assessed and 892 (46%) proceeded to transplantation [48] with a growing 
waiting list (Figure 2.2). Studies report that between 10-20% of patients die while waiting 
[46, 49-50]. This shortfall between supply and demand continues despite more recent 
approaches to increase the pool of available organs and reduce the wastage of organs 
including: rehabilitating marginal grafts, splitting livers, improving selection criteria and 
efforts to generate greater public interest in organ donation [29, 34].  
 
Figure 2.2 Australia and New Zealand Liver Transplant statistics based on the 20
th
 Report 
2008 [37].  
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According to Starzl [31], the original pioneer of liver transplantation, the major issue facing 
OLT today does not involve medical scientific problems associated with patient survival and 
quality of life. Rather they are issues to do with ethics, equity and other humanitarian issues 
concerning the allocation of scarce donor organs. Transplant services over the last two 
decades have been involved in a continuous process of developing and implementing more 
precise selection guidelines to optimize the allocation of a limited supply of donor grafts. 
According to Neuberger [41] transplant services have to balance the competing demands 
involving the individual autonomy of the recipient, the utility of the donor organ against a 
background of justice, access and equity.  
 
Liver transplantation programs are dependent on the generosity of the general public who 
are the suppliers of donor organs. Transplant units are expected by the general public to 
maximise the utility of the organ, to be publicly and professionally accountable and to 
operate from sound medical and ethical principles [7, 34]. 
 
In conclusion liver transplantation is a successful treatment for irreversible liver disease but 
the shortfall in the supply of donor organs means that transplant units have to rely on 
comprehensive medical and psychosocial evaluation in order to assess who will be 
prioritized for OLT. Furthermore the public expect transplant programs to maximise the 
utility of each organ donated making patient selection very important. This is particularly the 
case for ESALD as an indication for OLT.  
 
End-stage Alcoholic Liver Disease and OLT 
 
Key Developments in end-stage Alcoholic Liver Disease and OLT  
 
In the first decade of OLT there was widespread concern that those with alcohol related liver 
disease would have a high peri-operative mortality, higher complication rate, poor 
compliance and post- transplant outcomes; and if they were to survive, they were at risk of 
redeveloping ALD [33, 51]. In a 1983 conference the National Institutes of Health (NIH) 
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formally pronounced that OLT was a viable treatment for patients with ALD who were able 
to abstain from alcohol and who showed no clinical indicators of mortality [32]. The NIH 
(p.108) concluded that “only a small proportion of alcoholic patients with liver disease 
would be expected to meet these rigorous criteria”. In fact, at that time only 25 of 540 
patients (4.6%) had received transplants for ESALD [52]. This statement marks the 
beginnings of careful selection processes for those with ESALD and suggests an intention to 
restrict the use of OLT for those with ESALD [53-54]. Nevertheless the NIH conference 
marked the acceptance of transplantation for ESALD. 
 
The chief criterion for consideration (and exclusion) for OLT for ESALD transplant 
candidates involved a substantial period of abstinence from alcohol prior to pre- transplant 
evaluation. In 1986 in a court case in Michigan, an alcoholic patient sued the state Medicaid 
Board for declining to pay for a liver transplant operation on the grounds that the patient had 
not been alcohol free for a sufficient period of time [55]. The court established the legal 
precedent that alcoholism alone did not contraindicate liver transplantation on the grounds 
that the Board had set a pre-operative abstinence period of two years which was longer than 
the likely natural course of the end-stage liver disease itself. The court also highlighted the 
lack of any reasonable set of criteria challenging both the transplant and the alcohol research 
communities to establish a reasonable set of criteria for use in selecting alcoholic patients for 
liver transplantation [56]. 
  
Between 1980 and 1987, Starzl transplanted 42 patients with ESALD reporting a 73% 
survival rate in the first year, equal to that of patients with ESLD attributable to other causes. 
Three decades later a large body of evidence reported equal if not better patient and graft 
survival rates for ALD transplant recipients compared to patients transplanted for non-
alcoholic liver diseases [25, 57-61]. One of the largest studies ever conducted examined 
adult survival rates of over 3,700 adults transplanted between 1987 and 1995 for ALD, 
showing survival rates for 1, 3 and 7 years post-- transplantation to be 81%, 73% and 59% 
respectively [62]. A step further was taken by Burra [63] who compared the 1, 3, 5 and 10 
year survival rates of 9880 ALD patients with 10943 viral cirrhosis (VC) patients and 2410 
cryptogenic cirrhosis (CRYP) patients and found higher survival rates amongst ALD patients 
of 84%, 78%, 73%, and 58% respectively. Transplant outcomes in Australia are equal and 
even slightly higher. Transplant registry reports show that between 1985 and 2008 survival 
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outcomes for ALD patients at 5, 10 and 15 years were 85%, 74% and 61% respectively [37].  
 
ALD patients have been reported to have lower rates of liver rejection, graft failure and the 
need for re-transplantation compared with patients transplanted for other conditions [64]. 
Medical compliance involving immunosuppressive medication, adherence to follow-up 
clinic appointments and sobriety has been found to be generally good [61, 65] but poor 
compliance has been reported amongst those to relapse to heavy alcohol use [60].  
 
The majority of studies have found the quality of life (QOL) for ESALD patients (medical, 
social and employment status) to improve following transplantation and to be similar to non- 
alcoholic transplant recipients [66-70]. Numerous studies have shown that QOL improves 
within 1 year after OLT. A long term study by Ruppert [71] involved collected clinical 
information, survival data and data on five quality of life domains for 381 liver transplant 
patients over a 12 year period rather than the usual 1 year study period. Mixed model 
analysis was used to determine whether initial gains in QOL were sustained long term. A 
gradual and consistent decrease in physical and social role function for all transplant 
recipient was observed. Within- group comparisons showed that ALD and HCV reported 
worse QOL in all domains at year 1 and had the greatest rate of decline physical functioning 
and physical symptoms over time. According to Ruppert the first post-operative year 
represents a critical time for QOL recovery, and may be an optimal time for intervention. 
Studies investigating the quality of life specifically amongst ALD patients have reported 
lower employment opportunities [72], poorer social re-integration [73], less life satisfaction 
[66], higher stress levels and worse health outcomes after transplantation [74], especially 
amongst those who had relapsed. 
 
ESALD a leading but controversial indication for OLT  
  
The distribution of liver grafts to individuals with ESALD has grown beyond the original 
framework created by the National Institutes of Health in 1983. ESALD is now one of the 
leading indication for liver transplantation, second only to liver disease as a result of chronic 
HCV infection [62, 75]. In the United States between 1988 and 1995, 3,785 (23.4%) had 
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ALD while 24.8% of transplant recipients were patients with hepatitis C viral liver disease 
[62]. In Europe between 1988 and 2008, 33% of OLT were conducted for patients with 
alcoholic cirrhosis while 38% were for those with virus–related cirrhosis [40]. In the United 
Kingdom the percentage of ESALD patients receiving OLT increased two fold from 7.5% 
during 1987 and 1996, to 16% between 1996 and 1999 [57]. In Australia between 1985 and 
2008, 2516 liver transplants (OLT) were performed, 307 (12%) were ALD patients and 20% 
had chronic viral hepatitis the remainder consisted of small percentages of other liver 
diseases [37]. A randomised controlled trial found no survival benefit and an increased risk 
for extrahepatic cancer when less sick ALD transplant patients with Child Pugh Stage B 
alcoholic cirrhosis were immediately listed for OLT versus patients assigned to standard 
treatment until they progressed to stage C disease [76] 
 
According to the UNOS database, the number of OLT procedures performed annually for 
ESALD has been relatively constant between 1992 and 2001 with an increase in the number 
of liver transplants for those with combined ESALD and HCV infection (Figure 2.3) [77]. 
 
Figure 2.3 Liver transplantation for alcoholic liver disease (ALD) and hepatitis C (HCV), 
1992–2001 in the U.S.A. [77]. 
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Public and professional attitudes to transplantation for ESALD transplant 
candidates  
 
Despite OLT being an effective treatment for ESALD the provision of donor organs to those 
with ESALD continues to attract considerable debate and controversy amongst the transplant 
community, non-transplant medical practitioners in the community and the general public 
[78]. Public attitudes to transplanting ALD patients have been shown to be unfavourable as 
assessed by the use of standardized surveys or questionnaires [79-80]. In the United States, 
when the public were asked to assign organ priorities for 714 disorders or treatments, OLT 
for non-ALD patients was ranked by respondents as 364 out of 714 whilst OLT for ALD 
patients was rated 695 out of 714 [81]. This lack of enthusiasm for offering liver transplants 
to those with ESALD is believed by many authors to be based on the assertion that 
alcoholics are considered to be personally responsible for engaging in behaviour that caused 
their disease [56, 82-83]. The stereotypical view of the recalcitrant alcoholic is deeply 
entrenched in the public psyche. The public are not well informed about the genetic 
predisposition to ESALD, the role of environmental factors and that those individuals 
chosen for OLT sometimes drink no more than their peers, friends or family [83-84]. Neither 
is the public aware that OLT is also an indication for other behaviourally associated cases of 
end stage liver disease such as chronic hepatitis C viral infection which is a consequence of 
intravenous drug use and for non-alcoholic fatty liver disease associated with obesity [85-
86].  
 
Non-transplant physicians were more than twice as likely as the general public to consider a 
patient with any alcohol use that harmed his liver as being unsuitable for transplantation. In 
the United Kingdom, non-transplant family physicians who are the main referrers to OLT 
have been found to believe that alcoholic patients should take lower priority than other 
candidates given the scarcity of donor organs [87]. Similarly a recent study found that 55.2% 
of French physicians, when asked to allocate transplants, would have allocated less than 50 
out of a 100 transplants to ALD patients. Also only 14.1% of French physicians endorsed the 
opinion that alcoholics were not responsible for their condition or that alcoholism was not 
morally reprehensible [88]. Studies have reported referral rates by physicians for 
transplantation to be around 5% to 10% of all patients diagnosed with ESALD [83, 89]. 
Professional reluctance, continuing alcohol use by ALD patients (therefore not meeting 
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selection criteria) and the patient’s personal choice not to undertake OLT, have been 
considered influential factors in the low referral rate.  
 
In contrast, transplant physicians and psychiatrists from 13 out of 14 transplant centres held 
it acceptable to consider ESALD patients for OLT despite their past alcohol drinking history 
[90]. However leading transplant physicians, Moss and Seigler [91], in 1991 published an 
article titled, ‘Should alcoholics compete equally for liver transplantation?’, arguing that 
patients who have end-stage liver disease which was not self-induced deserve a higher 
priority than those with ESALD. The latter were seen as having a self-induced condition, 
failing to seek treatment for their alcoholism prior to the stage of requiring OLT. They were 
therefore less deserving of priority. They proposed more rigorous standards in the selection 
of OLT for ESALD on the grounds that ESALD is a principal cause of liver failure and such 
patients can therefore become high utilisers of donor livers. 
 
The controversy is especially heightened whenever the public receives news of a celebrity 
liver transplant recipient relapsing to alcohol use. This can have a negative impact on the 
transplant team, can be demoralising for the transplant coordinators, social workers and 
nurses, and can affect donor rates [86]. Subsequently transplant centres have been reported 
to be reluctant or ambivalent about providing OLT to ESALD transplant candidates due the 
perennial risk of alcohol relapse after transplantation [86, 92-93]. 
 
According to Lucey [94], the key issue at the core of the debate and controversy is that of 
alcoholism and the significant risk of relapse rather than liver disease itself. The debate 
becomes complicated by the shortage of available donor organs to meet the demands of 
increasing number of candidates, the medical and hospitalization costs of OLT, and issues 
concerning equity and access [89].  
 
Evaluation and selection of ESALD candidates: overview  
 
The majority of patients with advanced ALD never come to transplantation. A recent review 
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estimated that around 70-100,000 patients with ESALD per year would warrant a referral for 
OLT each year but fewer than 10% of these are actually referred [89]. ESALD patients 
referred to a liver transplant unit and selected for OLT represent a highly selected group, 
comprising fewer than 50% of all ESALD patients referred for OLT evaluation and 
considered to be the best candidates amongst a cohort of better prognosis patients [95-96]. 
While the principles of evaluation for liver transplantation apply equally to patients with 
ESALD, the process of evaluation is more rigorous and stringent than other forms of end-
stage liver disease due to concerns about relapse to alcohol use following transplantation 
[78, 97].  
 
The evaluation of ESALD transplant candidates considers both medical and psychiatric 
issues. The medical assessment examines coexisting alcohol related medical problems or 
contraindications which may complicate transplantation such as neurological injury, 
pancreatitis, heart disease, myopathy, peripheral neuropathy and other conditions [98]. A 
psychiatric evaluation is essential in order to assess the presence of other psychiatric 
conditions, the patient’s compliance with the medical regimen and to identify those patients 
who are most likely to maintain long term abstinence from alcohol and other drugs [99]. It 
has become more common for transplant units to utilize the services of psychiatrists and 
specialists in substance misuse in order to carry out the evaluation. The psychiatric and 
substance abuse evaluation is considered to be crucial as OLT is a demanding procedure due 
to the stress and uncertainty of waiting for OLT, as well as the physical and psychological 
demands of the procedure in the pre and post- transplant period [43, 78]. The most 
commonly assessed psychosocial factors utilized by transplant units to determine the 
likelihood of maintaining long term abstinence include: pre-transplant abstinence, other 
substance abuse, stable social support, family history of alcoholism, psychiatric disorders, 
insight, compliance and previous treatment responses [100]. 
 
Most liver transplant centres worldwide require patients with ESALD to demonstrate a 
commitment to alcohol abstinence prior to being accepted for listing, usually for at least 6 
months of abstinence [101-102]. Extending OLT to selected patients with severe alcoholic 
hepatitis is still being debated and is compounded by the lack of data on the outcome of OLT 
amongst those with the condition. In the United Kingdom alcoholic hepatitis is considered a 
contraindication to OLT. In the United States, the 6 month period of mandatory abstinence, 
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is considered an essential requirement for OLT which can preclude all patients with severe 
alcoholic hepatitis, as they are unlikely to survive [86].  
 
In conclusion the provision of OLT to ESALD patients reveals a careful and comprehensive 
process of selection in order to achieve medical outcomes and to ration scarce donor organs. 
Despite the positive medical outcomes concerning the transplantation of those with ESALD 
the issue of relapse and stereotypes associated with alcoholism contribute to the controversy 
surrounding the provision of OLT to those with ESALD. Therefore it is important to 
examine the nature and extent of relapse especially as relapse is a rationalization for 
prescribing alcohol treatment.  
 
 Alcohol Relapse 
 
Defining relapse 
 
There is no standard definition for alcohol use relapse in the transplant literature. The term 
‘recidivism’ is utilized heavily in the literature and is associated with individual blame, just 
as it is in the criminal justice system [103]. The literature reveals a semantic distinction in 
how the term, relapse, is utilized between liver transplant physicians and surgeons and 
amongst those in the addiction medicine field [98, 104]. Studies of alcohol use after OLT 
generally define relapse as the use of any alcohol. For example, a transplant patient drinking 
a glass of champagne at his daughter’s wedding a few years after OLT might be classified as 
a relapse, along with the patient who returns to dependent daily alcohol use immediately 
after transplantation [78]. The clinical significance of labelling episodes such as these as 
relapse can be questioned. Such a definition of relapse is in contrast to how the term is 
utilized in the addiction field where a relapse refers to prolonged and harmful drinking 
behaviour. Consumption of lesser amounts of alcohol is described as a lapse. The term, slip, 
is sometimes used to describe a sporadic drinking event followed by re-establishment of 
abstinence.  
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In an article by Fuller [103] titled 'Definition and diagnosis of relapse to drinking' the author 
highlights the problems associated with the lack of a standard definition of relapse in the 
treatment research and the definition of relapse as a deviation from abstinence used in the 
transplant context. According to Fuller, outcomes such as frequency of drinking, quantity, 
proportion of days drinking versus abstinence or measuring the physical and social 
consequences of drinking are not elucidated when researchers rely on a strict definition of 
relapse as no alcohol use. Also there have been few data defining ‘relapse’ after 
transplantation for ALD in terms of the level of alcohol consumption that would contribute 
to hepatotoxicity or how long or short the duration of drinking must be before the risk of 
cirrhosis is increased. Likewise the threshold of consumption associated with psychosocial 
harms has not been defined. These are all important variables to consider when evaluating 
treatment outcomes.  
 
Pre-transplant alcohol use  
 
Pre-transplant abstinence is required for two reasons. Firstly, to provide adequate time for 
natural improvements in liver function and potentially obviate the need for OLT [105]. 
Secondly, a period of abstinence has been argued as a reliable indicator of long term post- 
transplant abstinence. There are only four published studies on alcohol use in patients with 
ESALD while listed for liver transplantation. The pre-transplant rates of alcohol use 
established in these studies were 15% [106], 17% [107], 50% [108] and 25% [109]. None of 
these studies correlated pre-transplant drinking with post- transplant drinking so there are no 
research data investigating the relationship between pre-transplant drinking and the 
likelihood of relapse after transplantation. Pre-transplant drinking can result in temporary 
removal or permanent delisting from the waiting list, making it difficult to obtain truthful 
and accurate information about alcohol use in circumstances in which the consequence of 
admitting drinking would be risking the opportunity to receive a transplant [93]. The United 
Kingdom has introduced nationally agreed and clear criteria for both selection and listing. 
ESALD must comply with abstinence requirements and recommends permanent delisting in 
cases of non-compliance with an appeals system [41] 
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Alcohol use after transplantation  
 
The rate of return to alcohol use, after liver transplantation has been reported to be between 
10% to 50% in over 30 studies with follow up periods of up to 5 years [25-26, 57, 60, 65, 
110-115]. One of the primary reasons for the wide variation in relapse rates is due to 
different definitions of relapse across studies [77, 101]. As already mentioned, the above 
definition of relapse in these studies has not been consistent and has ranged from any use of 
alcohol involving drinking one standard drink at any time over the course of the study 
period, to over 20 drinks per week. According to Lim [101], studies which have used the 
definition of relapse as “any alcohol use” tend to report a very high relapse rate during the 
post-transplant period. This is consistent with the fact that most, if not all, transplant centres 
view any alcohol use to be unacceptable and define relapse as any use of alcohol [116-117]. 
The variation in reported relapse rates are also due to different lengths of follow up periods 
and diverse sample populations in terms of sample size and selection criteria.  
 
A number of methods of detecting and eliciting alcohol consumption have been utilized 
across studies. These include: the use of medical records, biochemical testing, retrospective 
analysis of interviews with patients and/or family during routine follow up, the use of 
screening tests and questionnaires. These methods may underestimate consumption due to 
reporting errors arising from retrospective accounts and the pressure on patients to deny 
drinking when patients know that it may not be in their best interests to be candid [86, 93, 
118]. Biochemical markers such as blood alcohol, urine toxicology screens, carbohydrate 
deficient transferrin and other methods are attractive due to their objectivity but have been 
hindered by their low sensitivity or lack of specificity making it difficult to interpret the 
histological and biochemical changes in the post-transplant liver patient [114, 119]. 
 
More recent research studies examining relapse rates in this population have started to apply 
more consistent and systematic use of collaborative evidence involving interviews with 
patient and family, supplemented by random urine and liver function tests, including the 
observation by medical staff with all monitoring and recording occurring post-operatively at 
outpatient clinic visits. Additionally they have distinguished a slip from a return to harmful 
drinking [118]. 
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The study which provides the best data about post- transplant drinking practices by ESALD 
candidates was conducted by Di Martini and colleagues [120]. This study overcame many of 
the methodological shortcomings found in previous relapse research studies, by relying on 
objective methods of detecting relapse and by distinguishing slips from relapses. Di 
Martini’s study was a large prospective study sample of 167 ALD liver transplant recipients 
who were observed over a 5-year period. Four ascertainment measures of alcohol use were 
utilized every 3 months for the first year followed by every 6 months and included: clinical 
interview, prospective patient report utilizing a daily profile of alcohol use, caregiver reports 
and biochemical markers. Three alcohol use outcomes were used by the authors to define a 
drinking event which included: time to first drink (onset of use), time to six drinks in a day 
for men and four drinks in a day for women (termed binge use) and time to four drinking 
days in a week (frequent use).  
 
By the end of the first year 22% of ALD transplant recipients had used any alcohol with 10% 
having had their first drink within 3.5 months post- discharge. Figure 2.4 does show that 
most of those who returned to drinking did so by two years post- transplant. By five years 
post- transplantation 42% of alcoholic recipients had consumed at least one drink; 20% 
drank in a frequent pattern and 26% drank in a heavier binge pattern (six drinks a day for 
men, four drinks a day for women).  
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Figure 2.4 Time to alcohol use outcomes following discharge (N=167). Reprinted from 
[120]. 
 
 
 
An Australian study, based at the Australian National Liver Transplant Unit in Sydney, 
reported by Kelly et al [121], also stratified alcohol use and examined time to harmful 
drinking. Harmful drinking was defined as recorded medical or social harm or drinking 
above 140 g ethanol/week. ‘Harm’ included evidence of ongoing abnormal liver tests 
consistent with alcohol and not accounted for by other investigations as well as any other 
documented complication related to alcohol use. Based on the medical notes of 90 patients, 
18 (20%) relapsed to harmful drinking, 10 (11%) drank below harmful levels and 62 (69%) 
remained abstinent after a mean of 5.6 years follow-up. Forty percent of patients had 
returned to harmful consumption by 10 years post-transplant. A number of other studies also 
report a return to heavy or frequent alcohol use of 10%-20% post-transplant patients [26, 92, 
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112, 121-126].  
 
This relapse picture is different to the 60% to 80% rate of relapse found amongst alcohol 
treatment seekers without liver disease who complete a structured alcohol rehabilitation 
program [127] or higher rates of 90% for those who complete less intensive treatments. The 
lower rate of relapse amongst ESALD transplant candidates is believed to be associated with 
selection and management of ESALD transplant candidates and life threatening liver disease 
and OLT as a potent motivating force [24, 78, 99, 127]. Program elements, including the 
close and supportive contact with the OLT clinical team, have been credited with exerting a 
therapeutic effect on alcohol addiction, serendipitously providing effective relapse 
prevention [127].  
 
Di Martini’s study provided important data about the time to relapse. The time to relapse was 
early amongst those who drank heavily in their first drinking episode with 40% bingeing 
within 6 months and most advancing to heavy use within the first or second year. There was 
a steady decline in the number of abstinent subjects over the 5 year post-transplant period 
suggesting that adherence to lifelong abstinence may be difficult in this population. This 
pattern of relapse, marked by early instigation of heavy drinking within the first two years of 
transplantation and a steady increase in relapse involving any alcohol use, has been 
suggested by other studies [61, 110-111, 114, 121, 128]. In Kelly’s [121] study, time to 
relapse post- transplant varied from 2 months to over 10 years, but 50% of relapses occurred 
in the critical 1 to 2 years post- transplant (Figure 2.5).  
 
Another illustration of time to relapse patterns was provided by Dew showing relapse (any 
alcohol use) beginning early post-transplantation with a cumulative decline in abstinence for 
around 5 years post-transplant (Figure 2.6).  
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Figure 2.5. Cumulative survival to time to first record of harmful drinking following 
transplant (days) (N=90). Reprinted from [121].  
 
Figure 2.6. Time to alcohol relapse (any use) after OLT in 11 studies reporting time to 
relapse after adjusting for differences in patients’ follow up duration, the range of time to 
relapse is plotted (earliest point, midpoint, latest point) as well as length of total follow in 
the sample. Reprinted from [129]. 
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A major gap in relapse research has been the absence of data investigating the duration of 
relapse and whether there is a return to abstinence by ESALD transplant candidates who 
have relapsed. Recently Di Martini and colleagues [130] examined trajectories of alcohol 
consumption following liver transplantation, collecting detailed prospective data to elaborate 
on the ongoing patterns of use. Four distinct alcohol use trajectories were identified: those 
able to abstain or drink minimally and three distinct patterns of moderate-to-heavy 
consumption (Table 2.3). These trajectories showed that a return to alcohol use varies for 
different patients with different timing of onset, quantity and duration. One group will 
maintain complete abstinence, two had early onset with either rapid moderate or heavy use 
while another group will return to a gradual increase to moderate use over a few years. It 
does show that after transplantation some recipients can quickly lose control over their 
alcohol use while others can begin years after OLT. However the amount of alcohol in 
standard drinks shown in this study is surprisingly less compared with pre-transplant 
drinking. 
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Table 2.3 Specific characteristics of alcohol use trajectories. Reprinted from [130]  
 
Group  
 
 
 Onset of use   
after LTX 
discharge 
 
         Pattern of use  
 
Average 
consumption at 
peak amount* 
 
Timing of         
Heaviest Use 
 
1 
 
 
None 
 
Complete Abstinence  
  
 
2 
 
 
2.8 months 
 
Fluctuating low level of use  
 
 
0.5standard 
drink/week 
 
 
3 
 
 
3.5 months 
 
Early onset rapidly 
accelerating moderate use  
 
 
3.5standard 
drinks/week 
 
Peaked 1.7 years 
 
4 
 
 
 
2.8 months 
 
Steady increase to moderate 
use after 3 years post--LTX  
 
2 standard drinks 
per day  
 
Peaked at year 6 
 
5 
 
 
 
42 days 
 
Early onset continuously 
increasing heavy use  
 
 
3.7 standard drinks 
a day  
 
Peaked at year 3 
 
 
* USA standard drink units ( 14 grams alcohol i.e. one 12-ounce beer, 5–6 ounces of 
wine or a one-ounce ‘shot’ of hard liquor). 
 
Medical consequences of alcohol relapse after transplantation 
 
Recent studies examining post-transplant outcomes reveal significantly lower long term 
survival rates amongst ESALD transplant recipients who relapse to heavy or frequent 
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alcohol use compared to ESALD transplant recipients who maintain abstinence. Pfitzmann 
[26] conducted a 7.5 year retrospective analysis of 300 alcohol liver disease patients after 
transplantation investigating survival rates and alcohol consumption. Researchers graded 
ALD patients into 3 groups: those who had minor lapses or slips, abusive drinking and those 
who resumed drinking with unknown severity. Patients who resumed abusive drinking had 
substantially lower survival rates at 5 and 10 years post-transplant of 69.5% and 20.1% 
respectively while abstinent patients experienced a 90.3% and 81.5% survival rate. 
Cuadrado [123] evaluated the rate of alcohol relapse after OLT amongst 54 subjects and the 
impact of relapse on allograft and patient survival including the development of co-
morbidities and de-novo cancers. The major finding was a significantly lower survival rate 
after 10 years close to 50% in those who relapse, and attributed to a higher frequency of 
death primarily from cancer and cardiovascular events (Figure 2.7). Other studies have also 
found an association between heavy drinking and both mortality and morbidity [122-123, 
128] (Table 2.4). 
 
Figure 2.7 Kaplan-Meier survival curves from patients with alcoholic liver disease, with or 
without alcohol relapse. Reprinted from [123].  
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Table 2.4 Survival rates for 1, 5 and 10 years with alcohol liver disease patients with or 
without relapse 
  
1 year 
 
5 year  
 
10 year 
 
Abstainers 
Cuadrado [123] 
Pfitzmann [26] 
Pageaux [128] 
 
 
100% 
 
97% 
 
 
92.4% 
90.3% 
80% 
 
 
85.5% 
81.5% 
69% 
 
Relapsers  
Cuadrado 
Pfitzmann 
Pageaux 
 
 
100% 
 
100% 
 
 
92.9% 
69.% 
95% 
 
 
45.1% 
20.1% 
64% 
 
Several studies have shown that liver damage may develop rapidly after alcohol relapse 
including steatosis, alcoholic steatohepatitis and alcohol induced fibrosis [65, 114, 131]. 
Steatosis and pericellular fibrosis have been observed in the liver biopsy specimens of 
patients who reported heavy drinking compared with abstinent patients [124].  
 
There are mixed findings regarding whether relapse to heavy drinking affects compliance 
with clinic visits and immunosuppressive therapy. Some studies have found an association 
[60, 124] with one study directly relating relapse and non-compliance with graft injury and 
organ rejection [124]. Another study reported no impact of relapse on compliance but this 
may be due to close follow up interventions in that program [61]. Little is known about the 
impact of slips or moderate drinking on the health outcomes of ESALD transplant 
candidates. Further research is required involving long term prospective follow-up, careful 
monitoring of alcohol consumption, regular planned liver biopsies and stratification based 
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on alcohol use.  
 
Psychosocial consequences of alcohol relapse post-OLT  
 
There is little research examining the psychosocial consequences of alcohol relapse post-
OLT. Poor post-transplant health has been reported by those who relapse to harmful alcohol 
use involving more bodily pain, less energy, more perceived stress and benzodiazepine use 
{68,146}. Coffman [67] reported high correlations between a return to drinking and poor 
relationships with immediate family members, psychological distress, and poor sexual 
relations with spouse. [68]. Anecdotal reports in the literature regarding the consequences of 
relapse to harmful drinking include common alcohol related problems such as drink driving 
offences, hospitalizations and marital breakdown [121]. Post--transplant quality of life 
scores have been shown to be poorer in patients who relapse to harmful drinking [67, 72]. 
Reduced quality of life and increased physical morbidity have been linked to poor 
psychological adjustment in organ transplantation studies [134]. 
 
To summarise, there is sufficient evidence showing an increasing risk of relapse over time 
after transplantation. Also there are sufficient data reporting a link between harmful alcohol 
use and a number of negative medical and psychosocial consequences for the 10% to 30% of 
patients who relapse to harmful alcohol use. However at this stage there is minimal evidence 
showing any negative health outcomes as a result of low to moderate drinking after OLT. 
Therefore there is little ground for requiring that the large majority of ESALD transplant 
patients who remain abstinent or engage in light to moderate drinking participate in 
treatment programs for managing alcohol use.  
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Table 2.5 Predictors of relapse and literature investigating both an association and no 
association 
Predictor  Associated  Not Associated 
Lack of social support 
 
 
 
 
 
 
Coffman et al (1997) 
Foster et al (1997) 
Gish et al (1993) 
Gish et al (2001)  
Pageaux et al (2003)  
Pfitzmann et al(2007)  
Kelly et al (2006)  
Karman et al (2001)  
Platz et al (2000)  
Mackie et al (2001) 
Pageaux et al (1999) 
Jauhar et al (2004) 
 
Psychiatric diagnosis  
 
 
Pfitzmann et al (2007)  
Kelly et al (2006)  
Gish et al (2001)   
Coffman et al1997)  
Tripp et al (1996)   
Karman et al (2001)  
Platz et al (2000)  
Karim et al (2010)  
Walter et al (2002) 
De Gottardi (2007) 
Jauhar et al (2004) 
Di Martini et al (2001 
 
Substance abuse  
 
 
DiMartini et al (2001) 
Foster et al (1997) 
Hillebrand et al (1997) 
Di Martini et al (2006) 
      Kelly et al (2006) 
      Di Martini et al(2010) 
Coffman et al (1997)  
Jauhar et al (2004) 
 
 
 
Family history of alcoholism  DiMartini et al (2001) 
Foster et al (1997) 
Jauhar et al (2004) 
Dew et al (2008) 
 
Mackie et al (2001) 
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Relapse research outside the transplant field has identified the lack of personal and social resources 
and interpersonal difficulties to be strongly associated with alcohol relapse [137-138]. Similarly, 
there is ample evidence pointing to the lack of social support as predictive of a higher risk for relapse 
amongst ESALD transplant candidates (Table 2.5). The presence of a partner or spouse has been 
associated with greatly reducing the risk of relapse [67, 119, 121, 139-140] and a high divorce rate 
has been found amongst those who relapsed [92, 113]. Family and psychosocial support networks 
have been observed to play an important role with respect to survival and morbidity across organ 
transplantation in general [134, 141-143]. Again, the presence of a spouse has been found to be 
significant [144]. A large epidemiologic study found marriage to be positively associated with 
recovery from alcohol dependence [145]. Recently Di Martini [146] found poor health-related 
quality of life to be linked to relapse with subjects reporting more medical and life stress, worse 
health, pain and less energy after transplantation. As discussed earlier quality of life has been found 
to be poorer amongst some ESALD transplant patients especially those who relapse.  
  
 The 6 month rule as a predictor of abstinence  
 
The 6 month period of pre- transplant abstinence has been used as a condition of eligibility for OLT 
and several studies have examined whether it is a predictor of relapse. Research findings have been 
divided regarding the 6 month mandatory period of abstinence as a reliable predictor of relapse with 
some studies supporting the 6 month abstinence period [25, 113, 119, 147-149] while other studies 
have not found a significant association between the 6 month rule and relapse [8, 57, 60, 110-112, 
121, 150-152]. 
 
These studies have faced a number of methodological shortcomings. The majority have been 
retrospective, involving short periods of follow up and have not been stratified based on alcohol use. 
Many of these studies have included patients with varying degrees of sobriety, some less than or 
greater than 6 months. Accordingly, the exact threshold for determining a predictive interval of 
sobriety is yet to be investigated [93, 153]. The positive association of the 6 month rule with long 
term abstinence may be a result of having selected those with a number of favourable criteria for 
listing apart from the 6 month period of abstinence [154]. Thus the 6 month rule may be filtering out 
high risk patients from those with less than 6 months of abstinence [155]. Finally, no study has 
randomly assigned patients to a waiting list on the basis of duration of pre-transplant abstinence. 
These studies are thus limited by a number of confounders.  
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In sum, there is insufficient evidence to conclude whether the 6 month rule of pre- transplantation 
abstinence is a reliable predictor of long term stable abstinence especially in the context of end-stage 
liver disease. Research findings from the general addiction field suggest that the marker of true 
predictive abstinence for alcohol dependent patients involves years, not months. Relapses occur 
commonly for up to five years after initial sobriety [127]. Thus it could be argued that more than 6 
months are required to identify patients at low risk of relapse. Many seriously ill patients, notably 
those with hepatocellar carcinoma, could not wait longer, making six months a pragmatic rule.  
 
Insight 
 
Insight or awareness that alcohol is the cause of liver disease is considered a good prognosis for 
stable abstinence and used extensively as part of the psychiatric evaluation for suitability for liver 
transplantation [154]. However the findings are mixed as to whether the lack of insight is a predictor 
for alcohol relapse. Most studies have reported no association between lack of insight and stable 
abstinence [61, 96, 110, 113, 156] and this may due to the fact that patients who deny the etiology of 
liver disease and alcohol dependence are less likely to be considered for transplantation. Recent 
studies however appear to be finding a relationship between lack of insight and relapse [121, 157-
158]. The large majority of studies rely on the evaluation by either transplant hepatologists or 
psychiatrist and do not use any empirically based psychometric measure.  
 
Limitations of relapse research  
 
One of the major gaps in the research investigating predictors of relapse is the paucity of supporting 
prospective and longitudinal data. Most studies rely on the antecedents of relapse collected 
retrospectively or are based on pre-transplant variables. However variables collected in the pre-
transplant period such as social support, marital status, mental health and substance abuse can alter 
and fluctuate over the long course of transplantation.  
 
Alcohol use is known to be highly influenced by personal risk factors such as genetic predisposition, 
as well as environmental and psychological factors. Miller [159] examined a number of variables to 
account for relapse including: pre-treatment characteristics and potential antecedents of relapse. The 
latter included: negative life events, cognitive appraisal variables, coping resources, craving and 
mood states. More recent or proximal antecedents (from the prior 2-month interval) and an 
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individual’s coping resources proved to be most predictive variables in relapse. This finding 
underscores the importance of addressing current events in the client’s life and the value of teaching 
coping skills. Among pre-treatment characteristics, alcohol dependence symptoms were the only 
variable positively associated with relapse.  
 
There are few data available in the literature reporting the social and psychiatric outcomes and life 
events for ESALD post-transplant candidates and their association with relapse. For example, the 
stress associated living with a chronic life threatening illness and waiting for organ transplantation 
can contribute to psychiatric difficulties, including adjustment disorder, depression and anxiety in a 
small proportion of patients. A cohort of 75 patients discovered that 23% of patients developed a 
psychiatric disorder following OLT. Of these 50% developed major depression, 5.3% post- traumatic 
stress disorder (PTSD) and 17.3% partial PTSD [160]. In a recent study DiMartini [74] collected data 
on psychological and medical stressors within 3 months post-liver transplantation, assessing 
symptoms of depression (Beck Depression Inventory-BDI), anxiety (Zung Anxiety Scale-ZAS), 
perceived stress (Cohen’s Perceived Stress Scale-PSS), health-related quality of life (SF36) and 
several items reflecting transplant-specific concern. Those more likely to drink in the early post-
transplant period and in a problematic pattern (groups 3 and 5) were more stressed, reported worse 
health, and reported more pain and less energy. It was proposed that alcohol use may have been a 
way of handling stress by ESALD transplant patients gravitating to drinking in response to the 
difficulties of the early post-transplant phase. Di Martini recommended early identification and 
treatment of stress especially as it relates to early post-transplant recovery, attention to complaints of 
pain and fatigue, and resumption of addiction counselling in aiding the stabilization of these patients. 
 
Another limitation of the research into relapse predictors amongst ESALD transplant candidates is 
that it has tended to evaluate the independent effect of each risk factor. Dew [129] and others have 
proposed that future research into relapse will need to consider investigating relapse as involving a 
constellation and concomitant risk factors, each having predictive power, with the number of risk 
factors possibly contributing to a critical threshold of risk burden [129, 161]. Therefore predictors 
such as lack of social support and psychiatric illness may work in tandem to increase the risk of 
relapse. This is suggested by studies which have found lower rates of depression amongst ESALD 
transplant candidates with good social support, suggesting a link between poor mental health, limited 
social support and relapse [61]. Studies have found that social support is known to be an important 
contributor to protecting individuals from depression [162].  
 
More recent models conceptualise relapse as involving multidimensional and dynamic variables and 
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processes incorporating key predictors rather than one single factor. Witkiewitz & Marlatt [163] 
developed a model of relapse which views the individual as a self-organising system. Relapse is 
considered to occur as a result of changes involving the interplay of both proximal and distal risk 
factors (e.g. years of dependence, family history, co-morbid psychopathology, and limited social 
support), cognitive processes and coping skills, physical withdrawal, substance use behaviour. Such a 
model may help explain triggers to relapse amongst ESALD transplant candidates in the context of 
post-transplant recovery.  
 
Conclusion 
 
ESALD is a widely accepted indication for OLT and is associated with good outcomes in health, 
survival rates and quality of life in appropriately selected patients. Whilst the majority of ESALD 
patients selected for transplantation are able to comply with the transplant program requirement of 
long term stable abstinence, relapse to heavy or frequent drinking has been reported amongst a 
proportion of recipients. Relapse to heavy drinking has been found to be detrimental, contributing to 
morbidity, mortality, poorer psychological functioning and reduced quality of life. Transplant 
programs are also concerned about unfavourable public reactions to reported relapse amongst 
transplant candidates, potentially influencing the reputation of the program and /or supply of donor 
organs. In order to reduce the likelihood of relapse, transplant programs have devised and validated 
evaluation and selection criteria and a predetermined length of sobriety. However alcohol use 
disorders often involve a continuing relapsing and remitting course, and despite abundant research 
into the predictors of relapse clinically it is difficult for transplant programs to reliably predict who 
will relapse. Considering the role of a number of psychosocial factors, which can change over the 
long course transplantation, OLT programs may need to monitor and treat changes in psychological 
and social status in order to minimise the relapse rate. Psychiatric distress, limited social support and 
poor quality of life, may be amenable to intervention while others such as familial alcoholism are 
more immutable and not responsive to treatment.  
 
The next chapter will discuss the current approaches utilized by transplant units to clinically manage 
ESALD transplant candidates, and the preliminary research efforts into providing onsite and 
appropriate alcohol treatment for this highly selected group of patients in order to address the 
problem of relapse.  
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CHAPTER 3 
Management and clinical characteristics of ESALD transplant 
candidates 
 
 
 
This chapter will discuss the current alcohol management program utilized by the majority of 
liver transplant programs. This is followed by a review of the alcohol treatment research studies 
which have attempted to provide on-site treatment for ESALD transplant patients in order to 
address the problem of relapse. The chapter ends by presenting the current research examining 
the demographics and clinical characteristics of the ESALD transplant population compared to 
alcohol treatment seekers. This chapter will close with a discussion on alcohol use disorders 
and subgroups, and will present research findings which assist towards building a clinical 
profile of ESALD transplant patients compared with ALD patients and alcohol treatment 
seekers.  
 
Clinical management of ESALD transplant patients  
 
The majority of transplant programs utilize a standard approach to the clinical management of alcohol 
use disorders amongst ESALD transplant candidates. The approach relies heavily on the selection and 
evaluation of patients likely to maintain abstinence and on the 6 month period of mandatory abstinence 
as a prerequisite for transplantation [1, 2]. A verbal and at times written ‘contract’ is initiated in the pre-
transplant phase whereby transplant recipients understand the requirement of lifelong abstinence and 
compliance. Referrals to alcohol rehabilitation usually involving Alcoholic Anonymous (AA) or off site 
alcohol treatment services [3] are typically offered, with variable compliance. This approach heavily 
relies upon ongoing monitoring of alcohol use during the pre- and post-transplant period by random 
blood or breath alcohol testing, routine questioning about alcohol use and reminders not to drink at 
outpatient clinic appointments [4]. It may be considered as a form of brief intervention. Most transplant 
units do employ the services of psychiatrists, and addiction specialists for the purposes of pre-transplant 
assessment and evaluation of candidates with ALD [5], but these workers play a secondary role in 
ongoing treatment.  
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There are few data evaluating the effectiveness of this management approach by liver transplant 
programs, especially in terms of reducing the rate of alcohol relapse. Everhart [6] and colleagues was 
the first and only group to investigate the management of ESALD transplant candidates by transplant 
program and to verify the approach taken. A total of 69 centres in the United States were surveyed, 
capturing information about the number of transplants conducted, pre- transplant evaluation, post-
transplant monitoring and relapse prevention efforts. Survey forms were completed by transplant 
surgeons (57%), hepatologists (20%), co-ordinators (15%) and other persons familiar with the 
evaluation of alcoholism (8%). The adherence to a contract of abstinence was evident with 81% of 
programs considering any alcohol use by pre-transplant patients on the wait list a contraindication to 
transplantation. Relapse to alcohol use during this period generally results in a removal of a relapsed 
patient from the list permanently or for at least 6 months. If drinking relapse occurred, 15% of centres 
would permanently remove the patient from the transplant list. Most centres would remove and re-
evaluate the patient: 5 centres (7%) in 3 months (7%), 32 centres (47%) in 6 months and 14 (21%) as 
clinically indicated. Only two (3%) of the centres would recommended counselling but not remove the 
patient from the list. The 6 month rule of abstinence before listing was utilized by 85% of centres, 39% 
always asked patients to sign a contract, 39% usually and 23% never. Most programs told patients not to 
drink after transplantation and all programs were found to monitor drinking by asking the patient and 
the patient’s family.  
 
Critical appraisal of current alcohol management programs  
 
It has been argued that the management approach taken by transplant programs to ESALD transplant 
candidates exerts a therapeutic effect contributing to the substantially lowering relapse rates amongst 
ESALD patients compared to relapse rates found in standard alcohol treatment settings [7-9]. The four 
key prognostic factors predictive of stable abstinence identified by Valliant [10] are believed to be 
naturally incorporated throughout the processes of the transplant procedure, follow up-care and the 
transplantation experience itself [7, 8, 11-13]. 
These factors include: (i) the presence of a rehabilitation relationship found in the therapeutic and caring 
bond established with transplant staff, and the support of spouse, family and friends who understand the 
necessity for abstinence [3, 9, 14]; (ii) substitute dependencies or activities that structure time otherwise 
spent in drinking with the structured medical regimen of transplantation [13, 15]; (iii) a source of hope 
derived from being released from the edge of death, given new life and an expensive operation. Also, 
involvement in a health care team unscarred by past misuse of alcohol all helping to generate a ‘born 
again’ quasi-religious experience [9, 13, 14] (iv) negative consequences of drinking whereby any 
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exposure to an episode of drinking is an unpleasant and humiliating experience [14]. However these 
therapeutic aspects of transplantation tend to diminish as the original relationship and intense contact 
with the transplant team lessens over time following successful transplantation [16].  
 
The importance of lifelong abstinence for patients undergoing OLT is never disputed in the literature but 
authors have strongly proposed incorporating a relapse prevention approach whereby transplant 
programs recognize lapses in abstinence as slips that indicate a need for treatment [5, 17-21]. According 
to Lucey [4] ,“although few would claim ab initio that the efficacy of liver transplantation should be 
measured by its ability to treat alcoholism, liver transplantation is sometimes considered a failure when 
it is accompanied by a relapse into drinking” (p.228). Thus relapse may be considered by transplant staff 
as a failure (even shameful behaviour by candidates themselves). Further research is required to 
determine the impact of the strict abstinence model on ESALD transplant candidates.  
 
The strict requirement for abstinence, especially the 6 month rule of abstinence and de-listing for any 
recognised alcohol use in the absence of a relapse prevention approach, is seen as a powerful inhibitor 
on the patient for disclosing any alcohol use. According to Weinrieb [2], admission of drinking with the 
strict implementation of the 6 month rule can have potentially harsh clinical consequences resulting in 
delisting or requests by transplant centres for a further 6 months of sobriety where a patient risks serious 
illness and death. Fifty six percent of patients with severe alcoholic cirrhosis referred for OLT will 
otherwise die within 6 months [22]. Patients thus have a vested interest in maintaining secrecy about 
drinking and importantly may also be reluctant to be seen as requiring help or treatment for the same 
reason [2, 19, 23-25]. Offending ESALD transplant candidates are placed in a difficult position of 
having to choose between hiding their drinking in order to remain eligible for transplantation or 
forfeiting a life-saving liver transplant by disclosing slips or for asking for alcohol treatment. Research 
studies investigating relapse rates have confirmed that some ESALD transplant candidates do conceal 
alcohol use [26]. Anecdotal reports have been made in the literature about incidents where transplant 
staffs were unaware that patients had relapsed only to discover this after patients had been admitted to 
an emergency department with life threatening illnesses related to alcohol use [15].  
 
More open discussion between patient and transplant staff about alcohol use is considered an important 
area for improvement. Weinrieb [2] has advocated that transplant programs strive for an atmosphere of 
candour in which patients can feel safe about reporting alcohol use and about asking for addiction 
treatment if they return to drinking while awaiting transplantation. Wagner recommends a more open 
and less defensive patient-clinician relationship starting from the selection period, to allow for more 
accuracy of prediction of future relapses and a decrease in relapse rates. Wagner [19] writes  
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Therapists may not be perceived as collaborative consultants with expertise in helping 
individuals resolve substance related issues through a collaborative relationship…...Instead 
they may be perceived as powerful individuals with preconceived and rigid notions of 
patients’ problems, whose goals include catching patients in the act of using, proving that 
patients are addicts, and punishing them for delaying or preventing organ transplantation. 
Patients may deny problems with substances in order to present themselves in a more 
positive light and prevent themselves from being disqualified from consideration for 
transplant (p.392).  
 
To conclude, liver transplant programs follow a strict abstinence policy, consider relapse as a 
failure of transplantation and do not provide relapse prevention support considering the physical 
and psychosocial demands of transplantation. The literature is replete with recommendations for 
an effective alcohol intervention to support abstinence amongst ESALD transplant candidates, 
especially for those who are at increased risk of drinking or who have resumed drinking [3, 8, 12, 
23, 27-33].  
 
Alcohol treatment research amongst ESALD transplant patients  
 
Early studies reported a lack of treatment motivation or treatment seeking by ESALD transplant 
candidates. Tang [25], in a case-controlled study involving a sample of 56 ALD patients, reported 
that 33 (59%) could not recollect receiving advice on post-transplant alcohol consumption during 
the period, 18% recalled receiving advice to abstain completely, and 23% claimed they were 
advised to drink in moderation. In a comparison group of matched non-alcoholic liver transplant 
patients, 40% accurately recalled medical advice regarding alcohol use. The majority of ALD 
transplant recipients have been reported to have stopped drinking on their own and to have not 
attended any formal treatment or AA meeting [32]. 
 
Only four studies have attempted to treat alcohol use disorders within the context of the liver 
transplantation and these will be discussed individually.  
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Study 1 
 
The first attempt to provide alcohol treatment within the liver transplant setting was conducted by 
Weinrieb and colleagues [33] at the University of Pennsylvania Liver Transplant Centre. The 
study involved 55 alcohol dependent liver transplant recipients with a diagnosis of alcohol 
dependence, who last used alcohol no more than 12 months before being placed on the waiting 
list. Patients were randomised after transplantation to one of three groups: naltrexone (50mg), 
placebo (once/day) and motivational enhancement therapy MET (4 sessions). Motivational 
enhancement therapy (MET) was chosen being an established alcohol treatment regimen based on 
Project MATCH (Matching Alcoholism Treatment to Client Heterogeneity, Miller 1994). MET 
involves personalized feedback of assessment results and counselling, aimed at producing 
internally motivated change, by mobilizing the individual’s own change resources. Weinreib and 
colleagues postulated that MET would mobilize a patient’s motivation towards maintaining 
abstinence and enhance insight and acknowledgment of alcoholism. The utilization of a 
pharmacotherapy agent, naltrexone, was selected to assist in reducing cravings to prevent relapse.  
 
The authors encountered significant recruitment difficulties and treatment resistance. Of the 55 
subjects identified, 9 died and 15 were not approached as they rarely came to clinic appointments 
and were difficult to contact. Of 31 potential subjects, 20 were ineligible (7 abstinent beyond 12 
months, 5 did not meet DSM IV criteria for alcohol dependence, 2 lived too far away, 1 with 
opiate and alcohol dependence and five too ill to participate in the study). Out of the remaining 11 
potential subjects, 6 refused or declined to enter the study. Only 5 subjects were randomized with 
no patient completing more than 4 months of the 6 month treatment period. One of the main 
reasons for the lack of treatment motivation was ‘denial’ as patients did not perceive a current 
problem or past problem with alcohol. Other reasons identified by the researchers included the 
demands of a complex medical regimen and fear of naltrexone induced hepatotoxicity. Weinreib 
and colleagues concluded that it was important to initiate therapy in the pre- transplant phase in 
order to avoid conflict with post-transplant management, to increase motivation for treatment and 
strengthen the need for long term abstinence.  
 
Study 2  
 
More recently Weinreib and colleagues [34], conducted another controlled clinical trial of MET 
and case management (MET/CM), offered in the pre-transplant period and designed to be 
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incorporated into the patients’ medical care. It did not target abstinence alone but included other 
self-identified health behaviour problems. The study randomised 91 subjects to either 
motivational enhancement therapy (MET) (n=46) or treatment as usual (TAU) (n=45). MET 
consisted of 7 sessions over a period of 3 to 6 months and addressed relevant health-related 
behaviours and included case management. TAU involved a referral to community AA and a 
standard out-patient therapy. Alcohol use was measured at each study visit using self reporting 
via the time line follow back measure, collateral interviews and use of a breathalyser. Candid 
responses about alcohol use were encouraged by providing confidentiality without jeopardizing 
their position on the transplant waiting list, except cases involving life threatening emergencies. 
Baseline and follow up measures after randomization included: mood and anxiety symptoms 
(Beck Depression Inventory, Beck Anxiety Inventory, treatment motivation (Stages of Change 
Readiness and Treatment Eagerness Scale), quality of life (Medical Outcomes Study Short Form- 
12). Follow up of subjects occurred every three months until transplantation and then again at one 
month post-transplant, six months and one year post-transplant. The aim of the study was to 
evaluate whether patients randomized to MET/CM had lower rates of drinking compared to those 
receiving TAU.  
 
In this study, the prevalence of drinking was the same in both groups with 26% (12) for MET and 
24% (11) for TAU. The 24 subjects who drank reported a total of 64 episodes over 2 years of pre-
transplant observation. The median number of drinks per drinking day was 3.75 for MET and 4.3 
for TAU (p=0.025) including an outlier. When the outlier was excluded, MET drinkers had 
significantly fewer total number of drinks than the TAU group 7 for MET and 59 for TAU 
(p=.003). Also MET had lower total number of drinking days, 2 for MET and 7 for TAU (p= 
0.004). Quality of life was similar in both groups. The scores measured by the Stages of Change 
Readiness and Treatment Eagerness Scale were similar for both groups; however the MET group 
showed a small decrease in ambivalence and a significant decrease in problem recognition scores 
over time. Treatment adherence was similar except that MET did result in greater attendance for 
at least one session (83%) over TAU (40%). Only 50% of MET subjects attended the required 4-7 
sessions. The failure to attend more than four MET sessions was attributed to illness, 
transplantation and transportation problems. The limited efficacy of an established alcohol 
intervention with this population was considered to be due to insufficient number of subjects 
experiencing enough MET sessions. Also the change in transplant classification system and a lack 
of detailed information regarding treatment attendance in the TAU group limited comparisons. 
The impact of MET on post-transplant alcohol consumption was not investigated in this study. 
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To summarise, MET resulted in a reduction in number of drinks per drinking day, decrease in 
ambivalence for change, and engaged more patients in treatment completion. No significant effect 
on alcohol consumption was found in terms of the total number of drinks and total number of 
drinking days when an outlier was included. Treatment adherence was unsatisfactory as nearly 
half of the MET group attended fewer than 4 of the 7 sessions, despite some having relapsed. 
MET was found to have no effect on mood, general health or psychosocial outcomes despite high 
Beck Depression Inventory scores being found amongst those involved in high risk drinking.  
 
The limited effectiveness of MET to reduce the quantity and frequency of drinking, may be 
explained by the fact that it does not directly assess and target the complex and multiple 
psychological and environmental factors contributing to relapse, especially in context of 
transplantation. MET is primarily a cognitive behavioural approach which aims to build a 
commitment to change based on an individual’s awareness of the disadvantages of an undesired 
behaviour. Dropout or lack of treatment persistence may be due to patients not seeing the value or 
purpose in this treatment approach contributing to a lack of internal motivation for change [35]. 
 
Study 3 
 
Georgious and colleagues [36] conducted a feasibility study offering a brief psychosocial 
intervention in the pre-transplant phase, titled Social Behaviour and Network Therapy (SBNT). 
This was offered to 32 patients with alcoholic liver disease undergoing transplantation at the 
Birmingham Liver Transplant unit in the United Kingdom. SBNT is a treatment currently being 
evaluated by a United Kingdom national alcohol treatment trial. The intervention offered in this 
study consisted of three one hour sessions every 2 to 4 weeks including education about alcohol 
related liver disease and abstinence, relapse prevention, developing positive social support and 
pleasurable activities. Members of the patient’s social network participated. A contract showing a 
commitment to abstinence from alcohol post- transplant was agreed by all parties and signed by 
the patient. The alcohol liaison nurse and social worker then followed up the patient and family 
member regularly pre-transplant, and subsequent follow up at 6 months post- transplantation. 
Relapse was generally defined as persistent use of alcohol determined by interview and random 
blood alcohol testing.  
 
Of the 32 patients offered the intervention at time of assessment for transplantation, 20 accepted 
the offer, 5 patients declined the brief intervention and 7 failed to be assessed based on study time 
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schedule. It is unknown why 5 of the 32 possible subjects declined to participate in the study. No 
clear conclusions can be derived from this study regarding treatment outcomes as it did not 
involve a control group and was not a randomised trial. Alcohol rates seem to be equivalent to 
rates found generally in studies into relapse not involving an intervention. Eight (42%) of 19 
reported drinking some alcohol after transplantation; of these 4 (21%) drank weekly, and 1 (5%) 
drank more than 21 units per week. This study nevertheless illustrates that it is possible to deliver 
an acceptable time- limited psychological intervention which can be readily integrated into the 
OLT process. ESALD transplant candidates and close family members reported feeling less 
stigmatized and judged, and appreciated being able to communicate their experiences in an open 
and neutral situation.  
 
It is important to note the presence of treatment resistance. A proportion of patients initially 
approached the sessions with scepticism, annoyance and sometimes hostility feeling that alcohol 
was no longer a problem in their lives but nevertheless completed the sessions. The authors 
recommended further research to clarify the treatment outcomes of SBNT and emphasized the 
importance of carefully matching the intervention to the individual patient’s history and other 
clinical factors.  
 
These findings concur with anecdotal reports about ESALD transplant candidates showing 
significant treatment responsiveness. In research studies where patients have been encouraged to 
openly discuss their alcohol use without fear of judgement or penalties, patients have been willing 
to listen to advice and recommendations on addiction treatment and to actively request assistance 
with alcohol rehabilitation [3, 37]. Also, no patient denied the potentially detrimental effects of 
alcohol on their health. Some patients who had resumed drinking were relieved to learn that the 
liver transplant team would not abandon them because of their alcohol use [3].  
 
Study 4  
 
An uncontrolled, single-centre Scandinavian study by Bjornsson et al [38] examined the impact 
of structured management on the risk of relapse following transplantation for ESALD. Structured 
management (SM) involved the introduction and involvement of a dedicated addiction team lead 
by a psychiatrist with addiction specialisation and involving a transplant coordinator, social 
worker, general practitioners and patient coordinator. At the work-up before transplantation, there 
was an obligatory interview and evaluation by the specialist and the team. This included an 
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interview with close family members examining patients’ current and previous abuse problems, 
referral to a motivation program to assure total abstinence, a formal contract on abstinence, 
agreement to follow up and alcohol treatment involving 12 step therapy for those with no prior 
treatment history. After surgery the transplant unit’s social worker and transplant coordinator kept 
in contact with the patient and local physician and clinic visits after 3 months. At 1, 3 and 5 years, 
transplantation interviews were conducted by the addiction team. 
 
Alcohol relapse was defined as any alcohol use. This was detected either through patient and 
family reports at interview and during clinic follow up appointments, from medical records and 
clinical judgment of transplant team. Heavy drinking was loosely defined as periods involving 
repetitive and excessive drinking where the patient reported intoxication versus those who had 
used alcohol on special occasions.  
 
The impact of SM was investigated by comparing ALD patients transplanted from 1998 to 2003 
(63 patients) who received SM, with a control group of ALD patients before the introduction of 
SM during the period 1988-1997 (40 patients). SM was found to halve the relapse rate. The 
original program before the introduction of SM reported a 48% (40) relapse rate compared to a 
22% (13) relapse rate with SM. Treatment completion was higher amongst those transplanted 
from 1998 onwards 58% compared to only 30% before SM. The lower relapse rates could have 
been attributed to improved selection of candidates during that period of transplantation due to 
the introduction of formal psychiatric evaluation. Alcohol use was retrospective based on medical 
records and the clinical judgement of medical staff, self or family reports. No figures were given 
about the percentage of heavy drinkers in either group to assess the impact of SM on heavy 
drinking. Despite these limitations, SM generated positive outcomes by providing a medically 
endorsed program, integrated with the liver transplant program that combined monitoring and 
professional support by a dedicated group of addiction specialists. 
  
This study suggests that the addition of an alcohol support service, offered by multidisciplinary 
staff experienced in the field of addiction medicine, and integrated with the standard liver 
transplant program, can enhance treatment outcomes. Similarly another study reported lower 
relapse rates from 31% to 13% with the introduction of specialist psychology services involved in 
pre-transplant evaluation and patient selection, long term psychological follow up and CDT 
monitoring coinciding with transplant program clinic appointments with transplant surgeon [39]. 
Consistent and close monitoring of ESALD transplant candidates, especially in the post- 
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transplant period is important to preventing relapse rates, particularly in light of absences in 
outpatient appointments and/or breakdown in the family and other support systems [15, 40, 41].  
  
Summary 
 
Alcohol treatment studies have reported reluctance by ESALD transplant patients in participating 
in alcohol treatment with initial scepticism, anger, low retention or recall of referral for treatment, 
treatment dropout, poor attendance and lack of therapeutic outcomes. Explanations for treatment 
resistance amongst ESALD transplant candidates have been suggested which have included: 
denial, patient preoccupation with the demands of a complex medical regimen, time scarcity, 
transportation problems and lack of interest due to current abstinence.  
 
Clinical characteristics of the ESALD transplant patient 
 
Although there is mixed evidence regarding whether matching clients to treatment type results in 
better treatment outcomes [42] in clinical practice patients characteristics are considered to 
determine the most suitable treatment [43]. Also while project MATCH failed to demonstrate a 
significant matching effect but results may not be applicable to the full spectrum of disorder 
beyond that included in that study. This section will begin with a discussion on alcohol use 
disorders followed by the clinical characteristics of ESALD transplant patients, ALD patients and 
ATS as reported in the literature.  
 
Alcohol use disorder subtypes  
 
The diagnosis of an alcohol use disorder as defined by DSM V is a psychiatric diagnosis that 
includes the diagnoses of alcohol dependence (AD) or alcohol abuse (AA) according to DSM IV. 
A wide range of subtypes have been identified amongst those with an alcohol use disorder, based 
on a number of covariates including: age of onset of alcohol dependence, childhood risk factors, 
physiological factors, severity of dependence, familial alcoholism, antisocial behaviour, alcoholic 
course and co-morbid psychiatric disorder. Alcohol dependence however manifests with diverse 
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clinical characteristics and for over 150 years clinicians and researchers have recognised the 
heterogeneity of individuals with AD.  
 
In 1960, Jellinek [44] was one of the first researchers to develop an alcohol use typology and 
described five different types of alcoholism defined in terms of their abnormal physiological 
processes. Beta alcoholism was marked by polyneuropathy or cirrhosis of the liver, with or 
without physical or psychological dependence and influenced by social customs. The more severe 
AD, gamma alcoholism showed tissue tolerance, physical dependence and loss of control typified 
by the more severe alcoholic attending AA meetings. Since Jellinek’s, research a number of other 
researchers have classified individuals with AD into a number of subtypes based on the influence 
of family history of alcoholism and co-morbidity [45, 46], the complexity of genetics and 
environmental factors on biopsychosocial etiology of AD [45]; while others have taken a life 
course perspective revealing long-term prognostic outcomes [47, 48]. Sannibale [49] concluded 
that existing typology for alcohol dependence could not be empirically confirmed and this 
remains a controversial question.  
 
One of the few studies to examine the typology of alcohol treatment utilization was by was a 
national epidemiological survey conducted by Moss in the United States [50]. This study revealed 
subgroups of alcohol dependence along a severity spectrum and identified treatment seeking 
behaviour (Table 3.1). Five clusters were found with specific characteristics: Cluster 1 (Young 
Adult Subtype), Cluster 2 (Functional Subtype), Cluster 3 (Intermediate Familial Subtype), 
Cluster 4 (Young Antisocial), and Cluster 5 (Chronic Severe Subtype). Clusters 4 and 5 were the 
most likely to seek alcohol treatment and had the most severe AD profile including: co-morbid 
psychiatric and other drug use disorder, and lower levels of psychosocial functioning. These 
findings are consistent with studies which reveal that those with alcohol dependence and a co-
morbid affective disorder are more likely to seek treatment [51]. Moss’s findings are also 
consistent with studies which have found that only 15% of the general population with alcohol 
dependence will attend specialty treatment [51-53], and those over 55 years of age and male with 
alcohol dependence are less likely to attend treatment [51].  
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Variables Cluster 1 
Young Adult subtype 
 
Cluster 2 
Functional Subgroup 
Cluster 3 
Intermediate Familial  
Cluster 4 
Young Antisocial 
 
 
Cluster 5 
Chronic Severe Subtype 
Mean Age Younger (24.5 years) 
 
Older (average 41 years) 
 
Older age ( average 38 years) 
 
Younger age (26.4) 
 
Average age (37.8 years) 
Onset of AD Early (19.6 years) 
 
Later onset (mean 37 years) 
 
Onset of AD at age 32 years 
 
Earliest onset (18.4 years) 
 
Later onset (29 years) 
 
 
Rate of ASPD Low probability (1%) 
 
Low probability ((<1%) 
 
Modestly elevated (12.5%) 
 
High probability (54%) 
 
47% diagnosis of ASPD 
 
Familial alcoholism Moderate probability (22%) 
 
Moderate probability (31%) 
 
Elevated levels (47%) 
 
High levels (52.5%) 
 
Highest levels (77%) 
 
Co morbidity probabilities Low probability relative to 
other clusters 
 
Major depression (24%) 
Low rates of anxiety 
disorders 
Low probabilities of SUDs 
Major Depression (47%) 
bipolar disorder (22%) 
Anxiety disorder (15%) 
Elevated levels of SUDS  
Major depression (37%), 
Bipolar disorder (33%) 
Social phobia (14%) 
Highest probability of 
SUD 
Major depression (55%) 
Dysthymia (25%) 
Bipolar disorder (34%) 
Generalized anxiety (24%) 
Social phobia (26%) 
Highest for elevated SUSs 
Pattern of alcohol use High probability of hazardous 
use  
 
Lowest probability for using 
alcohol despite problems 
(14%)cluster; for endorsing 
a reduction in activities due 
to alcohol (7%) and 
drinking despite problems 
(40%) 
 Endorsement of all 
alcohol abuse criteria, 
show tolerance  
Highest endorsement for most 
AD criteria  
 
Demographics 
 
75% never married 
54% work full-time 
36.55% at school f/t or p/t 
 
Males (60%) to females 
(40%) 
50% married 
62% work full-time 
26% with college degree 
Highest rate of retired (5%)  
 
64% males 36% female 
38% are married, 
 21% divorced 
 20% have college degree or 
higher, 68% work full time 
 
76% males and 24% 
females 
 15.3% married 
Lowest proportion college 
degree (7.6%) 
 47% employed.  
 
65% males 35% females 
28.7% married 
Highest divorce rate (25.1%) 
9% college educated 
Lowest employment 43% full 
time 7.6% disabled  
Table 3.1 Socio demographic and clinical characteristics of subjects assigned to AD clusters reported by Moss 
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Amount of alcohol use  Less frequent use  
143 days in last year  
73% of this is 5+ std drinks 
Maximum 13.8 std on 
drinking days 
181 in days in last year 
54% of this 5+std drinks 
on  
Maximum 10 std on 
drinking days 
172 days in the last year of 
which 54% of this 5+ drinks 
Maximum 9.8 std when they 
drink 
Average 201 drinking 
days in last year 5+ 
drinks on 80% of days 
17.1 drinks on drinking 
day  
247 days 5+ drinks on 69% 
of those days.  
15.4 drinks on any drinking 
day  
 
Treatment seeking   
 8.7% have ever sought help 
and will chose AA rather 
than professional or 
specialty treatment 
 
 
 
17% have ever sought 
help and tend to 
participate in 12 step 
groups or treated for AD 
by private health care 
professional 
 
 
27% have ever sought help, 
they tend to go self-help 
groups, specialty treatment 
programs, detoxification 
programs and individual 
private health care providers 
 
 
 
35% tend to go to self-
help groups, specialty 
treatment programs , 
detoxification and 
individual private 
health care providers  
 
Highest treatment attendance 
66%, self-help groups, 
specialty rehabilitation 
programs specialty alcohol 
treatment with high rates 
inpatient programs, 
emergency room visits, 
psychiatrists, social workers 
and psychologists 
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Alcohol use disorder and the ESALD transplant candidates 
 
The diagnosis of ALD is a complex pathophysiological process involving sufficient exposure to 
alcohol to cause significant liver injury. As stated earlier the diagnosis of an alcohol use disorder is 
a psychiatric (behavioural) diagnosis involving alcohol dependence (AD) or alcohol abuse (AA). 
This is to be distinguished from the diagnosis of ALD [54]. The majority of cases of ALD have 
both the physical and psychiatric diagnosis but proportions have a physical diagnosis of ALD 
without the psychiatric diagnosis of alcohol dependence (Figure 3.1).  
 
 
Figure 3.1 Overlap of psychiatric versus physical diagnoses in patients with ALD and 
alcohol dependence (SE, sufficient ethanol exposure; ESALD, end-stage ALD; TX liver 
transplant; AD, alcohol dependence). Reprinted from [54]. 
 
  
 
Only two studies in the transplant literature have examined alcohol use disorder subtypes 
amongst ESALD transplant patients. DiMartini [55] found that 75-80% of the ESALD 
transplant population have alcohol dependence, 20-25% alcohol abuse and 4-5% did not 
meet diagnostic criteria for any alcohol use disorder. In the following year, DiMartini [56] 
conducted a study to determine whether there were distinct clusters of liver transplant 
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recipients who showed specific combination of alcohol-related symptoms. 120 ALD liver 
transplant recipients received the Structured Clinical Interview for DSM-IV (SCID) for 
alcohol abuse/dependence and a cluster analysis was performed. Four clusters where 
identified as illustrated in the following figure. .  
 
 
Figure 3.2 Proportion (%) in four Cluster Groups who endorsed each DSM-IV Alcohol 
Criterion Symptom and their rates of DSM-IV Alcohol Abuse and Alcohol Dependence 
Diagnoses. Reprinted from [56] 
 
 
 
 
 
 
 
Cluster 1, (25.6%) of the sample presented with a full range of the DSM symptoms. These 
were less educated, had higher daily alcohol consumption pre-transplant, were more likely 
to have attended alcohol rehabilitation, and had an additional diagnosis of non-alcohol 
substance use disorder. Cluster 2 (18.6%) met all the criteria for alcohol dependence but 
showed a greater likelihood of symptoms of tolerance. Cluster 3 (17.7%) reported no 
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withdrawal symptoms but alcohol consumption had interfered with social roles. Cluster 4 
(29.2%) tended to meet a criteria of abuse and were least likely to endorse DSM 
symptoms. Cluster 4 reported that alcohol use did not interfere with their daily activities 
and life roles, nor did it contribute to legal problems. Cluster assignment did not predict 
those likely to relapse but those assigned to Cluster 4 were significantly less likely to drink 
any alcohol or binge drink than those with alcohol dependence. Again further research is 
required to confirm these subtypes.  
 
To conclude this section it is important to note that recent research has disputed the 
existence of a typology of alcohol use disorders in the general population. Investigations 
into the taxonomy of alcohol use disorders have prompted experts in the field to move 
from categorical classification systems to a dimensional system encompassing symptom 
clusters. This is due to the numerous possible theoretical subtypes [57] and because 
taxonomic systems fail to take into account factors such as family history, personality or 
gender differences [49]. Efforts to classify ESALD transplant patients should also be 
treated cautiously until there is sufficient and consistent empirical evidence. The 
examination of sub-groups of alcohol use disorders has been used for the purpose of 
determining what variables may be associated with alcohol treatment seeking.  
 
ESALD transplant candidates and alcohol treatment seekers  
 
In this section a review of the small body of research which has compared ESALD transplant 
patients, ALD patients with alcohol treatment seekers is provided to help characterise and 
distinguish these groups. Table 3.2 presents a summary of research findings investigating the 
baseline characteristics of ESALD transplant candidates, ALD patients attending liver or 
gastrointestinal clinics and alcohol treatment seekers. 
 
A little more addiction data is available about ALD patients with severe liver disease who 
attend gastroenterology outpatient clinics than ESALD transplant patients. However 
ESALD transplant patients are likely to be selected from an ALD population. Lower 
alcohol dependence has been reported among ALD patients. A UK study by Wodak [58] 
found only 18% of patients with ALD attending a liver unit showed severe alcohol 
dependence compared with 56% in an alcohol treatment group. Similarly Smith [59] found 
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58% of those with severe alcohol-induced liver disease scored none/mild dependence, 
32% moderate and 9% severe in contrast with patients attending detoxification with 76% 
graded as severe and 34% as moderate. Figlie [60] compared the clinical characteristics of 
151 outpatients from a gastroenterology clinic and 175 patients from the specialist alcohol 
treatment service also found less dependence on alcohol. As a clinical population ALD 
patients tend to have lower alcohol consumption indices [58, 61], less severe 
psychological problems [60, 61], fewer consequences from alcohol [60] and more likely to 
be married or employed [61]. According to Smith [61] 
 
the majority of patients presenting with ALD appear to be heavy controlled or 
social drinkers, leading relatively controlled lives, perhaps not feeling that their 
drinking is necessarily a major health issue until they present with end-stage liver 
disease, at which point the liver has been silently damaged to the extent that only 
30% will be long term survivors (p.279).  
 
In contrast those with an alcohol use disorder who attend specialty treatment tend to have 
high levels of co-morbidity, high severity of alcohol dependence, co-morbid substance 
abuse, more likely to be divorced and socially under resourced (Table 3.2).  
 
The only study to compare ESALD transplant patients with ATS was conducted by 
Weinreib and colleagues [28] where 30 ESALD patients with prolonged abstinence on a 
pre-transplant waiting list were matched to a group of alcohol patients seeking alcohol 
treatment without clinical evidence of end-stage liver disease and recruited to a research 
trial of naltrexone. Addiction severity, alcohol and drug use, alcohol craving, treatment 
motivation, psychiatric symptoms and interpersonal adjustment were examined. The 
ESALD transplant group had a lengthy period of abstinence, higher lifetime alcohol 
consumption, more standard drinks per drinking day and more drinks per drinking month 
but no differences in duration of alcohol drinking career, periods of abstinence or age of 
onset. Few group differences existed in terms of psychiatric symptoms and interpersonal 
adjustment using the addiction severity Index.  
 
These findings contrast with studies which have compared ALD patients attending liver 
clinics and what is known about treatment seeking populations. Apart from differences in 
methodology, one explanation for the differences between Weinrieb’s findings and these 
studies is that the former study recruited subjects from advertisements and for medication 
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trials, perhaps attracting a different AD population to the alcohol dependent treatment 
seeking population.  
 
In relation to motivation or readiness to change both ALD and ESALD patients have been good 
making behavioural change but have been reported to be pre-contemplative or contemplative or 
having low problem recognition [28, 62, 63]. It has been proposed that medical treatment may be a 
reason for the temporary alcohol abstinence behaviour among ESALD and ALD population. 
Wagner [19] posited that ESALD transplant patients have a cognitive-behavioural split across 
stages of change being cognitively stuck in pre-contemplation and behaviourally in maintenance. 
The lack of problem recognition among ESALD transplant patients has been suggested as a reason 
for the lack of treatment motivation among ESALD transplant patients.  
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Table 3.2. Comparison of baseline clinical characteristics of ESALD transplant candidates, ALD patients and Alcohol Treatment Seekers 
 
Patient group  
 
Alcohol Diagnosis  
 
Severity of 
Dependence  
 
Alcohol  
Consumption  
 
Psychiatric 
Diagnosis  
 
Motivation  
 
Other 
Substance 
Abuse  
 
Social Factors  
 
ESALD  
 
75-80% alcohol 
dependence [55] 
 
20-25% alcohol abuse [55] 
 
4-5% no criteria[55] 
 
≥ 4 symptoms based 
on DSM [55] 
 
No cravings[28] 
Less alcohol related 
consequences [58] 
 
Greater lifetime 
consumption than 
AD [28] 
 
Tend to be 
abstinent [28, 55] 
 
17%-36% depressive 
disorder [55, 64]  
 
12% anxiety disorder 
[64]  
 
Pre-contemplative 
low problem 
recognition but 
high action 
 [28, 63] 
 
20-42% will 
have another 
substance use 
problem [28, 
64, 65] 
 
45-78% married [28, 
29, 65-67], less conflict 
with spouses than ATS 
[28]  
35% divorced [38] 
 
ALD  
 
50% dependence [68] 
33% no dependence 
77% some dependence 
(consisting of 19% severe, 
21% moderate, 28% mild) 
[69] 
 
Lower scores for 
alcohol dependence 
[58, 59, 70] 
Less alcohol related 
consequences SADD 
[71] 
 
Lower daily intake 
[58]  
 
Less alcohol per 
month when 
drinking [59] 
 
20%depression or 
anxiety[68] 
 
Pre-contemplative 
low problem 
recognition but 
high action  
[71] 
 
 
 
68% married [59] and 
tend to be in stable 
relationships[59] 
 
More likely to be 
employed [59] 
 
Alcohol 
Treatment  
Seekers  
 
 
 
Over 80%-100% are 
dependent[68, 72]  
 
Higher scores for 
alcohol dependence 
[58, 59, 71, 73-75] 
 
More alcohol related 
consequences [71, 
74, 76] 
 
Higher rate of 
alcohol 
consumption or 
heavy daily intake 
[58, 77] 
 
25%-44% Depressive 
Disorder [75, 78-80]  
26-37% Anxiety [79] 
 
High prevalence of 
Personality disorder 
[79]  
 
Higher 
motivation for 
change and 
treatment 
SOCRATES 
[28, 71] 
 
 
26- 60% [81-
83] greater 
odds of drug 
dependence 
[55]  
 
42-48%married [81-84] 
less likely to be in 
stable relationship more 
likely to be divorced  
[59, 75, 81, 82, 85] 
Less social network [84, 
86].Less likely to be 
employed [59, 77] 
Less education [77, 84, 
87] 
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Conclusion  
 
Alcohol management programs utilized by liver transplant programs around the world rely heavily 
on the careful selection and evaluation of potential ESALD transplant patients, and ongoing 
monitoring of alcohol use in order to ensure abstinence. It has been argued that this alcohol 
management approach exerts a therapeutic effect contributing to the substantially lowering relapse 
rates amongst ESALD patients compared to relapse rates found in standard alcohol treatment 
settings. Personal and motivational factors, as well as program factors, including: rehabilitative 
relationships with staff, the medical regimen and consistent reminders regarding the negative 
effects of alcohol, are believed to help patients maintain abstinence. Transplant programs, however, 
remain concerned about alcohol relapse rates firstly because of the negative health effects on the 
individual and secondly, public reactions that can potentially influence the reputation of the 
program and the supply of donor organs.  
 
ESALD transplant patients and those with ALD, tend to be on the low end of the severity 
continuum marked by less psychiatric co-morbidity, less alcohol dependence, few cravings, greater 
social resources and longer periods of abstinence. In contrast, alcohol treatment seekers, tend to 
require more intensive and specialised treatment due to problems with mental health, drug use, 
severity of dependence and limited social support. There is some evidence to suggest that there are 
subgroups within the ESALD transplant population with one subgroup sharing similarities with 
alcohol treatment seekers and thus are at risk of reinstatement of alcohol dependence especially in 
the context of mental health problems, life stressors and limited social support.  
 
Attempts at providing alcohol interventions within the transplant program have faced significant 
treatment resistance. Only two of the four studies involved randomised controlled trials using 
evidence based alcohol interventions, limiting the confidence in these findings. Key unresolved 
issues include the factors that precipitate treatment resistance and treatment seeking by ESALD 
transplant patients, and the barriers and reasons for not seeking treatment.  
 
The next chapter will provide a special literature review for the case control study, discussing 
treatment resistance and treatment seeking. 
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CHAPTER 4 
Treatment resistance and treatment seeking  
 
 
 
The development of an alcohol problem is not straightforward and there is no reason to 
expect the process of recovery, nor help-seeking as part of that process to be so 
      Vaillant [1] (p.455) 
 
This chapter reviews literatures that informs the design and conduct of the case control study, and 
will identify factors contributing to resistance to alcohol treatment by ESALD transplant patients. 
Psychosocial and pharmacotherapy treatment for alcohol use disorders are effective and available 
to the community [2]. However few people with an alcohol use disorder seek professional help 
despite the harmful effects of excessive alcohol consumption. As a result of the treatment 
resistance by ESALD transplant patients, it is important to understand what factors contribute to 
treatment resistance. This chapter will begin by discussing the existing literature explaining the 
phenomenon of treatment resistance from a number of psychotherapeutic perspectives. Secondly it 
will present the theory and research pertaining to the treatment-seeking process and the correlates 
of treatment seeking amongst clinical and community populations. It will also explore the clinical 
characteristics of ESALD transplant patients, patients with ALD and those with alcohol use 
disorder without liver disease. The chapter will close with a discussion on the aims, hypotheses for 
Study 1- the case control study.  
 
Theories of treatment resistance  
 
Since the emergence of Freud’s endeavours in the area of psychoanalysis, resistance has intrigued 
and perplexed clinicians whose efforts have been directed towards assisting the client achieve their 
goals and overcome their psychological problems. 'Treatment resistant' is a term used by clinicians 
to refer to an individual who is not improving or having difficulty improving in spite of treatment 
provided and/or who is resistant to following treatment recommendations. It can manifest in a 
variety of ways including: slow or reluctant compliance, compliance with resentment, passive 
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withdrawal, anger, emotional exacerbation, cognitive dissonance, helpless withdrawal, premature 
termination from treatment and poor treatment outcomes [3]. In substance abuse treatment, 
resistance may manifest as: no change in drug consumption, scepticism regarding the value of 
treatment, dropout from treatment including not taking prescribed medication, reluctance to self-
disclose, resentment of limitation of one’s freedom to act or denial of one’s problem [4, 5].  
 
Psychotherapy research and practice provides a number of different theories for explaining 
treatment resistance. According to classical psychoanalytic theory, resistance is attributed to the 
individual’s unconscious conflicts and serves as a psychological defence against conscious 
awareness of unacceptable drives, feelings, fantasies and behaviour patterns [6]. From this 
perspective, resistance acts to maintain the sense of self and is an adaptive response to traumatic 
memory which can cause considerable distress whilst in psychotherapy [3]. Research have 
identified that individuals resist seeking professional help due to a desire to avoid discussing 
distressing personal subjects and experiencing painful feelings [7].  
 
In contrast, behaviour therapy generally ignores resistance or attributes it to inadequate or incorrect 
techniques used by therapists in relation to behavioural tasks [8]. The cognitive and behavioural 
approach to treatment resistance proposes that it is a natural, healthy and adaptive mechanism 
which protects core cognitive structures from rapid reconstructive change. According to the theory, 
individuals actively organise and construct their perception of the world or reality into meaning 
systems known as cognitive schemata which consist of core and peripheral belief systems. The 
core cognitive structures involve beliefs by which an individual actively organises and constructs 
their perception of the world, serving to preserve meaning structures from too rapid change and 
potential loss of self identity. Core cognitive structures are more resistant to change as they 
provide meaning structures. Resistance, therefore, is not an expression of neurotic needs, perverse 
unwillingness, and inappropriate therapeutic technique. Rather, it is a psychological mechanism to 
protect the individual from data arising from the occurrence of specific schema-disconfirming 
events which do not conform to or confirm the individual’s core cognitive structures or beliefs [9].  
 
With the advent of social-psychology theory, the concept of resistance achieved extensive 
recognition and was referred to as reactance. The theory of psychological reactance was first 
developed by Brehm [10, 11] who proposed that psychological reactance is a state of mind aroused 
by a threat to an individual’s perceived legitimate freedom and which motivates them to restore the 
thwarted freedom. The assumptions of this theory are that freedom of choice and action is valued 
by all human beings and that human beings will react negatively to perceived or actual threats to 
104 
 
their freedoms. Reactance arousal reflects an individual’s striving or motivational force for control 
as they attempt to restore the endangered freedom [12]. Unlike psychodynamic theories which see 
resistance as originating purely from the client’s intrapsychic processes, reactance theory takes a 
more relational approach. Resistance is seen as a phenomenon that emerges between the client and 
therapist as their differently organised subjective experiential worlds interact in a mutually 
influential manner [13]. A therapist’s intrapsychic view in itself can be sufficient to arouse an 
adversarial reaction from a client while a more collaborative alliance has been found to contribute 
to treatment success [3]. Kirmayer argues that resistance, is as much a reaction of the therapist’s 
perceptual rigidity as it is a feature of the client’s interpersonal style [14].  
 
Reactance theory, when combined with cognitive theory, suggests that reactance involves a 
challenge to very powerful core cognitive assumptions that individuals should be in control of self 
and situations [15]. Treatment resistance or reactance is significantly higher amongst those who 
perceive that they are forced into treatment versus those who perceive themselves as having 
volunteered [16] with more compulsory treatment practices reported in the area of substance 
misuse treatment [17-19]. Coercion has been defined as a form of institutionalised pressure 
resulting in an individual feeling pressured to enter treatment [20]. Coercion has been presumed to 
be a dichotomous variable applying only to those in the criminal justice system and other extreme 
cases of coercion, thus limiting its investigation, relevance and scope. However coercion can 
involve referral to treatment, workplace referrals, early and family intervention programmes. 
Whilst some research findings have found treatment coercion to be positively related to treatment 
attendance, it is negatively related to therapeutic involvement and behavioural change [21, 22].  
 
Denial  
 
ESALD transplant patients who resist alcohol treatment have been described as in ‘denial’ – a 
psychological state reported as a major reason for treatment resistance. Denial is a concept which 
emerged over 100 years ago and has bewildered theorists, clinicians and researchers. Sigmund 
Freud (1925) first introduced the concept of denial describing it as a defence consisting of an 
individual’s refusal to acknowledge both the internal and external experience resulting from 
trauma. It is essentially a disavowal of reality [23]. From the psychoanalytical perspective, denial 
is a mechanism which functions to reduce or shield an individual from unpleasant realities and 
reduce psychic distress. It is distinguishable from insight which generally involves the experience 
of increasing knowledge, awareness and acceptance of a condition.  
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In the early 1900’s, an organic perspective was favoured with denial being associated with 
neurological illness or deficit signified by the term, ‘anosognosia’. By 1970’s cognitive 
behavioural theorists no longer used the term denial. The focus of research turned to coping theory 
and conceptual frameworks for understanding how individual with medical illness/injury responds 
to the stressors and demands of their conditions. Contemporary psychodynamic theorists however 
reintroduced the concept. Horowitz (1986), for example argued that denial is a normal temporary 
response to trauma, overwhelming stress or disruptive situations and has a self-protective function 
[24]. Denial operates as a means to restore homeostasis as an individual experiences gradual 
innoculation of painful affective states characterised by alternating states of intrusion and denial.  
 
Denial remains a complex psychological construct which has no standard definition, measurement 
or comprehensive theoretical conceptualisation [25, 26]. The consensus in the literature is that 
denial is no longer considered an ‘all or nothing’, rigid, maladaptive mechanism preventing 
healthy adjustment but a dynamic process which may be used in adaptive and maladaptive ways 
[27]. Researchers have focused on describing the indicators and markers of denial in terms of 
affect, cognitions and behaviour; and adaptive and maladaptive presentation. Adaptive denial is 
essential to maintaining health giving the individual time to mobilize coping strategies and 
resources and has been found to improve patient outcomes in social and psychological functioning 
and improvement in quality of life [26]. Research amongst patients with heart disease and cancer 
has revealed that when denial is used excessively and over a long period of time, it can become 
maladaptive. This manifests in non-compliance, rejection of a diagnosis and future implications or 
consequences, lack of mastery of important coping skills, relapse, interpersonal difficulties with 
friends, family and professional staff and importantly refusal, to participate in treatment [26].  
 
Substance abuse treatment seeking  
 
Rates of treatment seeking for alcohol use disorders 
 
Only a small proportion of the population with alcohol use disorders will enter treatment for a 
substance abuse problem despite the related harms, and the availability and effectiveness of 
treatment. A US epidemiological study involving 40,093 people drawn randomly from the general 
population found that while 4781 (30.3%) meet the criteria for alcohol dependence, only 24.7% 
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had sought help at some point in their lifetime [28]. Other national surveys in the United States, 
Canada and the Netherlands show that 10% to 30% of individuals with alcohol use disorder seek 
alcohol treatment[29-33]. In Australia Proudfoot and Teesson examining patterns of alcohol 
dependence and treatment seeking in Australia and using the data from the Australian National 
Survey of Mental Health and Wellbeing (ANSMHWB), found 29.5% of those with alcohol 
dependence sought help from a general practitioner or other professional in the last 12 months 
[34]. Amongst those with a lifetime diagnosis of alcohol abuse or dependence, the most commonly 
utilized service was consulting a medical practitioner (29.7%), followed by attending the self- help 
group, Alcoholics Anonymous (12.3%). Formal addiction services were seen to be utilized by 
those with more severe alcohol problems [35]. Several explanations for this low uptake of 
treatment have been proposed including stigmatisation of alcohol use disorders and its treatment, 
limited access to treatment, perceived lack of effectiveness of treatment, and the perception that 
alcohol use is a lifestyle rather than a health disorder.  
 
Models of treatment seeking  
 
.... there must surely be a process which leads up to this point [of help-seeking], a 
sequence of events, actions and reactions, self-appraisals and appraisals by others.  
                          Edwards [36] (p.307) 
 
Various models have been developed to describe health care or treatment seeking behaviour. The 
models that will be discussed will be those which have been selected to guide this research study. 
Three key health services models emerged in the 1970s and 1980s examined the utilization of 
health services and have influenced the development of models of treatment seeking in the 
substance abuse field. These include Aday and Andersen, Becker’s Health Beliefs Model and 
Goldberg’s Model of Pathways to Care.  
 
Aday and Andersen’s framework of access to health care  
 
The first and the most comprehensive framework for understanding access to health care was 
devised by Aday and Andersen [37]. It stressed the interaction between characteristics of the 
health care system (health policy and health delivery system) and personal variables (Figure 4.1). 
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The individual determinants consisted of predisposing, enabling and need factors. Predisposing 
factors are variables associated with the propensity to use services consisting of socio-cultural 
characteristics of the individual such as social background, demographics, and health beliefs. The 
enabling component is the means individuals have for obtaining health care such as knowledge of 
how to access health services, income, health insurance coverage, available health personnel and 
facilities. The need factors is the most immediate cause for health care use according to Andersen, 
and involves an individual’s perceived need for health care due to symptoms of illness, pain and 
worries about their health and whether they judge their problems to be of sufficient importance and 
magnitude to seek professional help. Professional judgement and recommendation for medical care 
also heightens an individual’s need for treatment.  
 
In revised versions of the model Andersen (1995) has highlighted the role of the health services 
and professionals to creating ‘potential access’ and ‘realized access’ which involves the actual use 
of services. This model is especially relevant to this investigation as it takes into account the 
interaction between individual and health care service (policy, delivery and utilization of treatment 
services). 
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Figure 4.1 Aday and Andersen’s Framework for the study of access. Reprinted from [8] 
 
 
Health Beliefs Model 
 
The Health Beliefs Model attempts to explain health behaviour based on an individual’s 
assessment and expectancies involving perceived susceptibility, severity of the illness threat, 
benefits seen in taking action and where costs and barriers are not seen as negative [38]. In the 
revised model, Becker [39] introduced the concept of motivation proposing that positive compliant 
responses to health risk situations are a result of personal readiness interacting with modifying and 
enabling factors (demographics, relationships with service staff, social or professional 
pressure/advice) (Appendix A, Figure 1). This model tends to focus on the individual cognitive 
factors that elicit treatment seeking and behavioural change, particularly in response to medical 
illness.  
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Pathways to Care Model  
 
Goldberg & Huxley’s Pathways to Care Model (1980), developed for mental health services, 
focuses on system variables which affect help seeking [40]. This model is particularly interesting 
as it illustrates the filters and levels of care which can ultimately lead to specialist service use. This 
model provides a context for exploring structural barriers to care at various levels within the 
system. No progress to care can take place without recognition of a problem (filter 1) and no 
referral to specialist services can occur if the case is not recognised at the primary care level (filter 
2) and so forth (Appendix A, Figure 2). 
 
Substance abuse models of treatment seeking  
 
A number of models exist in the addiction literature and majority of these conceptualize the 
treatment-seeking process as consisting of a series of steps or decisions [41-46]. The general 
consensus on treatment seeking in the addiction research literature is that treatment seeking 
involves a complex multi-step process dependent on the interplay of a number of intra- and extra-
personal influences which promote or hinder treatment entry [47-49]. For the purpose of this 
research, three models are discussed as they will guide the research project and will be useful 
when interpreting and analysing the data.  
 
Saunders and colleagues [44], in an attempt to understand barriers and deterrents to treatment 
experienced by those with alcohol use disorders, proposed a model where treatment seeking 
consists of four steps and at each step there exist possible barriers to the next step (Figure 4.2). 
Barriers are categorised as either ‘person-related’ or ‘treatment-related’ barriers. Person- related 
barriers consist of cognitive and emotional factors such as negative attitudes toward treatment or 
failure to realise the seriousness of the drinking problem. While treatment-related barriers include: 
format, cost, availability or access difficulty. To validate the model, researchers provide empirical 
support from research into correlates of treatment seeking and these are highlighted in italics in the 
text below. 
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Figure 4.2 Model of the treatment seeking process by Saunders and co-workers. Reprinted from 
[44] 
 
 
 
The first step in the process of treatment seeking begins with problem recognition, followed by 
deciding that change is required. This model is relevant to the study as it refers to barriers or 
reasons for not seeking professional help (Step 3) which can include denial, minimization, self-
recovery, self-help groups and stigma. At this point, self-stigma rather than public stigma may be 
activated. Self-stigma involves damage to self-esteem as one recognises a problem and that change 
is required. Self-stigma may be overwhelmed by a desire to reduce the problems associated with 
drinking.  
 
Stress and coping model 
 
The second model of relevance to this thesis is that by Finney and Moos (1995) who developed a 
Stress and Coping Model involving three sets of variables similar conceptually to Andersen’s 
predisposing, enabling and need factors in health care utilization [46] (Appendix A, Figure 3). The 
impetus to enter treatment is considered to be a response to the degree of hardship or distress as a 
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result of drinking and/or psychological distress, accumulation of stressful events or and/or social 
pressure to seek help. The impetus to treatment may be diminished, however, by counteractive 
factors which can act as barriers to treatment. These include having more social resources, a 
problem-focused rather than affect-focused coping response, and limited optimism regarding the 
effectiveness of treatment. Factors which may facilitate treatment will include prior help seeking, 
referral to treatment, treatment availability.  
 
Transtheoretical model 
 
The third and most extensively utilized model in the addictions field is the Transtheoretical Model 
(TTM) of behaviour change by Prochaska, DiClemente and Norcross [50]. TTM provides a 
comprehensive explanation for how people change their behaviour proposing that change involves 
a movement through a process of five discrete and sequenced stages with each stage being marked 
by a constellation of attitudes beliefs and behaviours. The stages therefore describe a person’s 
motivational readiness or progress. Returning back to earlier stages can occur before achieving 
sustained change such as long term abstinence or controlled use. The stages include: pre-
contemplation, contemplation, preparation, action and maintenance. Individuals in the pre-
contemplation stage are either unaware of their drinking problem or unwilling to change their 
drinking. In the contemplation stage, individuals think seriously about change and evaluate the 
pros and cons both of the problem behaviour and the change required. Those in the preparation 
stage intend to take action in the near future, while individuals in the action stage have started to 
modify or alter their behaviour in order to overcome their drinking problem. Engagement in 
treatment is one of the potential actions. The maintenance stage is characterized by taking steps to 
maintain stable behaviour change and avoid relapse. Figure 4.3 presents the spiral pattern which 
illustrates how people move through the stages of change.  
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Figure 4.3 A Spiral model of the Stages of Change. Reprinted from Prochaska, DiClemente & 
Norcross, 1992, p1104 
 
 
 
 
While this model does not explain the process of treatment seeking, the stages and processes of 
change are similar for persons who change their drinking without utilizing treatment as for 
treatment seekers. It is expected that those in the maintenance stage are unlikely to seek treatment 
as they would have made sustained behavioural and environmental changes. While there have been 
several criticisms of the Transtheoretical Model, there is empirical evidence that it can predict 
clinical outcomes and it has been used to enhance treatment amenability by tailoring interventions 
to the client’s motivational level or stage of change.  
 
Correlates of treatment seeking  
 
A body of research has investigated the barriers and correlates of treatment entry amongst clinical 
populations of those with alcohol and drug misuse. These studies have compared treatment seekers 
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with non-treatment seekers in the general population, examining a variety of biological, 
psychological and social factors. Much of this research has been marred by methodological and 
conceptual problems including: a lack of standardized measures, not controlling the presence of 
other variables, lack of multivariate analyses illustrating how variables interact, and the lack of 
qualitative studies revealing the client’s perspective [48, 51]. Despite this, a number of key 
correlates have been consistently associated with treatment utilization. Identification of these key 
correlates will be useful to understanding which variables predispose, facilitate or create the need 
for professional help. This research is briefly presented in this section. 
 
Problem recognition 
 
Problem recognition has been identified as one of the primary correlates of treatment seeking in 
clinical populations. In a recent review by Tsogia and colleagues [48] involving 17 quantitative 
studies exploring reasons for or against entering treatment for alcohol and drug misuse, problem 
recognition was one of the most powerful predictor of treatment entry. Accordingly the lack of 
recognition that one’s problem is serious enough to require professional help was found to be a 
major barrier to treatment entry. The importance of problem recognition in influencing treatment 
entry was identified by an earlier review by Jordan & Oeil (1989) [49] and supported by more 
recent studies [47].  
 
Cognitive appraisal is a related process that can lead to problem recognition which involves 
evaluating and weighing up the pros and cons of drinking or not drinking and making the decision 
that change is required. Studies have identified that many substance misusers engage in a cognitive 
appraisal process prior to seeking treatment. Cunningham and colleagues (1994) asked subjects to 
give 10 reasons leading to treatment seeking and to how much they were influenced by these 
reasons Weighing the pros and cons, along with hitting rock bottom and experiencing a major 
lifestyle change were predictive of professional help seeking and treatment completion. [52]. 
Treatment seekers generally exhibit high internal motivation and tend to be in the contemplative or 
action stage of change [53-56].  
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Accumulation of negative life problems  
 
Problem recognition alone however does not inevitably lead to help-seeking as there is a time 
lapse between problem recognition and entry into treatment which can range from 1-15 years [48]. 
Studies suggest that problem recognition works closely with the impact of negative life events as 
impetus for treatment entry. The intensity or frequency of these negative life events and 
psychosocial impairments related to drinking has also been found to be predictive of treatment 
seeking [34, 46, 47, 57-62]. Life events or stressors found to be significant to treatment entry have 
included: drinking while driving and traffic crashes, arrests for criminal offenses, relationship 
problems, health and work problems. One of the few well conducted and largest qualitative studies 
was by Orford [47] in the United Kingdom which involved open ended interviews asking 98 
clients who self referred to treatment about their reasons for seeking treatment. According to 
Orford (2006, p. 174) the most influential factor in help seeking was ‘ the sheer weight of 
problems, often in several life domains, worsening to the point at which their meaning was 
inescapable and action unavoidable’ .  
 
Psychiatric problems  
 
Co-morbid mental health problems, especially involving a diagnosis or symptoms of depression 
and anxiety, have been reported to be a major factor in treatment utilization [30, 63-68]. 
Recognising a problem with alcohol use and the necessity for change is more probable when 
emotional distress is substantial and when psychiatric problems are present [44]. Lower levels of 
co-morbidity and higher psychosocial functioning have been found to result in moderate levels of 
help-seeking compared with those with higher psychiatric problems [69]. 
 
Severity of dependence and other drug use 
 
Severity of dependence and its association with alcohol treatment utilization has not been 
consistently investigated. A small number of studies however have found an association between 
alcohol treatment utilization and severity of dependence symptoms [70-75]. In a recent study Moss 
(2007), using data from a nationally representative epidemiological survey examining alcohol 
dependence subtypes, found that those with substantial rates of multigenerational AD, severe AD 
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criteria profile engaged in significant help seeking. The presence of three or four symptoms of 
dependence has been found to be a strong factor for treatment seeking among individuals with 
alcohol dependence [76-78]. Those with additional substance dependence other than alcohol are 
also more likely to seek treatment [74, 79, 80].  
 
Demographics 
 
Efforts to identify which individuals based on demographics are most likely to enter treatment has 
yielded mixed findings. Only a few studies have examined demographic variables and treatment 
entry, most of which have not employed a prospective research design or used comparison groups 
[48]. Studies of the relationship between age, ethnicity, gender and alcohol treatment utilization 
reveal variable findings. A number of studies report treatment seekers to be generally female [64, 
81-83], unmarried [41, 80, 84-86], lower income [61, 79], having less education [74, 79] 
unemployed [61, 87], middle aged rather than older [57, 64] and lacking a good support network 
[74, 88]. These characteristics are common in treatment populations but may not necessarily be 
predictive of treatment uptake. 
 
Social Pressure 
 
Social pressure is considered to involve confrontation from members of one's social environment 
concerning the negative aspects of one's substance use and a request that the need for treatment be 
seriously considered by the substance misuser. Early studies focused on mandated forms of social 
control and its impact on treatment utilization [89]. More recent studies have found informal social 
pressure to significantly influence treatment entry more than even mandated social controls [90, 
91]. Nevertheless adults seeking treatment solely in response to social or external pressure were 
less likely to make decrease their substance use, make positive behavioural change and engage in 
treatment compared to those who self refer for treatment [92]. 
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Health problems  
 
There are mixed findings as to whether health problems contribute to treatment utilization [49, 60, 
93-95]. This may be due to studies not adequately assessing medical and health problems at the 
time of assessment. Health problems however are common reasons for individuals changing their 
drinking without accessing treatment [96], especially amongst those who have decided to become 
abstinent [97]. Health beliefs specifically involving high perceived illness severity and cues to 
action are endorsed by alcohol treatment seekers compared with those with an alcohol use problem 
and not seeking treatment [98]. These perceptions appear to pre-date entry into treatment. 
 
Quality of life 
 
The complications of alcohol misuse affecting nearly all life domains are well known and alcohol 
treatment seekers may enter treatment as way of managing physical, mental, social and economic 
problems. Quality of life as a predictor of treatment seeking has not been specifically researched 
however numerous studies have reported very low quality of life scores among those who enter 
specialty alcohol or substance abuse treatment [99-101] and these scores can be lower than those 
with chronic medical conditions [102].  
 
Barriers at the latter steps of treatment seeking  
 
Barriers to treatment are factors which hinder or counteract decisions that otherwise lead to 
treatment seeking. Once the decision is made that change is needed, research suggests that there 
are certain factors which hinder the decision to seek professional help and complete treatment.  
 
Stigma  
 
According to Vogel, stigma is the perception of being flawed because of a characteristic (personal 
or physical) which distinguishes an individual as socially unacceptable [7]. Stigma is the most 
cited reason for not seeking both general and substance abuse professional treatment. Studies 
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reveal that the fear of stigma represents a major barrier to the utilization of substance abuse 
treatment with consumer concerns about being labelled an ‘alcoholic’, loss of privacy and it being 
seen as an admission of personal failure [49, 82, 103-105]. A recent U.S. study by Keyes and co-
workers [106] involved a nationally representative sample of adults with an alcohol use disorder. It 
tested whether perceived stigmatization of alcoholism was associated with a lower likelihood of 
receiving alcohol-related services. The study involved a face-to-face epidemiologic survey of 
34,653 adults interviewed in 2004-2005. Their alcohol use was formally diagnosed and stigma 
measured using a perceived Devaluation-Discrimination Scale. The main outcome was that 
individuals with a lifetime diagnosis of an alcohol use disorder were less likely to utilize alcohol 
services if they perceived higher stigma toward individuals with alcohol disorders. The 
relationship between stigma and treatment seeking decreased in a stepwise fashion after 
controlling for demographic characteristics and alcohol disorder severity. Higher perceived stigma 
was associated with male gender, non-white compared with non-Hispanic white race/ethnicity, 
lower income, education and being previously married. 
 
It has been argued that self-stigma is more important than public stigma and contributes to an 
individual shunning treatment in order to avoid a lower of self-esteem whereas public stigma 
involves the fear of others’ reaction [107]. Self-stigma involves a lowering of an individual’s self-
esteem or self-worth which emerges from identification with a stigmatised group. The prospect of 
voluntarily utilizing substance abuse treatment according to Saunders [44] (p.268) presents ‘a self-
stigmatizing challenge threatening an individual’s sense of control and self–esteem’.Seeking help 
from another individual can be internalized as feelings of inferiority, inadequacy, a sign of 
weakness or failure [7], making help-seeking a threat to an individual’s self-esteem and an 
avoidance of treatment a means of maintaining a positive self image. Thus a strong personal and 
public admission and acceptance of a stigmatizing diagnosis is needed before need for outside help 
to overcome it but also a failure at self-help [108].  
‘Prefer to manage the problem myself’  
 
The most frequently endorsed reason for not utilizing formal treatment services provided in both 
quantitative and qualitative studies involves ‘wanting to solve one’s drinking problem on one’s 
own’ without the need of professional help [32, 44, 104, 105, 109, 110]. Self-stigma may be a 
factor behind an individual’s preference for handling the problem without treatment, perhaps 
reflecting misplaced self-efficacy and fear of challenges to one’s self-esteem’[44].  
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Program attributes  
 
While individual variables correlated to treatment seeking play a pivotal role in treatment seeking, 
service delivery plays a significant especially in the latter steps of the treatment seeking process 
[29, 44]. In 1964 Chafetz was one of the first to illustrate that retention in alcohol treatment could 
be enhanced by altering service delivery [111]. He conducted a series of experiments with patients 
in an alcohol clinic after referral from an emergency service in a general hospital to see whether 
improving service approach would alter retention. The changes he incorporated to the standard 
approach included: welcoming patients and treating them with respect at initial contact, reducing 
waiting times, increasing patient contact, and offering service that dealt with patient concerns 
(housing, finances). All these interventions caused a manifold increase in initial and long term 
attendance despite the patients’ poor prognoses. In a later study Beckman and Kocel studied 
aspects of the treatment delivery system as it related to women entering 53 alcohol treatment 
agencies and found that organisation and attitude of treatment agencies influenced the initiation 
and maintenance of treatment [42].  
 
One study found that 10% of the variance in therapeutic involvement was due to program 
attributes [112]. Even after adjusting for patient differences, programs offering the same type of 
treatment orientation have been shown to have differential effectiveness and influence the 
initiation and maintenance of help seeking [113]. Program attributes which have been found to 
alter treatment seeking and retention include: providing a broader array of service [112], 
improving access by reducing wait time [114-116], role induction [117], staff composition and 
attitudes, agency attitudes [42], cost [70], structured programming and clear policies [118], 
offering more psychosocial treatment [118] and treatment matching[119, 120]. The literature 
suggests that treatment agencies have an important role in shaping community attitudes and 
response to alcohol problems and may indirectly influence the personal beliefs that lead to 
initiation and maintenance of treatment. 
 
Temporal sequencing of treatment seeking  
 
There are few data about the timing of treatment seeking in relation to the clinical course of an 
alcohol use disorder and the development of alcohol-related problems. Jellinek (1964) placed 
clinical treatment late in the developmental sequence after drinking problem onset, developmental 
milestone and problem recognition. Schuckit found that 74% of war veterans hospitalized for 
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alcohol problems reported early problems in their early 20s, a worsening of their problem in their 
30s and treatment contact in their 40s [121]. 
 
Figure 4.4 Temporal sequence of Alcohol-related events and Treatment Seeking 
 
 
 
A recent study conducted by Simpson [122] extended past research examining temporal 
sequencing of contact with formal services. A community sample of 101 male and female problem 
drinkers who varied in their help seeking histories (no assistance, AA only, treatment plus AA) 
were assessed on past and present drinking practices, other drug use, help seeking episodes for 
alcohol related problems and the date that participants first experienced alcohol related problems. 
They were also questioned about the year in which they had initial contact (if ever) with alcohol 
focused interventions including professional treatment providers. A rank order analysis was 
conducted to examine the temporal sequence of alcohol related events and significant milestones 
in their drinking careers. Although individual differences were observed, generally pathological 
drinking practices emerged early in the general sequence and were often closely connected with 
problem recognition. Legal, relationship and financial problems tended to develop somewhat later, 
followed by the development of dependence symptoms such as tolerance, withdrawal, neurological 
consequences (e.g. memory impairment, blackouts). Emotional problems emerged after these 
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events with alcohol related health problems being the last adverse consequences to develop. 
Physical health problems due to drinking were relatively late occurrences (Figure 4.4) just prior to 
treatment. These results complement the findings of past studies.  
 
Simpson proposes that the reticence of ‘problem drinkers’ to seek help is not driven by denial and 
believes that there is the opportunity to introduce lower threshold interventions in order to engage 
individuals in treatment. Nonetheless, initial help seeking occurred on average about a decade later 
than problem recognition [113]. Problem recognition was found to occur somewhat early in the 
overall sequence shortly after the onset of pathological drinking practices. Greater alcohol related 
problems and higher dependence levels were reported by resolved participants who were quicker 
to recognise their drinking problems and to seek help compared to non resolved participants. Less 
severe but serious drinking problems and a social network which accommodates to the drinker 
may make problem recognition more difficult thereby functionally ‘enabling’ the problem drinking 
pattern and delaying help seeking. Informal help seeking occurred 4 years before professional help 
seeking. 
 
Recovery from substance dependence without treatment  
 
       All recovery is natural recovery 
                      Griffith Edwards [123] (p.747) 
  
One reason for individuals with alcohol use disorders refusing to participate in treatment and 
which is extremely relevant to this investigation is the issue of self-change or natural recovery. 
Natural recovery studies have examined abstinence or controlled drinking for at least a period of 
12 months. Natural recovery has been defined by Cloud and Granfield as ‘ termination or 
‘cessation’ of substance dependence without the aid of formal treatment or participation in 12- step 
groups such as Alcoholics Anonymous, Narcotics Anonymous or other mutual-help groups, 
including non-12 step groups such as SMART, Moderation Management etc.’ [124]. In the 
addictions field, several terms have been utilized namely: spontaneous remission, auto-remission, 
self-change, natural resolution, maturing out, spontaneous recovery, natural recovery, untreated 
remission, untreated recovery [125].  
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Prior to the emergence of natural recovery research in the 1970’s, natural recovery was considered 
a taboo subject. Addiction was considered not self-curing and that without treatment, alcoholism 
could lead to fatal consequences such as total degradation, prison and mortality [126-128]. The 
recognition of natural recovery continued to be underreported in the literature due to the bulk of 
research taking place within the context specialized treatment for a treatment seeking population 
further reinforcing the assumption that treatment is essential to mobilizing behavioural change 
[108]. With the increase in natural recovery research studies, it has been uniformly demonstrated 
that a large majority of individuals with alcohol problems in the general population resolve their 
alcohol problem without specific help from formal treatment services or self-help groups [93, 129, 
130].  
 
Epidemiological studies using general population surveys have found that between 54% and 85% 
of those with alcohol use problems make change without professional help [131-133]. The 
variability in the range is influenced by the definition of natural recovery and methods of 
measuring alcohol problems. Natural recovery may be defined either by abstinence, moderate 
drinking or a reduction in the DSM symptomotology maintained for at least a 12 month period. 
More than three quarters of subjects in natural recovery studies had a less severe drinking problem. 
However, recovery from severe dependence has also been reported.  
 
Little is known about how natural recovery occurs. Studies have tended to be exploratory or 
retrospective, frequently fail to identify many of the antecedents or events associated with the self 
change process, have a short follow up period, and are lacking in corroboration of respondent 
reports [93, 126]. A review of 40 natural recovery studies by Sobell [93] highlighted the reasons 
for natural recovery. The most frequent reason for natural resolution involved health concerns with 
17 samples (42%) reporting these concerns. Others were financial issues (30%), negative personal 
issues relating to substance use (30%), cognitive changes (27.5%) and influence from significant 
others (22%). 
 
Natural remitters as a group show different clinical characteristics to treatment seeking 
populations: 
 
1. Demographics: they tend to be older, married, have greater education, employed and 
greater social stability [109, 129, 134-136].  
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2. Alcohol indices- they tend to experience less severe forms of alcohol dependence 
[133, 137-139], less lifetime alcohol consumption [135, 140, 141] and less alcohol 
related consequences and psychosocial problems, especially in social and 
interpersonal relationships compared to treatment seekers [109, 132, 142, 143]. 
3. Health problems can be a major reason for change [93, 97, 109, 144]. 
4. Greater social resources in terms of a socially stable support network of family [109, 
135, 139, 145, 146] and a view of their spouse as integral to recovery [142].  
 
Natural remitters rely on cognitive appraisal in order to facilitate change with a reliance on will 
power and reasoning [109, 147, 148]. They also show greater self-efficacy [149]. Maintenance of 
change has been largely attributed to: adequate social resources, financial stability, greater self 
efficacy, and use of will power, an approach rather than avoidance coping style and alternative non 
alcohol related activities.  
 
Barriers to seeking professional treatment for natural remitters include: 
1. not wanting to be stigmatized or labelled [59, 109, 142, 150] 
2. believing that they could quit on their own [59]  
3. privacy or not wanting to share one’s problems with others [59, 151]  
4. perceiving their problems as not severe enough to warrant treatment [59].  
 
An important point to note about those who abstain without treatment is that they are more likely 
to involve a return to low risk drinking or controlled drinking while treatment seekers have been 
found to achieve a longer period of abstinence [129, 152, 153]. Moos (2006) examined the rates 
and predictors of 3 year remission among untreated individuals and treatment individuals with 
alcohol use disorders with a 16 year follow up period. Those likely to relapse were less likely to 
see their drinking as a significant problem, had less self-efficacy, and relied on avoidance coping. 
By Year 16, 60% had relapsed amongst self remitters versus 43% amongst the treatment group.  
 
Research aim and design 
 
As discussed in the literature review the need for alcohol treatments is involves a number of 
complex factors. Comparing the clinical characteristics of ESALD transplant subjects with 
alcohol treatment seekers (ATS) will help to explain resistance to alcohol treatment by ESALD 
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transplant patients. The case control design was selected in order to test the hypotheses by 
comparing cases with controls. The primary aim of the case control study is to compare ESALD 
transplant patients who see no need for alcohol treatment (cases) with a group of alcohol 
treatment seekers (ATS) who are actively engaged in treatment (cases) on variables correlated 
with treatment seeking.  
 
The case control design was also selected as it involves fewer and more readily accessible 
subjects, requires less time to complete and relatively inexpensive to administer. To help guide 
this investigation a model of alcohol treatment seeking was formulated (Figure 4.5) incorporating 
the theoretical tenets of treatment seeking models along with clinical and demographic variables 
linked with alcohol treatment seeking. 
 
The research question and hypotheses  
 
The primary research question of this project is:  
 
What are the barriers and factors associated with the lack of participation in 
specialist alcohol treatment seeking amongst ESALD transplant patients?  
 
In this study treatment seeking refers to the voluntary utilization of professional, formal or 
specialist alcohol treatment services including both medical and psychological/counselling based 
interventions aimed at addressing alcohol use disorders.  
 
Hypothesis 1 
 
ESALD transplant patients differ from alcohol treatment seekers (ATS) and they do not perceive 
the need for specialty alcohol treatment nor are they well matched to standard alcohol 
interventions. These groups differ in length of abstinence, motivation, health beliefs, alcohol 
severity, psychiatric and substance abuse co-morbidity, quality of life and demographics. 
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Hypothesis 2 
 
ESALD transplant patients are less comfortable with seeking professional help for alcohol related 
problems.  
 
 
Conclusion  
 
This chapter has outlined factors contributing to treatment resistance and treatment seeking. 
Treatment resistance is likely to occur when core cognitive structures or beliefs are challenged, if 
treatment is perceived as coercive, incorrect use of therapeutic approaches or if interventions 
activate distressing feelings and memories. The pathway to specialty treatment is a complex, 
multi-step process involving the interaction of a number of factors involving biological, 
psychological, social and organisational variables. Alcohol treatment seeking is more likely to 
occur in the presence of problem recognition, culmination of adverse negative life events or 
stressors as a result of drinking, psychiatric problems and social pressure. Treatment related 
barriers may hinder individual motivation for help seeking and treatment completion. Natural 
recovery is also a possible explanation for treatment refusal as at least half of those with an alcohol 
use disorder in the wider community will make changes to their alcohol consumption without 
participating in treatment. The majority of those with an alcohol use disorder including natural 
remitters will be deterred from accessing professional treatment due to the fear of stigma and 
believing that they can change without utilizing professional help. The aims, research questions 
and hypotheses for Study 1, a case control study, have been provided. Chapter 5 will discuss the 
method to be used in the case control study.  
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Poor support network  
Past treatment history  
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Readiness to change 
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consequences)  
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Contact with professional alcohol 
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Decision that change is 
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 Self Change 
 
  Relapse  
 
Problematic Drinking 
 
Decision that professional 
help is required 
 Figure 4.5  Alcohol treatment seeking model based on the correlates of alcohol treatment seeking 
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CHAPTER 5 
Case Control Study - Method 
 
 
 
This chapter outlines the methodology for Study 1 - the case control study. It includes ethics 
approval, participants, recruitment and assessment procedure. Details of all measures and 
instruments utilized are explained in detail followed by a description of the approach to statistical 
analysis.    
 
The study was carried out between September 2009 and July 2011. Prior to recruitment 
commencement, the study protocol was approved by the Ethics Review Committee of Sydney 
Southwest Area Health Service (RPA Zone) (Appendix B). Ethics approval was also granted by 
the Ethics Committee of Concord Repatriation General Hospital Research Office to distribute a 
flyer or recruitment advertisement (Appendix C) to potential participants. Interview data was 
collected by the student investigator. Blood samples and fibroscans were conducted at Royal 
Prince Alfred Hospital. The study was undertaken in collaboration with University Sydney 
Faculty of Health Sciences and Royal Prince Alfred Hospital.  
 
Study variables  
 
The dependent variables in this study included a diagnosis of ESALD and being a liver transplant 
candidate or recipient. The independent variables included many of the correlates of treatment 
seeking namely: demographics (marital status, education, employment history, social support 
network, housing stability), alcohol use, severity of alcohol dependence, substance use history, 
alcohol treatment history, psychological distress, motivation, quality of life, risk of relapse, health 
beliefs and help seeking. It is expected that variations in any of these variables could affect 
treatment motivation.  
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Participants and recruitment  
 
A total of 40 cases and 40 controls were recruited. Controls were matched to cases based on age 
and gender. This sample size was considered adequate to achieve the goals of the study and to 
elicit an effect of scientific and statistical significance.   
 
Cases consisted of patients with a diagnosis of ESALD and who were either in the pre- transplant 
or post- transplant stage of liver transplantation. All cases were recruited from the Australian 
National Liver Transplant Unit (ANLTU) Royal Prince Alfred Hospital, Sydney Australia. As 
requested by the Ethics Committee, subjects were approached and informed about the study by 
transplant staff including the nursing unit manager, drug and alcohol specialist and transplant 
psychiatrist. According to the Ethics the researcher has no clinical relationship with the patient 
and therefore it would not be appropriate for the researcher to approach the patient whilst they are 
in hospital for care. In such circumstances, the HREC routinely requires a member of the patient’s 
clinical team to tell the patient that the study is taking place and seek the patient’s permission for 
the researcher to approach them to discuss possible participation. This was considered important 
to avoid any breach of patient privacy.  
 
 Potential participants were informed about the study and presented with the recruitment 
advertisement by transplant staff and encouraged to contact the investigator if they were 
interested in participating in the study. The flyer was worded and designed so that it would not be 
directly confronting regarding alcohol use problems (C).  
 
On receiving a phone call from the potential participant, screening for suitability was conducted 
along with attending to any queries or concerns the participant may have had about the study. If 
eligible for the study an appointment was made for an assessment. Potential participants were 
given the choice of being assessed at the liver transplant unit or at the outpatient drug health 
service situated in another building on the same hospital campus. The large majority of potential 
participants preferred to be assessed at the liver transplant unit whilst attending their outpatient 
appointment at the transplant unit.  
 
Controls included 40 individuals with alcohol use disorders, without significant end-stage liver 
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disease who had commenced alcohol treatment. Controls were recruited from outpatient 
counseling services, an inpatient detoxification unit and residential rehabilitation program. All of 
the above organizations serviced the same area as the liver transplant unit to minimize the effects 
of population stratification.  
   
Controls were approached by the intake officer, treating staff member and the investigator about 
participation in the study. On receiving a participant’s willingness to be involved in the study an 
appointment was made. Controls were interviewed either at the outpatient drug health service or 
the residential treatment facility 
 
Other organizations and services were targeted for recruitment and were contacted on a regular 
basis however did not prove to be sources of potential participants. These included other 
residential rehabilitation programs (Kathleen York House, We Help Ourselves (WHOS), 
Foundation House and Alcoholics Anonymous (AA). Recruiting controls matched in age and 
gender took twice as long as recruiting cases which pointed to the lack of alcohol treatment 
seeking by males in that age group.   
 
Inclusion and exclusion criteria  
 
All potential participants who were interested in participating in the study were screened for 
eligibility.  
 
Cases were eligible on the following criteria: 
 
1. Age 18 years or over. 
2. A clinical diagnosis of ESALD and either in the pre or post-transplant stage. 
Patients transplanted for ALD and Hepatitis C Virus (HCV) were also included.  
3. Adequate understanding of English (essential for informed consent and 
comprehension in order to complete questionnaires and interviews). 
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Cases were excluded on the following criteria:  
 
1. Current history of injecting drug use  
2. Acute psychiatric illness (eg. schizophrenia, psychosis, bipolar disorder)  
3. Hepatic encephalopathy  
4. Alcohol dependence treatment since being placed on the pre-transplant waiting 
list. Treatment seeking was defined as the commencement of specialist alcohol 
treatment such as inpatient or residential treatment programs, outpatient 
counseling treatment with or without specialist medical treatment. No subject was 
excluded based on this criterion.  
 
During the recruitment period no patients were excluded due criteria 1, 2, 4 and only one patient 
for criteria 3.  
 Controls were considered eligible based on the following criteria: 
 
1. Age 18 years or over  
2. Diagnosis of alcohol dependence or abuse 
3. Basic literacy and ability to communicate in English to ensure comprehension 
and ability to complete questionnaires and interviews 
4. Commenced alcohol treatment  
 
Controls were excluded on the following criteria: 
 
1. Current evidence of substance use disorder other than alcohol or nicotine drug 
dependence  
2. Life threatening medical conditions contributing to initiation of alcohol treatment  
3. Involuntary treatment seeking including referrals by probation and parole  
4. Major psychiatric illness (e.g.. schizophrenia, psychosis, bipolar disorder). 
5. Serum liver tests (AST, ALT, GGT) greater than 1.5 times normal within the last 
three months or findings on a fibroscan suggesting advanced liver disease (liver 
stiffness > 13kPa).  
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Study procedure  
 
This research project used a structured interview as the primary research instrument. The 
interviews were conducted face to face on an individual basis. All participants were required to 
read the ‘Information for Participant Sheet’ (Appendix D) which provided detailed information 
about the study procedures, assured confidentiality and provided the option to withdraw from the 
study at any time. Written consent (Appendix D) was obtained from each participant before data 
collection commenced. Participants were informed that they would be given a $20 gift voucher at 
the end of the interview. 
Interviews took on average one hour for controls and one and half hours to two hours for cases to 
complete. Assessment sessions were longer for cases as they had the extra component of the 
semi-structured interview. Measures were conducted by the investigator experienced with 
conducting drug and alcohol assessments and with a master’s degree in drug and alcohol studies.  
All measures were selected based on sound psychometric properties and for the purpose of testing 
the hypotheses. We expected the majority of ESALD transplant participants to report being 
abstinent in order to assess certain variables, it was important to select measures which had a 
retrospective perspective so the participant could respond in relation to a period when he/she was 
drinking.  
Both cases and controls were asked to complete the following measures. Copies of all assessment 
measures used in this study are contained in Appendix E.  
 
Assessment measures  
 
Demographics  
 
Participants were asked their age, gender, marital status, presence of HCV, past IVDU, family 
history of alcoholism, housing stability, history of mental illness, employment, social support 
network, education level (Appendix E).  
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The Lifetime Drinking History (LDH) 
 
The Lifetime Drinking History (LDH) [1] is a retrospective, structured interview designed to 
provide quantitative data on an individual’s alcohol consumption patterns in a chronological 
manner. It was chosen in order to compare a number of alcohol indices throughout the lifetime 
drinking careers amongst cases and controls. The data obtained from LDH included: duration of 
regular drinking (years), duration of “heavy” drinking (years), duration of abstinence (years), 
lifetime total (grams absolute alcohol/kilograms body weight), daily average (g/kg), average per 
drinking day (g/kg), volume variability (maximum per day – daily average), beverage Type: % 
Beer, spirits, Wine, style: Occasional, weekend, binge, frequent, life events that influenced 
consumption levels, context: % drinking Alone vs. With Others, time: % drinking during 
Morning, Afternoon, Evening.  
 
The LDH interview takes approximately 20 to 30 minutes to complete. The investigator used 
probing, cross referencing of facts, provided participants with a chart showing the number of 
standard drinks in various beverages, and used memory aids to assist in accurate recall. The 
measurement of standard drinks was based on the Australian National Guidelines [2] where a 
standard drink is defined as 10g of alcohol (equivalent to 12.5 mL of pure alcohol. Harmful 
drinking whilst using the LDH was defined as reported drinking above 2 standard drinks daily for 
females and 6 standard drinks daily for males. Harmful drinking also included regular binge 
drinking of over 6 standard drinks. 
 
LDH is one of the most widely used lifetime drinking measures and has been used in a number of 
research projects including amongst those with alcohol-related liver disease [3-4]. Reliability 
estimates [5] [6-7], correlations for a number of drinking indices [1], validity and concurrent 
validity has been high [8] [9] [10].  
 
SCID I 
 
The Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders 
DSM-III and DSM-IV (SCID I) [11] was used with the LDH to determine alcohol use diagnosis 
at the time of problematic drinking. As the majority of ESALD transplant patients were abstinent 
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and in remission a retrospective account was required in order to make a diagnosis. A diagnosis 
of alcohol dependence is based on 3 dependence items coded ‘3” having occurred within same 12 
month period. The diagnosis of alcohol abuse requires 1 item coded “3”. No diagnosis is made if 
no items were reported. The SCID has been reported to yield highly reliable diagnoses when 
using appropriate semi-structured interviews [12-13] and moderate to excellent inter-rater 
reliability [13-15]. The SCID I was conducted by the investigator experienced with conducting 
drug and alcohol assessments and with a master’s degree in drug and alcohol. 
 
Mini-Mental State Examination (MMSE) 
 
The MMSE or Folstein test is a brief 30 point questionnaire used to screen cognitive impairment 
providing a brief, objective measure of cognitive functioning [16]. The MMSE was used in the 
current study only if the participant appeared to be have cognitive impairment, difficulties with 
comprehending questionnaires or with retrospective recall during the interview.  
 
SIP 2-R 
 
The Short Inventory of Problems – Recent (SIP-R) is a 15 item self report questionnaire with 
sensitivity for measuring alcohol related consequences amongst a wider sample of problem 
drinkers not just those with severe alcohol dependence. Version SIP2-R asks respondents to rate 
consequences at the time their drinking was the most problematic or heaviest allowing for recall 
of past drinking consequences. The SIP provides a total score and scores on each of the domains 
based on a clinical treatment population. A profile sheet provides a means of interpreting the 
decile range as either: very low, low, medium, high, very high consequence. The original SIP-R 
was derived from DrInC-R questionnaire by Miller [17]. Miller developed a shorter version of the 
DrInC-R to develop the SIP which included 15 items from the original. The latter version showed 
internal consistency, test-retest stability [18-19].  
Short Alcohol Dependence Data (SADD)  
 
The Short Alcohol Dependence Data (SADD) was developed by Raistrick [20] and based on the 
Alcohol Dependence Syndrome created by Edwards and Gross [21]. The SADD was chosen for 
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its discriminative power to measure the degree of alcohol dependence among drinkers in the mild 
to moderate range of dependence rather than strictly for the clinical population who tend to have 
severe dependence [22]. Questions are framed for participants to provide a retrospective account 
about when their drinking was the most problematic or heaviest again suitable for participants 
who are abstinent.  
 
A total score is obtained by adding the score from each of the items. Scores between 1 and 9 
indicate low dependence, those between 10 and 19 indicate medium dependence and a score of 20 
or more indicates high dependence. Each item is scored as follows: never = 0; sometimes = 1; 
often = 3; nearly always = 4. Davidson and colleagues [23] demonstrated that the SADD 
measured the alcohol dependence syndrome. The instrument has also been found to show good 
test-retest reliability (r = .87), acceptable split-half reliability (a correlation between total score on 
odd and even numbered questions) [20, 24] and construct, concurrent and content validity[22-23].  
 
Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES 8A)  
 
The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) developed by 
Miller & Tonigan [25] is one of the most extensively cited and utilized instruments for measuring 
readiness for change amongst adults with alcohol problems. This study utilized SOCRATES 
(Version 8A) consisting of 19-items. SOCRATES was chosen over other readiness to change 
scales due to its good psychometric properties.The theoretical underpinnings of the SOCRATES 
are based on the Transtheoretical Model (TTM) and was modelled after a general stages of 
change measure known as the University Of Rhode Island Change Assessment (URICA) [26]. 
While the URICA asks about the client's "problem" and receptiveness to change in relation to 
problem behaviours, the SOCRATES on the other hand, was specifically intended to categorize 
alcoholism treatment clients according to their motivation for change. The measure identifies 
continuously distributed motivational processes that may underlie stages of change allowing for 
the degree of problem recognition, ambivalence and taking steps to be measured as three separate 
and validated subscales.  
 
As the majority of ESALD transplant patients are abstinent in order to assess their stages of 
change and readiness for treatment, both cases and controls were asked to complete a past and 
present SOCRATES. The retrospective assessment using the SOCRATES involved measuring the 
 
 
145 
 
motivational processes when alcohol use was most problematic. The second assessment involved 
a current measure of readiness to change. Items on the SOCRATES were modified slightly in 
terms of tense but not content in order to capture retrospective data and to adjust to the probability 
that both cases and controls may be abstinent or drinking. 
 
The psychometrics of the earlier SOCRATES (Version 5.0) was extensively evaluated in two 
studies associated with Project MATCH multisite clinical trial and conducted by Miller and 
Tonigan [27-28]. The three-factor structure described above was identified as stable and good 
internal consistency of each subscale verified by a number of other studies [29-31]. The 
Ambivalence scale has been found to have lower internal consistency than the other two scales 
[32] consistent with the Project Match findings. This may be due to a problem inherent in the 
measurement of ambivalence [27]. These findings generalise to SOCRATES 8A. Two studies 
have reported good predictive validity one involved a sample of 125 male clients who met DSM-
III-R criteria for alcohol dependence and who were treatment seekers, high ‘Taking Steps’ scores 
were predictive of abstinence during the 1 year post-treatment period while high ‘Recognition’ 
scores predicted participation with Alcoholics Anonymous (AA)(Isenhard -1997). A large sample 
of alcohol-dependent inpatients (n = 350) the association of client motivation with alcohol use, 
self-efficacy and treatment outcome at 3-month follow-up was examined. Readiness to change 
was positively associated with pre-treatment self-efficacy and accounted for 9.4% of the variance 
in treatment outcome (Demmel 2004).  
 
History of Substance Use  
 
Past use of cannabis, opioids, sedatives, methadone, amphetamines, cocaine and ecstasy was 
assessed by asking participants whether this involved: never having used, having used a few times 
only, past non-problem, past problem, current non-problem and current problem. 
 
Previous substance abuse treatment  
 
Participants were asked about past treatment history and how many treatment episodes or times 
they had utilized the following: inpatient detoxification units, outpatient detoxification, residential 
treatment, day programs, outpatient counselling and Alcoholic Anonymous (AA) meetings.  
 
 
146 
 
Health Beliefs  
 
The Health Beliefs model [33] proposes that positive behavioural responses to health risk 
situations result from an individual’s assessment of perceived susceptibility, severity of the illness 
threat, benefits seen in taking action and where costs and barriers are not obstructive. There are no 
standardized questionnaires based on the health beliefs model. Researchers developed scales 
based on the theoretical model while these scales showed face validity they lacked construct 
validity [34]. Latter scales improved the construct validity but were not tested on specific patient 
groups thus limiting their applicability to different groups. Cockburn and colleagues [35] 
developed and tested a questionnaire measuring health beliefs amongst a large sample of general 
practice patients with a wide range of different illnesses examining factor analysis, reliability and 
validity testing based on the responses. The results of the analysis provided empirical evidence 
for the reliability and construct validity of the questionnaire. Factor analysis and theory supported 
that ‘perceived severity’ and ‘perceived susceptibility’ be grouped under ‘threat of illness’.  
 
The questionnaire for this study was developed for the study based on the Cockburn questionnaire 
measures 4 scales namely: perceived illness threat (items 2,4,5,10,11,12) , perceived barriers to 
abstinence (items 6,7), medical motivation (8,14,17) and perceived control over illness (Item 9). 
Two items were included to examine beliefs regarding causal attribution for liver disease. Only 
14 of the 22 items were included in the questionnaire as some appeared to be irrelevant to this 
patient population or were duplicates.  
 
 Depression Anxiety Stress Scales (DASS-21)  
 
The Depression Anxiety Stress Scales (DASS) was originally developed by Lovibond & 
Lovibond [36] consisting of a 42-item self-report questionnaire designed to be a valid and reliable 
measure of three dimensions of negative emotional states namely: depression, anxiety and 
stress/tension. Participants were asked to rate the extent to which they had experienced each 
symptom for the previous week on a four point Likert scale ranging from 0 to 3. The original 
DASS 42-item has been reported to be a psychometrically sound instrument with high internal 
consistency [37], good convergent and discriminant validity [36], test-retest reliability [38], a 
replicable three-factor structure [38-39].  
The DASS-21 [36] is a short-form of the DASS in which each of the three subscales contain 
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seven (rather than 14) items. This instrument has been widely used Australian population norms 
have been published allowing results to be reported against a normal range. DASS-21 was chosen 
for its brevity, sound psychometric properties and most importantly as it discriminates between 
anxiety and depression disorders amongst both clinical and non clinical populations. It has a 
number of advantages over the full-length version. It is less time consuming. The items retained 
from the full-length version are generally superior to those not present and as a result it has a 
cleaner factor structure. The downside is that, although the DASS-21 has high reliability, its 
reliability is a little lower than that of the full-length DASS [39]. There appears to be a ceiling 
effect limiting the capturing of symptoms indicative of severe depression limiting assessment of 
‘pure’ cases of depression involving vegetative symptoms and suicidal ideation [37]. Antony [40] 
compared the two instruments and reported high Cronbach alphas for both scales. Cronhach’s 
alpha is used as an estimate of the reliability of a psychometric test.  
 
Quality of Life Index (QLI)  
 
The Quality of Life Index (QLI) was developed by Ferrans and Powers [41-42] was 
chosen to measure subjective quality of life in terms of satisfaction with a number of life 
domains. The QLI is a self-report scale where the scales (satisfaction and importance) are 
on a 6-point Likert scale, ranging from 1, very dissatisfied (very unimportant), to 6, very 
satisfied (very important). Respondents are asked first to rate their satisfaction followed 
by importance for in 4 major life domains: health and functioning, 
psychological/spiritual, social and economic, and family. Importance ratings are weighted 
against satisfaction responses so that the respondent’s subjective satisfaction with their 
life can be determined. Five scores are generated consisting of a total score and the 4 
domains each giving a score from 0 to 30. General population data are available for 
research interpretive purposes. The QLI is a well-established instrument with sufficient 
evidence of reliability, validity and sensitivity and has been utilized in more than 200 
published studies [43] [41].  
 
High-Risk Alcoholism Relapse Scale (HRAR)  
 
The High Risk Alcoholism Relapse (HRAR) [44] is a scale comprising of three items : duration in 
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years of heavy drinking, usual number of daily drinks and the number of prior alcoholism 
inpatient treatments. Each item can be scored between 0 and 2 for a total possible score ranging 
from 0 to 6. Subjects scoring between 0 and 2 are considered a low risk for relapse, 3 to 4 at 
medium risk and 5 to 6 at high risk for relapse.  
 
The scale was developed from a study of relapse following in-patient alcoholism treatment in a 
cohort of male US veterans who were asked to rate the risk of alcohol relapse after alcohol 
rehabilitation [44-45]. The HRAR scale identified 107 (35.8%) alcoholics at high-risk for relapse 
prior to discharge. Of the HRAR group 61% were re-admitted within 6 months compared to 28% 
of the low-risk alcoholism relapse (LAR) group (OR = 4.0, 95% CI = 2.4-6.8). The HRAR was 
found to have predictive validity for early relapse in the first 6 months after treatment with a 
sensitivity of 69% and a specificity of 65% The items in the HRAR were derived from a Cox 
proportional hazards model that used alcoholism severity variables present at the index treatment 
[44]. Another study by Yates [46] also found a high correlation between HRAR scores and 
duration of sobriety. Recently De Gottardi [47] used the HRAR to test 387 patients who 
underwent liver transplantation for alcohol cirrhosis and found a HRAR score higher than 3 
(P=.001) as one of the predictors of relapse. The HRAR is the only standardized instrument 
developed to assess risk for alcohol relapse in this population. One of the advantages of the 
questionnaires is that it did not require subject involvement being derived from the data supplied 
by other study measures.  
 
Help seeking  
 
A help seeking questionnaire was developed based on issues raised in the literature concerning 
barriers to and factors contributing to treatment resistance taking into account patient-program 
factors. There were no suitable measures for this patient population in the literature. This survey 
consisted of nine items where participants were asked to rate their confidence about seeking help 
for alcohol related matters from staff. Participants were asked to rate on a Likert scale of 1 to 7 to 
what degree they would endorse each item where 1 = disagree strongly and 7 = agree strongly. 
The 9 items included: how comfortable they felt about discussing alcohol related matters, whether 
staff would be disappointed or see them as a failure for drinking, whether they would be 
embarrassed to disclose alcohol use with staff, whether treatment would be altered by disclosure 
of alcohol problems, whether staff encourage candour and their perception of staff support. They 
were also asked about how much they wanted alcohol treatment. To interpret the results of the 
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survey a scoring system was constructed whereby items 2, 3, 4, 5 and 9 were reversed scored 
therefore providing a means of generating a total scores. The survey’s reliability as psychometric 
measure were investigated and a Cronbach’s alpha of 0.74 was identified suggesting good internal 
reliability of the survey.  
 
Data management and statistical analysis  
 
Data were analyzed using Statistical Package for the Social Sciences (SPSS 2006 ) for Windows 
(Version 15.0). Matched cases were compared with controls. ESALD transplant candidates were 
compared with non-ESALD treatment seekers on a number of variables. Missing data, involving 
3 questionnaires for two participants, was indicated using a user-defined method whereby missing 
values were given numeric value which was defined as missing for SPSS.  
In order to identify the factors contributing to treatment resistance by ESALD transplant patients 
to specialist alcohol services a comprehensive examination and comparison with alcohol 
treatment seekers was required. Comparisons across the samples were made using chi-square 
analyses, ANOVA and Paired Samples T Test. Chi-Square (χ²) tests were used for categorical 
independent variables. Significant mean group differences for parametric variables were analysed 
using one-way analysis of variance (ANOVA) statistical procedures. Analysis of variance was 
used for comparison of continuous normally distributed variables. Continuous variables are 
presented as the mean, standard deviation (SD) and categorical variables are presented as 
proportions. Cohen’s d standardized measure of effect size was utilized to compare the means and 
the strength of the relationship between two variables. Box plots provided visual presentation of 
the data and were also utilized to determine whether an association exists. The Paired Samples T 
Test was used to compare the means of two variables to see if the average difference is 
significantly different from zero. For all statistical analyses reported, the alpha was set at p<.05, 
unless otherwise indicated. All tests performed were two-tailed.  
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CHAPTER 6 
Case Control Study - Results  
 
 
This study sought to identify the reasons for and barriers to the use of alcohol treatment by ESALD 
transplant patients. The results are presented in relation to the two hypotheses. The first hypothesis was 
that ESALD transplant patients do not participate in alcohol treatment as they see no need for 
treatment. The second hypothesis was that ESALD transplant patients tend to not seek professional 
help from transplant staff for alcohol related issues. The final section of the chapter provides the results 
of an exploratory data and analysis investigating who amongst ESALD transplant patients may need 
alcohol treatment.  
 
Participants  
 
The study participants consisted of 40 end-stage alcoholic liver disease (ESALD) transplant patients 
and 40 alcohol treatment seekers (ATS). The ESALD group comprised of 16 (40%) pre-transplant 
patients and 24 (60%) post-transplant patients. The ATS group consisted of 40 subjects from three 
alcohol treatment sites: 24 (60%) outpatient counselling service, 8 (20%) inpatient detoxification unit 
and 8 (20%) from two residential rehabilitation programs. The majority of ATS were interviewed 
within the first week or month of commencing treatment. For the ATS group the primary reasons for 
entering treatment include 15 (37.5%) due to mental health issues (depression), 11 (27.5%) life stress 
(including relationships), 7 (17.5%) legal (DUI), 4 (10%) dependence and 3 (7.5%) work issues.  
 
Hypothesis 1  
ESALD transplant patients differ from ATS and they do not perceive the need for specialty 
alcohol treatment nor are they well matched to standard interventions. These groups were 
expected to differ on length of abstinence, alcohol severity ( lifetime drinking history, 
diagnosis, severity of dependence, alcohol related consequences, risk of relapse). It was also 
hypothesized that they were also likely to have a progressive readiness to change profile and 
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health beliefs supportive of behavioural change. Also ESALD were expected to have less past 
substance abuse, less psychiatric co-morbidity, better quality of life, different demographic 
profile, and less likely to have utilized specialty substance abuse treatment in the past. The 
results for each of these clinical variables will be present as follows.  
 
Current alcohol use  
 
The majority of ESALD group reported being abstinent and had been so for a longer period of time 
compared to ATS who were more likely to be drinking at harmful levels (Table 6.1).  
 
Table 6. 1. Baseline measures of alcohol use  
 ESALD    (n=40) 
Mean (SD) or  n (%) 
ATS (n=40) 
Mean (SD) or n (%) 
Statistical 
Test 
F or χ²** 
 
 P value 
Number abstinent since 
commencing treatment  
Any use*  
 
28 (70%) 
33 (83%) 
 
22 (55%) 
 
χ² (1)= 7.0 
 
0.008 
Abstinence since 
commencing treatment 
Pre-Transplant  
Post-Transplant  
 
 
9.1 months(7.8 months ) 
4.1years  (4.4 years) 
 
9 weeks (20 weeks) 
 
F(1,79)= 
0.18 
 
<0.001 
Recent harmful 
Drinking  
 ( ≥ 140g ethanol/week )  
 
7 (18%) 
 
18 (45%) 
 
χ²(1) = 10.3 
 
0.001 
 
Number with past 
abstinence period prior to 
treatment 
 
 
11 (27.5%) 
 
 
22 (55%) 
 
 
χ² (1) = 6.2 
 
 
0.021 
* Commencement of treatment for the ESALD group was defined as participating in the liver transplant program 
while for ATS it was the commencement of alcohol treatment. Abstinence included nil alcohol use or occasional 
infrequent drinking no more than 2 standard drinks on any one occasion as recommended by the transplant 
program. ** For continuous variables, P values were derived from one way ANOVA test for comparing mean 
values between groups. For categorical variables P values were derived from χ² Square test 
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Liver function tests  
  
Liver function tests at baseline for pre-transplant ESALD were abnormal for total bilirubin, GGT, 
ALT, AST, INR along with low platelet counts (Table 6.2). LFTs were normal or near normal for ATS 
due to the selection criteria for this study which excluded any significant liver disease. ESALD post-
transplant patients were just within the normal high range on all liver function tests except for GGT. 
However GGT values fell to normal range when LFT for relapsers were removed showing no 
difference in LFT with ATS. As a group ATS had fewer subjects with positive Hepatitis C than the 
ESALD group however the latter was most likely due to opportunistic recruitment practice with ATS.  
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Table 6.2. Liver Function tests in Pre- and Post- ESALD transplant patients, ATS, ESALD post-transplant abstainers and relapsers 
*PT= Post transplant * For continuous variables, P values were derived from one way ANOVA test for comparing mean values between groups. For categorical variables P values were 
derived from χ² Square test. 
   ESALD Transplant group       Significance  
 ATS  
(n=40) 
Pre-Transplant  
 (n=16) 
Post-Transplant 
  (n=24) 
 P/T Abstainers 
 (n= 17 ) 
P/T Relapsers 
  (n= 7) 
Pre/Post transplant Abstainers/Relapsers 
Serum albumin 
(g/L) 
41.9 (9.9) 36.1 (6.5) 39.5 (9.9) 38.9 (10.8) 41 (7.70) 0.06 0.542 
Total bilirubin 
(umol/L) 
10.1 (8.8) 29.1 (22.2) 12.4 (8.8) 12.3 (9.6) 12.6 (7.1) <0.001** 0.524 
ALP (U/L) 73.2 (27.2) 153.3 (126.9) 129.6 (93.8) 127.8 (100.4) 134 (82.3) 0.34 0.829 
GGT (U/L) 57.5 (55.3) 130.3 (117.4) 123.5 (170.3) 63.9 (46.3) 268 (266.4) 0.878 0.002 ** 
ALT (U/L) 33.9 (34.6) 125.6 (159.6) 50 (44.8) 43.1 (48) 66.7 (33) 0.226 0.813 
AST (U/L) 65 (16.4) 106.1 (114.9) 48.1 (34.4) 38.5 (24.9) 71.4 (44.3) 0.088 0.482 
Platelets (x10^9/L) 226.6(113) 98.9 (42.6) 180.5 (76.4) 204.4 (71.4) 122.4 (56.6) <0.001** 0.173 
INR 0.94 (0.22) 1.5 (0.4) 1.1 (0.18) 1.0 (0.1) 1.2 (0.3) 0.088 0.79 
HCV Seropositive  
 
6 (15%) 8 (50%) 
 
5 (21%)  2 (11.8%) 3 (42.9%) 0.02* 0.020 
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Past alcohol consumption  
 
The Lifetime Drinking History questionnaire showed that ESALD transplant subjects had lower past alcohol 
consumption (lifetime drinking total, daily average, average per drinking day and fewer years of heavy 
drinking) than the ATS group (Table 6.3).  
 
There were no clear trends or differences between the two groups in relation to the volume variability, 
duration of overall drinking in years, the type of alcohol consumed and style of drinking. For the ESALD 
group alcohol consumption was significantly influenced or associated with peer pressure and social events 
while ATS were more likely to drink in response to emotions and stressors (Table 6.3). There were no 
significant differences between the two groups regarding the drinking context or time of drinking. 
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Table 6.3. Past alcohol use based on Lifetime Drinking History (LDH) 
 ESALD (n=40) 
Mean (SD) or n (%) 
ATS (n=40) 
Mean (SD) or n (%) 
Statistical Test 
F or χ² 
 P value 
Quantity     
Drinking total (kg/ kg body weight) 12.8 (7.7) 19.9 (16.7) F(1,78)= 6.1 0.016 
Duration lifetime drinking (years) 32.7 (6.5) 35.5 (80.1) F(1,78)=2.9 0.088 
Duration of heavy drinking (years) 25.1 (8.8) 30.6 (12.4) F(1,78) =5 0.027 
Daily average (g/kg body weight) 1.10 (0.7) 1.5 (1.0) F(1,78)= 4.2 0.043 
Average per drinking day (kg body weight) 1.25 (0.7) 2.2 (1.7) F(1,78)=11.3 0.001 
Volume variability  5.2 (3.5) 5.3 (4.3) F(1,78) =0.2 0.887 
 Type 
 Beer 
 
56.3% (34.3) 
 
54.6 %(37.9) 
 
F(1,78)= .04 
 
0.829 
 Spirits 14.8% (16.2) 17.3%(20.5) F(1,78)=3.6 0.546 
 Wine  28.9% (31.1) 28.3% (34.7) F(1,78)=.007  0.933 
 Style 
Occasional 
 
4.8%(12.4) 
 
1.8% (7.7) 
 
F(1,78)=0.69 
 
0.198 
Weekend 4.9% (9.2) 3.7% (8.7) F(1,78)=0.38 0.538 
Life Events  
Peers 
 
45.8% (27.5) 
 
28.5% (19.7) 
 
F(1,78)=10.5 
 
0.002 
Work 17.9% (20.1) 12.6% (17.1) F(1,78) = 1.6 0.215 
Family 13.4% (17.3) 13.7% (17.2) F(1,78) =0.006 0.938 
Emotion/Stress 11.6% ( 13.4) 30.2% (20.7) F(1,78) = 22.5 <0.001 
Drug use 6.3% (13.9) 6.7% 20.7) F(1,78) = 0.15 0.903 
Other 1.9% (5.1) 7.4% (12.4) F(1,78) = 6.7 0.012 
Context 
Alone 
 
20.8% (20.9) 
 
26.6 (20.9) 
 
F(1,78)= 1.5 
 
0.232 
Others 79.2% (20.9) 73.9(21.7) F(1,78)=1.2 0.280 
Time 
Morning 
 
6.8% (22.1) 
 
9.5 (16.1) 
 
F(1,78) = 0.50 
 
0.233 
Afternoon 29.5% (24.8) 28.6 (21.2) F(1,78) = 0.59 0.823 
Evening 63.5% (8.8) 59.5 (12.4) F(1,78) = 5.1 0.446 
 % refers to the percentage of time that drinking was associated with specific life events  
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Past alcohol severity 
 
The ESALD group had a significantly lower alcohol problem severity compared with ATS (Table 6.4). The 
SCID 1 interview schedule used to measure retrospective diagnosis (at the time when drinking was considered 
to be a problem) found fewer of the ESALD group had a diagnosis of alcohol dependence. Also the ESALD 
group had fewer symptoms of dependence compared to ATS. ESALD also had less severe alcohol dependence 
than ATS based on SADD scores. They also had fewer negative consequences as a result of alcohol use using 
the SIP measure in the areas of social responsibility, impulse control, interpersonal and intrapersonal 
experiences. However negative consequences of alcohol use in terms of physical health were no different 
between the groups. No differences were found in terms of familial alcoholism.  
 
Table 6.4. Past alcohol dependence  
 ESALD (n=40) 
Mean (SD) or n (%) 
ATS (n=40) 
Mean(SD)or n(%) 
Statistical Test 
F or χ² 
 P 
value 
SCID Alcohol diagnosis  
 Dependence 
 Abuse 
 No diagnosis  
SCID Number of symptoms 
 
23 (58%) 
13 (33%) 
4 (10%) 
3.7 (2.5)    
 
35(88%) 
5 (13%) 
0 (0%) 
5.5 (2.0) 
 
χ² (2) = 10.04 
 
 
F(1,78) = 13.2 
 
0.007 
 
 
0.001 
SADD  13.9 (11.2)      22.8 (10.5) F(1,78) = 13.7     <0.001 
SIP-2R 
Physical  
 
4.9 (2.9) 
 
6.0 (2.8) 
 
F(1,78) = 3.34 
 
0.071 
Interpersonal  4.0 (3.2) 5.5 (2.7) F(1,78) = 4.91 0.030 
Intrapersonal  4.0 (3.2) 5.8 (2.8) F(1,78) = 7.05 0.010 
Impulse control  3.4 (2.8) 6.3 (2.5) F(1,78) = 24.6 <0.001 
Social responsibility 4.0 (3.1) 5.5 (2.9) F(1,78) = 5.10 0.027 
Total Score  20.2 (13.6) 29.0 (11.4) F(1,78) = 9.77 0.002 
SCID 1 - Structured Clinical Interview for DSM IV, SADD- Short Alcohol Dependence Data, SIP  
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Risk of relapse  
 
The risk of relapse derived from the High Risk Alcoholism Relapse Scale (HRAR) showed the ESALD 
group having a significantly lower risk of relapse 3.4 (S.D =1.3) (p value = 0.034). and ATS having a mean 
score of 4 (S.D = 1.4) .A closer evaluation of HRAR scores based on low risk = 0-2, medium risk 3-4 and 
high risk 5-6 [1] are illustrated in Figure 6.1 revealing that the majority of ESALD transplant subjects 
showed a medium risk of relapse while most ATS had a high risk of relapse.  
 
Figure 6.1. Risk of relapse based on High-Risk Alcoholism Relapse (HRAR) score comparing ESALD and 
ATS groups. 
 
 
 
Readiness to change  
 
Readiness to change is one of the most significant factors contributing to a change in alcohol consumption and 
is strongly associated with the need or participation in treatment. The SOCRATES measure was used 
retrospectively (at the time of problematic drinking) and at current (baseline) to develop a stage of change 
profile in order to assess readiness to change for both groups overtime (Table 6.5). In the past ESALD 
transplant subjects reported lower Problem Recognition than ATS but no difference in their Ambivalence or 
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Taking Steps. At baseline ESALD were equivalent to ATS in Problem Recognition and Taking Steps however 
their Ambivalence had decreased significantly.  
 
Table 6. 5. Past and current readiness to change SOCRATES scores 
  
 ESALD 
(n=40) 
Mean (SD) or  
n (%) 
ATS 
(n=40) 
Mean (SD) or  
n (%) 
Statistical Test 
F 
Significance 
p value 
Socrates (Past)*     
Problem Recognition 21.3 (8.3)           27.0 (8.1)     F(1,79) = 9.44 0 .003 
Ambivalence 15.8 (7.2)            14.2 (4.8)      F(1,79)= 1.42 0.238 
Taking Steps 18.3 (8.2)           21.4 (8.3)     F(1,79) = 2.74 0.102 
Socrates (Current)*     
Problem Recognition 27.0 (9.2)          28.8 (7.4)      F(1,79)= 0.90 0.346 
Ambivalence 10.8 (4.7)    15.5 (4.8) F(1,78)=20.2 0.000 
Taking Steps 33.8 (8.3)           33.8 (8.2)      F(1,79) =0.16 0.694 
 
* Retrospective account referring to time when drinking was perceived as a problem  
** Current account at the time of interview  
 
A paired Sample T-test comparing past and present readiness to change using the SOCRATES was used to 
develop stages of change profile in order measure what changes in the subscales had occurred over time 
(Table 6.6, Figure 2). The ESALD group had a progressive readiness to change profile from the time of 
problematic drinking to their current participation in a liver transplant program. There were significant change 
on all SOCRATES subscales with an increase in Problem recognition, decrease in Ambivalence and increase 
in Taking Steps since the time of their problematic drinking. ATS on the other hand only showed a change in 
Taking Steps since the time of problematic drinking and current participation in treatment.  
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Table 6.6. Paired Samples T-test showing Past and Current SOCRATES Scores  
 
  
     ESALD  (n=40) 
 
         ATS (n=40) 
 Past Score  
Mean (SD) 
Current 
Mean (SD) 
P* value Past Score  
Mean (SD) 
Current  
Mean (SD) 
 
P* value  
 
Problem 
Recognition 
 
21.3 (8.3) 
 
27.0 (9.2) 
 
<0.001 
 
27 (8.1) 
 
28.8 (7.4) 
 
0.185 
 
Ambivalence 
 
 
15.8 (7.2) 
 
10.8 (4.7) 
 
 
<0.001 
 
14.2 (4.8) 
 
15.5 (4.8) 
 
0.096 
Taking Steps 18.3 (8.2) 33.8 (8.3) <0.001 21.4 (8.3) 33.8 (8.2) <0.001 
       
 
 
 
Figure 6. 2. Past and Current SOCRATES scales for the ESALD group and ATS group  
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Health beliefs  
The health beliefs model predicts that individuals are likely to change their behaviour if they 
perceive certain health behaviours to be a threat, perceive benefits of and minimal barriers with 
respects to behavioural change. A questionnaire by Cockburn [2] which standardized the 
measurement of the components of the health belief model showed that the ESALD group and ATS 
had equivalent and high scores on perceived illness threat, alcohol as causative in liver disease and 
medical motivation (Table 6.7). Therefore both groups acknowledged the risks to healthy liver 
functioning as a result of alcohol consumption and the benefits of adhering to or considering medical 
advice. The ESALD group perceived fewer barriers to abstinence and a greater sense of control over 
cravings and alcohol related behaviour than ATS.  
 
Table 6.7. Health Beliefs  
 
 ESALD 
(n=40) 
Mean (SD)  
ATS 
(n=40) 
Mean (SD)  
Statistical Test 
        F 
Significance 
p value 
 
Illness threat 
 
41.9 (11.6) 
 
43.5 (10.2) 
 
F(1,79) = 0.43 
 
0.514 
Barriers to Abstinence 3.7 (3.1) 6.7 (4.1) F(1,79) =13.45 <0.001 
Medical Motivation 16.7 (5.5) 17.4 (4.4) F(1,79) = 0.42 0.517 
Control  
Causation  
5.8 (2.1) 
12.3 (3.4) 
4.8 ( 2.0) 
12.1 (2.9) 
F(1,79) = 5.11 
F(1,79) = 0.283 
0.027 
0.596 
 
Past substance abuse  
 
There were no significant difference between the groups regarding the number of subjects who had never used 
cannabis, heroin, methadone, benzodiazepines, amphetamines, cocaine and ecstasy or had a problem with 
those substances (Table 6.8). No differences were found between the groups on IVDU.  
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Table 6.8. Past history of no substance abuse problems  
 
 ESALD 
(n=40) 
n (%) 
ATS 
(n=40) 
n (%) 
Statistical Test 
χ² 
P value  
 
Cannabis 
 
 
33 (83%) 
 
31 (78%) 
 
 
χ²(1) = 1.0 
 
0.31 
Heroin 30 (75%) 
 
34 (85%) 
 
χ²(1) = 1.5 0.22 
Methadone 
  
38 (95%) 
 
38 (95%) 
 
χ²(1) = .033 0.96 
Benzodiazepines  
 
37 (93%) 
 
38 (95%) 
 
χ²(1) = 0.27 0.60 
Amphetamines  
 
36 (90%) 
 
34 (85%) 
 
χ²(1) = 97 0.70 
Cocaine 
 
38 (95%) 
 
37 (93%) 
 
χ²(2) = 1.63 0.34 
Ecstasy  
  
40 (100%) 
 
37 (92.5%) 
 
χ²(1) = 3.12 
 
0.09 
 
IVDU 
 
10 (25%) 7 (17.5%) χ²(1) = 0.67 0.41 
 
Psychiatric co-morbidity and Quality of life  
 
The ESALD group were significantly less likely to have had a past history of mental health problems or to 
have utilized formal mental health treatment. Also the ESALD group showed significantly lower DASS scores 
on the anxiety, depression and stress subscales (Table 6.9). They also showed fewer severe or extremely 
severe ratings on all these scales. DASS scores for the ESALD group were equivalent to normative data 
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derived from a number of Australian samples [3] . Quality of life using the Quality of Life Index measure was 
significantly higher for the ESALD group than the ATS especially in the socio-economic, 
psychological/spiritual and health function domains (Table 6.9). The total quality of life score, 
psychological/spiritual, socio-economic domains for the ESALD group was close to that found amongst the 
general population.  
 
Table 6.9. Psychiatric history, DASS and QLI scores  
 
 
 
ESALD(n=40) 
Mean (SD) or 
n (%) 
ATS(n=40) 
Mean (SD) or 
n (%) 
Statistical Test 
F or χ² 
Significance 
p value 
Healthy 
Norms 
Diagnosis of mental 
disorder (past or present) 
9 (23%) 30 (75%) χ²(1) = 22.06 <0.001  
DASS Total Score  17.8 (19.5) 46.2 (33) F(1,78) = 23.1 <0.001  
Depression              
  
5.6 (6.5)  16.7 (13.6) F(1,78) = 21.8 <0.001 6.34 (6.97) 
Anxiety  3.9 (6.5)     12.2 (9.3)  F(1,78) = 21.0 <0.001 4.7 (4.91) 
Stress Score 7.9 (8.9)            17.3 (11.8)   F(1,78) = 16.0 <0.001 10.11 (7.91) 
Quality of Life (QLI)  
Health Function  
 
21.8 (3.8) 
 
18.4 (6.2)       
 
F (1,78) = 8.27 
 
0.005 
 
23.19 (4.47) 
Socio-economic 22.1 (4.3)         18.7 (5.6)     F(1,78) = 9.30 0.003 21.83 (4.11) 
Psychological/spiritual 22.2 (5.0)     17.1 (7.2)     F(1,78)= 12.45 0.001 22.95 (5.21) 
Family  23.4 (5.7) 21.1 (6.5) F(1,78) = 2.86 0.095 25.60 (4.49) 
Total Score  22.1 (3.5)        18.5 (5.5)     F(1,78)= 11.57 0.001 
 
23.0 (4.49) 
 
Demographic Factors  
 
The following section provides the findings for gender, age, marital status, education, social support network, 
and prior treatment at baseline for both groups. These variables have been associated with alcohol treatment.  
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Demographic characteristics of both ESALD and ATS at the time of the interview are presented in Table 
6.10. The ESALD group were significantly more likely to be married and perceived themselves as having 
good general and abstinence social support consisting of family and friends who support their abstinence. 
They were also more likely to have stable housing in the last 2 years, and to be un employed at the time of 
the interview. There were no differences between the groups on education.  
 
Table 6.10. Demographics  
 
 
Variable  
ESALD(n=40) 
Mean (SD) or 
n (%) 
ATS(n=40) 
Mean (SD) or 
n (%) 
Statistical Test 
F or χ² 
p* 
 
Age at interview  
 
57 (5.9) 
 
55 (6.2) 
 
F(1,78)= 4.3 
 
0.042 
Gender (Males) 34 (85%) 34 (85%)   
Married/De facto  25 (64%) 12 (30%) χ²(1) = 9.22 0.002 
Perceived social support 36 (85%) 5(38%) χ²(1)= 23.85 <0.001 
Employed at interview  13 (33%) 23(58%) χ²(1 )= 5.05 0.025 
Housing stability (≥ 2 years)          38 (95%) 26 (65%) χ²(1)= 11.25 0.001 
Highest level of education 
 ≤SC                ≤HSC                     
≤TAFE                     
≤University 
 
19 (48%) 
6 (15%) 
6 (15%) 
9 (23%) 
 
19 (48%) 
6 (15%) 
7 (18%) 
8 (20%) 
 
χ²(3)= 0.150 
 
0.985 
 
* For continuous variables, P values were derived from one way ANOVA test for comparing mean values between 
groups. For categorical variables P values were derived from χ² Square test.  
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Prior treatment  
 
The ESALD group was less likely to have had prior treatment contact. ATS were significantly more likely to 
utilize residential rehabilitation, outpatient counselling services or AA meetings (Table 6.11).  
 
Table 6.11. Prior substance use treatment  
 ESALD (n=40) 
n (%) 
 ATS(n=40) 
  n (%) 
Statistical Test   
χ² 
 p value 
 
 
Prior treatment  
 
13 (33%) 
 
30 (75%) 
 
χ²(1) = 14.6 
 
<0.001 
Inpatient detoxification  10 (25%)  18 (45%) χ²(1) = 3.5 0.061 
Outpatient detoxification 0 (0%) 7 (18%) χ²(1) = 3.1 0.077 
Residential rehabilitation 8 (20%) 18 (45%) χ²(1) = 5.7 0.017 
Day Program 0 (0%) 3 (8%) χ²(1) = 3.1 0.077 
Outpatient Counselling 4 (10%) 21 (53%) χ²(1) = 16.8 <0.001 
Alcoholics Anonymous  10 (25%) 17 (43%) χ²(1) = 12.1 <0.001 
 
 
Hypothesis 2 
The second hypothesis was that ESALD transplant patients are less comfortable with seeking professional 
help from transplant staff for alcohol related issues compared to those who seek alcohol treatment. Scores 
on a help-seeking survey revealed significantly higher scores on 6 out of 9 items for the ESALD group 
(Table 6.12). Each item was scored out of 7; items closer to a score of 7 indicate strong endorsement. The 
highest total score is 63. ESALD transplant patients were significantly more concerned about disappointing 
staff, reported being embarrassed about seeking help, did not feel encouraged by staff to discuss alcohol 
use, perceived less availability of alcohol support from staff; and were less motivated to utilize alcohol 
treatment if it were available within their treatment setting. These findings suggest that ESALD transplant 
patients may fear being stigmatized as a result of participating in speciality alcohol treatment programs. 
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Table 6.12. Help Seeking Survey scores  
*Some items have been reversed for ease of scoring 
 
 
Item* ESALD 
Mean (SD) 
ATS 
Mean (SD) 
T-value 
F value 
Significance 
p value 
1. I feel comfortable letting staff know about 
problems I may be having with alcohol.  
 
2. Staff would not be disappointed if I was to 
tell them about problems with drinking  
 
3.I would not be embarrassed to let staff know 
about any problems with abstinence   
 
4 .If I let staff know about problems with 
alcohol they will not see me as a failure 
 
5. If I talk about alcohol with staff it will not 
affect the type of treatment I get. 
 
6. Staff encourage patients to talk about their 
alcohol use.   
       
7. Staff have provided help and advice  
with any alcohol related problems      
 
8. I want alcohol treatment provided by this 
service 
         
9. There is a staff member available who 
you can discuss alcohol issues with  
 
Total Scores  
 
6.2 (1.6) 
 
3.2 (2.6) 
 
4.7 (2.6) 
 
5.4 (2.5) 
 
 
5.2 (2.7) 
 
5.2 (2.1) 
 
4.9 (2.3) 
 
 
4.4 (2.3) 
 
5.4 (1.9) 
 
42.6 13.8) 
 
6.5 (1.4) 
 
5.7 (2.2) 
 
5.9 (2.0) 
 
5.5 (2.4) 
 
 
6.0 (2.0) 
 
6.1 (1.6) 
 
6.2 (1.6) 
 
 
6.3 (1.7) 
 
6.5 (1.1) 
 
54.6 (11.7) 
 
F(2.77)= 8.15 
 
F(2,77)=20.97 
 
F(2,77)=5.15 
 
F(2,77)= 2.1 
 
 
F(2,77) = 0.77 
 
F(2,77)=5.06 
 
F(2,77)=9.04 
 
 
F(2,77)=15.49 
 
F(2,77)=10.30 
 
F(2,77) = 8.7 
 
0.369 
 
<0.001 
 
0.026 
 
0.129 
 
 
0.383 
 
0.027 
 
0.004 
 
 
<0.001 
 
0.002 
 
<0.001 
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Indicators for alcohol treatment amongst ESALD transplant patients  
     
As discussed in the literature review, studies have estimated that between 10% and 25% of ESALD transplant 
patients will relapse to harmful drinking within two to five years of being transplanted. Relapse occurs despite 
transplant programs carefully selecting and evaluating potential candidates and a mandatory period of 
sustained abstinence before being listed. An exploratory analysis was undertaken comparing ESALD 
transplant patients who relapsed firstly with ESALD transplant abstainers and secondly with ATS. The aim of 
this analysis was to explore the clinical characteristics of relapsers to determine under what conditions ESALD 
transplant patients may need treatment and what kind of treatment may be more suitable for this population.  
 
As reported earlier of the 24 post-transplant ESALD participants, 12 (50%) returned to any alcohol use, 5 
(21%) drank alcohol in low amounts infrequently while 7 (29%) had relapsed to harmful alcohol use (defined 
as drinking above 140g ethanol/week for both males and females). Pre-transplant participants were not directly 
asked about current alcohol use at the time of the interview and no subjects reported any alcohol use at 
baseline. Due to the small numbers of abstainers and relapsers the following results concerning relapse are 
only a preliminarily exploration into possible trends regarding the possible need for treatment amongst the 
ESALD transplant population.  
 
ESALD post-transplant abstainers and relapsers   
 
ESALD post-transplant abstainers were significantly different to ESALD relapsers on a number of measures. 
Abstainers were less likely in the past to have used other substances (heroin, amphetamine, and methadone) 
whilst they were drinking, more likely to be beer drinkers and to have HCV. Abstainers were more likely to be 
married. In terms of motivation for change, abstainers had higher scores on past Problem recognition and 
Ambivalence suggesting that in the past abstainers had higher perceived severity and acknowledgment of their 
alcohol problem and conflicted about their alcohol use (Figure 6.3). At baseline Abstainers had higher Taking 
Steps in the high decile range (36.41) with a paired –t test showing a p value of 0.001. In contrast relapsers 
scored in the very low decile (22.71) with a significance of p= 0.03 in a paired t-test [4].  
 
 
 
 
 
171 
 
Figure 6.3. Past and Baseline SOCRATES scores for ESALD post-transplant abstainers and relapsers  
 
 
      
Abstainers perceived drinking as causative in liver disease and as threat to their health. They also perceived 
themselves as medically motivated and having more control over cravings and drinking behaviour than ATS. 
No differences existed between the two groups on perceived barriers to abstinence (Figure 6.4). Abstainers had 
higher quality of life total score particularly in health and family domains (Figure 6.5). There was no statistical 
significance between the groups on previous history of mental illness or DASS scores.  
 
There were no differences ESALD abstainers and relapsers on the total help seeking score except that relapsers 
strongly endorsed they were not comfortable letting staff know about problems they may be having with 
alcohol related matters and that they did not perceive that staff were available to support them with alcohol 
related matters (Table 6.13). Relapsers were more likely to have used outpatient detoxification or rehabilitation 
services in the past. 
  
 
 
 
 
172 
 
Figure 6.4. Health Beliefs scales for ATS, ESALD post-transplant abstainers and relapsers 
   
 
Figure 6.5. Quality of life for ESALD post-transplant abstainers and relapsers 
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ATS and ESALD relapsers 
 
ESALD relapsers had less past severity of dependence, fewer alcohol related negative consequences, less likely 
to have alcohol dependence diagnosis and fewer symptoms of alcohol dependence than ATS. They were less 
likely to drink in response to emotions/stressors but more likely to be influenced by their peers and less likely 
to drink alone. ESALD relapsers were also more likely to have used heroin in the past and less likely to have 
had a history of mental illness. On the SOCRATES profile (Figure 6.6) ESALD relapsers had a lower past 
Problem Recognition, Ambivalence and Taking Steps scores than ATS. At baseline relapsers had lower scores 
on all the subscales. They had lower Problem Recognition, less Ambivalence and lower Taking Steps scores.  
 
Figure 6.6 Past and Current SOCRATES scores for ATS and ESALD relapsers 
 
 
In terms of Health Beliefs (Figure 6.4) ESALD relapsers were less likely to perceive drinking as a threat to 
their health and as causative in liver disease than ATS. They were also less medically motivated and 
perceived less control over cravings and their drinking behaviour. There were no differences between 
ESALD relapsers and ATS in terms of housing, presence of partner, IVDU, Hepatitis C, prior treatment 
history, social support or family history of alcoholism. Quality of life was the same for ESALD relapsers 
and ATS. ATS scored significantly higher on all help seeking items compared with relapsers (Table 6.13)             
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*p<0.05, **p<0.001 
Table 6.13. Help seeking beliefs comparing ESALD abstainer and relapsers and ESALD relapsers and ATS 
Item ESALD 
Abstainers  
ESALD 
Relapsers  
ATS  Abstainers and Relapsers              
Significance and d value            
ESALD relapsers and ATS       
Significance and d value            
1. I feel comfortable letting staff know about problems 
I may be having with alcohol.  
6.71 (0.59) 3.83 (2.79) 6.5 (1.4) F(1,23) = 17.3 ** 1.99 F(1,46) = 14.5**  1.65 
2.Staff would not be disappointed if I was to tell them 
about problems with drinking  
3.00 (2.57) 1.71 (1.70) 5.7 (2.2)   F(1,46) = 20.6** 1.91 
3.I would not be embarrassed to let staff know about 
any problems with abstinence  
4.59(2.647) 3.14 (3.07) 5.9 (2.0)   F(1,46) = 9.2* 1.30 
4.If I let staff know about problems with alcohol they 
will not see me as a failure 
4.24 (2.25) 2.43 (2.9) 5.5 (2.4)   F(1,46) = 9.7* 1.27 
5. If I talk about alcohol with staff it will not affect the 
type of treatment I get. 
5.59 (2.32) 4.14 (3.58) 6.0 (2.0)     
6. Staff encourage patients to talk about their alcohol 
use   
4.88 (2.18) 3.33 (2.42) 6.1 (1.6)   F(1,46) = 3.5** 1.63 
7.Staff have provided help and advice with 
any alcohol related problems  
4.76 (2.02)  4.33 (2.66) 6.2 (1.6)   F(1,46) = 6.1* 1.07 
8. I want alcohol treatment provided by this service    4.00 (2.09) 2.17 (2.48) 6.3 (1.7)   F(1,46) = 6.3** 2.31 
9. There is a staff member available who you can 
discuss alcohol issues with  
5.47 (1.63) 3.33(2.5) 6.5 (1.1) F(1,23) = 5.782 *0.32 F(1,46) = 28.3** 2.36 
Total Scores 42.4 (9.83)  38.14(18.3 54.4(11.7)   F(1,46) = 9.6*   1.34 
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Table 6.14 Severity of alcohol dependence, mental health and stages of change scores amongst ESALD post-transplant abstainers and relapsers,      ESALD 
relapsers and ATS  
  
ESALD 
Abstainers 
 
ESALD 
Relapsers 
 
ATS 
 
ESALD abstainers and relapsers χ² 
Significance or P significance and 
d value 
 
ESALD relapsers and ATS χ² 
Significance or P significance 
and d value 
Alcohol Dependence  7 (41%) 3 (43%) 35 (60%) 0.976   0.005 
Number of symptoms 3.2 (2.5) 2.9(2.4) 5.5 (2.0) 0.774   0.004 
SADD total 13.7 (10.3) 8.4 (7.8) 22.8 (10.5)  ** 1.44 
SIP Total 18.7 (11.4) 15.9 (14) 28.98(11.4)  * 1.14 
DASS Total  17.7 (21.8) 23.4 (23.9) 46.2(31.9)  * 0.78 
Socrates Retrospective 
Problem recognition 22.4 (5.0) 13.9 (8.2) 
 
26.95 (8.1) 
 
*1.47 
 
** 1.65 
Ambivalence  15.4 (5.3) 8.7 (4.5) 14.2 (4.8) *1.35 * 1.19 
Taking steps 18.1(6.6) 13.9 (9.9) 21.4 (8.3)  * 0.90 
Socrates Baseline  
Problem recognition  27.2 (9.4) 19.4 (11.8) 
 
28.8 (7.4) 
 
 
 
* 1.17 
Ambivalence 12.5 (4.6) 7 (8.4) 15.5 (4.8)  ** 1.16 
Taking steps 36.4 (3.6) 22.7 (13.0) 33.8 (8.1) **1.96  * 1.27 
*p<0.05, **p<0.001 
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Table 6.15 Health beliefs, Quality of life, Partner, HCV, past treatment history and substance use amongst ESALD post-transplant abstainers and relapsers, ESALD 
relapsers and ATS  
 ESALD 
Abstainers 
ESALD 
Relapsers 
ATS ESALD abstainers and relapsers χ² 
Significance or P significance and 
d value 
ESALD relapsers and ATS χ² 
Significance or P significance 
and d value 
Health beliefs  
Control 6.7 (0.59) 2.9 (2.7) 
 
4.6 (1.96) 
 
**2.71 
 
*1.65 
Illness threat  44.8 (5.7) 25.4 (19.1) 43.5 (10.2) **1.85 **1.57 
 
Medical motivation 17.7 (3.7) 9.4 (7.9) 
 
17.4 (4.4) 
 
*1.65 
 
**1.63 
Alcohol Causation 12.9 (1.9) 8.3 (5.96) 12.1 (2.9) *1.37 *1.12 
QOL Total  23.2 ( 3.3) 19.1 (4.4) 18.5 (5.5) * 1.18  
Partner (%) 72.7 16.7 30 0.008 0.499 
Hepatitis C (%) 11.8 42.9 15 0.020 0.084 
Inpatient detox (%) 5.9 42.9 45 0.027 0.916 
Rehabilitation (%) 5.9 42.9 45 0.027 0.916 
Nil Heroin use (%) 100 42.9 85 0.001 0.012 
Nil Methadone (%) 91 71.4 95 0.021 0.039 
Nil Amphetamines (%) 100 85.7 85 0.004 0.084 
  *p<0.05, **p<0.001 
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Conclusion  
 
ESALD transplant patients will not identify nor perceive a need for speciality alcohol treatment 
due to their lengthy abstinence, a progressive readiness to change profile and constructive health 
beliefs. ESALD transplant patients are less likely to engage in standard alcohol treatment having a 
less severe alcohol problem, good social support, better quality of life, less psychological distress 
and less contact with mental health or substance abuse treatment services. There were no 
differences between the ESALD group and ATS in perceived physical harm due to alcohol use, a 
family history of alcoholism, IVDU and past substance use. ESALD transplant patients unlike 
those in an alcohol treatment setting were less comfortable with reaching out for help from 
transplant staff which suggests that stigma may be relevant in respects to treatment resistance. 
Tentative findings suggest that ESALD transplant patients may need treatment if there is 
deterioration in quality of life, poor social support, changes in health beliefs and motivation. Those 
with a history of IVDU, prior substance abuse treatment and other substance abuse at the time of 
drinking may perceive alcohol as not strongly contributing to their liver disease. Unlike ATS, 
ESALD transplant patients who relapse are less confident about seeking professional help from 
staff.  
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CHAPTER 7 
Case Control Study - Discussion 
 
 
This chapter provides an overview of the case control study and discusses the results in relation to the 
previously outlined objectives and hypotheses. The results of the case control study pointed to two 
reasons why ESALD transplant patients will resist alcohol treatment and confirmed the two 
hypotheses. Firstly, the majority of ESALD transplant patients do not perceive a need for treatment 
lacking many of the need and predisposing variables significantly correlated with alcohol treatment 
seeking. Secondly, ESALD transplant patients, unlike ATS are less comfortable and experience 
barriers to treatment seeking suggesting a fear of stigma and lack of access to alcohol services. 
Indications for alcohol treatment for ESALD transplant patients, strengths and limitations of the 
current study are also discussed. 
 
Absence of need factors  
 
ESALD transplant patients who have achieved a considerable period of abstinence are likely to 
perceive alcohol treatment as unwarranted and therefore will resist treatment. In this study 70% of 
ESALD transplant subjects reported abstinence (which included minor infrequent alcohol use) since 
being diagnosed with ESALD and accepted for liver transplant candidacy (Table 6.2). Weinreib and 
colleagues in a similar case control study also concluded that ESALD transplant patients who have 
achieved abstinence will naturally reject established alcohol treatment. In that study ESALD pre-
transplant patients had a mean of 36 months abstinence compared with only 20 days in the past month 
for alcohol treatment seekers [1]. 
 
Lengthy periods of abstinence by ESALD transplant patients have been widely reported in the 
literature. Recently, Di Martini (2010) reported that 54% of post-transplant patients had maintained 
complete abstinence for nearly four years Maintenance of long-term abstinence by ESALD transplant 
patients is not surprising considering selection and evaluation procedures, mandatory abstinence, 
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monitoring of alcohol use by transplant programs and the patient’s personal motivation to remain 
abstinent due to a life threatening medical condition.  
 
Motivation, health beliefs and abstinence 
 
In order to determine whether poor motivation or readiness to change is a contributing factor to 
treatment resistance by ESALD transplant patients this study examined past and current SOCRATES 
subscales. A progressive stages of change profile was found amongst ESALD transplant patients 
showing an increase in problem recognition, decrease in ambivalence and increase in taking steps. 
This readiness to change profile suggests that since the time of problematic drinking and on being 
diagnosed with ESALD, transplant patients had gained awareness of the problems associated with 
harmful alcohol use, had made behavioural changes to achieve abstinence and experienced little 
struggle with maintaining change [2].  
 
The results of this study of ESALD subjects showed a low ambivalence score of 10.8 and a high 
current taking steps score of 33.8 which were very similar to those of Weinreib [3] who found a mean 
score of 10 for Ambivalence and a Taking Steps score of 36 among pre-transplant subjects. The same 
profile of low ambivalence and high taking steps has been found amongst abstainers in the PROJECT 
MATCH study and was associated with alcohol treatment completion, high abstinence self-efficacy, 
less temptation to drink, greater control and more behavioural change [4]. High action scores amongst 
medical inpatients with unhealthy alcohol use strongly predicted readiness to change and reduced 
alcohol consumption [5, 6].  
 
In this study while problem recognition for the ESALD group had increased over time and it was 
equivalent to the current problem recognition score of ATS, it was a low score. The problem 
recognition score for ESALD transplant subjects in the current study was 27 which is a low. Weinreib 
[3] found an even lower problem recognition score of 17. The presence of low problem recognition 
amongst ESALD transplant subjects despite low ambivalence and high taking step scores suggests 
that ESALD are behaviourally in the action stage but cognitively in the pre-contemplative or 
contemplative stage. As discussed in Chapter 3 there have been a few reports of ESALD and ALD 
patients as being in the pre-contemplative stage despite evidence of abstinence or marked reduced 
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drinking. This pre-contemplative status has suggested that abstinence by these patients is only due to 
medical illness, associated with less insight, and raises concerns that their abstinence may not be 
enduring.  
 
However cognitive processes found to be important in the contemplation stage decrease as behaviour 
changes. Research evidence has found a reduction in problem recognition among individuals who 
have made behavioural change due to increasing self-efficacy and no longer requiring maximum 
awareness of the alcohol problem [4, 7]. Similarly, recent research has found high problem 
recognition scores to be associated with more severe alcohol consumption and alcohol problems 
while high scores on Taking action have been found to be the strongest predictor of decrease in 
drinking [5, 8, 9]. In this study the use of the SOCRATES measure did have limitations as it was 
observed that some subjects preferred not to endorse items where the word ‘alcoholic’ appeared 
therefore lowering their problem recognition score. Finally, to be behaviourally in action stage but 
cognitively in the pre-contemplative stage points to the presence of cognitive dissonance [10]. To 
maintain abstinence but continue to be pre-contemplative suggests that ESALD patients are able to 
maintain dissonance in their motivation for change over a number of years. However the increasing 
tension and discomfort of dissonance motivates people to alter their attitudes, beliefs or behaviours to 
reduce the discomfort and restore consonance; especially if there is high discrepancy and 
subsequently higher magnitude of dissonance [11].  
 
The data on health beliefs does suggest that ESALD have sufficient problem recognition. The 
majority of ESALD subjects acknowledged heavy alcohol use as causative in liver disease, had a 
sense of illness threat, recognised the importance of medical motivation, and showed greater control 
and fewer barriers to abstinence. Similarly, a recent study found that 60% of alcohol liver disease 
patients at their first psychosocial evaluation for transplantation were aware of alcohol toxicity [12].  
 
Together the findings of lengthy abstinence, a progressive SOCRATES profile and constructive 
health beliefs suggest that ESALD transplant patients who are abstinent have made a genuine change 
to drinking behaviour and therefore do not require a specialty alcohol treatment intervention. These 
findings do not support denial and the denial stereotype of ESALD transplant patient as a reason for 
treatment resistance in the majority of cases. As discussed in Chapter 4, ESALD transplant patients 
have been observed as being in ‘denial’, having limited insight or awareness of their alcohol problem 
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[13, 14]. Denial is widely regarded as a prognostic factor for the likelihood of relapse and may 
jeopardize liver transplant candidacy depending on other factors associated with stable remission 
from alcohol relapse. There is little in the transplant literature defining, identifying or measuring 
denial nor is the context where denial manifests (e.g. personal, interpersonal, medical) taken into 
account. In the transplant field, denial may involve any one or combination of the following 
mechanisms: the denial of alcohol dependence, denial of the etiology of liver disease or denial of the 
diagnostic label of alcoholic liver disease. It may also involve denying the need for abstinence, the 
possibility of relapse or the need for treatment. It may be a defensive reaction to the fear of stigma 
associated with alcoholism or a reaction to transplant evaluation which may involve direct or 
confrontational strategies by the clinician. Also as discussed in Chapter 4 patients facing threatening 
medical illness such as end-stage liver disease will experience a period of denial. According to Travis 
[15], in the field of gastroenterology, denial can be both adaptive and maladaptive and should not be 
stigmatized. Denial in the early phase of illness can act to minimize emotional flooding and 
disturbing cognitions while helping to preserve the individual’s hope of the invincibility of the body 
and psychological integration [16]. This complexity and issues surrounding denial have yet to be 
addressed in the literature [17].  
 
A less severe alcohol problem  
 
The need for specialty alcohol treatment is heightened not only by motivation for change but a 
number of other factors including the severity of the alcohol use disorder. This study found that 
during the period of problematic drinking ESALD transplant patients had a less severe form of 
alcoholism than the ATS group. ESALD subjects were less likely to have an alcohol dependence 
diagnosis, fewer symptoms of dependence, less severity of dependence, lower past alcohol 
consumption and fewer negative alcohol related consequences.  
 
There is a small body of research investigating the severity of alcohol problems among ESALD 
transplant patients using standardized addiction measures. The current study’s finding of lower 
severity of alcohol dependence is consistent with reports amongst those with severe ALD or awaiting 
transplant evaluation [18-23]. In one of the few studies to use a severity of dependence scale among 
ESALD transplant patients Gledhill [24] found very low SADQ scores before and after 
transplantation. In this study the proportion of ESALD patients meeting diagnostic criteria for alcohol 
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dependence was 58%, a similar percentage found among ALD patients however much lower than the 
75% to 80% usually reported using pre-transplant evaluation data [25-27]. Although Kelly and 
colleagues reported only 32% of their sample as having a diagnosis of dependence based on case 
notes records of diagnosis of dependence, withdrawal, alcohol seizures or treatment for withdrawal. 
The disparity of these findings may be due to the retrospective review of dependence at the time of 
problematic drinking which usually predated medical problems and therefore subjects were less likely 
to meet the necessary three symptoms to meet the criteria for an alcohol dependence diagnosis.  
 
ESALD transplant subjects had a lower lifetime alcohol consumption with less daily average and 
average per drinking day (Table 6.3) consistent with studies comparing ALD patients with treatment 
seekers presented in Chapter 3 [28, 29]. However this finding contrasts with Weinreib [1] who found 
higher lifetime alcohol consumption and more standard drinkers per drinking day amongst ESALD 
transplant patients compared with alcohol dependent patients seeking treatment. This study reported 
an average intake of 6.7 drinks per day for the ATS group and 9.8 drinks per day for ESALD 
subjects. Other studies have reported around 15 standard drinks for treatment seekers [30] and 107 to 
144 grams of alcohol per day for ESALD transplant patients [25, 27, 31, 32]. A possible reason for 
the higher alcohol consumption found in Weinrieb’s study among ESALD subjects compared with 
ATS was this study used subjects who were part of a research trial for pharmacotherapy and not 
typical of alcohol treatment seekers. If ESALD transplant patients were to have a lower level of 
alcohol dependence with fewer symptoms it is expected that they are likely to drink somewhat less 
than alcohol treatment seekers due to fewer symptoms of dependence [19]. 
 
No studies have measured alcohol related consequences among ESALD subjects but alcohol 
treatment seekers are known to have a high prevalence of behavioural, social and interpersonal 
problems concomitant to alcohol consumption which increases their need for alcohol treatment [19]. 
Based on the above finding the cohort of patients in this study match the profile of ALD patients 
(discussed in Chapter 3) who are described as engaged in heavy controlled drinking most of their 
lives, have minimal consequences as a result of drinking and a pattern of drinking which existed in a 
stable peer and social structure [19, 28, 33-36].  
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Psychiatric co-morbidity  
 
Psychiatric co-morbidity is a key predictor for alcohol treatment seeking as discussed in Chapter 4. In 
the current study lower rates of psychiatric co-morbidity were found amongst ESALD subjects with 
23% of the sample having had any formal treatment for a mental health problem compared with 75% 
of ATS. Furthermore ESALD transplant subjects had lower anxiety, depression and stress scores on 
the DASS. These levels were lower or equivalent to values found in the general community. 
 
The rate of mental health problems found in this study is consistent with studies reporting between 
20% and 35% of ESALD transplant patients will have had a history of depression or other mental 
health problem based pre-transplant evaluations [37, 38]. A recent comprehensive study into 
trajectories of depressive symptoms within the first post-operative year in a cohort of 167 patients 
transplanted for alcoholic cirrhosis found 56% with low depression levels and only 18.6% with 
consistently high depression levels [37]. Again low levels of psychiatric morbidity is expected 
considering liver transplant selection criteria whereby those with good mental health are considered 
more suitable candidates due to the physical and psychological stressors associated with liver 
transplant surgery and recovery. 
 
Quality of life  
 
In this study quality of life was defined an individual’s own perception of wellbeing that 
stems from the discrepancy between satisfaction and importance with aspects of life that are 
considered personally important. The ESALD group had a higher quality of life than alcohol 
treatment seekers. As discussed previously a poor quality of life amongst alcohol treatment 
seekers in substance abuse treatment has been reported [39-41] and a quality of life which 
can be lower than those with chronic medical health conditions [42]. Accordingly an 
improvement in quality of life has been linked with reduction in alcohol consumption [43].  
 
Quality of life scores for ESALD pre- and post-transplant subjects (excluding relapsers) in the same 
age group using the same measure as that used in this study (QLI) were found to be similar to cancer 
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survivors [44] and blood stem cell transplant patients [45]. Quality of life scores for the ESALD group 
in this study when compared with the general population norms were lower in the health and family 
but equal on the psychological and social domains.  
 
Social resource  
 
In this study the ESALD group were more likely to be married, to have stable housing, general and 
abstinence social support but no difference in education levels. Kelly [32] who investigated ESALD 
transplant patients in the ANLTU between 1987-2004 noted that the majority of patients (n=72) 79% 
had family/friends, 84% stable housing, 78% had a partner. Studies have reported only 16% to 26% 
of ESALD transplant patients to lack family support or live alone [32, 46, 47] while ATS are known 
to have a much poorer social network [48, 49]. As presented in Chapter 3, research shows that 
between 50% and 78% of ESALD transplant patients tend to be married [1, 25, 32, 50, 51] while 
marital rates among ATS range from 42% to 48% [48, 52-54] and they are more likely to be divorced 
[28, 53-56].  
 
Based on the treatment seeking model used in this study the lower levels of current employment 
among the ESALD group compared with ATS could predispose them to seeking alcohol treatment if 
there is a return to drinking. As a result of the medical demands of transplantation and ill-health, and 
therefore unsatisfactory unemployment may contribute to psychosocial and economic difficulties 
Research has pointed to the lack of employment among ESALD transplant patients as contributing to 
relapse [57]. 
 
Barriers to treatment seeking  
 
One of the most unique contributions of this study was its inclusion of a help seeking survey to assess 
the views of ESALD transplant patients regarding seeking help from transplant staff for alcohol 
related issues. ESALD transplant patients were less confident than alcohol treatment seekers about 
reaching out for professional assistance. They were significantly more concerned about disappointing 
staff, reported being embarrassed about seeking help, did not feel encouraged by staff to discuss 
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alcohol use, perceived less availability of alcohol support from staff; and were less motivated to 
utilize alcohol treatment even if it available. The endorsement of these kinds of statements suggests 
the threat of self-stigma. Self-stigma associated with professional help-seeking involves the 
perception of oneself as inadequate or weak, the fear of losing self-regard, self-competency, and 
overall self-worth [58]. As discussed in Chapters 4 and 8, self-stigma is the most cited reason for 
individuals’ avoidance of substance abuse treatment (particularly in the latter stages of the treatment 
seeking process) in order to avoid negative self-evaluation and loss of self-esteem. The in-depth 
interview study (Study 2) of this thesis found stigma to a major barrier to utilizing alcohol treatment 
by ESALD transplant participants. Lucey [59] refers to contextual factors reducing professional help-
seeking by ESALD transplant patients 
 
This resistance to treatment may reflect the fear that a declaration of a desire for 
alcohol will be interpreted by the transplant team as a sign of poor candidacy or a lack 
of commitment to sobriety. (p.757) 
 
As discussed in Chapter 3 the clinical management of alcohol use disorder by transplant programs 
and the contrasts with alcohol treatment provided by addiction medicine services. Long term 
abstinence after transplantation continues to be an important goal for liver transplant programs with 
relapse considered as a failure by hepatologists. While in addiction medicine, alcohol dependence is 
recognised as a relapsing condition and individuals are encouraged to discuss their alcohol use, 
relapse and any difficulties they may have with maintaining change. It has been argued that the strict 
abstinence policy by transplant programs is not conducive to patients seeking help for alcohol related 
issues [59]. Weinreib and colleagues [60] have written extensively about how transplant programs do 
not encourage candour about alcohol use and the negative consequences for patients if they were to 
disclose any alcohol use especially during the pre-transplant period.  
  
The findings of this survey are consistent with these comments. Relapse to alcohol use is a time when 
professional treatment needs to be seriously considered. Disclosure of alcohol use in this setting not 
only threatens an individual’s candidacy for transplantation but also a lack of candour establishes a 
state of affairs which prevents the patient seeking help from transplant staff in the event of a relapse 
[59].  
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Indications that treatment is required  
  
A comparison of clinical variables between ESALD transplant abstainers and relapsers was used to 
identify the type of treatment that may be more suitable for this population. Relapsers had lower 
scores on the SOCRATES showing less motivation for change on all the SOCRATES subscales than 
ATS and less taking steps than ESALD abstainers. This suggested that ESALD transplant relapsers 
are less open to making change or seeking treatment. Cognitively relapsers perceived more barriers to 
abstinence, were less likely to be medical compliant, and less likely to consider alcohol as a 
contributing factor to liver disease.  
 
A tentative finding was that relapsers tended to have HCV and co-morbid substance abuse. It is 
possible that among ESALD transplant patients with a co-morbid substance dependence whose liver 
disease involved HCV and where alcohol may have been a secondary dependence may not be fully 
convinced that alcohol was causative factor in their ESALD. DiMartini and colleagues found ESALD 
transplant patients with a history of other substance use and HCV had more depressive symptoms and 
had greater alcohol consumption when they relapsed [37, 61]. 
 
One of the key findings of the study was that relapsers had a lower quality of life than ESALD 
abstainers but equivalent to ATS. These findings are consistent with studies which have referred to 
poor quality of life among ESALD relapsers discussed in Chapter 3 in the areas of employment, social 
life, health, psychological wellbeing. A recent study by Di Martini [61] found relapse to moderate or 
heavy pattern of drinking occurred amongst those who were more stressed, reported worse health, had 
more pain and less energy. She proposed that alcohol was being used to handle these stressors and the 
difficulties of the early post-transplant phase. Interestingly, Ruppert [62] found a steady decline in 
most quality of life domains over a 12 year period for all transplant patients with patients with 
ESALD and hepatitis C having the lowest quality of life in all domains. Relapsers were also less 
likely to be married or in a cohabitating relationship than abstainers, commensurate with studies 
which have found an association between a lower risk of relapse amongst ESALD transplant patients 
with the presence of a partner or spouse [32, 63-67] while a high divorce rate has been found amongst 
those who relapsed [68, 69]. Similarly the wider drug and alcohol research literature has also shown a 
link between relapse and the absence of social support and being unmarried [70-76].  
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An unexpected finding was the relative lack of psychiatric co-morbidity among ESALD relapsers 
considering the large body of research which has linked psychiatric co-morbidity with relapse both in 
general substance abuse area and the ESALD transplant area [32, 64, 77]. A recent study found a lack 
of association between relapse and presence of low to high depressive symptoms among ESALD 
transplant patients in the first year post-transplant [37] but another study by the same researcher 
found quality of life as predictor for relapse. Quality of life may be good predictor of relapse. As 
discussed in the literature review quality of life has been found to be poorer among some ESALD 
transplant patients especially those who relapse and may be a good predictor of relapse.  
 
Overall, the findings derived from this study of relapsers compared to abstainers and treatment 
seekers, suggests that changes in motivation, health beliefs, quality of life, marital and social support 
are factors that may contribute to relapse. Interventions that address these areas may enhance 
willingness to enter treatment and improve transplant outcomes.  
 
Study Strengths  
 
This research focused on an important gap in the research. Rather than trial another alcohol treatment 
program the present study took a different approach by asking why ESALD transplant patients resist 
alcohol treatment. A significant strength of the current study is that, to the best of the author’s 
knowledge, it is the first study of its kind to comprehensively profile the pre-transplant and current 
clinical characteristics amongst ESALD using a number of standardised alcohol measures. 
Furthermore ESALD transplant subjects were effectively matched to those who commonly utilize 
alcohol treatment services on age and gender whilst effectively controlling for the presence of liver 
disease by providing laboratory results. 
 
An innovative approach used in the current study was an examination of the stages of change amongst 
ESALD transplant subjects from the time of problematic drinking to becoming a transplant patient. 
The purpose of this was to accurately explore and measure the process of behavioural change by 
ESALD transplant subjects allowing for the identification of continuously distributed motivational 
processes and behaviours that underlie stages of change. Another original aspect of the current study 
was the surveying of the attitudes and perceptions of ESALD transplant patients regarding the alcohol 
management program provided by liver transplant programs. While a number of researchers and 
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clinicians have pointed to the controversy and complexities surrounding the transplantation of 
ESALD patients there has been no research investigating client satisfaction of the alcohol 
management approach utilized by liver transplant programs.  
 
Limitations  
 
One of the main limitations of the study was the reliance on standardized measures as these depend 
on self-reporting and retrospective responses. While standardised measures selected for the current 
study had good psychometric properties (reliability and validity) in the general alcohol using 
population, they have a number of shortcomings. These include the validity of causal conclusions due 
to social desirability, systematic response distortions, the influence of setting or context in which self-
report occurs, method variance and rely formally on the honesty and conscious awareness of the 
individual. These measures were not validated in the population with ESALD.  
 
Retrospective measures are prone to memory biases, especially considering the presence of mild 
cognitive impairment amongst pre-transplant patients. To minimise these limitations, measures and 
procedures were used to enhance memory, patients were carefully screened out who had 
encepathalopathy and a cognitive impairment test (Mini-Mental State Examination test) was used if 
cognitive impairment was suspected. It was observed that subjects, being older in age, enjoyed the 
retrospective nature of the measures.  
 
A number of limitations need to be discussed in relation to use of the SOCRATES measure. The 
validity of stage assessments as discrete stages by the SOCRATES measure has been reported [77] 
however the subscales represent attitudes and activities related to the stage of change and are not 
designed to precisely measure stage status rather they reflect dimensions of the process of change [2]. 
It may be argued that the use of past and present SOCRATES may not be reliable for assessing shifts 
in subscales and that subscales change over time. However studies reporting good predictive validity 
with the SOCRATES and movement towards high action scores have been related to positive 
outcome and congruent with the tasks, attitudes and activities related to that stage [78, 79]. Higher 
motivation for change has been correlated with greater reductions in substance use and treatment 
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engagement, retention and outcomes [80].  
 
The SOCRATES measure (including other readiness to change measures ) has limitations as it is not 
able to sufficiently measure the maintenance stage and is not setting-sensitive [81]. Anecdotally, this 
study noticed subjects rejecting the stereotypical word “alcoholic’ found in many items of the 
measure affecting the response and endorsement of these items by subjects due to the stigma 
associated with this term.  
 
The method of detecting and eliciting alcohol consumption in this study relied on self-report with 
occasional blood analysis and staff reports. However more recent research studies examining relapse 
rates in this population have started to utilize collaborative evidence involving interviews with 
patients and family, medical records, random toxicology screen, and collateral information from 
primary supports. While more biochemical markers could have been utilized such as urine toxicology 
screens, carbohydrate deficient transferrin and other methods they can be limited by low sensitivity or 
lack of specificity [14, 63]. The biochemical markers do not provide a measure of the amount of 
alcohol confirmed or frequency of use [82]. They are less useful for this study than self-report.  
 
Discrepancies can exist due to self-reports of alcohol use as patients may underestimate consumption 
due to reporting errors arising from retrospective accounts and the pressure on patients to deny 
drinking when patients know that it may not be in their best interests to be candid [60, 83, 84]. 
However retrospective self-reporting continues to be one of the most effective methods of estimating 
lifetime alcohol consumption in clinical populations. In general, several studies have validated self-
report for alcohol research [85-87] and the use of measure LDH has been reported to have good 
validity and reliability (Chapter 5). 
 
Confidence in self-report data used in this study was increased with the use of the following 
strategies. The use of memory aids, the preponderance of abstinent subjects, corroborative data from 
liver function tests, exclusion of cognitively impaired subjects, lack of acute psychiatric problems, 
assurances of confidentiality and independent administrator [15, 88]. Special care was taken to ensure 
the confidentiality of disclosures about alcohol use in order to encourage candor lest patients perceive 
that there would be negative consequences for open disclosures. However despite these measures it 
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remains possible that subjects were reluctant to accurate report their alcohol or drug use.  
 
Another limitation was the lack of standardized measures and medical records to confirm or assess 
for the presence of familial alcoholism, history of mental illness and presence of a social support 
network. This study also did not examine the role of medical health problems, demands of the 
transplant regimen and geographical location and these may constrain or impact on treatment 
motivation or attendance. Finally and importantly the small sample size may limit the generalisability 
of the findings and comparisons were not made with healthy controls which could have further 
improved our understanding of this population. For example Glesson [20] recently pointed out that 
while dependence amongst ALD patients may be not as high as alcohol treatment seekers, it was not 
as low as heavy drinking controls or those in the general population sample of ‘heavy drinkers’ who 
were not seeking health care. This can distract clinicians from recognizing that some may have severe 
dependence.  
 
The use of multiple hypothesis testing and repeated statistical testing is known to increase the 
potential for Type I error increasing the probability that a statistically significant outcome appears at 
least once especially in a small sample. In order to reduce the chance of type I error a Bonferroni 
adjustment was utilized in most statistical tests. Importantly the current study was an explorative 
study and a stringent criterion for statistical significance and methodological rigour would have 
compromised the opportunity to research a range of variables essential to developing a clinical profile 
on these two clinical populations.  
 
Another possible bias may be selection bias as patients were drawn from two distinct groups as 
demonstrated on demographic characteristics. Patients were selected on matching variables of age 
and gender which may be considered potential confounders and perhaps not true in the population of 
interest. However the average age of liver transplants is around 50-60 years old and thus 
representative of the liver transplant sample. Also this age group is unlikely to be treatment seeking 
and therefore is not a significant confounder. As the majority of the transplant population is male and 
again older males are less likely to seek treatment, the use of gender was not considered a significant 
bias. Other potential matching variables may be been added such as dependence severity, 
consumption (history), relationship status. These were considered however due to difficulties 
recruiting older ATS males a further matching variable would have delayed completion of the study 
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for another 12 months.  Thus there were pragmatic reasons for restricting to age and gender. It may be 
argued that pre and post-transplant patients are a different population and this would have influenced 
results on a number of the markers of treatment seeking. We did a few comparisons between pre and 
post transplant subjects however there were no identifiable differences between these two groups on. 
Importantly due to small sample size this study had limited statistical power to evaluate this question.     
 
Conclusion  
 
ESALD transplant patients are less likely to seek or utilize specialty alcohol services as these services 
are not tailored to their needs. Firstly, their clinical profile of lengthy abstinence, progressive stages 
of change, constructive health beliefs, less severe alcohol problem, less psychiatric co-morbidity, 
higher quality of life and social resources make alcohol treatment unsuitable among those who can 
maintain abstinence.  
 
Secondly, alcohol treatment programs are not suitable to ESALD transplant patients who generally 
have a very different clinical profile to those who would attend speciality alcohol services. Stigma 
and structural factors such as the lack of onsite suitable alcohol support services act to minimise help 
seeking by ESALD transplant patients. 
 According to Tripp [86] 
 
The vast majority of our patients are maintaining sobriety without treatment, without 
reported psychosocial sequelae, cravings or relapse behavior, and without any feeling on 
their part or the part of their families that treatment is needed. They are people who say that 
if we insist on AA they will go, but they really feel very little need. (p252) 
 
The clinical profile of most ESALD transplant patients is closer to ALD patients who have changed 
their drinking or self-changers who have recovered from an alcohol use disorder without needing 
professional help. Like self-changers they have used a cognitive appraisal to generate change, have a 
less severe form of alcohol dependence, less alcohol consumption, fewer alcohol related 
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consequences, married and tend to have greater social stability. Health problems are the primary 
motivation for change.  
Chapter 12 will present the final conclusions and recommendations for alcohol treatment for ESALD 
transplant patients.  
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CHAPTER 8 
Harmful alcohol use, stigma and treatment: a review of the 
literature 
 
 
Beyond the richness and complexity of their interpersonal (and inter-role) meeting, doctor and 
patient are surrounded by rich and complex contexts. They are surrounded by the claims and 
concerns of their families. They are surrounded by societal values and expectations and by 
those of their small religious and social circles. They are often surrounded by a hospital or 
clinic and other members of the health care team. They are surrounded by hospital polices, 
governmental regulations, the demands of third-party payor paperwork, the limitations of the 
law, and the possibility of malpractice suits. From this perspective neither patients nor 
caregivers will be regarded as naked individuals stripped of all historical, social, institutional 
and convictional connections [1] (p.21).  
 
Spectacular results, especially improved physical, emotional and social function of those with 
ESALD, have been achieved through the process of medical management of ESALD and execution of 
liver transplants (Chapter 2). Similarly, advances in addiction medicine have increased the 
understanding of harmful alcohol use and improved the treatment of this condition. At the same time, 
however, there remains significant resistance to the use of alcohol treatment services by those who 
engage in damaging alcohol use, including those who seek liver transplant surgery. As previously 
explained, this resistance poses considerable challenges for managing and preventing relapse into 
alcohol use of those who engage in transplant surgery.  
 
As mentioned in Chapter 4, arguably the most significant barrier to treatment is stigma. This chapter 
conducts a review of the literature that focuses on stigma as a deterrent or obstacle to medical 
treatment. Despite the availability of effective alcohol treatments by medicine, 54% to 85% of those 
with harmful alcohol use in the general community will not pursue treatment, with stigma being 
frequently identified as a major reason. Little is known about the relationship between stigma and 
why medical treatment for harmful alcohol use. Few studies have identified the mechanisms behind 
why medical treatment triggers a fear of stigma by those with harmful alcohol use [2]. This is a 
complex issue and most of the research has been conducted with those with mental health problems. 
In order to explore this issue, it is important to first refer the sociological literature pertaining to 
chronic illness as ESALD transplant patients deal with two chronic illnesses, firstly end-stage liver 
disease and secondly, harmful alcohol use therefore the sociology of chronic illness is important to 
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examine. This will be followed by the findings of key sociological researchers in the area of health- 
related stigma.  
 
 
The Sociology of Chronic illness  
 
Chronic illness has been defined as those forms of health disorders that hinder an individual’s social 
interaction and role performance. The sociological interest in chronic illness has partly developed due 
to the limitations of medical treatment for chronic illnesses. While the medical management of 
disease is an important resource to people in times of illness, especially useful for quantifying, 
measuring and treating illness, it has however been criticised for being too narrow. Sociologists have 
argued that chronic illness is more than the disease and it’s pathophysiology and that medical practice 
disregards the social aspects of illness, its meaning and experience for those living with a chronic 
illness [3, 4]. Research exploring illness perception has found illness behaviour significantly 
contributing to mental health, coping responses, health behaviours and interestingly degree of 
involvement with healthcare professionals [5].  
 
A great deal of sociological work has been on the conceptualisation and consequences of chronic 
illness. Over the last 50 years the conceptualisation of illness behaviour by medical sociologists has 
been modified and broadened since Talcott’s Parson’s more static conceptualisation of the ‘sick role’ 
in 1951. The results of suggest the need for a multidimensional view. A number of important social 
and psychological processes associated with chronic condition/s and the illness experience have been 
reported as a result of recent interpretive sociological studies of chronic illness.  
 
 
 
 
Charmaz (1991) landmark research highlighted that chronic illness was not only an assault on an 
individual’s physical self, but also their self-identify and self-worth [6]. Charmaz referred to the 
potential for ‘loss of self’ as individuals become more immersed in the illness experience and the day-
to-day aspects of managing illness. Illness can contribute to a restricted life through the  loss of 
conventional life activities, social isolation, with nothing to look forward to, and nothing to do. 
According to Charmaz without the development of an equally valuable and meaningful new selfhood, 
the individual with chronic illness may feel the loss of self-image. Similar to the ‘loss of self’ 
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described by Charmaz,, Anderson (1991) spoke about the devalued self experienced by women with 
type 1 diabetes and the need to reconstruct a new self [7].   
 
Another leading figure in the sociology of chronic illness has Bury (1982) who argued that chronic 
illness might be conceptualized as form of ‘biographical disruption’ [8]. Chronic illness can prompt 
disruption in a number of areas – assumptions and behaviours, explanatory systems, self-concept and 
resources. It can require a re-evaluation of one’s former life and identity and new illness identity, 
reflection on consequences and mobilisation of social-economic resources.  
 
A number of sociologists have also referred to the ‘moral’ dimension of illness. According to Parsons, 
the sick role obliges the patient to do everything possible to achieve ‘the goal of complete recovery’ 
[9]. More recently, Townsend and colleagues (2006) in their qualitative study describe how 
participants feel the need to demonstrate their moral worth as individuals, that to manage symptoms 
and their daily lives becomes a moral obligation [10].  
 
Sociological taxonomies include stigma as an important component of the lived experience of chronic 
illness especially for those with a chronic stigmatizing condition such as alcoholic liver disease.  
  
 
What is stigma? Erving Goffman and the creation of ‘spoiled identities’ 
One of the major contributors to understanding stigma in health settings is Erving Goffman, an 
American sociologist. His work on stigma provides a necessary and comprehensive understanding of 
the core processes connected with stigma. His work, Asylums: Essays on the Social Situation of 
Mental Patients and Other Inmates (1961), was the first sociological examination of the social 
experiences of patients with mental health problems in the hospital environment. He described the 
social processes that are set in motion on entering the hospital and how they challenge and change 
people’s pre-institutional social roles and identity. He observed the ‘moral career’ of patients, 
referring to the experience of being a ‘good patient’, to the humiliating circumstances of being a ‘bad 
patient’, to the changes in judgement of self and others, to restrictions of freedoms and, finally, the 
need for defensiveness. Goffman’s study highlights the process of medical socialization as patients 
experience the disorienting processes associated with entry into hospital-based social relations and the 
change in identity that such institutionalised arrangements necessitate. 
 
Goffman (1963) further explored the experience of stigma associated with addictions, mental illness, 
deformity and disability in his Stigma: Notes on the Management of Spoiled Identity (1963). Here he 
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proposed that stigma was an ‘attribute that is deeply discrediting’ reducing the stigmatized person 
‘from a whole and usual person to a tainted, discounted one’ [11] (p.3). In describing the sociological 
and psychological antecedents of stigma, Goffman drew attention to the ‘ground rules’ or structures 
involved in human social interaction. He proposed that individuals, like actors on a stage, attempt to 
sustain a positive and consistent self-image and to acknowledge the same in others. He referred to 
one’s virtual social identity, which he differentiated from actual social identity, attributes a person in 
fact possesses. According to Goffman, some attributes, such as a physical or mental disability, can 
discredit or ‘spoil’ the virtual identity of the bearer, making them undesirable, bad, dangerous or 
weak.  
 
A central idea in Goffman’s work is that the self is ‘not a property of the person to whom it is 
attributed, but dwells rather in the pattern of social control that is exerted in connection with the 
person by himself and those around him’ [34 (p168)]. Stigma arises in the course of social interaction 
whereby a person’s identity is marked or rendered as unacceptable – what Goffman called ‘spoiled’. 
This dynamic can lead to exclusionary social processes that limit the individual’s ability to fully 
participate in everyday life, including social relationships. Goffman proposed a taxonomy of stigma 
based on three distinct types: overt or external physical deformations, ‘tribal traits’ such as those 
pertaining to ethnicity, and finally, ‘blemishes of individual character’ connected with weak will, 
passions and dishonesty.  Based on Goffman’s classic formulation, stigma has been identified by 
sociologists as a social process involving a relationship that can operate inter-personally, between 
groups and institutionally. It is a dynamic process of interaction that produces adverse personal effects 
including profoundly damaging affect. Since Goffman, there has been an explosion of research 
emphasizing the situational nature of stigma, the cognitive social components and the role of the self 
and identity in responses to stigma.  
 
Health-related stigma research  
 
Stigma has become an important topic in health and health care research, as contributions by medical 
sociologists, social psychologists, public health researchers and clinical psychologists, on the 
relationship between stigma and the social burden of illness attest [12-17]. These researchers have 
been working to formulate a concept of health-related stigma to guide health social science research, 
policy and practice. The results of this enterprise, however, have been overly broad, lacking the 
detailed specification and depth of conceptualisation and analysis of the relationship between self-
conception and social identity theory. 
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Health- related stigma theory and research continue to be guided by Goffman’s ideas and therefore 
focuses on stigma as a social process linked to an ‘attribute that is deeply discrediting’ as 
demonstrated by exclusion, rejection, blame or devaluation. According to health-related stigma 
researchers, a medical diagnosis or health problem elicits stereotyping, prejudice and discrimination. 
Weiss and colleagues offer a definition of stigma that illustrates this approach:  
 
Stigma is typically a social process, experienced or anticipated, characterized by exclusion, 
rejection, blame or devaluation that results from experience, perception or reasonable 
anticipation of an adverse social judgment about a person or group. This judgement is based 
on an enduring feature of identity conferred by a health problem or health-related condition 
and the judgment is in some essential way medically unwarranted. In addition to its 
application to persons or a group, the discriminatory social judgement may also be applied to 
the disease or designated health problem itself with repercussions in social and health policy 
[18] (p280)]. 
 
American socio-medical scientists, Link and colleagues (1989), influenced by Goffman’s construct of 
discrediting attributions which reduce the self-worth of individuals,  developed what they called a 
modified theory of stigmatization. The modified labelling theory emphasizes that individuals, as part 
of daily socialization, internalize the negative stereotypes and conceptions of what it means to be 
labelled with a mental illness. These stereotypes are fully in place before an individual enters 
treatment and, according to Link and colleagues (1989), are activated and internalized by individuals 
once they enter treatment and are officially labelled through diagnosis. This triggers an array of 
cognitive and behavioural responses in which people involved in the labelling process (the labelled 
and labellers) infer that the labelled person possesses undesirable characteristics [19]. This is acute if 
labelling is conducted within specialist medical settings as specialist treatment is perceived by 
individuals as a more powerful labelling event. [20].  
  
The official public label brings personal relevance to a labelled person’s views about the attitude of 
the community towards those with a stigmatized condition. If the person accepts the label, he/she 
internalises the attributes associated with the stereotype and  devaluation becomes a part of a person’s 
view of him/herself. It also shapes the nature of their social relations and connectedness. According to 
Link and associates [19] ‘labelling triggers powerful expectations of rejection that in turn erode 
confidence, disrupt social interaction and impair social and occupational functioning’ (p.179). They 
argue that stigma might be expected to occur in situations where sufficient power exists to confer a 
label which resonates in public culture.  
 
In health care, such a label has the potential to control access to services and core institutions. 
Therefore, stigma may be embedded in health systems through the application of certain diagnoses, 
the attitudes and behaviours of health care providers towards the condition, the organisation of health 
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services and the design of health interventions and health policies [18]. In terms of treatment seeking, 
those who perceive high levels of stigma may avoid contact with treatment services as it may confirm 
their membership of a stigmatized group. Individuals may opt to avoid the stigma all together by 
denying their group status and not seeking to participate.  
 
Link and colleagues conducted research which tested modified labelling theory showing that despite 
diagnosis and contact with treatment services, stigma continued to have a relatively strong and 
pervasive effect on mental health, functioning and behaviour linked to labelling-activated 
expectations of rejection [19, 21, 22]. Psychiatric labels, including diagnosis of substance abuse, were 
found to be associated with stereotypes by the public, leading to social withdrawal, avoidance and 
rejection and maladaptive interaction strategies, including secrecy coping, in order to deal with their 
stigmatized status [21, 23]. 
 
Recently, Link and Phelan [13] expanded their definition of stigma to include ‘elements of 
stereotyping, separation, status loss and discrimination occurring in a power situation that allows 
these processes to unfold’[13] (p.367). They explain how stigma operates through a combination of 
five interrelated components: i) differentiation and labelling human differences, ii) linkage of labelled 
persons with negative stereotypes associated with dominant cultural beliefs, iii) categorization of 
labelled persons in order to accomplish some degree of separation of ‘us’ from ‘them’, iv) status loss 
and discrimination experienced by labelled people that lead to unequal outcomes and v) unequal 
access to social, economic and political power that renders some more vulnerable than others to i) – 
iv).   
 
According to Link and Phelan, stereotypes are social phenomena because they represent collectively 
agreed-upon ideas. They can automatically and quickly generate impressions and short- hand 
decisions about individuals who belong to a stereotyped group [13]. While social identity theorists 
focus on self-categorization and prototypical group evaluations in understanding health related 
stigma, American medical sociology and social psychology focus on the role of cultural stereotypes, 
and the role that medical diagnosis plays in triggering and generating them [15, 17, 18, 24-26].  
 
 
Chronic Illness and Stigma  
 
As mentioned earlier, sociological taxonomies include stigma as an important component of the lived 
experience of chronic illness. Jacoby (2005) from Division of Public Health United Kingdom, 
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reviewed the literature on the relation between stigma and the neurological disorder of epilepsy [27]. 
Using a multi-causal model incorporating neurological, psychosocial, demographic and treatment 
variables, stigma emerged as one of the seven key predictors variable for impaired self-esteem, low 
self efficacy, helpless, anxiety and depression, reduced life satisfaction and a predictor for 
psychopathology. Perceived stigma contributed to poorer quality of life along with psychological 
distress, loneliness and adjustment difficulties, with clinical variables associated with disease 
contributing less than expected.    
 
In the case of chronic illness, the devaluing or discrediting may be due to a number of factors. Stigma 
is part of chronic illness because individuals who are chronically ill have less ‘social value’ than 
healthy individuals. In their investigation those unable to participate in the process of ‘reciprocal 
exchange’ because of ill health are considered to have less social value and so stigmatised [27]. 
Furthermore they propose that in order to simplify good and poor reciprocators, whole groups of 
people may be perceived to have poor social value, rather than individuals. According to Millen and 
Walker in their paper of stigma of chronic illness the greatest threat comes from self-labelling as 
sufferers internalise the lower status revealed to them by ‘normals’ in society including medical 
professionals. Sufferers of chronic illness can lose personal physical space as they are invaded by 
‘normals’ with ‘probes and measures’ and who handle the ‘end products of their bodily functions’. 
The continuing need to explain one’s incapacities from a range of ‘normal’ social interactions helps 
generate a negative self-narrative that justifies exclusion. The stigma associated with chronic illness 
has also been attributed to perceived responsibility for the illness by individuals [28]  
 
Harmful alcohol use and stigma 
Alcohol disorders are among the most highly stigmatized of the psychiatric disorders [23, 
29]. Research continues to show that the public perceives individuals with an alcohol 
problem as being responsible for their illness as well as being dangerous, blameworthy and 
immoral [2, 30-35]. While public health education campaigns have resulted in greater public 
understanding of alcohol use disorders as a medical or psychiatric condition, this has not 
markedly decreased public stigma or the maintenance of social distance by the general public 
[36, 37] . 
 
Recently, Schomerus (2011) conducted a systematic literature review exploring aspects of the 
stigma of alcoholism compared with other health problems. ‘Alcohol-dependent persons’, 
compared with people dealing with mental disorders, were perceived more negatively, less 
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frequently regarded as mentally ill, held more responsible for their condition, incited more 
social rejection and more negative emotions (anger, irritation, indifference) , and were at risk 
for structural discrimination. According to Schomerus, the difference between the stigma of 
alcoholism and that of other health conditions, particularly mental health issues, was that it 
was used to enforce social norms, making ‘the deviant’ conform establishing acceptable 
behaviour.  
 
Robin Room [30] in Stigma, social inequality and alcohol and drug use asserts that the most 
stigmatizing stereotype or attribute of ‘alcoholism’ is that the person has little or no will 
power to resist alcohol and this is a sign of moral and character weakness. He argues that 
character weakness is one of the most vivid and isolating distinctions which can be made by a 
society where attributes of success, morality and respectability are associated with self 
discipline and will power. Alcohol use can serve as a demonstration of the extent of valued 
personal qualities such as self-control. Entering treatment for alcohol problems, as a result, is 
potentially humiliating evidence of failure in self-management. 
 
Stigma and alcohol treatment seeking 
Stigma has been found to be a major barrier to professional treatment-seeking reducing treatment 
compliance and participation [19, 38-45]. As previously discussed, despite the availability of effective 
alcohol treatments by health services, the majority of those in the general community with harmful 
alcohol use will not pursue treatment, with stigma being frequently identified as a major reason.  
 
A recent national epidemiologic survey by Keyes and colleagues [2] involving 34,653 adults between 
2004-2005 in the United States with alcohol abuse/dependence, and using the perceived devaluation-
discrimination scale, examined whether perceived stigmatization of alcoholism was associated with 
less likelihood of using alcohol services. The study found that individuals with a lifetime diagnosis of 
an ‘alcohol use disorder’ were less likely to utilize alcohol services the greater their association of 
stigma with alcohol use disorders. Higher perceived stigma of harmful alcohol use among the 
participants was associated with male gender, lower income and education, being previously married 
and non-white.  
 
High levels of stigma have been reported by individuals with substance use disorders receiving 
treatment. Luoma and colleagues (2007) examined stigma related experiences of 197 patients from 15 
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residential and outpatient substance abuse treatment facilitates. Patients were asked to complete a 
number of questionnaires regarding the experience of stigma whilst undergoing treatment [46]. The 
majority of individuals who entered substance abuse treatment believed that: most people held 
stigmatizing attitudes or behaviours; people would treat them unfairly on knowing about their 
substance use; others were afraid of them on finding about their substance use; and family and friends 
rejected them once they knew about their substance abuse. Elevated levels of enacted, perceived and 
self-stigma were reported by participants. Enacted stigma was defined as experiences of social 
discrimination (such as reduced access to housing, employment opportunities or social rejection); 
perceived stigma involved beliefs that members of a stigmatized group have about the degree of 
stigmatizing attitudes and reactions by others; and self-stigma as feelings of shame, negative self-
evaluation and loss of confidence that arise from the identification with a stigmatized group. Secrecy 
coping (or concealment strategies), detrimental to recovery from addiction, were related to lower 
quality of life, experiences of stigma-related rejection in the past, higher internalized shame, and 
employment problems.  
 
This study also showed that treatment systems were more likely to stigmatize people with a greater 
number of treatment episodes, a finding consistent with other studies [47]. According to the 
researchers, these findings support Link et al (1989) modified labelling theory which proposes that 
stigma begins to impact with an official label from a treatment establishment. This finding was 
confirmed by Sirey [43] who showed an increase in perceived stigma at the start of treatment resulting 
in poorer compliance with prescribed antidepressant regimens.  
 
Cognitive beliefs and utilizing professional services  
 
In both quantitative and qualitative studies, the most frequently endorsed reason for not using formal 
substance abuse treatment provided in both quantitative and qualitative studies involves ‘wanting to 
solve one’s drinking problem on one’s own’, without the need of professional help [39, 41, 48-51] 
(Chapter 4). Self-stigma may be a factor behind an individual’s preference for handling the problem 
without treatment, perhaps reflecting misplaced self-efficacy and fear of challenges to one’s self-
esteem [50]. It is important to note that stigma is also a major reason cited by the general public for 
avoiding professional psychological help, apart from a desire to avoid discussing distressing or 
personal information. To be seen as seeking help from another is often internalized by the individual 
as a sign of weakness, or an acknowledgment of failure, inferiority or inadequacy and therefore 
treatment-seeking poses a threat to one’s self-esteem and self-efficacy [14, 52, 53]. Subsequently, not 
seeking professional help acts to protect one’s self-esteem [54]. Stigma has been found to contribute 
to loss of self esteem, resulting in depressive symptoms [14, 19, 23, 55-58].  The stigma associated 
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with seeking professional psychological help results in negative attitudes [52], a decrease in treatment 
adherence and termination of treatment [43, 44]. 
 
 
Social identity theory 
Social identity theory is one of the most prolific contemporary theories approaches to explaining the 
relationship between self, group and intergroup behaviour, and addresses phenomena associated with 
stigma. The theory was first developed in Britain by Henri Tajfel in the 1970s and derived from his 
scientific and personal reflections in social perception, social categorization, and social comparison. 
According to Tajfel, large scale social behaviour cannot be adequately explained by personality traits 
or interpersonal interactions. Rather, he proposed, an individual’s self-concept and intergroup 
behaviour are derived from perceived membership in a relevant social group. He defined social 
identity as ‘the individual’s knowledge that he (sic) belongs to certain social groups together with 
some emotional and value significance to him (sic) of this group membership’ [59] (p. 292). 
Intergroup contexts drive people to make comparisons that maximize differences between self (as an 
in-group member) and other (as an out-group member) [60]. Over the last few decades, social identity 
theory has developed both conceptually and empirically with an extensive explanatory scope and 
range addressing stereotyping, self-conception, motivation, collective behaviour, norms and social 
influence, multiple categorization, and intragroup phenomena [61]. 
 
Social identity theory differs and progresses further than Goffman’s perspective of self and stigma. 
For Goffman stigma involved face to face interaction, ordinary social life rather than large scale social 
behaviour in a range of social contexts. Social identity theory elaborates in detail the operation of 
intergroup processes, the range of group behaviours, and contextual salience of specific social 
identity, and recognizes that individuals can differentiate into multiple identities.  
 
According to social identity theory, a social group is defined as at least three people sharing the same 
social identity. According to Hogg 
They identify and evaluate themselves in the same way and have the same definition of who 
they are, what attributes they have, and how they relate to and differ from people who are not 
in their group or who are in specific out-groups. Group membership is a matter of collective 
self-construal – ‘we’ and ‘us’ versus ‘them’. [61] (p.115) 
 
Individuals can have many social and personal identities depending on the groups they affiliate with, 
the personal relationships they are involved in. Also, as the situation or context changes, the form that 
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the identity takes also changes. In any given situation, however, only one identity is psychologically 
salient to direct self-construal, social perception and social conduct.  
 
 
Social categorization and prototypes   
 
One of the key conceptual components of social identity theory, used to explain the relationship 
between self-conception and group processes, is social categorization [62, 63]. Social categorization 
is considered the cognitive basis of social identity processes, with categorization of self and others 
playing a pivotal role in social identification, group life and group membership. From a social identity 
perspective, groups are strongly associated with categories of people and social categories. Social 
categorization involves the establishment of a group as a prototype. Michael Hogg (2006) describes 
prototype as ‘a fuzzy set of attributes (perceptions, attitudes, feelings and behaviour) that are related 
to one another in a meaningful way and that simultaneously capture similarities within the group and 
differences between the group and other groups or people who are not in the group’[61] (p. 118). 
Prototypes prescribe group membership, they graph the contours of social groups – the norms, 
characteristics, how people will behave and interact with one another, and how the group differs from 
other groups. Prototypes emphasize attributes that favour the in-group over the out-group, and tend to 
describe ideal, often hypothetical, in-group members.  
 
The act of categorizing a person as a group member means that the idiosyncratic nature of individuals 
is seen and evaluated through the lens of the prototype and prototypical attributes. This is the means 
by which the self is assimilated to the in-group prototype and individual behaviour is transformed to 
correspond to the appropriate self-defining group prototype and in-group norms (normative 
behaviour) [62, 64, 65]. Once the norm has been established, it is internalized as the context-specific 
in-group prototype to which people conform through self-categorization. Group norms prescribe 
attitudes, perceptions and behaviour, and serve to express in-group similarities and in-group identity 
but also polarise the in–group from the out-group.  
 
According to Hogg [61], social categorization depersonalizes and sorts out both in-group and out-
group members:  
 
Depersonalized perception of out-group members is more commonly called stereotyping – 
you view ‘them’ as being similar to one another and all having out-group attributes. When 
you categorize yourself, exactly the same depersonalization process applies – you view 
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yourself in terms of the attributes of the in-group (self-stereotyping), and since prototypes 
also describe and prescribe group-appropriate ways to feel and behave, you feel and behave 
normatively. (p.119)  
 
The categorization and depersonalization of group prototype has a number of advantages. It serves to 
create a positive self-concept, optimal distinctiveness (as attributes tend to be ideal and positive), a 
sense of belonging, uncertainty reduction, group cohesion, conformity and ‘patterns of in-group 
liking, trust, and solidarity’ (p.119). The darker side of categorization is that intergroup harmony and 
self-enhancement is dependent on polarizing and differentiating between group members and groups, 
a ‘we agree that we are like this and they are like that’.  
 
If out-group attributes are highly negative and degrading, it may produce dehumanization, generating 
prejudice, discrimination, ethnocentrism, intergroup conflict, deviance and stereotyping. Out-group 
members, by being associated with undesirable attributes, tend to have to strive harder for self-
distinctiveness, status, privilege, resources and social mobility. Also, less prototypical members, 
particularly those that are in-group rather than out-group members, are cast as deviants or 
marginalized, especially when they threaten the integrity of group norms [66-68]. It is important to 
note that social categorizations that affects identity and behaviour must be psychologically salient. 
People tend to draw on social categorization that are valued, important, easily linked to their self-
concept and when situation favour an in-group membership [69].   
 
Honneth and mutual recognition  
 
A more recent and critical theoretical contribution to understanding stigma and social identity, has 
been made by German philosopher, Axel Honneth [70], whose work focuses on relations of power, 
recognition and respect. Honneth draws heavily on the phenomenology of recognition, as discussed 
by Georg W. Hegel and George Mead and on the object relations school of psychoanalysis, 
particularly the work of Winnicott. These schools of thought have long recognized the importance of 
interactive experiences or mutual social recognition in the formation of identity, self esteem and 
mental health. In Honneth’s view, intersubjective relations and mutual recognition in social relations 
are essential to an individual’s identity formation, self-confidence, self respect and social esteem: ‘the 
experience of being socially esteemed is accompanied by a felt confidence that one’s achievement or 
abilities will be recognized as ‘valuable’ by other members of society’ [45 (p33)].  
 
Mutual recognition is acquired and maintained intersubjectively where each member of a society is 
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capable of experiencing social esteem, a self-respect whereby each individual acquires the sense of 
universal dignity of persons, morally responsible agents and something of value. The withholding of 
recognition and the lack of societal solidarity (in which every member is in a position to be valued) 
act to undermine an individual’s identity and self esteem. Consequently those who experience 
exclusion, insult and degradation will struggle for recognition in an effort to redeem identity and 
dignity. For Honneth, the importance of the social group can be seen in the significant role played by 
group pride or collective honour in social movements, such as in the homosexual gay rights or 
American black human rights movements.  
 
For Honneth, self-esteem depends on a process of social inclusion based on mutual recognition, and 
therefore his theory proposes a means of correcting and responding to stigma. Unlike social identity 
theorists, Honneth provides a means of correcting and responding to stigma and associated processes 
of inclusion and exclusion. He emphasizes the importance of establishing supportive relations which 
involve social inclusion based on mutual recognition and community solidarity. Social identity theory, 
by contrast, does not offer a foundation for challenging stigma. It is largely descriptive, arguing the 
necessity of processes of devaluation and exclusion of others in the establishment of social identity. 
To a significant extent, it is functionalist in its approach insofar as it suggests that the splitting and 
othering it identifies are requisites of social identity. Honneth’s approach is demonstrably critical of 
this putative necessity. Anderson, in his preamble to Honneth’s book, makes an important point about 
members of marginalized groups: they ‘have been systematically denied recognition for the worth of 
their culture or way of life, the dignity of their status as persons, and the inviolability of their physical 
integrity and of their worth’ [45(p1)].  
 
Honneth’s theorisation is supported by a growing body of evidence on the social and environmental 
determinants of health and disease. Social processes and circumstances determine the extent to which 
a person possesses the physical, social, and personal resources to identify and achieve personal 
aspirations, satisfy needs, and cope with the environment (a broader definition of health). Research 
has consistently shown that quantitative and qualitative improvements in socioeconomic conditions in 
relation to early childhood, health and social services, housing, education, nutrition, employment 
security and working conditions contribute to better health and longevity [71, 72]. Sociological 
research has also demonstrated that exposure to stressful experiences (such as death of a spouse, 
trauma or abuse, unemployment, divorce, poor education, financial limitations, or living in dangerous 
neighbourhoods) has a strongly negative impact on the physical and mental health of certain groups 
[73].   
 
It is powerfully evident that supporting social relationships benefit health: adults who are more 
socially connected live healthier and longer lives than their more isolated peers [73]. Unmarried 
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individuals (particularly those who experience stressors such as separation, divorce and widowhood) 
have more illnesses and disabilities, shorter lives and more psychiatric disorders than do married 
persons [73]. Marriage stress has been associated with compromised immune and endocrine function, 
depression [74].  
 
According to Honneth, it is the symbolic dimension of social life – involving the processes that 
accord value and esteem for individuals’ specificity and include them as integral members of 
collective life – that is foundational to people’s sense of self-worth and efficacy. From such a 
perspective, stigma can be understood as a pervasive feature of culture that consistently dishonours, 
humiliates, marginalizes and excludes those who are not valued for their individual specificity or for 
their contribution to and inclusion in collective or group life. Honneth’s approach suggests that 
recognition and respect, operationalized through social participation and social inclusion, is the 
answer to stigma.  
 
Self-management and self-transcendence  
 
In-depth interviews of those with chronic illness, involving a range of disabilities, have provided 
insights into how individuals adjust to chronic illness and illness-related stigma. This is a growing 
literature and beyond the scope of this thesis however a brief summary will be provided. Self-
management is a dynamic process central to actively managing a chronic illness. According Kralick 
[75] self-management creates order, discipline and control in their lives, manage the shift in self-
identity and enjoy a better quality of life. While the processes have not been clearly delineated 
optimal self-management consists of an ability to monitor illness and to use cognitive, behavioural 
and emotional strategies to maintain quality of life [76]. 
 
Two processes appear critical firstly, acknowledging the self as ‘changed’ and ‘sick’ and secondly, a 
purposeful search for meaning, normalisation and self-validation with entry back into usual social life 
despite limitations.  Bury[77] referred termed this process ‘legitimation’ whereby Individuals come to 
construct meaningful explanations making sense of their life circumstances and biographies,  and 
thereby gaining perspective in order to re-establish credibility in the face of the assault on self-hood.  
According to Bury normalisation plays an important role in coping with illness as it is the 
‘psychological bracketing off’ of the impact of the illness, so that its effects on the person’s identity is 
not too distressing. Normalisation acts as means of protecting individuals from stigma in order to 
preserve the social and emotion self. Royer (1995) identifies a number of strategies where avoidance 
assists to ‘normalise’  and therefore adjust to chronic illness by engaging in usual activities, 
 
 
215 
 
maintaining normal appearance, avoiding embarrassing situations, limiting contact with persons in 
similar circumstances and engaging in denial [78].  
 
Self-transcendence, while not developed by sociologists is theory developed by Reed (1991) found in 
nursing research literature. Self-transcendence is a complex, developmental process precipitated by 
life challenging events [79]. It has been associated with positive life outcomes including a high 
quality of life, emotional well-being and lower levels of illness distress [80]. Self-transcendence is a 
growth process especially high during ‘end- of- own- life experiences’ in which individuals broaden 
their personal perspective, and activities beyond physical psychological and social boundaries to find 
meaning and purpose during a challenging life experience [79, 81] It is considered to be a dimension 
of spirituality precipitated by a spiritual emergency as individual face their mortality. Outcomes 
described by participants include a renewed sense of purpose and meaning in life, acceptance of 
personal circumstance, connectedness with self and others [81]. Liver transplant patients have been 
found to have a higher liver of self-transcendence than other patient population. Bean [80] using a 
mixed method design found self-transcendence to be positively correlated with lower levels of illness 
distress, being employed, high perceived quality of life, strengthening of interpersonal relationships as 
a result of the informants’ transplant experience.    
 
Medicine, stigma and harmful alcohol use: the way forward  
 
According to Link [19] the findings of stigma research poses a key challenge for medicine and health 
care providers:  
 
Stigma has important effects, effects that remain even when people improve while 
participating in treatment programs. Health care providers are therefore faced with the 
challenge of how to address stigma in its own right if they want to maximize the quality of 
life for those they treat and maintain the benefits of treatment beyond the short term. (p.187). 
 
Research has revealed the diverse negative effects of stigma including diminished social network  size 
[30], restricted employment opportunities [82, 83], lowered self esteem, and increased depressive 
symptoms [14, 19, 23, 55-58], discrimination [23, 58, 73], limited social opportunities [73, 84], 
increased reliance on a counter-culture [30], and stress-related illness and impairment in daily 
functioning and relapse [45, 73, 85].  
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As previously mentioned, stigma has also been found to be embedded in health systems [18]. For 
example, health care professionals may hold stereotypical attitudes that substance use is within the 
control of the individual. Accordingly they may blame them for their condition resulting in inferior 
service provision. Brener et al [86] found that staff attitudes can influence the quality of care provided 
to those in substance abuse treatment affecting treatment retention. Staff who have developed skills in 
establishing a therapeutic collaborative working alliance, are non-threatening and supportive, retain 
clients in treatment. Many can hold unconscious negative attitudes towards their clients but may 
report no awareness of such attitudes. A number of studies show that general practitioners and health 
professionals experience discomfort, lack confidence or try to avoid patient disclosures about alcohol 
use [87]. They report fears that questions about drinking may harm the patient-provider relationship 
[88-90] or contribute to stigmatization [91, 92].  
 
Some have suggested that medicine has sought to protect individuals from the societal stigma 
associated with ‘alcoholism’, by emphasizing that alcohol dependence is a medical condition that 
requires treatment [93]. Yet, in a critical essay by Williamson [94], it has been argued that despite the 
availability of public education and neurobiological data over the years, and enduring negative 
attitudes by the public, medicine has not succeeded in reducing the stigmatization of those with 
addictive disorders. According to Williamson, even if alcohol use disorders were regarded as illness 
rather than bad behaviour, the public would continue to have legitimate concerns about the medical 
costs, violent behaviour, and reluctance of patients to participate in treatment and take responsibility 
[37]. 
 
In response to this situation, sociologists have proposed that medicine needs to incorporate a social 
model of health, which focuses on reducing stigma and improving the quality of life and well-being of 
those vulnerable to stigma, reducing its adverse effects [18, 95]. Williamson proposes an integrated 
medical-ethical approach:  
 
One task of an integrated medio-ethical approach to alcohol dependence must be to disabuse 
the public (and professionals) of the notion that the condition can be addressed by focusing on 
the behaviour of individual drinkers. Science has long acknowledged the role that social 
environment plays in the development of dependence and its remedy...…Responsibility for 
preventing and controlling dependence also exists at a community level and the work is 
required to assess the extent to which and in what ways individuals and organisations might 
be accountable for alcohol misuse and the dependence of others. Together biomedical and 
ethical arguments for affording more detailed attention to social environment and social 
responsibilities in debates on alcohol dependence can help to dissipate the blame that falls on 
individual drinkers and that lies at the heart of stigma. (p e7) 
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Similarly Schomerus [96] posits that  
 
.. stigma could be quite a dysfunctional way of pursuing the goal of keeping someone within 
the in-group of those able to control their drinking……Here, the social purpose of the stigma 
of alcoholism can directly be addressed: to recover from alcohol dependence, people need 
personal strength and help from others. A stigma is downright contrary to these needs, 
because it weakens and isolates those affected, and it thus aggravates a problem it was 
probably intended to control. (p.110).  
 
Conclusion 
 
Medical practice has enhanced the health and quality of life for individuals, families and community. 
The experience of end-stage liver disease and transplantation has many physiologic, psychological, 
social and spiritual manifestations contributing to the potential for illness distress, requiring the 
transplant recipient to continuously adjust to the chronic aspects of living with transplantation. 
Individuals may have to adjust to the changes in identity, self-worth and social relationships. 
 
Stigma is a central concern for those with a stigmatized chronic condition and  remains a major 
barrier to treatment seeking and treatment participation. A review of the sociological literature has 
revealed the complexities of stigma as a social process. In the health field, researchers have identified 
a number of critical processes involved in stigmatization including: medical diagnosis, labelling, 
stereotyping, discrimination and ensuing adverse health and social effects. Those with harmful 
alcohol use continue to attract considerable negative public attitudes which serve to undermine their 
motivation for treatment. Attitudinal, organisational and policy changes are required by medicine and 
other health care services in order to make treatment of harmful alcohol use less stigmatized and 
treatment more accessible. Recognizing those who use alcohol in harmful way, as agents who can 
participate constructively with service providers in treating their alcohol use, and including them in 
the planning, provision and follow-up of such treatment, appear to counteract practices that result in 
stigma. Precisely how such recognition and inclusion might work in a medical setting such as that 
associated with ESALD is an issue that requires further investigation. Chapters 11 and 12 discuss 
these issues further. 
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CHAPTER 9 
IN-DEPTH INTERVIEW STUDY   
METHODOLOGY 
 
 
As outlined in the literature review, international studies have shown that ESALD transplant 
participants are reluctant to participate in specialty alcohol treatment involving both 
pharmacotherapy and/or psychotherapeutic interventions, especially when this is offered within a 
liver transplantation program [1-3].  Treatment avoidance and treatment seeking amongst those 
with alcohol use disorders has been investigated using both qualitative and quantitative research 
methods, but no previous research has examined barriers to treatment seeking amongst ESALD 
transplant participants.  Accordingly, an exploratory, qualitative research design was adopted in 
this part of the study. 
 
The broad aim was to explore the experiences and understandings of alcoholic liver disease 
transplant participants in liver transplant management programs. The following specific questions 
were addressed:  
 
What are the intrapsychic, social and organisational social factors contributing to a lack of 
treatment seeking? 
What are the social factors that contribute to a lack of treatment seeking?    
What are the organizational or program factors that contribute to lack of treatment seeking? 
 
This chapter explains the methodology used to generate relevant data using a in-depth interview 
study involving semi-structured interviews with 42 ESALD transplant participants.  
 
Research paradigm  
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A research paradigm provides a philosophical framework that generates knowledge and informs the 
strategies, criteria and techniques on which research practice is based [6-8].  According to Guba 
and Lincoln (1994: 105), a paradigm is ‘the belief system or worldview that guides the investigator, 
not only in choices of method but in ontologically and epistemologically fundamental ways’ [9]. A 
paradigm may be considered as consisting of four elements: ethics (study of moral principles that 
guide right conduct); epistemology (theory of knowledge); ontology (theory of the nature of reality 
and of human beings in the world); and methodology (best means for gaining knowledge about the 
world) [6]. Thus the paradigm and its associated concepts and practices are important to the design, 
conduct and implementation of a research project, since it  determines what knowledge is, how it is 
generated and how it is verified [8]. The research paradigm informs the selection of appropriate 
methods of data collection [9]. 
 
Commonly used research paradigms include the empirico-analytical paradigm (quantitative 
scientific approach), the interpretive paradigm and the critical research paradigm. These are based 
on the theoretical positions of positivism, idealism and realism respectively [8]. This study is a 
qualitative research project informed by the interpretive paradigm. Qualitative research can employ 
a number of data collection techniques, such as semi- or minimally structured interviews, 
participant/non-participant observation and document analysis.  
 
The interpretive research paradigm is based on the proposition that there are multiple realities and 
that these can differ across time and place. The interpretive paradigm is philosophically different 
from  positivism, which holds that knowledge is objective, generalisable, collected and analyzed 
from parts of phenomena, capable of generating a single truth, and universal [7].   
 
While interpretivism can embrace a number of theoretical perspectives [7], this study is informed 
by symbolic interactionism, an approach derived from the American pragmatism of George Herbert 
Mead and Charles Cooley.  Herbert Blumer, a student and interpreter of Mead, coined the term and 
argued that individuals continually reflect on and interpret the symbolic meanings of their 
environment or social world and that human action is mediated by the ascribed meanings derived 
from social interaction and modified through interpretation [10].  The symbolic interactionist 
assumption of the indeterminacy of action rests on the human capacity to objectify self and to 
ascribe meanings to self, as to any other object. Human beings are not passive recipients of 
meaning, but construct meaning from their interaction with the world; even when they encounter 
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the same objects, people experience them in different ways [11]. Therefore human knowledge and 
action are contingent on interpretation that is constructed in and out of interaction with the social 
world [7].  
 
According to Blumer (1969: 188), the aim of the researcher working from an interpretive symbolic 
interactionist perspective is to ‘catch the process of interpretation through which people construct 
their actions’ [10]. The focus of research is on the subjective experience or interpretive process of 
the individual in dealing with others and with the environment. Furthermore, the subjective world 
of the researcher is itself important, as the interpretation emerges from the interaction between the 
researcher and the participants. The research is influenced by the questions being asked and by the 
values of the researcher, as well as how the findings are analyzed.  
 
Research design 
 
A complex set of factors is associated with the action of treatment seeking or non-treatment 
seeking by ESALD transplant participants within the specific organizational world of the liver 
transplant program. The interpretive paradigm with its associated qualitative methodology was best 
suited to capturing this complexity. In-depth interviews can reveal details of participants’ 
experiences, understandings (beliefs and attitudes) and feelings in relation to their engagement in 
the liver transplant program. Such an approach is ‘open-ended’ because it allows participants the 
opportunity to speak freely and to recount their experiences without being forced to choose 
between specific, pre-determined answers. It also allows the researcher to probe for additional 
information or otherwise explore responses in more depth [13].  
 
In contrast, the methodology generally associated with the empirico-analytic paradigm proceeds 
from hypotheses about the reasons for human behaviour that are established at the outset. Using 
statistical techniques, the researcher measures the frequency or intensity of a phenomenon and the 
relationship between variables. Such an approach imposes significant limitations, because the 
researcher is required to identify in advance what variables will be tested using quantitative 
instruments such as standardized questionnaires [14].  
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Qualitative methods are increasingly used in health services research [15-16] to generate detailed 
accounts of health-related issues [17]. Such methods can provide in-depth information about  how 
something is experienced (such as illness or a treatment approach), how things are done (such as 
how wards operate),  how something is represented by people (relationships between doctors and 
nurses) or how to bring about change [12]. Qualitative methodology has been used to examine 
physician-patient relationships, primary care, and novel interventions, and to conduct clinical 
evaluations.  
 
According to Daly (2007: 44), qualitative studies ‘may illuminate treatment issues, for example, 
indicating why some patients respond in a particular way to treatment, it is also common for a 
qualitative study to generate critique of current practice,  indicating where standard practice may 
not be beneficial to one or more groups of people’ [5].  Qualitative research has been widely used 
to investigate compliance and treatment adherence and a number of specialised approaches, such as  
‘post-positivism’ [18], ‘ethno-epidemiology’ and ‘qualitative epidemiology’ have been applied in 
the drug and alcohol field [19-20] and in the liver transplant area [21-24]. 
 
The interpretive paradigm underpins a number of research methodologies, including 
phenomenology ethnography, case studies, biographical methodology, ethnography and grounded 
theory (Figure 9.1).  
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Figure 9.1. Qualitative methodologies and their orientation [12] 
 
 
Thematic analysis and theoretical orientation    
 
This study utilized in-depth interview study using thematic analysis to analyze the data. In 
epistemological terms, thematic analysis leans towards many of the features of phenomenology and 
grounded theory, making it suitable for both interpretive and positivist approaches [26]. Thematic 
analysis does not reflect any particular theoretical or epistemological perspective, and no single text 
or author represents thematic analysis. According to Guest et al. [26], thematic analysis comprises 
‘a bit of everything—grounded theory, positivism, interpretivism, and phenomenology—
synthesized into one methodological framework. The approach borrows what we feel are the more 
useful techniques from each theoretical and methodological camp and adapts them to an applied 
research context’ (p.15). Thematic analysis has been used to organise and ‘make sense’ of 
unstructured data within a number of paradigms. Lodged between the two poles of essentialism and 
constructionism, it acknowledges individual meaning, social context and the limits of reality [25].  
 
The theoretical freedom of thematic analysis, therefore, provides researchers with a flexible and 
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effective means of organising and interpreting unstructured (qualitative) data. It is essential, 
however, that the theoretical position from which the analysis is developed be made transparent, 
since each theoretical framework brings with it a number of assumptions about the nature of the 
data and what they are claimed to represent [25].  
 
In this study the epistemological leaning was towards the interpretive paradigm of phenomenology 
(which seek to understand the meanings that people give to lived experiences) and to the positivism 
of grounded theory (in which interpretations are seen to be ‘grounded in’ the data, and which 
insists that techniques of collecting and analysing data should be systematic and transparent).  
 
 
Selection and recruitment 
 
Participants were recruited from the Australian National Liver Transplant Unit (ANLTU) at the 
Royal Prince Alfred Hospital in Sydney, Australia, between September 2009 and May 2011. 
Participants included those selected for the case control study (Study 1) of this research project and 
included two extra participants (total 42 participants). It was an ethical requirement that the 
researcher not directly recruit potential participants. Rather, they were to be referred by the Nursing 
Unit Manager or medical personnel. Thus the study relied on opportunistic recruitment to some 
degree but a diverse sample was sought including pre- and post-transplant participants; men and 
women; those with a diagnosis of ALD and of ALD and Hepatitis C virus; attendees and non-
attendees of the outpatient liver clinic; and those who had relapsed.  
 
The student researcher chose to tread carefully and commenced the study with less intensive semi-
structured interviews based on the broad topic areas (see below). There were a number of reasons 
for this. First, the student researcher lacked clinical experience with this patient population, so 
familiarity had not had a chance to develop. Secondly, the transplant literature had clearly 
identified the reluctance―even irritation―among alcoholic liver disease transplant participants at 
the prospect of participating in alcohol interventions and their denial of any problem with alcohol. 
Thirdly, the majority of patients were dealing with serious health problems, a time consuming and 
complex medical regime, and time restrictions. Many had to travel from outside the Sydney 
metropolitan area to attend three monthly appointments. I was conscious of the demands of this 
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study on the participants and the confronting nature of the subject. Accordingly, data collection was 
arranged in one session.   
 
Halfway through the recruitment phase, when I had had enough time to become immersed in the 
ESALD transplant community and gained familiarity with the context and the population [4] more 
intensive semi-structured interviews were conducted with key-informants and those who had 
relapsed. Key informants, included those who demonstrated a need to communicate further and 
elaborate on their experiences in more detail.  Participants who had relapsed were purposely sought 
for another interview. Relapsers who had dropped out of the liver transplant program were 
specifically recruited for a semi-structured interview which occurred over the phone.  
 
 
Data collection and recording 
 
Interviews are the primary data gathering tool in qualitative research. They allow participants to 
recall, reflect, and reveal aspects of their subjective experiences and interpretations [40]. There are 
various forms of research interview (structured, semi-structured and unstructured). In the present 
study, semi-structured interviews were used. For most participants the interview occurred in the 
one session for some participants this may have included a two-stage process due to them being 
key informants or the decision to interview relapsers further. 
  
The interview protocol included a number of open-ended questions about participants’ experiences 
of alcohol issues and the alcohol management program.  It was important to approach the subject of 
any alcohol use cautiously, especially with pre-transplant participants, who would not feel 
comfortable reporting any alcohol use as this could jeopardise their place on the waiting list. To 
overcome this obstacle, potentially sensitive questions were phrased in the third person or in 
relation to hypothetical situations (e.g. ‘What do you think leads to people relapsing either before 
or after transplantation?’ rather than ‘What would make you relapse?’). Appendix Interview Guide 
shows the questions asked in the semi-structured interview, followed by questions utilized in the 
more in-depth semi-structured interview and exploratory probing questions.  
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As previously mentioned, a second round of more in-depth semi-structured interviews was 
conducted with selected participants. Participants were free to respond in any way they chose. Thus 
the process was more open-ended and free-flowing one, commensurate with participant comfort 
levels and time constraints. The researcher used listening and mirroring statements to encourage 
participants to reflect and to elicit additional detail or clarification of issues [20, 40-41]. Following 
Van Manen’s [42] recommendation, my role during the interview was to keep myself and the 
participant oriented to the phenomenon at hand and to maintain focus on the participant’s lived 
experiences.  
 
Participants could choose the location of the interview―either at the transplant unit or at a room in 
the nearby Drug Health services building. The majority of participants preferred to have their 
interview at the transplant unit and for it to coincide with their outpatient clinic appointment. A 
quiet, private room located just outside the busy outpatient clinic was made available for this 
purpose. One participant, who was known to the nursing unit manager as a patient who did not 
attend any clinic appointments, preferred to meet at a nearby club.  
 
All interviews were recorded, with the participant’s consent, using a cassette recorder. Written 
notes were also taken as backup. Interviews were audio-taped and transcribed by the student 
researcher. After each interview, field notes and preliminary analysis of the participant’s responses 
to particular questions were recorded [40, 42].   
 
The initial round of interviews lasted between 15 and 30 minutes. As most participants were 
dealing with health problems and time constraints due to their complex medical regimens, attempts 
were made to complete the interview tasks for both Study 1 and Study 2 in one sitting and to keep 
the session as brief as possible. The duration of the second set of interviews was between 30 
minutes and one hour. A total of 42 interviews were conducted of these 10 involved more in-depth 
interviewing.   
 
The student researcher’s lack of direct clinical involvement in the liver transplant program helped 
to create a neutral environment in which participants were comfortable speaking as freely as they 
wished. The student researcher was also comfortable with the interviewing process due to her 
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extensive experience in assessing and counselling individuals with alcohol use disorders, including 
situations involving denial, fear of stigma and resistance.  
 
 
Data handling and analysis 
 
All interviews were transcribed verbatim and all transcripts were then checked for accuracy against 
the original recordings.  A master copy of the interview transcript was kept in the participant’s 
research file. Another copy, formatted with double spacing, wide margins, and page numbers, was 
used for analysis.  
 
Throughout the project I also used a research diary to record my observations and reflections on the 
research process and emerging ideas. The transcript file contained raw data from the interviews. 
Memos or field notes were not typed but were available for review in hard copy when needed 
during the analysis.  All data belonging to a particular participant were stored in a folder labelled 
with the relevant pseudonym. All folders and audiotapes were stored in a locked filing cabinet. A 
folder was created for each participant on a password-protected computer, and all data belonging to 
that participant were stored there.  
 
Thematic analysis is the most widely used method of analysing qualitative data within the fields of 
sociology, psychology and public health. According to Braun and Clarke (2006), it is a technique 
for: ‘identifying, analysing and reporting patterns (themes) within data. It minimally organises and 
describes your data set in (rich) detail. However, frequently it goes further than this, and interprets 
various aspects of the research topic’ [25] (p.79).  
 
There is no clear agreement about what thematic analysis is and how it should be implemented 
[25]. Some of the phases and tasks of thematic data analysis are similar to the phases of other 
qualitative research. In broad terms, the process of thematic analysis involves: familiarising oneself 
with the data, identifying possible codes, generating themes, reviewing, comparing and contrasting 
themes and constantly checking these constructs against the data [25-26]. The endpoint is a report 
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of the content and meaning of patterns (themes) in the data.  
 
The present study followed the analytic procedures outlined by Strauss and Corbin [14]. These 
comprise: data immersion, coding (open and axial), creating categories and identifying themes. It 
did not, however, fully conform to the methodological requirements of grounded theory. It was an 
exploratory study conducted with limited time and resources, so theoretical saturation was not 
attempted. At the same time, the thematic analysis did not involve merely a semantic content 
analysis of data. I used a latent approach that sought to identify the underlying ideas, assumptions, 
and conceptualisations that informed the semantic content of the data [25]. Therefore the 
development of themes did involve interpretative work, and the analysis moved beyond description 
towards theory development.   
 
Data immersion involved listening to and transcribing the interview recordings, reading and re-
reading the interview transcripts, diary keeping, memos, discussions with staff, and engagement in 
follow-up counselling with some participants who requested it after they had completed the study.  
 
Coding is a formal process of examining and organizing the data from each interview and for the 
whole data set. Coding involves sorting and tagging data ‘bits’ (paragraphs, sentences or words) 
with descriptive labels (codes). In this way, key concepts can be identified while the context in 
which these concepts occur is taken into account [15, 35]. Two steps are involved in this 
process―open and axial coding.  
 
Open coding was conducted on four transcripts to get an idea of the range and scope of codes that 
were present in the data. The coding process was undertaken independently by both the researcher 
and academic supervisor. Both read the transcripts and developed the code and came together to 
consult and discuss the agreed codes.  
 
Coding involved examining, breaking down, comparing, conceptualizing and, eventually, 
categorizing the data. The transcripts were examined line by line, sentence by sentence, and 
paragraph by paragraph and codes of two to four words were attached to relevant segments. The 
codes, which were written beside the content in the margin area, provided a descriptive label for 
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what was being said, or for incidents, ideas or events. Loosely conceptualized, general categories 
were also identified at this point.  
 
In axial coding, the main tasks are to locate the codes within subcategories and relate subcategories 
under a single category. According to Strauss and Corbin [14], open coding fractures the data and 
allows the researcher to identify some categories, their properties and dimensional locations. Axial 
coding puts the data back together in new ways by making connections between a category and its 
subcategories. It is at this stage of data analysis that descriptive labels or codes are raised to a 
conceptual level. The model proposed by Strauss and Corbin was used to identify the conditions, 
context, action/interactional strategies and consequences inherent in the codes. From this, 
subcategories can be formed and these begin to specify the features of a category, giving it 
precision and allowing for variation and depth of understanding. According to Strauss and Corbin 
(1990: 90), ‘The discovery and specification of differences among and within categories, as well as 
similarities, is crucially important and at the heart of grounded theory’.  
 
The next step was to examine how codes can be linked in order to create coherent categories [35]. 
Categories were formed from codes that were logically related, that is, based on similar events, 
properties, attributes or consequences. The name of the category or subcategory came either from 
key words in the literature or from expressions used by the participants themselves (so-called in 
vivo codes).  Once the scope and details of the codes and categories were identified, all transcripts 
were then open coded in this fashion.  
 
Each category was examined in terms of its conditions, consequences, processes and relationship to 
other conceptual categories. The core category was selected on the grounds that it was sufficiently 
abstract to encompass and relate systematically to all the other categories in terms of conditions, 
context, strategies, and consequences. The core category has the following features: it frequently 
recurs in the data; it is linked with other data; it has explanatory capacity; it has verification in the 
literature; and it allows for variation in the experiences of most participants. After the core category 
had been identified, other categories were related at the dimensional level and relationships 
between categories were validated against the data.  Categories needing further refinement or 
development were identified [14].  
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The final step was to identify themes. According to Braun and Clarke:  
 
A theme captures something important about the data in relation to the research question, and 
represents some level of patterned response or meaning within the data set....Furthermore, the 
‘keyness’ of a theme is not necessarily dependent on quantifiable measures – but in terms of 
whether it captures something important in relation to the overall research question . [25] (P.82). 
 
Themes are general propositions that emerge from the diverse and detail-rich experiences of 
participants. They evolve from the conceptual codes and sub-codes and are suggestive of a 
relationship between codes [15]. The generation of themes is not purely a process of describing a 
range of categories; it involves shifting to an interpretation of the issue under investigation [35].  
The generation of themes requires testing the explanation both with the data and with the theory, 
with specific reference to the theoretical concepts relevant to the study. 
 
 
Ethical considerations 
 
The main ethical considerations in the study were those of informed consent and 
participant privacy and confidentiality. Informed consent is defined by Sim [38] as the 
‘voluntary and revocable agreement of a competent individual to participate in a 
therapeutic or research procedure, based on an adequate understanding of its nature, 
purpose and implications’ (p.584).  In this study, the key elements of informed consent 
were: providing information about the research; ensuring comprehension of the 
information; voluntary participation; and the freedom to withdraw at any time without 
adverse consequences [39].  
 
All participants were given a flyer (Appendix X) introducing the study by referring 
transplant staff. If they agreed to be contacted, they were provided with an information 
sheet (Appendix Y) that explained the aim of the research and what their participation 
would involve. The information sheet was written in a simple, jargon-free style and 
provided the researcher's contact details. I ensured that all participants had the opportunity 
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to ask questions and that they were fully aware of their right to withdraw at any time. 
Written consent (Appendix Z) was obtained from each participant before data collection 
commenced. There was no special relationship or power imbalance between the researcher 
and participants that could be perceived as coercion. Participants received a $20 gift 
voucher at the end of the interview as a token of appreciation. 
 
Patients were excluded if they declined or were unable to give consent (for example, if 
they were suffering from encephalopathy) or if they indicated a belief that participation 
would improve their place on the waiting list. At the time of interview, participants were 
reminded that they could ask for the audio-tape recording to be switched off at any time.    
 
Confidentiality and anonymity were maintained through the use of pseudonyms on all files 
and by changing any potentially identifying contextual details in the final report. Data were 
stored in a locked filing cabinet in a locked office at the Drug Health Services Research 
Department. Data will be stored for seven years before being disposed of, in accordance 
with the requirements set out by the University of Sydney's ethical guidelines for research 
involving humans.   
 
 
Quality assurance 
 
Many qualitative researchers have been reluctant to provide prescriptive criteria for 
judging the quality of their research. As a result, evidence from qualitative studies is not 
routinely incorporated into systematic reviews in the health field [5, 35]. A team of 
Australian researchers has developed a set of criteria for assessing the capacity of four 
different qualitative research methods to provide evidence for practice or policy in health 
and medicine [5]. This is displayed in Figure 9.2 and Table 9.1 
 
 
 
 
 
 
 
 
238 
 
 
  
Figure 9.2. A hierarchy of evidence-for-practice in qualitative research study types and 
levels [5].  
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Table 9.1 A hierarchy of evidence-for-practice in qualitative research – summary features [5].   
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These and other qualitative researchers in the health field have described the standards and practices 
that are required for a high quality, well-developed, generalizable interview-based qualitative study 
[4-5, 16, 35-36]. These can be summarized as follows: 
  
i. A comprehensive literature review is essential. This provides the conceptual framework for 
the research problem structures the study design and informs the process of sampling and 
data collection.  
 
ii. A grounding in sociological concepts and theory is required because human action takes place 
in a social context. 
 
iii. Diversification and intensification of sampling and data collection is necessary in order to 
explore the diversity of the sample, to search for cases that do not fit the developing 
conceptual understanding and to identify the analytical point at which additional conceptual 
categories are required.  
 
iv. Data analysis should involve a rigorous, systematic and essentially taxonomic process of 
sorting and classifying data. At the same time, the researcher should maintain a focus on 
understanding the meanings in the data based on the full range of accounts and explaining 
the conditions under which exceptions occur.   
 
v. Relying on de-contextualized illustrative quotations that are not embedded in the overall 
analysis of the data set reduces the quality of a research study. It is important to provide the 
methodological detail necessary to exclude bias or impressionistic description and to 
demonstrate how well the identified issue/s are represented in the whole data set.    
 
vi. Generalizability of the findings is determined with reference to the pertinent literature (i.e. 
how the study’s findings relate to other settings or groups). Qualitative studies identify 
themes by linking the observed categories with social theory until an overriding explanation 
is reached. This justifies the application of the study’s conclusions to other social contexts 
and groups. 
 
Daly [5] points out that not all qualitative research can reach this standard, given the demands 
involved in an ‘ideal’ study. Many health-related studies fall short of the ideal processes for 
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producing generalizable results. This may be due to poor research practice, poor reporting of well-
designed studies, lack of funding for data saturation, accessibility of participants, and/or a lack of 
understanding of social theory or of the literature so that theories and concepts do not fully frame the 
research process.  
 
Verification in qualitative studies is dependent on the rigorous use of systematic methods of data 
collection and analysis. Throughout the present study, the student researcher strove to maintain rigour 
and validity by systematically following the grounded theory approach. This involved detailing the 
philosophical underpinnings of the chosen paradigm and approach and aligning this with the chosen 
methods of data collection and analysis. Proposed relationships were supported over and over again 
in the data even though the particulars of each participant’s experience may have differed. Theory 
development was limited to the categories, their properties and dimensions and statements of 
relationships that existed in the data. The researcher engaged in a constant interplay between 
proposing and checking. The use of an independent analyst and feedback from those working in the 
field helped to validate the applicability of findings to the wider context of liver transplantation and 
the experiences of alcoholic liver transplant participants.  
 
In qualitative research, credibility refers to the trustworthiness of the findings [6] and the extent to 
which they vividly and faithfully describe the phenomena [37]. The strategies used to ensure the 
credibility of the study included rigorous and systematic data collection and analysis through which 
the voices of participants emerged in all their complexity and were sensitively interpreted in relation 
to the developing theory. The researcher was also alert to the possibility that theoretical frameworks 
derived from conventional drug and alcohol settings could affect one’s interpretation in the setting of 
a transplant unit.  
 
Credibility in qualitative research is also enhanced by authenticity. Authenticity is evident when the 
theory demonstrates a range of realities, thus presenting a fair and consistent view of the patient 
population. This is strengthened when the multiple constructions and interpretations of events and 
experiences show consistency with the philosophical underpinnings of the interpretive paradigm [7].  
Transferability is also indicative of credibility. This means that findings can be applicable tosimilar 
settings and contexts [37].  
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Reflections on using a mixed method approach. 
 
As described earlier a gulf appears to exist between qualitative and quantitative research, with each belonging 
to distinctly different paradigms thus the movement between the paradigms can be difficult throughout 
different phases of a research project. For example data collection and analysis using a quantitative approach 
relies on the use of questionnaires and scale using deductive reasoning, and more descriptive analysis of 
incidence and frequency. While qualitative involves the self as instrument involving flexible and reflexive 
practice, participant observation, and reflexivity. Data analysis consists looking for patterns of inter-
relationships, dealing with concepts and categories 
 
For the researcher a great deal of flexibility was required and a number of pragmatic consideration. and 
practical constraints.  The tension that that a mixed method project can induce was also alleviated by 
maintaining very clear boundaries regarding the differences between the research approaches in order to avoid 
confusion and contamination of the processes and equal weight given to both projects . Being organized as a 
research and diligent to each project individually was important. Knowing that in the study of psychosocial 
experience there is no one truth and human experience is multi-faceted helped deal with the theoretical divide 
.All data captures the subjective perspective whether one uses questionnaires or interviews which are not the 
objective neutral and scientific instruments they claim to be. Therefore the two approaches integrate at this 
level At the level of data analysis and discussion there are different explanations and flexibility is required. . 
Daly would argue that there is a place for post-positivist elements in qualitative studies as diversification and 
intensification of sampling and data collection is necessary in order to explore the diversity of the sample. 
Certainly the political perspectives and values which drew upon sociological theory was challenging 
especially when the project was set within a medical setting, organization of the research team,  and the 
subject was considerably controversial. A mixed method approach certainly makes the researcher work hard at 
understanding the relationship between theory, methods and data  and to consider the relationships between 
the data sets created by different methods.   
 
 
Conclusion 
 
A qualitative in-depth interview study was selected in order to capture the lived experiences, attitudes 
and interpretations of ESALD transplant participants of the alcohol management program. The aim 
of this study was to identity factors contributing to resistance to alcohol treatment by ESALD 
transplant participants. Semi-structured interviewers were conducted among 42 participants exploring 
 
 
243 
 
broad topic areas to do with abstinence, relapse, treatment seeking and the alcohol management 
program provided by the liver transplant program. A diverse population of ESALD transplant 
participants contributed to the study. Method of data analysis consisted of thematic analysis outlined 
by Strauss and Corbin whereby themes were identified within the data set. 
 
The following chapter will present the data collected from this in-depth interview study.  
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CHAPTER 10 
Management programs for ESALD transplant candidates patient 
experiences 
 
 
 
‘Alcoholism is a disorder of remission and relapse, and some recurrence of drinking by alcoholics 
who have undergone liver transplantation is to be expected, no matter how stringent the selection 
process…. Abstinent patients with alcoholic cirrhosis often resume drinking, even after a life-
threatening decompensation or liver transplantation.’                     Dureja &Lucey [1] (p.761-762)                                    
 
‘These data suggest a powerful urge to drink exists in some patients with alcohol-related cirrhosis 
at risk of life-threatening decompensation. Apparently, neither variceal hemorrhage, distal 
splenorenal shunt, transjugular intrahepatic portal systematic shunt or risk of losing access to liver 
transplantation are sufficient of themselves to induce and sustain abstinence.’  
                                                                                                         Weinreib [2] (p.545) 
 
‘Although undergoing liver transplantation can be viewed as a traumatic learning experience for 
the patient with ESALD, it is clearly insufficient to promote abstinence and the risk of returning 
to alcohol consumption remains.’                                                                                Tang [3] P.144 
 
The current study interviewed 42 ESALD transplant patients. Of these, 30 were interviewed using a 
structured interview and 12 using a semi-structured, more in-depth interview. The qualitative data obtained 
from the combination of structured and semi-structured interviews are discussed in this chapter.    
 
Characteristics of the participants  
 
The majority of participants were men (35/42), the average age was 57 years, with more than half of the 
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group (26/42) married or in a stable de-facto relationship at the time of the interview.  Virtually all (40/42) 
reported stable housing for more than 2 years.  In terms of educational background, 22/42 had the equivalent 
of the School Certificate, 7/42 Higher School Certificate, 5/42 TAFE qualification and 8/42 had University 
education. Of the participants, 29/42 had a diagnosis of ALD, 13/42 had a diagnosis of ESALD/HCV and of 
these 11had a history of intravenous drug use.  
 
Of the total participants, 16/42 were pre-transplant participants and 26/42 were post- transplant participants.  
Post-transplant participants ranged from three months to sixteen years post transplant with the median 
number of years being five. The median time on the waiting list for both pre- and a post-transplant candidate 
was 8.5 months with a range of two months to 3 years. The majority of participants (27/42) reported being 
able to abstain but over one third (15/42) returned to alcohol use, with 10 of these relapsing to heavy drinking 
(over 6 standard drinks per day). 
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Table 10.1. Characteristics of ESALD transplant participants (n=42) 
 Age     Mean age : 57 
Range : 45-70 
 
Gender Males : 83% (35) 
Females 17% (7) 
 
Number of pre-transplant participants                                                      
 
16 (38%) 
Number of post-transplant participants 
                             
26 (62%)  
Median years post-transplant  
 
5 years   
Range (3 months – 16 years) 
 
Median period on waiting list    
 
8.5 months 
Range ( 2months to 3 years) 
 
Diagnosis of ESALD  
 
 29 (69%) 
Diagnosis of ESALD/HCV 
 
 13 (31%) 
Number reporting abstinence ( including the  
occasional celebratory drink)  
 27 (64%)  
Number reporting return to any alcohol use 
 
 14 (33%) 
Number reporting relapse to harmful  
drinking (above 140g ethanol/week)     
 
 10 (23%) 
Years post-transplant abstinence before relapse  
 
Average 1 year and 10 months  
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Participants who had relapsed to heavy alcohol use, compared with abstainers (Table 10.2), were significantly 
less likely to have a partner and a social support network, and more likely to have had a formal psychiatric 
history or current psychiatric problem. There were no significant differences between relapsers and abstainers 
related to familial history of alcohol problems, housing stability and education level.    
 
 
Table 10.2. Socio-economic and psychiatric history of successful abstainers and relapsers  
 
 
 
 
 
Family history 
of alcohol 
problems 
 
Housing 
Stability 
 
Presence of 
Partner 
 
Past or 
present 
psychiatric 
history 
 
Social 
Support 
network 
 
Education 
 
Abstainers*  
(n = 32) 
 
22 (66%) 
 
31 (94%) 
 
23 (70%) 
 
5 (15%) 
 
30 (91%) 
22 (69%) SC 
5 (16%) HSC 
4 (13%) TAFE 
6 (19%) University  
 
Relapsers  
(n=10) 
 
 
7 (70%) 
 
9 (90%) 
 
3(30%) 
 
6 (60%) 
 
6 (60%) 
5 (50%) SC 
2 (20%) HSC 
1 (10%) TAFE 
 2 (20%) University  
 
Thematic analysis of interview data 
 
The essence of the ESALD transplant participant’s experience of the alcohol management and liver transplant 
program is expressed in five themes which include:  
 
 
 
 
251 
 
 The contract: ‘a gift with conditions’ 
 
Subthemes included:  
Conformity to the contract – degree of conformity, degree of difficulty, degree of disclosure, breach of contract, 
participant response to breach, awareness of contract.   
Participant attitude to contract – ethics, gratitude, personal responsibility and critique of contract.  
Staff attitude and influence regarding the contract and breach of contract 
 
Abstinence: a do-it-yourself process 
 
Subthemes:  
Motivation facilitating abstinence – self-motivation, personal responsibility, reward of  life,  contract, 
end-stage liver disease  
Maintenance of abstinence – degree of difficulty, family support, staff monitoring, relapse prevention 
skills, self-transcendence, mobilising social resources 
Resistance to alcohol treatment 
Denial of relapse  
 
Relapse 
 
Subthemes – personal responsibility, triggers to relapse, guilt, family and social support, public opinion 
and staff reaction, personal choice and the contract 
 
Fear of stigma 
 
Subthemes – label of ‘alcoholic’, personal shame, failure and responsibility, alcohol treatment , fear of 
disappointing staff, fear of penalty  
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No available and suitable alcohol support program- 
 
Subthemes – ‘gap in the program’,, lack of candor, living with chronic illness, wholistic perspective, 
‘wanting to talk to someone’  
 
Each of these themes is discussed below and key subthemes are selected. All of themes and sub-themes were in 
some way connected with the theme of ‘the contract’.   
    
Appendix F contains Table 10.3 which provides a quantitative table showing the number and percentages of 
ESALD transplant participants (abstainers, relapsers and total group) and their responses to the semi-structured 
interview questions.   
 
i)  The contract – ‘a gift with conditions’  
 
‘The contract’ was the most influential factor in participants’ experience of the management programs for 
transplant patients with alcohol-related liver disease. It involved a verbal agreement or understanding made 
with transplant staff for a period of abstinence (as a condition of candidacy for a liver transplant) followed by 
long term stable abstinence (apart from the special and occasional celebratory drink which was an agreed part 
of the contract).  It was a covert category which was only indirectly referred to in the structured interviews 
and more explicit in semi-structured interviews.  This category was intricately linked to other categories and 
themes. The contract is in force throughout the pre and post-transplant period. Participants noted that it was 
referred to and spoken about by transplant staff. Compliance with the contract was regularly monitored by 
staff who monitored compliance with it regularly. Participants referred to it as being written in the ‘blue 
book’ (the liver transplant patient information booklet).  One participant reported a written contract although 
this was not a practice adopted by the Australian National Liver Transplant Unit (ANLTU) where the study 
was conducted.  
 
The majority of participants interviewed (40/42) were aware of the contract of abstinence. They stated 
explicitly that they understood the importance of long term abstinence as a condition for transplantation in 
order to ensure positive transplantation outcomes and to preserve the healthy functioning of the new liver. 
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Participants were aware of the contract not only in terms of its important medical function and utility but also 
the social or ethical responsibility associated with receiving a scarce and life giving public resource.     
 
The management of patients’ alcohol use by transplant staff revolved around compliance with the contract. 
The majority of participants referred to methods used by staff to monitor their drinking and ensure their 
compliance, including regular blood analysis (20/42) and questions by staff at clinic appointments regarding 
their alcohol use (18/42).   
 
The following quotes illustrate the program’s emphasis on strict abstinence:  
 
Every time I go there they ask me if I have been drinking. It is a recurring theme. You are constantly 
mindful of the fact that they do not want you to drink. I think they have a duty of care to the organ donor 
family to make sure that the organ is treated with respect.                                                          Daniel 
 
Staff were totally against alcohol. It was always in the air that it (drinking) was frowned upon         Bruce 
 
They have mainly been interested in me staying on the straight and narrow (abstinence).                 Pat  
 
There  is pressure to not drink. Everyone I know would give me a kick up the backside. It is not an easy 
thing to hide anymore. Everyone would have a go at me. The pressure is positive though            Mathew  
 
 
A strong sense of moral and social obligation was associated with the theme of the contract. As participants (25/42) 
felt an obligation for being selected or for having received the ‘gift of life’. This obligation involved a number of 
relationships: the donor’s family, the deceased donor, transplant staff who worked tirelessly to preserve the 
patient’s life, the hospital, the patient’s own family and finally, the participant him/herself. Maintaining abstinence 
was seen as a way of repaying the gift. The shame or self-disgust for not being able to abide by the contract was 
evident in the  transcripts of relapsers.  
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The following extracts illustrate the moral and social obligation expressed by participants for having received 
organ transplantation:  
 
If you give in (relapse), it is a breakdown of your whole moral fibre, to me. I could not look my doctor 
in the face or the organ donor’s family if I was to damage this liver all because of careless personal 
behaviour.There are stressful things you go through when you have a transplant. There are times when 
you think about going back to drinking. The obligation stops you from drinking.It is a gift with 
conditions and I have accepted those conditions.                                                                Daniel 
 
They said you were not to drink. I signed a thing that said I would not drink but that went through the 
roof, but when I woke up after the transplant I recognized I do have a responsibility and that is when I 
did take it seriously                                                                                                     Douglas 
 
The expectation is lifelong abstinence and I think this is stressed because of the donation rate being 
very low. Having an organ is a very precious commodity and should only be given to people are most 
likely to have a successful outcome. If you don’t look after it you shouldn’t have one.             Natalie   
 
A lot goes into this investment in doctors, nurses, psychologists, psychiatrists. Someone has given an 
organ up for me and you yourself have gone through so much to get to that point. If that is not 
motivation enough I don’t get it. If you fail you feel that you have let so many people down not just 
yourself. RPAH transplant staff, your own medical people, your family, you have disappointed all of 
them and I am sure they would say something about it. Even though you don’t know them the donor 
and their family you have let them down. If you fall over you go back to alcohol or drugs because you 
have let so many people down …I wouldn’t have the strength to come back and ask for help because 
you would be basically saying you are not worthy that’s all....                                        Mathew  
 
For the majority of relapsers this moral and social obligation surfaced as intense guilt for having failed to 
abide by the contract – a theme which will be discussed further on in this chapter.   
 
ii) Abstinence as a do-it-yourself process    
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End-stage liver disease is a powerful motivator for behavioural change with all participants reporting the 
decision to abstain from alcohol with the diagnosis of end-stage liver disease. Participants tended to recall an 
immediate heightening of their consciousness when their transplant doctor informed them about the terminal 
nature of their condition and the necessity for abstinence and transplantation. The experience of pain and 
illness, the threat of death and the desire to live and connect to others resulted in a powerful and focal 
incentive to stop drinking.  
 
Many participants spoke about the importance of living longer and maintaining good health in order to see 
their grandchildren or children grow up. When participants became fully aware that further drinking would 
lead to their mortality, they described having to seriously and swiftly weigh up whether they were prepared to 
fully commit to an abstinent lifestyle. This change was also solidified and supported by the medical demands 
of transplantation and ‘the contract’ with transplant staff..    
 
The following extracts describe the motivation for change:   
 
The specialist told me if I was to have another drink I would be dead so I didn’t have any more to drink. 
I believed him because I was crook as a dog at the time.... It wasn’t difficult for me. They (the doctor) 
said don’t drink. So I didn’t drink                                                                                       Geoff 
 
My health was suffering and I lost the urge to drink and to self-medicate. I was concerned about my liver 
and general health; my bout of encephalopathy and waking up in hospital scared me. I had passed out; it 
was disturbing, a crisis for me and then I found out I had liver disease.....    However having an 11 year 
old daughter is worth living for and to have a father who dies on her is a prime reason for trying to 
continue to live and not drink. My attitude now is I am not interested in drinking ever again because it 
has been quite a while since I have stopped                                                                          .Miles 
 
Well that really woke me up because if someone tells you, ‘If you don’t stop what you are doing, you are 
going to be dead’. Well that sort of puts everything in perspective; it was like being wacked in the chin’. 
I just thought about my grandchildren and what I would be missing out on                                George 
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I think it finally sunk in how much damage I was doing. They could tell me until I was blue in the face 
before but I think I thought I was invincible..but I had so many blackouts in a row and put in intensive 
care and that wasn’t very nice because most of my life was in hospital. I think the day when the doctor 
told me I would be lucky to see another Christmas it was then that it sunk in. That it was bad enough 
(liver) that I would die and that was when it sunk it....it was only until he came in and blurted out like 
that. That gave me real quick wakeup call and you never look back after that. I wrote that doctor a letter 
and told him I was grateful to the team and that I was thankful to him because he scared the daylights 
out of me.                                                                                                                       Erica 
 
For 27/42 participants there were no difficulties in achieving total abstinence as requested by the liver 
transplant unit. (This included pre transplant candidates). These participants reported no need for treatment due 
to their sobriety, motivation and self-efficacy. The majority also reported not having experienced any cravings 
or compelling urges for alcohol and related the lack of cravings to being too sick and preoccupied with the 
medical demands of transplantation. For many, past drinking behaviour was seen as a result of habit and 
socially learnt behaviour.  
 
Successful abstainers reported some difficulty in the beginning with the initial change to a non-drinking 
lifestyle when having to deal with social situations however many persisted in establishing a normal life as 
much as possible.  Once over this initial hurdle, abstinence was felt to be achievable.  
 
I gave up drinking four years ago due to liver problems. I had no problems stopping for the liver 
transplant and after. I still go out and socialise with friends but I drink soft drink. There are times 
when I think about drinking but I can’t do it, I have a strong will. Not drinking is part of my life and I 
have stopped drinking with mates. Abstinence has not been difficult. I didn’t drink to get a high, just to 
relax after work. It is harder for my friends to go along with my change than for me, so it can be hard 
in social situations.                                                                                                          Ken 
 
The majority of abstainers demonstrated individual responsibility and competency in being able to successfully 
change and used relapse prevention principles and skills (see below) maintained over a long period of time. 
Participants emphasized the use of will power, firm decision making, and the strength of personal resolve to 
maintain change. This was reported by 23/27 abstainers. This approach is characteristic of the cognitive 
processes found to be essential in the stages of change resulting in positive and enduring behavioral change. 
Most participants quietly acknowledged the role of alcohol in contributing to ESALD. Some spoke about their 
 
 
257 
 
propensity for rapid dependence if they were to drink and expressed regrets for not having realized the health 
risks associated with harmful drinking before the development of cirrhosis.   
 
Relapse prevention skills 
 
Relapse prevention skills used in initiating and maintaining abstinence by those who had not relapsed to heavy 
drinking included avoiding or learning to adapt to high risk social situations in 21/32 abstainers and adopting 
consequential thinking to managing cravings or thoughts of drinking in 18/32.  Again these skills show how 
ESALD transplant participants adjusted to their chronic illness and self-managed. 
 
The following examples illustrate the effective use of relapse prevention skills  
 
I approached stopping drinking the same way I stopped smoking.... I said I will never have another 
drink. I have an addiction and if I give in to the temptation I would likely have another drink and 
become addicted. I would lose all the health benefits I have gained. Everyone in my family has been 
supportive and understanding. They know I can’t drink.                                                             Gavin  
 
I don’t think the challenge ever goes away but some days are easier than others... I could be fine but 
then I don’t know what triggers it off (cravings). But I think about what I have put people through, my 
wife, my daughters and the transplant. I don’t want to throw this away ( the new liver). The hepatitis C 
is still in my liver and I am going to fight that sort of thing. But if this liver goes or deteriorates it is 
because of a disease I can’t beat not because I am sitting in a hotel chair throwing schooners down my 
throat because I can’t handle society, or I can’t handle the cards I have been dealt. And that is what is 
making me strong.                                                                                                     Douglas   
 
Many drew on their moral obligation to ‘the contract’, transplant staff and family as a way of combating 
cravings and this was endorsed by 16/32 of participants as a method of maintaining abstinence. Life threatening 
illness and transplantation triggered a strong moral and social connection to others which had meaning and 
value, different to their pre-transplant life.  
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I stopped at the bottle shop and I looked in and I thought ‘will I, won’t I, should I, should I not have 
it?’ I stood there and said ‘No, you have been given this wonderful opportunity and I am straight now 
and I am not going to do it. I can’t hurt anybody and not myself. I feel obligated to the hospital, to the 
doctors; to everybody that has helped me; to my partner the kids who have put up with me Pat  
 
Apart from occasionally you smell a beer and you would love one, but, as I say someone lost their life 
for me.…. you can’t get rid of having thoughts or urges they are in there, but I think I always think 
about the person that lost their life for me; there is no greater gift than life for anyone to give. I am not 
going to jeopardize that.                                                                                                                 Douglas  
 
(by drinking)...I would be disrespecting the person who has done this for me. I feel very strongly about 
this.  This person has died and the family has given me this precious gift and that would be a slap in 
the face if I turned around and starting drinking. You have no idea how I feel towards them. I wrote a 
letter and wrote a beautiful letter and cried all the way through it and I said to them all the happiness 
that they had given us we know the heartache they have been through and Christmas day I cried for 
them. And wondered what they were going thorough. They have given my kids a mother and one day 
they will have a grandmother. Every day I used go out and see other people with their grandchildren 
and I thought I will not be there for this. I feel so grateful and I would not do anything to disrespect 
that gift I have been given. It is a pretty amazing gift. People say what is your best Christmas present 
and what do you think I say it was being given life. And my kids were so grateful. Well someone up 
there is watching over them.                                                                                               Erica  
 
Self-transcendence 
 
Many participants described the experience of self-transcendence as they adjusted to their life-threatening crisis. 
Of the abstainers, 9/32 referred to the positive benefits derived from abstinence. They spoke of an epiphany they 
experienced as a result of transplantation and their near death experience which positively reinforced their 
resolve to abstain. The epiphany consisted of a change in their world-view, attitude to life and personal 
relationships, and could occur either in the pre- or post-transplant period. In this psychological state, participants 
were able to process their existential anxieties, gained relief from the physical pain, illness and even any distress 
associated with transplantation. After transplantation, participants described finding greater fulfillment in 
personal relationships, a greater vitality for living, empathy for others, relief from negative behaviors such as 
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overworking, and finding satisfaction in alternative life activities which had replaced drinking. The following 
extracts give examples of the epiphany and its positive role in enhancing the quality of life of some participants     
 
I now look forward to the time I have with the family. I became a grandfather three weeks ago and all 
these things I would not have seen. There is another driving force. My granddaughter has just been 
born I hold her in my arms I don’t want to drink. I want to hold her in my arms until I can’t hold her 
anymore. I appreciate my life more now than I ever did                                                       George   
 
Because you don’t drink anymore, your mind is clear. Having a transplant changes your attitude you 
see things different in life, even nature you see different. Like a baby is born again you see life in 
totally different eyes                                                                                                   Anthony  
 
I have never tried to explain it, it is very surreal.... Once you get over the majority of the physical pain 
and discomfort then you have this spark of life and get back into it and you want to get into it......I was 
just ready to jump out and tackle the world and they said just be careful if you have a downer just take 
it easy.                                                                                                                      Mathew 
 
This experience of self-transcendence also involved a change in self-identity and self-renewal.   
 
I have changed a lot. I think I am a much better person. I am much happier with myself. I am sure 
there is a long way to go.                                                                                              Miles  
 
Your whole attitude is changed and your attitude to life is changed. Your values are different things; I 
used to take things for granted you don’t take for granted anymore. I used to be cranky and irritable 
but that was just the alcohol. I think I am a lot calmer now and I am a lot more at ease with myself. 
Daniel   
The whole world has opened up.  I am like a new person in my life. I used to look terrible, all skinny 
and sunken with a big stomach. I hated going out.. Everything is so good I keep getting all this good 
karma coming to me. Everybody has said I am like a new person. They say to me you look ten years 
younger you are so much more outgoing. The kids have said ‘you have come out mum, you are such a 
better person’. ....Now I do everything with them (children) I go to coffee with friends, I go out to 
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dinner, I am doing everything now. I am having a really good life.         Erica 
 
Whilst successful abstainers talked at great length about the use of will power and individual responsibility 
required for the change, it was apparent - and acknowledged by participants -  that social support, especially of a 
partner and that of the transplant team was critical in their success. Reaching out for support from family or 
friends occurred among 21/32 of participants while 7/32 relied solely on friends and NA/AA support. This issue 
is explored further below in this chapter under the heading  psychosocial resources.   
 
Relationship with transplant staff  
 
The development of a strong rehabilitative relationship with transplant staff was also helpful in maintaining 
abstinence. The large majority of participants described a ‘special’, ‘positive’ and ‘helpful’ relationship, 
especially at those times when they were in extreme pain and distress. This was a two way process characterized 
by intensive support by staff and specialized medical care throughout transplantation, and unconditional trust by 
patients in staff. Staff provided ongoing support, encouragement and motivation for patients’ abstinence. 
Participants referred to staff as almost like family:  
 
They were fantastic down here, the aftercare I got in that ward was absolutely fantastic, the nursing staff 
they were so beautiful... I was crying all the time and when they took the catheter out I was having a 
spasm in my bladder from a urinary infection that was there all the time. I was just at breaking point and 
they got me through it, Dr..I was so grateful to him he came and saw me and put me on three lots of 
medication and then I slept from then on. And got better and better. The team here are fantastic and if I 
have any worries I can just ask could I see a doctor.                                                               .Erica  
 
The staff here are brilliant. The whole Royal Prince Alfred Hospital (RPA) is a wonderful organisation, 
....run by caring people. You don’t call the doctor ‘doctor’, it is Simone. They are part of your family as 
well. I trust this place.  They see the worst of you and then they see the best of you. Everyone cares. 
Margaret and Simone are brilliant, they are my family.                                                            Douglas 
 
There has been nothing but pure excellence from all staff.                                                              Ron 
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Mobilizing social resources 
 
As mentioned previously ( see Chapter 2), there is some evidence to suggest that those able to mobilize and 
harness social  resources over the course of liver transplantation experienced greater self-efficacy and immunity 
to relapse, making them the ideal candidates for liver transplantation. As noted in Table 10.2 and based on 
thematic analysis, abstainers described good social support throughout both the pre- and post- transplant periods,  
more likely to have a supportive partner compared to relapsers and less likely to have had a formal psychiatric 
history or current psychiatric problem. ESALD transplant participants when asked which factors could 
contribute to relapse 21/42 reported personal problems, life stressors and depression to be a key factor.      
 
Treatment resistance amongst successful abstainers    
 
Amongst abstainers, 22/32 stated that they believed that alcohol treatment was unnecessary or unwarranted due 
to the fact that they had successfully achieved abstinence through their own individual efforts. Many participants 
spoke about needing a medical rationale for alcohol treatment from their transplant physician before they would 
consider compliance or engaging in treatment. The retrospective account of relapsers also described their early 
confidence that they would never return to drinking. These quotes reflect the personal confidence of successful 
abstainers:  
 
... I don’t need treatment. I have made a decision not to drink and I am very confident that I will never 
drink and that I am in control of that myself....I don’t need treatment I have managed to stop drinking on 
my own                                                                                                                            Gavin  
 
Those that are not drinking ....what would they be treated for?                                                       Lisa 
.  
If people have solved the problem themselves, then obviously they don’t need help. You have to identify 
the people who need help if they don’t need help that is not a case of refusing help it is a case of them not 
needing it. If you don’t have a broken leg why put a splint on it?                                                    Ron 
              
 If I thought alcohol was causing a problem I would have no problem going. If I thought I was losing 
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control, I would be very happy to go.                                                                                Jennifer   
 
Many successful abstainers reported that they would comply with a medical prescribed alcohol treatment 
program if it was necessitated by their transplant physician.  
 
Denial of relapse 
 
One of the major concerns observed whilst interviewing ESALD transplant participants was the lack of 
acknowledgement that relapse could be possible. When asked how they would deal with the possibility of a 
relapse, virtually all abstainers hesitated and paused for a considerable period, being unable to provide an answer 
or possible strategy. Many reiterated that they strongly believed they would never relapse. 
 
 
iii) Relapse   
 
As mentioned earlier, successful compliance with the contract of strict or stable abstinence was not the 
experience for all ESALD transplant participants. Of the total number of participants, 15/42 could not adhere 
fully to the contract reporting some alcohol use with10 of these relapsing to harmful alcohol use (4/15 relapsing 
during the pre-transplant and 11/15 during the post-transplant period). Post-transplant relapsers, in reflecting on 
their history, believed that they had made a strong commitment to abstinence and remained dismayed by their 
relapse.  
 
The reasons provided by ESALD transplant candidates for their relapse to harmful drinking tended to involve a 
combination of physical and psychosocial difficulties. The majority of relapsers (6/10) experienced the loss of a 
support network after transplantation. This generally involved the loss of a partner due to divorce 4/10, the 
experience of marital difficulties 1/10; 5/10 had relied on AA or NA and friends. Reference was also made to the 
difference in staff attention once the transplant was over and having to rely on one’s own resources. The lack of 
a support network after the transplant and the need to be ‘alive again’ and to belong, contributed to a return to a 
social life associated with heavy drinking. Even successful abstainers, when asked what could contribute to a 
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relapse, identified a lack of family support, psychological and personal problems and social pressure to drink as 
a main trigger for relapse. 
  
Mental health problems, specifically depression in the post-transplant period and anxiety in the pre-transplant 
period, were described by 9/10 of relapsers as a factor associated with their relapse. The experience of 
depression and relapse was associated with: ongoing medical problems, difficulties adjusting to changes and 
stressors associated with transplantation, loss of confidence about one’s health, longevity and self-efficacy in the 
world. Some participants reported the experience of financial difficulties and role loss as a breadwinner, wanting 
to return to the old social network and difficulties coping with negative life events.  
 
The following extracts exemplify the ‘biographical disruption’ created by a stigmatizing chronic condition and 
the difficulties adjusting.. Relapsers unlike abstainers describe a number of life events and experiences which 
coincide with their relapse. These included:   lack of social resources, mental health issues, illness distress,  the 
need to be like ‘normal’ people or society , problems mobilizing resources such as finances, employment.  
 
Before the transplant I never let up. I continued to work and did everything I needed to do even whilst 
attending hospital appointment. You think I have a second go at life but there are times when you think  
‘Why did I bother’. You feel better after the transplant then you want to feel like how you were before 
the operation and to be doing what you were doing. I think I am dead lucky if I make it to 70 especially 
when both parents died in their 60s. When you think like this you say, ‘Bugger it. Might as well drink. 
What am I going to do, live like a Trappist monk until something good comes along?’. I do think with 
the drinking you hit it harder than before perhaps it is because you feel guilty or depressed and there is 
an aspect of medicating yourself. Perhaps you get more dependent. No one understands that the 
transplant changes your life and you don’t want your life changed.                                                 Rick   
 
The risk of relapse is always on my mind, it never goes away. Hardest thing is finding a way to get 
things off my chest. Before you could talk to your mates: with drinking came a sense of 
camaraderie…You have to be strong physically and mentally to get through the transplant. I lost my 
wife, drinking lifestyle, female companionship, my career, employment and had financial problems. I 
didn’t see how you could get through it                                                                            Daniel 
 
Ever since the aftermath of the transplant I had a lot of personal problems involving finances, work 
 
 
264 
 
problems, anxiety, my daughter started having problems with depression. It has been an unsettling 
time. I got back into the drinking 18 months after the transplant. I also returned to smoking again due 
to the stress. Alcohol had a stress relieving effect and as the pressures got greater the dependence got 
worse. After a transplant you think that you can have a party but you feel left out whilst everyone else 
can enjoy a drink and you think ‘What have I got to do?’. You miss out on being gregarious. You are 
dealing with depression and the alcohol gives you a big lift. You have survived a big operation and you 
think you can move at the same pace you were at before the liver disease. No one shows you or assists 
you through that period                                                                                                  Peter 
 
Triggers to drinking in particular may be that one cannot underestimate the power of ‘what now’.  All 
the energy around you is about, am I going to live.? Am I going to die? The waiting for the phone call 
(from transplant unit with offer of a donor organ). What do I do when I get the phone call? What do I 
do now that life is given back? It is scary... So to have gone through that period totally sober, I may 
have gone through a lot more fear and loathing than I already did. I was hospitalized on occasions. I 
was in excruciating pain and had to call an ambulance and felt terrible and it was just overwhelming. 
Bill 
 
One woman who died during the study and who found it difficult to express herself said:  
 
There was support in the beginning from family and friends but then it dropped after the transplant. 
Katherine 
 
Pre-transplant participants described the psychological distress waiting for life saving surgery with the threat of 
death and physical pain.   
 
Before the transplant I was crook from the liver disease and I was given a death threat. I thought, 
‘what have I got to lose?’, because I didn’t think I would be given a transplant. The drinking helped 
with the pain and the depression. It was medicinal. It made me feel better ...I hid grog everywhere. I 
tried to give up but I couldn’t. You were in so much pain and the only thing that relieves that pain was 
alcohol. The issue of dying was hard and I was so crook and the only thing that gives you relief was 
the alcohol.                                                                                                                 Douglas 
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I do not want to go through liver disease again it is a shocking thing, it is a dreadful thing. The 
transplant was a difficult experience I did not know what I was in for.There are stressful things you go 
through when you have a transplant.                                      Daniel  
 
Relapsers describe the difficulty adjusting after transplantation being left lost and unsure regarding their life 
purpose and direction. 
  
There was something missing in your life. You are not really physically well but feeling much better, 
you need a bit of a boost.                                                  Lisa 
 
After the transplant my new wife of four years left me. All the drugs I had been taking prior to the 
transplant were fine but post transplant the drugs made me depressed and my mind went back onto the 
alcohol. I tried to go to AA but I just wasn’t interested. The drinking slowly increased over time. Call it 
arrogance, lack of will power whatever. I had no support.                                                          James  
 
Personal choice, the contract and relapse 
   
Of the 14/15 who had returned to alcohol use, 4 did not want to remain abstinent and abide by the contract. Two 
participants emphasized the importance of free choice, autonomy and taking personal responsibility for their 
drinking as opposed to strict adherence to ‘the contract’. One 58 year old woman who returned to drinking a 
glass of wine per week, two months after her transplant, said: 
 
I want to be able to drink a half to one glass of wine per week and when I choose to. I would be 
disappointed with myself if I didn’t, as I would like to think I have control over my drinking and my 
health. I would make sure that if or when if it did start affecting my liver results, I would stop. I would 
not agree with lifelong absolute abstinence. I feel it is important for people to make their own 
decisions. I am very strong about personal control and power within yours elf over what you are 
doing, having the freedom to do what you think whilst considering the impact of that decision. Jennifer  
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Another added that he preferred a harm minimization approach:  
 
One is told that your life will be taken away, then it is given back, and I can't put that experience into 
words. It (offer of a transplant) is a gift, a responsibility, a challenge and an invitation to live your life 
the way you truly want to live it. I wrestled with abstinence. I eventually didn't stay clean..... I don't 
want to live in recovery. Recovery (12 step abstinence) has given me a lot but I don't want to live my 
life that way.I spent my time in sobriety doing the right things so I have seen both sides I know how I 
want to live.                                                                                                                     Bill 
 
Others referred to how the ‘authoritarian’ experience of ‘the contract’ triggered a type of adolescent regression 
and resistance:     
 
It feels a bit authoritarian and that is something I would resist at all times. It is part of my personality.  
Jennifer 
 
You might be too scared to mention it which is sort of unfortunate. In a way it is like being too scared 
to talk to your parents because you think they are going to bite your head off as you would be hoping 
for some understanding.                                                                                                 Miles 
 
I presume they know I have an adolescent relationship with authority figures. I feel I am going to get 
into trouble if I tell them I am drinking now.                                                                        Bill 
 
Two participants denied the existence of a ‘contract’ requiring stable abstinence. One of these participants 
presented an inconsistent story describing how he only reduced his drinking during the pre-transplant period by 
drinking only  low alcohol drinks and only due to the pressure from friends, ‘mates’, doctors and the transplant 
staff. He quickly returned to heavy alcohol use one month after the transplant.  
 
This short extract from the interview describes his view of the contract:     
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Client: I don’t remember that (contract). I would not be surprised if it was a condition and I may have 
well have lied if it was a condition. I may have forgotten about it. I was never told about a contract.  I 
don’t think I was ill at the time or overwhelmed by things. I purely can’t remember any contract or 
condition.  
 
Int: What do you think if there was such a contract of abstinence?  
 
Client: That would be a form of blackmail. Are they giving me a liver or lending me one. Who is going to 
monitor if you are not drinking. They are coercing you or forcing someone to do what they don’t want to 
do. Taking away their choice to have a couple of drinks and if they want to drink heavily that is their 
choice. I was going to take control of my life again and I did not want someone else to determine what I 
do.  
 
Int: Blackmail? 
 
Client: That is when you take away a person’s free choice.  
 
Int: From your side there was no need to change your drinking at all. So you went through the waiting 
list without having to change your drinking? 
 
Client: It was always in the air that it was frowned upon but I don’t remember anyone specifically 
saying ‘if you don’t stop drinking you will not remain on the transplant list’. I don’t remember that being 
said.  
 
Int: What made you decide to cut down? 
 
Client: I suppose the demeanour of the medicos in there inferred that. That was what you were supposed 
to do, without me actually remembering that they had put it in black and white. It was inferred that 
drinking was not a clever thing to do and I wanted to get the transplant.   I thought it was an unfair 
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situation to be in as I say most of my mates drank just as much and did not have the same problem so it 
was down to the luck of the draw. That is what I put it down to. I did say it has taken me 45 years to stuff 
up one liver and if I get 20 years out of the next one I am laughing. They did not seem to think that was 
humorous and left it at that.  
 
..but I can say to you can quote me that a comment made by one of the staff, ‘a few drinks won’t hurt 
you’. I think they are totally paranoid about wasting a liver by giving you a donor’s liver and if you set 
out to destroy that they are not happy chappies. I can understand their point of view but my attitude is 
that I went through enough pain and grief with the transplant that I want to resume a normal life as 
normal as I possibly can.  
 
Two participants had mentioned knowing a small group of ESALD transplant candidates who had no genuine 
intention to abstain and who were waiting to receive their transplant then return to heavy drinking.  
 
We come down here to the clinic and talk to people who are going to have transplants. There was one 
bloke there who talked about going to the transplant Olympics and that they will get on the grog after 
the transplant. That was a bad message for me because it outweighs all the good things.                               
Douglas 
 
iv)  Fear of stigma  
 
The fear of stigmatization was the strongest deterrent to alcohol treatment seeking amongst ESALD 
transplant candidates. A total of 26/42 actually used the word, stigma, and referred to it as being the primary 
barrier to treatment seeking within the OLT context. Relapsing or being unable to manage one’s urge to drink 
and comply with the contract was seen as a sign of personal weakness and a behaviour which would attract 
criticism and disapproval.  
 
Participants who were abstinent said that they would be embarrassed or offended by the idea of seeking 
professional help due to a strong personal desire to handle the problem themselves to demonstrate self-
competency. They described the potential for embarrassment, shame, sense of failure, loss of privacy and the 
fear of being labelled ‘an alcoholic’. Those who relapsed described a strong abstinence violation effect, 
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especially guilt, which contributed to further drinking and for some, their alcohol consumption was greater 
than their pre-transplant consumption.  
  
These quotes illustrate the stigma, personal devaluing, moral obligation and  reproach that would or could be 
evoked by failing to comply with the contract:  
 
I would be very ashamed because I did not keep my promise and I would be very unhappy with myself 
that I had given my word and let them down. The shame would be worse than the drink             Nick 
 
They asked me whether I needed to see a counsellor or do I feel comfortable going to AA or that.  I 
said ‘no’  because I am not the sort of person  … I am not a person who could get up in a room and 
say my problems because I just have to deal with them. If I can’t deal with them no one can help me 
deal with them.That is the way I sort of  feel ....I think in our era men used to deal with their problems 
on their own. You don’t go and express yourself or push your problems to someone else, you have to 
deal with it yourself                                                                                                        Geoff 
 
I think it is very hard to give people advice, but it is important to have a doctor who you can talk to. 
You need private discussion because people might think of you as an alcoholic                       Katherine 
 
It would be embarrassing to let them know you are having problems.                                      Natalie 
 
I don’t like being labelled as being an alcoholic. It means that you haven’t got your shit together. They 
are belittling you. They are basically saying you are weak (if referred to treatment)’                 David 
 
I think people don’t want to be labelled as an alcoholic and put in a group with other alcoholics who 
have worse problems than you do.                                                                                     Greg  
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As discussed in Chapter 8, chronic illness invariably can create a sense of moral obligation and responsibility 
to be a good patient. Those with ill-health are expected to reciprocate as they can be perceived as having less 
social value. In this study participants described a strong obligation to reciprocate in some way.  
 
‘I would disappoint them (transplant staff). They have given me everything. If I went to the grog I 
would be giving them nothing. It is my responsibility to look after this.  If  I was thinking about  relapse 
this would be the first place I would ring because it is a lifeline. But I think I would be a failure if I 
relapsed.  If I relapsed I don’t think I could walk back in here because I would have let people down so 
badly and they have so much faith in me. The time and money spent on me… it would have been 
cheaper to let me go. I would feel quite ashamed. I didn’t live up to my end of it. I come here every 3 
months. It is my security bond. To me morally if I let them down I do not deserve a second chance it is 
up to me to preserve what I have got and look after what I have got and I could not walk back into that 
door if I had another drink. No way in the world could I do that because I will be on my back the other 
way (relapse).                                                                                                            Douglas 
 
You wouldn’t want to let them know that you relapsed and let them down. It would be a kick in the 
teeth for them. That is how I would feel. I would feel guilty and ashamed. I felt ashamed when I first 
came here I told my doctor about what I had done. I would disappoint them they have given me 
everything. If I went to the grog I would be giving them nothing.....I think it would be difficult to tell 
staff. I wonder if people do let them know. They do check your blood tests. I am sure people would find 
it hard to let them know. I would hope I would get it early before it became a problem               Erica  
 
There was a lot of guilt for going back to the grog. Once you are educated about what alcohol does to 
you and the lengths you take to stay abstinent with the 12 step program and transplant. It is right high 
up there with the highest guilt you can have. I was adamant prior to the transplant that I would never 
drink again but you should never say ‘never’.       ‘                                                                      James  
 
 ‘I will always be indebted. I always appreciate what I have been given however it gives you a great 
deal of guilt (relapse)’                                                                                            Rick 
 
The diagnosis of ESALD itself before transplantation was reported to create stigma for some participants:   
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I coped with it when I was first diagnosed with it (ESALD) and I knew I drank but as soon as you say 
cirrhosis, that is one of the biggest stigmas. Everyone thinks you are an alcoholic and then you start 
thinking, was I?                                                                  Miles 
 
Fear of disappointing staff  
 
Again the need to reciprocate for receiving transplantation was strongly expressed. Of  all the participants 
interviewed 27/42 confidently asserted that staff would be ‘extremely disappointed’, ‘hurt’ or ‘disapproving’ if 
they were to relapse or to be seen as having problems with abstinence. This is evident in the following extracts: 
 
You can approach staff if you have problems but staff will be disappointed and unhappy if you told 
them that you are having problems with drinking. They don’t want to see you fall off the rails as they 
go through a lot of work. Doctors and nurses work hard to give you a transplant.                                                        
Ken 
 
I can understand any disappointment staff may have. I got a good liver I got a good one and I am 
destroying it                                                                                                              Wayne 
 
…it (relapse) would be undoing all the good work they have done so far. I would feel bad.        Ron 
 
They would see it (problems with abstinence) as a sign of weakness..                                    Jennifer 
 
When asked about whether they would let transplant staff know about any alcohol use, about half answered 
confidently that they would let staff know and would be willing to comply with treatment. This response was 
generally amongst those who were successful abstainers and who had no problem abiding by the contract.  At 
least a third of successful abstainers recognized the potential for stigma and how the experience of stigma would 
be a major barrier to reaching out for help but they reported they would attempt to inform staff.  One participant 
described how difficult it would be, in practice, to let transplant staff know about alcohol use in the event of a 
relapse. 
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I probably wouldn’t want to tell staff. …a lot goes into this investment in that I have the right thoughts 
behind not drinking. If I did relapse I would feel a bit of a loser...I would feel weak. I would be thinking 
that I had failed.... I wouldn’t have the strength to come back and ask for help because you would be 
basically saying you are not worthy that’s all .. I have gone through a lot and I wouldn’t like to let 
others down. You hope you are smart enough and brave enough to do something about it by 
approaching transplant staff for help. I would like to think I could do this, as there is that personal 
devious behaviour to try and hide it.                                                                               Mathew   
 
Amongst the participants who had relapsed 9/10 did not openly inform staff about their drinking and felt totally 
to blame or responsible for their relapse. Three participants described how their doctors only became aware of 
their drinking once they were admitted to an emergency ward:  
 
I had not been asked about my drinking. They did not know I was drinking. I was in the causality ward 
after three suicide attempts. My psychiatrist was annoyed as he couldn't have made a proper 
diagnosis. I was editing myself for very good reasons. If I had told them I was drinking I would not get 
a liver and when I spoke to Dr.. I was told if they had known I had been drinking they wouldn't have 
given me a liver’.....I feel like I am being an ungrateful wretch for not disclosing.                     Wayne  
 
Some participants reported deterioration in the rehabilitative relationship with staff. This deterioration 
appeared to be a combination of staff being disappointed by the patient’s relapse and the patient’s own guilt 
and shame for relapsing. A post-transplant participant who had relapsed for a short period, and then returned to 
abstinence, spoke about the consequences of relapsing:  
 
There are a number of consequences that follow from not following through. The loss of respect from 
friends and family, loss of respect from medical staff and then having to deal with the action they may 
choose to take.  There are consequences you need to consider if you return to drinking.             Daniel 
 
The guilt and shame of relapse, especially when mixed with depression, was mentioned by participants as the 
primary reason for not attending clinic appointments:  
 
I couldn’t criticize the transplant staff. I feel guilty about letting people down. For years I have put off 
 
 
273 
 
going to the clinic and seeing the staff for that reason. I think about going then I think ‘I can’t handle 
it, I can’t go through the guilt’ and ‘what they are going to think?’.                                                Rick 
 
Fear of penalty  
 
Of the pre-transplant participants, 3/16 believed that to disclose any alcohol related problems  with liver 
transplant staff could or would result in penalties or unwanted consequences. They expressed their concern 
about being de-listed or moved down the waiting list if they were to report any alcohol use. At the same time 
they felt it was important to let staff know about their drinking as it could negatively impact on their medical 
care. One participant’s family was extremely nervous and cautious about the interview and documented the 
session. The following quotes describe the fear of penalty: 
 
I don’t know because I don’t know how they are going to react. Are they going to over-react and take 
you off the list? But that is the thing, so maybe you try and keep it to yourself and try and deal with it 
yourself or get outside help. You might be too scared to mention it, which is sort of unfortunate in a 
way. It is like being too scared to talk to your parents because you think they are going to bite your 
head off, as you would be hoping for some understanding. But then I don’t know if you would get the 
understanding, maybe you would.    .                                                                           Mathew 
 
There would be concerns but then I would tell them anyway. The concern would be that I would be 
shuffled down the transplant list…I am not certain that it would be a real concern to tell you the truth 
because I have been totally honest with them and they would probably recommend that I seek some 
counselling                                                                                                                  Steve  
 
v)  No available and suitable alcohol support program   
 
‘The gap in the program’ and lack of candour 
 
Participants referred to a ‘gap’ in the transplant program involving a silence between staff and participants 
concerning alcohol related matters and the lack of on-site drug and alcohol services. The absence of a drug and 
 
 
274 
 
alcohol service within the transplant program was evident in that 26/42 participants openly stated that staff did 
not discuss alcohol related matters apart from monitoring, advice and referral.  Some participants wanted an 
open and honest working relationship with transplant staff, wanting to be able to inform staff about all issues 
which could impact on their medical care during transplantation if required.  For relapsers, the lack of 
communication or candour about alcohol related matters acted as a barrier to candour and to support from staff 
with whom they had a rehabilitative relationship:  
 
Staff don't talk about it. They don't approach the subject...they could be more initiating and elicit some 
discussion. Perhaps having a drug and alcohol person on staff would help. However not sure about how 
honest people are prepared to be because if you are drinking, you don't want to tell people as you won't 
get a liver.                                                                                                                       Bill 
 
They really didn’t do a lot. I had a chat to one or two people about it. It never came up.I don’t recall any 
monitoring or bringing the subject up. As I said it was mentioned on the odd occasion. Prior to liver 
transplantation it was brought up along the lines of ‘have you had a drink?’. Nothing pushed past that. 
It was never a discussion point. I suppose if I presented as having an issue they would have brought it 
up. It suited me that the issue was not brought up                                                             Mathew 
 
The lack of discussion about alcohol related matters appeared to generate uncertainty in the minds of most 
participants about what would happen if such issues were raised.  Some participants openly believed that to 
disclose any alcohol related problems  with liver transplant staff could or would result in penalties or unwanted 
outcomes. Pre-transplant participants expressed their concern about being de-listed or moved down the waiting 
list if they were to report any alcohol use. This issue was relevant to pre-transplant participants as described in 
the following quotes:   
 
I don’t know how they would react if I told them I was drinking or what they would do as I said they 
don’t talk about the subject.                                                                                              Ron. 
  
There would be concerns but then I would tell them anyway. The concern would be that I would be 
shuffled down the transplant list…I am not certain that it would be a real concern to tell you the truth 
because I have been totally honest with them and they would probably recommend that I seek some 
counselling                                                                                                                    Steve  
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Some participants, especially those that had relapsed, noticed the ‘the gap’ or lack of an on-site drug and alcohol 
services and were not aware of any treatment pathway in the event of a relapse.  
 
‘Staff did not tell you who to see when you have problems with alcohol or having stressful changes in 
your life                                                                                                                         Daniel 
 
It seems strange that they would have to farm it (alcohol treatment)out to someone else  and that there is 
no service here.                                                                                                             Miles. 
 
There is no one here to talk to about it (difficulties with abstinence)...I wouldn’t mind if there was 
someone with the liver clinic that I could talk to. I would gladly be happy to talk to someone here. They 
should have a drug and alcohol (service) here.                                                                           Pat 
Living with the chronic illness of harmful alcohol use   
 
Three participants believed that the contract of strict abstinence was ‘unrealistic’ as it does not account for the 
fact that addiction is a relapsing disorder and a therefore an ongoing chronic condition which a recipient has to 
live with prior to and after transplantation.    
   
There has to be consideration and support for people who go through transplantation and who had a 
drinking problem… Alcohol is a big part of their life and if you get a liver transplant, you think it has to 
be understood and realised that there will be a strong likelihood that people will go back to alcohol.  
That is why I think Dr X . (drug and alcohol physician) and Dr Y (liver transplant psychiatrist)  should be 
more involved. I would have thought that part of the program would have involved Dr X. coming into the 
picture, telling you have had a history of heavy drinking and what the processes are and working with 
him in the post transplant time. That is a time you would work with anyone. It is the time when you are 
in the frame of mind to consider help                                                                                          Rick 
 
 Now just as an opening remark it seems to me that if it is true that the majority of liver transplant 
candidates are suffering from Hepatitis C. Then a high proportion of people seeking a liver transplant 
would have a history of intravenous drug use. Therefore it seems to me that if the intention is to 
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transplant these people, it is somewhat unrealistic to expect them all to be drug free. So that is the 
conundrum which exercises my mind. The idea that the person who needs a liver transplant due to 
intravenous drug use will have some sort of epiphany or is told by their doctor that you will not get a 
transplant unless you remain abstinent and that this is sufficient in order for them to change their 
lifestyle, I think that is ridiculous quite frankly.  
 
 
Wholistic perspective 
 
Participants referred to the limitations of medicine which focuses on the disease and it’s management but 
how it does not take seriously the human experience behind chronic illness and transplantation (as discussed 
in Chapter 8. Medical practice disregards the impact on human experience as medicine is conducted and the 
psychological and social aspects of  a living with a chronic illness. .  
 
Staff are very clinical, scientific, interested in blood analysis and tests, analyzing. I felt like a piece of 
meat. …..There is a gap between the clinical side of the transplant and the emotional difficulties of going 
through a transplant. Things could be improved in this area.                                                                                       
Daniel              
 
If someone like myself does make an attempt and is clean and sober for nine years, and then has a slip I 
think that should be taken into consideration because people are not machines. They are not perfect. 
Certainly that was my experience. It was a large period of time, about 9 years, where I had been sober 
and in the last of those 3 years when I was told I had to have a transplant and I was doing recovery and 
all the intentions were good and the actions were great and then some personal traumas happened 
around 1999 and I relapsed , I pulled myself out of relapse and then I relapsed again, just as I was put 
on the transplant list. So in my mind, because I'd been told abstinence was mandatory, I was not going 
to tell them about my past relapse. I was told I would not be given a transplant. I felt that this was unfair 
on the balance of my behaviour over a period of time.                                                 Bill 
 
Whilst the majority were open to some degree of discussion regarding alcohol related matters, some 
participants who were successful abstainers never felt the need to discuss the subject and some mentioned 
how they preferred the subject not to be mentioned as it felt confronting or embarrassing. 
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‘Wanting to talk to someone’  
 
The preferred choice of treatment by all participants, including relapsers 24/42, was being able to talk to 
someone without any risk, penalty, shame or discomfort. The need to talk (‘wanting to talk’) was evident 
among a further 14/42 who mentioned the value of a support group where patients could listen and learn from 
each other. Three participants proposed that access to a phone line, if they needed to speak to someone about 
alcohol related matters would be useful. There was a willingness and desire to reach out for assistance from 
their transplant doctor, transplant psychiatrist and nursing staff who they felt they could trust and who would 
understand their addiction or situation. This was strongly endorsed by 14/32 of the abstainers. However it 
was stressed that treatment seeking needed to be client driven, non-confronting and appropriate:  
 
If I had enough trust, I probably would disclose and ask things about drinkingmore. I think it would be 
quite useful post-transplant to discuss things with someone. Where you can receive really good 
information about alcohol and your liver, what was ok and what was not ok.                           Jennifer 
 
I think that you should have easy accessibility to a counsellor or someone when you feel something is 
amiss personally... I think the one- on-one counselling is important for when you feel that things are 
getting away from you. also that you feel that you are not being singled out and that there is a choice. 
After the single informal chat, then a person could be informed that ‘we do have a group with like 
minded people like yourself who do appreciate more support and who have already given up but don’t 
want to slip up along the way.                                                                                          Steve  
 
For me I had to make the decision (seek treatment). It is a personal decision whether you are going to 
indulge or not and that decision is influenced by some external forces but a lot of internal stuff too  Lisa 
 
Pre-transplant patients could be helped by seeing those people who have gone through the transplant so 
they know what it is like when you finally get over a transplant.                                                       Daniel 
 
I think it important for staff to understand what causes you to drink and the pressures who have to deal 
with. Something like you are doing now it starting to understand the issues once you understand the 
issues then you can work out how to give that support and understand what drives that person to drink. 
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Encourage people to talk about it and if you have people trained in that manner, those with people 
handling skills I think that is important. Current staff are not able to do this, you need staff specialised in 
that area                                                                                                                          Ron 
 
I would like to be directed to people to whom I am supposed to speak to. After all these years of speaking 
at AA and rehab I don’t want to speak to every Tom, Dick and Harry on the street about my alcoholism. 
Sometimes I have to work out to whom I should speak…discussing it with just anybody is not always 
very easy because at times it is wanting to discuss it with someone who can understand and relate to 
what you are talking about. I guess for me I would search for someone who had knowledge of the 
subject, who was empathic about it and someone I would trust.                                           Andrew  
 
 
Participants who had relapsed described experiencing unhelpful, at times distressing, alcohol treatment 
approaches designed to encourage their compliance with the contract. These approaches were felt as 
stigmatizing especially due to personal feelings of shame and failure for having relapsed. These approaches 
included: being coerced or strongly advised to attend off-site drug and alcohol treatment, being given 
simplistic professional advice, and being referred to Alcoholics Anonymous.One transplant recipient 
described how he felt when he was approached by alcohol transplant staff and how he would prefer to be 
approached: 
 
I did have pancreatitis due to a lapse. The drug and alcohol squad got called in. I felt like a criminal, six 
people descended on me. I felt bad that I had disappointed the staff. I knew I did wrong, that I had 
fucked up, let them down; the very people who meant something to me. They understood but I felt bad. 
The drug and alcohol squad tried to reform me. Staff did not tell you who to see when you have problems 
with alcohol or having stressful changes in your life. You need something less clinical, a presence to 
help you get through it, something friendlier, a drug and alcohol support worker would help, something 
not so Gestapo like the drug and alcohol team.                                                                   Daniel 
 
If I had said I don’t drink but gee I feel like one ,that would have led to a different response I am sure. 
They would have asked a lot more questions and probably gone more fully into what was happening and 
we support you with this and do you really think you are going to lapse  and you know how important it 
is not to drink when you have liver problems   and all that sort of stuff....                                  Lisa 
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I would not go to AA, it is not my personality to get into that. It is a great program but I would not go to 
it.                                                                                                                                  John 
 
There is the social barrier. Also no one likes to be pushed upon, interrogated about what they have been 
doing. I am not a person for AA groups prefer a one on one situation or a group of people going through 
the same boat. Questionnaires may be helpful but they need to be subtle and non judgemental, as they 
would help people get some more knowledge and insight into things they may not be thinking 
about....More information in the right environment would be helpful. You need an environment where 
you can talk to people and have a chat, a non aggressive environment and one that allows them to come 
out and talk about things and drinking could be mentioned                                                       Alan  
 
Two participants who clearly understood the dilemma of not wanting to seek treatment because of stigma and 
knowing that treatment would be useful, provided specific recommendations about how treatment could be 
conducted. This involved a non-confronting appointment with a drug and alcohol professional as part of the 
post- transplant outpatient clinic visits of the liver transplant program:  
 
There is a window of opportunity where you might be able to capture and prevent people from going 
back on the grog. This is after you are discharged. It should be mandatory to have alcohol treatment. 
Dr. X and Dr.Y  (addiction specialists) need to come into the situation. Recommending people to go to 
AA is not everybody’s bag. ..People don’t like to admit that they are dependent on grog. The word 
‘alcoholic’ has stigma to it and people don’t like to talk about the problem.  In that window of 
opportunity, perhaps in the blue book which people read so carefully, it should be pointed out that 
alcohol treatment is mandatory in the first 18 months after a transplant                                  Rick 
 
It scares people off (alcohol treatment). It is like so many other things, smokers get confronted by 
campaigns as it is putting it into people’s face, makes them jump back rather than engaging with 
people in an open environment. It would make me feel I failed whereas an open easy approach would 
invite me to talk. Perhaps having regular appointments alongside your outpatient appointments as part 
of the visit where you have a catch up with someone about how you are going. It would like how I have 
appointments at the clinic every 6 months. Somewhere to be able to discuss things like going back to 
work, finances and life after transplant. Michael 
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The contract and other key themes 
 
The theme of the contract as explained earlier was closely connected to all the major themes. It was linked to 
abstinence as a do-it-yourself process as the contract of abstinence provided motivation for long-term 
abstinence, stressed the importance of self-management, and connected the recipient with transplant staff, 
family, friends and the public.  Relapse was indelibly linked to the contract as it was a breach of the contract 
resulting in a number of consequences and significance. The contract acted to preserve and protect against 
self-stigma yet when breached contributed to self-stigma The theme of the  ‘gap in the program’ was due to 
the policy y associated with ‘ the  contract’ as recipients of transplantation are expected to abstain though 
their own efforts despite being in the transplant program and the stressors transplantation can create.        
 
Preferred treatment  
 
The results of a short survey about preferred treatment options (Table 10.3) suggested a dislike for direct 
alcohol interventions, independent of the liver transplant program. Most participants (30/42) preferred an  
approach that integrated an individual or group program during the post-transplant  period and that focused 
on recovery and lifestyle issues, including alcohol use. A group program focused solely on alcohol was only 
endorsed by one participant.  
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Table 10.3 Preferred treatment survey  
 
 
Intervention  
 
 
      Number (n=42) 
 
Individual alcohol counseling     
 
          8  
 
 
Group program addressing alcohol issues  
 
          1  
 
Individual post-transplant counseling  including alcohol and lifestyle  
issues  
 
          15  
 
Group program post-transplant recovery including  
alcohol and lifestyle issues  
 
 
          15  
Written workbook addressing alcohol issues  
 
          1   
None of these options  
 
          2  
Other suggestions 
 
          0 
 
  
 
 
Conclusion   
 
Self-management was important to ESALD transplant participants who attributed their lengthy abstinence to 
 
 
282 
 
their own efforts and therefore felt no need for alcohol treatment.. Yet it is evident that a number of factors, 
besides self efficacy, will-power, consequential decision making, relapse prevention skills and avoidance of 
high risk situations contributed to the initiation and maintenance of abstinence. One of the most significant 
was the power of the medical, moral and social obligation imposed by ‘the contract’. Furthermore, abstainers 
had greater access to psychosocial resources than their relapsing counterparts. The vast majority of abstainers 
had a partner or spouse who played a pivotal role in their recovery, and they also tended to have  good family 
and social networks.  Establishing close, rehabilitative relationships with transplant staff was also a critical 
feature. The experience of transplantation for abstainers was not marked by psychological stressors, 
psychiatric difficulties and unwelcomed life events.   
 
By contrast, those who had relapsed to harmful drinking reported fewer psychosocial resources. Many had 
lost the support of a partner after transplantation due to divorce or interpersonal conflict. Many lacked a 
social support network, feeling the enticement of the company of drinking peers. Relapse triggered a strong 
abstinence violation effect associated with increasing guilt and shame and further alcohol consumption. It 
contributed to: deterioration in the rehabilitative relationship with transplant staff, secrecy coping, avoidance 
of outpatient and other health care services, the need for re-transplantation and, finally, mortality. Most 
participants described relapse happening after this social collapse however it also appeared that relapse 
undermined their ability to access or enhance their psychosocial reserves.   
 
Stigma was the major deterrent to seeking or utilizing alcohol treatment. Alcohol treatment was associated 
with the label ‘alcoholic’ and the negative attributes associated with the stereotype. For many participants, 
treatment suggested a failure to self-manage and therefore a personal weakness. It was also a failure to abide 
by one’s moral and social responsibility to the contract.  
 
The study findings suggest that participants were open to alcohol treatment and were critical of the absence of 
a suitable alcohol support program that was an integral feature of the liver transplant process. Independent 
alcohol interventions, such as AA, were not favoured with participants suggesting integration of an alcohol 
support program with the medical program, particularly in the post-transplant recovery period. They preferred 
an approach which maintained their personal dignity and right to solve their problems, simultaneously it 
needed to be medically prescribed and integrated with the liver transplant program. It is worth noting the 
difficulties ESALD transplant patients may experience in accessing outside services due to the burden of 
illness, lack of knowledge of services, stigmatization, inconvenience, the energy and motivation involved in 
engaging with another service, transportation problems, geographical barriers and time constraints.  
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CHAPTER 11 
In-depth interview study - Discussion 
 
 
 
This study followed the experiences of end-stage alcoholic liver disease transplant participants. The aim of the 
study was to explore the barriers to and reasons for resistance to treatment for alcohol use among ESALD 
transplant candidates before and after liver transplantation. Two main reasons for treatment resistance were 
identified in the thematic analysis. Firstly, most ESALD transplant participants wanted to avoid alcohol 
treatment due to the fear of stigma. Secondly, ESALD transplant participants who were abstinent felt they 
didn’t need alcohol treatment. A barrier to alcohol treatment reported by most participants was the lack of a 
suitable alcohol support program that was integrated with the liver transplant program. Each of these findings 
will be discussed in this chapter, along with limitations of the study and directions for future research.  
 
Fear of stigma associated with alcohol treatment 
 
Stigma is rarely ever mentioned in the liver transplant literature, despite its frequent reference in alcohol 
treatment and medical sociological literature. One of the primary findings of the current study suggests that 
resistance to alcohol treatment by ESALD transplant patients acts as a defence against stigma. When ESALD 
transplant participants were asked an open-ended question about what would prevent them from seeking 
alcohol treatment, the majority replied, ‘stigma’. The present study found that the fear of stigma experienced by 
ESALD transplant participants involved self-stigma rather than enacted or perceived stigma. Self-stigma 
constitutes negative thoughts and feelings that emerge from identification with a stigmatized group, which leads 
to internalized shame, fear, and negative self-evaluation associated with behavioural impacts including 
treatment avoidance [1] 
 
As discussed in previous chapters, stigma has been theorized in a number of ways. Goffman defined stigma as 
an ‘attribute that is deeply discrediting’ and occurring within social interactions.  Proponents of the modified 
labelling theory, as previously discussed (see Chapter 8) argue that stigma is activated once an individual enters 
treatment and is diagnosed, activating stereotypes which can become internalized as self-stigma. A further 
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advancement of modified labelling theory (Link and colleagues) also previously discussed defines stigma as the 
anticipation or experience of labelling, stereotyping, blame or devaluation or discrimination (structural) in a 
situation characterized by unequal access to power and social resources. Social identity theory postulates that 
stigma is the result of polarization and differentiation in group membership, creating a positive in-group 
prototype and a negative out-group prototype. Individuals who become affiliated or categorized as an out-group 
member and the undesirable attributes associated with it, are subject to  depersonalization, dehumanization and 
discrimination. Honneth’s theoretical perspective on the significance of mutual recognition and respect among 
individuals and groups in social life suggests that stigma is one of the mechanisms by which respect and 
recognition are withheld resulting in the denial of social inclusion and self-esteem. We can understand the fear 
of stigma among ESALD by drawing on the explanatory power of these theoretical perspectives.  
 
ESALD transplant participants did not want to be referred to alcohol treatment independent of the liver unit as 
this inferred the label ‘alcoholic’. The label ‘alcoholic’ and alcohol treatment were associated with a failure of 
self-management and personal weakness. Furthermore, to be perceived as needing professional help was 
associated with a failure to abide by the social and moral contract of abstinence and, therefore, a failure to meet 
social obligations to family, friends and transplant staff. ESALD transplant participants reported that for alcohol 
treatment to be warranted and legitimate, it needed to be medically justified by their transplant physician. As 
significantly, the preferred intervention survey revealed, it needed to be intrinsic and integral to the general 
liver transplant program of recovery in the form of a post-transplant recovery intervention.  
 
The avoidance of the label ‘alcoholic’ and alcohol treatment can be understood from the perspective of the 
modified labelling theory which, as mentioned earlier, posits that once an individual enters treatment and is 
officially diagnosed, powerful stereotypes are activated [2]. If the individual accepts the label, s/he may 
internalize the stigmatized images and stereotypes associated with it, resulting in a range of adverse effects, 
including treatment avoidance.  
From a social identity perspective, the stigma reported by participants in seeking and attending external or 
independent alcohol treatment services, was related to the possibility of being designated a member of a 
negative out-group – in this case, those unable to abstain from using alcohol. As discussed in Chapter 2, liver 
transplant candidacy is dependent on rigorous selection criteria and donor organs are offered to a highly 
selected group, considered to be the best candidates amongst a cohort of better prognosis patients. Apart from 
the medical considerations for transplantation, candidacy requires the ability to demonstrate a commitment to 
abstinence, medical compliance, psychological resilience and a stable social support network, among other 
factors.  Liver transplant candidacy for ESALD transplant participants, therefore, inescapably involves the 
establishment and operation of an in-group prototype where normative behaviour, ideal patient attributes and 
formation of rehabilitative relationships with staff are essential to medical outcomes. According to social 
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identity theory, individuals in group life seek a positive self-concept, solidarity, reduction in uncertainty and to 
maximise their access to important resources. To be seen by the transplant team as having ‘alcoholic’ attributes 
(even needing treatment) would render liver transplant patients as possible ‘out-group’ members. Membership 
of the ‘out-group’ would be life-threatening, increase uncertainty, undermine medical compliance and staff 
relationships. Micheal  Lucey [3] refers to these processes when he states: 
 
This resistance to treatment may reflect the fear that a declaration of a desire for alcohol will be 
interpreted by the transplant team as a sign of poor candidacy or a lack of commitment to sobriety 
(p.757). 
 
The in-group prototype, as revealed by thematic analysis, involved attributes of: self-efficacy, moral 
responsibility to the contract of abstinence, will-power, strength of commitment, and invincibility to relapse to 
match the heroic medicine provided by transplant staff. To need alcohol treatment simultaneously and 
intrinsically signified membership of the out-group, which was linked to the label ‘alcoholic’ and which 
suggested failure of self-management and an inability to meet moral, social and public responsibilities. The 
importance of being valued and respected by transplant staff was evident in that the majority of participants 
asserted that staff would be ‘extremely disappointed’, ‘hurt’ or ‘disapproving’ if they were to relapse or to be 
seen as having problems with abstinence and needing treatment. 
 
An ‘us’ and ‘them’, in-group and out-group membership was evident amongst ESALD transplant participants, 
who displayed a lack of interest and even revulsion at the idea of being referred to, or being seen as needing, 
alcohol treatment. For many participants, even the formation of a support group evoked the fear of being in an 
out-group of ‘alcoholics’ and so they actively avoided being identified with this group. Research has shown that 
avoidance from a potentially stigmatizing group is a common response amongst individuals whose social 
identity is under threat [4]. It is important to note that there was a small subgroup of participants representing 
in-between and out-group members who specifically requested an alcohol support group, had no problems 
identifying as ‘alcoholic’ and who tended to be affiliated with AA.  
 
Using Honneth’s perspective, ESALD transplant patients can be understood as striving to maintain mutual 
recognition (with staff, family, and friends) by being seen as morally responsible agents and valuable 
contributors in a shared project through abstaining and preserving the ‘gift of life’. For some this was a new life 
role associated with an epiphany. In order to preserve self-esteem, it was important to disaffiliate from a 
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denigrated social group (‘alcoholics’) to prevent social patterns of humiliation and marginalization. As 
significantly disaffiliation was understood as critical to securing a place as a donor recipient.  
 
The qualities required to join the in-group prototype of ideal transplant candidates ignore the fact that alcohol 
dependence can be a relapsing condition. Therefore those who do not meet the criteria for membership of this 
ideal group prototype by relapsing are more likely to experience stigma.  The presence of stigma and its adverse 
effects were described by relapsers, effects that were consistent with research identifying the negative 
cognitive, affective, behavioural and health impacts of stigma [5, 6]. Relapsing participants described guilt and 
shame, negative self evaluation, depressive symptoms, secrecy coping, loss of employment, deterioration in 
quality of life, social avoidance, re-affiliation drinking peers, liver disease requiring re-transplantation and 
mortality. Treatment dropout from the transplant program and lack of alcohol treatment seeking were also 
reported by relapsers, both strongly associated with health-related stigma.  Goffman’s work including the 
research in health-related stigma, has identified how stigma can lead to exclusionary social processes that limit 
the individual’s ability to fully participate in everyday life, including social relationships.  Self-critical and 
devaluing thoughts in reaction to relapse have been found to increase the likelihood of substance use as a means 
of suppressing negative emotions [7]. Also, while substances are used to avoid and suppress shame associated 
with stigma, they reduce access to the useful regulatory function of the emotions of shame in order to regain 
self-control [8], with shame contributing to treatment dropout [9] and poor social functioning [10]. 
 
Stigma as a deterrent to participation in alcohol treatment is not unique to the ESALD transplant population. A 
large body of alcohol research has found stigma to be a major barrier to treatment seeking by the majority of 
those with harmful alcohol use in the general population [11-19]. Similarly, in these studies treatment was 
associated with social disapproval, low self esteem and being labelled an ‘alcoholic’ with a strong preference to 
handle one’s own problems [11-14, 20-22]. Treatment avoidance acts to preserve self-esteem, as seeking 
professional treatment can trigger feelings of  inferiority, inadequacy, a sign of weakness or failure [23]. 
However the limitations of these studies is there is little sociological and social psychological theory and 
analysis to explain these findings.   
 
The transplant literature has frequently referred to denial as a distinguishing feature of ESALD transplant 
participants and one of the main reasons for resisting alcohol treatment. This present study suggests that 
ESALD transplant participants reject the diagnosis or past alcohol problems, and alcohol treatment, to protect 
dignity and self-worth. Denial and stigma, however, can be closely connected as they both function to protect a 
person’s self-esteem and his or her interpersonal relationships. Like stigma, maladaptive denial manifests in  
non-compliance, rejection of a diagnosis, interpersonal difficulties and, importantly, refusal to participate in 
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treatment  [24].  Research has shown that persons with an alcohol dependence problem are afraid of openly 
admitting their condition, fearing adverse reactions from others while privately recognising  their problems with 
alcohol  [25]. Considering these processes, it appears that alcohol treatment for ESALD transplant participants 
that do not trigger stigma need to meet certain conditions in their provision. On the basis of the data from this 
study, two key conditions have been identified. One is the integration of an alcohol treatment program with the 
liver transplant program. The second involves the orientation of such a program towards the enhancement of 
self-management in a collaborative and respectful context, rather than in a context in which the person or client 
is seen as a failure because of alcohol use. It is also important to appreciate that denial in relation to a life-
threatening chronic illness assists in managing the challenges associated with chronic illness, maintain social 
roles, facilitates being a  ‘good patient’ and acts to normalise  [26]. Anger and denial has been found among 
patients recently referred for transplant [27]. 
The fact that men make up the large proportion of the ESALD transplant patients may also be 
important when examining denial and stigma. Males invest more energy keeping their illness 
contained and disability invisible in order to maintain their masculinity while maintaining another 
identity at home (Chapter8). 
 
Abstinence as a ‘do-it-yourself’ process  
 
Alcohol treatment was perceived by more than half of the study participants as unnecessary due to successful 
self-management having achieved abstinence without needing professional treatment. Weinrieb and colleagues, 
also noted that ESALD participants reject established alcohol therapies because they have already been 
abstinent for some time [28]. Also research shows that a large number of individuals can reduce or abstain from 
alcohol through self-initiated and not professionally facilitated change [12, 14, 29-32] [33-37].  
 
Achieving and maintaining abstinence by ESALD transplant participants involved many of the cognitive and 
behavioural tasks associated with the stages of change as identified by Prochaska and DiClemente, and relapse 
prevention as reported by Marlatt. In the current study, participants described a cognitive appraisal process in 
response to the diagnosis of life threatening liver disease. Decision making and relapse prevention strategies 
included dealing with high risk situations, challenging cravings or thoughts about drinking and consequential 
thinking. Behavioural strategies included achieving lifestyle balance by focusing on rewarding, non-alcohol-
related activities and a reliance on general and abstinence social support. Yet it is evident that a number of 
significant social factors, besides psychological techniques of managing cravings and self-regulation, 
contributed to the initiation and maintenance of abstinence.  
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Abstainers had greater access to close social relations and a sense of solidarity than their relapsing counterparts. 
One of the most significant factors was the role of the spouse and support of family and friends who supported 
abstinence. These factors were found to be lacking amongst relapsers who were more likely to have lost the 
support of a close partner, to experience depressive symptoms, more stressful events and a poorer quality of 
life. The role of socio-economic factors, including educational background, in relation to stigma and relapse, 
was not confirmed by this study, perhaps due to methodology and the small number of relapse participants.    
 
As discussed in Chapter 8, Honneth points to the important role of social connectedness, self-value and 
solidarity in the health and well-being of individuals, and how this is supported by sufficient evidence showing 
that social relationships and marriage benefit health and well-being [38] [39]. This is consistent with relapse 
research literature, both within the transplant research but also outside the transplant field, confirming the 
important role of a partner, and personal and social resources in alcohol relapse [40-42] (Chapter 2). Several 
clinical studies have reported that relapses may result from stressful life events, interpersonal conflict, 
affective/mood states and/or difficulties coping with stress [43-45]. Another factor which contributed to 
abstinence was the powerful social contract which has already been discussed.   
 
The study findings suggest that abstainers unlike relapsers were able to adjust to the ‘biographical disruption’ 
created by a stigmatizing chronic illness ( Chapter 8.). Many described adapting to their illnesses through the 
use of self-management, positive determinism, self-transcendence. maintaining a sense of value and meaning in 
life setting realistic goals in order to maintain everyday life, maintaining support and coherence. revealing the 
importance of self-management. Wainwright reported an overwhelming desire by liver transplant patients to 
regain lost independence and to live a normal life again [46] . 
 
Abstainers unlike relapsers did not report painful emotional journeys involving loss of partner, financial 
vocational distress, mental health problems, and illness distress.  These findings are consistent with a 
qualitative study by Newton [47]. The clinical themes suggest that liver transplantation, although life altering, 
does not necessarily transform one’s life in a positive way. The themes represent a spectrum of life-altering 
possibilities that range from the liver transplantation experience being very positive for some recipients to it 
being a taxing ordeal for others to endure. The data show that recipients who perceived their lives as full of 
afflictions had a higher likelihood of alcohol relapse after transplantation than did the recipients who described 
their lives in more positive terms, regardless of previous pathology or cause of liver failure. Newton (2003) 
reported that approximately 23% of ALTRs were assessed as having moderate to severe depression. Thus, it 
may be that the themes “impact of co-morbidities” and “life stinks” represents the views of ALTRs who are 
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clinically depressed after transplantation. it was found that alcohol relapse after liver transplantation was more 
likely when recipients identified with two of the themes: “impact of co-morbidities” and “life stinks.”[48] 
 
No available and suitable alcohol support program 
 
A barrier to alcohol treatment reported by most participants was the ‘gap in the program’ involving the lack of a 
suitable alcohol support program, described by participants as being integrated with the liver transplant 
program. Participants referred to a silence or lack of communication between patients and transplant staff 
around alcohol related issues, expressing a need for ‘someone to talk to’ in the event that they might need 
assistance with the psychological, social or health difficulties associated with transplantation and maintaining 
abstinence. At the same time they wanted an approach that was respectful of their personal achievement and 
self-efficacy.  
 
Weinrieb has attributed the lack of open communication between patients and staff regarding alcohol issues due 
to the policy of mandatory abstinence. For Weinrieb this policy acts as a barrier to candour and for those 
seeking medical assistance for ‘their problem’ and, places patients in the position of having to conceal their 
alcohol use for fear of penalties [49]. Alternatively studies report that when patients are encouraged to discuss 
their alcohol use openly, without fear of judgement or penalty, they feel more comfortable about disclosing 
their alcohol use honestly [42, 50]. Such an approach is considered a more effective way of identifying alcohol 
use in the post-transplantation period [49, 51, 52].  
 
Considering the important role of psychosocial resources and the negative impact of stigma associated with 
alcohol treatment seeking and relapse, it appears that liver transplant services are obliged to actively and 
directly support the social and interpersonal dimensions of transplantation. This approach to alcohol treatment 
is suggested by a combination of internationally recognised contributors to the field of social stigma and self-
esteem, especially in relation to health care settings, and by research into the social and environmental 
determinants of health discussed in previous chapters. The latter emphasize the important role that social 
relationships and support play in positive identity, self-esteem and recovery from relapse and as an antidote to 
stigma.  An onsite integrated program connected to their medical transplantation and addressing the social and 
emotional dimensions of post-transplant recovery would be seen more consistent with the reality of the 
challenges that participants face in managing their alcohol use and maintaining abstinence.  
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Limitations of the study 
 
As this was an exploratory study, additional valuable insights into patients’ experiences, especially the 
experience of stigma, could have been obtained by adopting a more in-depth, life history or narrative interview 
approach. The experience of end-stage liver disease and transplantation has many physiologic, psychological, 
social and spiritual manifestation of illness distress requiring the transplant recipient to continuously adjust to 
the chronic aspects of living with transplantation. Illness narratives could have brought more of the person back 
into the discussion of illness, stigma and relapse. It would have been possible to explore how participants 
adjusted to the changes in identity, self-worth and social relationships, how they make sense of their illness 
experience, agency and resistance in the illness experience. Also it would have been interesting to explore the 
‘biographical disruption’ between abstainers and relapsers.  
 
Another limitation of the study was the small number of more in-depth interviews especially with those who 
had relapsed. Time restrictions, as well as consideration of the participants’ health status and medical regimen, 
limited the scope and depth of the interviews that were used to generate qualitative data.  
 
The process of following up patients who had relapsed, proved difficult and time consuming, since they no 
longer attended the outpatient liver clinic. Some expressed willingness to participate in the study but, despite a 
number of scheduled appointments and telephone contacts, did not do so. It is also possible that participants 
were reluctant to give negative feedback about the alcohol management program due to their feelings of loyalty 
to and appreciation of the transplant program staff. The latter may have meant that participants were less than 
completely open and honest about their experiences. In future research, non–ESALD transplant participants 
could be included to address this concern.  
 
As is the case in all research, findings emerge from the interaction between the researcher and the participants 
and are influenced by the questions being asked, the values of the researcher and the analytic techniques 
adopted. The student researcher brought to the research processes her own theoretical perspective, subculture, 
and unique psychosocial history. Participants may have been influenced either consciously or subconsciously, 
by my background in drug and alcohol counselling, and this may have affected the comments they made.   
 
Through consultation with my academic supervisors, theoretical biases to the topic were identified by the 
researcher and these were considered but – as has been widely discussed in the methodological literature – no 
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research can ever be totally value-free. Ultimately, concepts derived from the psychology of addictive 
behaviour and models of treatment seeking, discussed earlier in the literature review, have been most influential 
in developing my theoretical perspective and interpretation of data. 
 
Directions for future research  
 
This study has identified a significant gap in our understanding of treatment resistance among ESALD 
transplant patients. It has highlighted the conceptual and empirical neglect of stigma as an explanatory tool.  
Further research is needed to identify the processes, mechanisms and antecedents of stigma, and whether 
ESALD transplant participants not only anticipate stigma but actually experience it during the course of their 
referral, evaluation and participation in the transplant program. Another fruitful area for future research is to 
explore whether some ESALD patients are more vulnerable to stigma by virtue of their socioeconomic status, 
gender and/or ethnicity. Such investigation should consider the chronicity of ESALD and liver transplantation 
as mentioned earlier and the  interaction of social structural (gender, ethnicity and class) dimensions of the 
experience of liver transplantation with other significant features such as mental health, coping capacity and 
social support.  It would also be worthwhile to investigate the attitudes and experiences of staff involved in the 
patient’s health care.  
 
Conclusion 
 
This study sought to better understand the barriers to, and reasons for, treatment resistance amongst ESALD 
transplant candidates before and after liver transplantation. Its findings suggest that ESALD transplant 
participants reject alcohol treatment for two main reasons: fear of self-stigma and the belief that treatment is not 
needed. The processes and mechanisms of stigma in the context of liver transplantation candidacy result in 
treatment being associated with the label ‘alcoholic’ and failing to live up to the group prototype of the ideal 
transplant candidate. The impact of stigma was evident among ESALD transplant participants who had relapsed 
to heavy drinking, contributing to the loss of self-esteem and treatment avoidance. ESALD transplant 
participants perceived no need for treatment because they believed they could undertake the process of 
remaining abstinent themselves, despite the fact that abstainers were strongly supported by intimate partners, 
social networks and ‘the contract’. For alcohol treatment to be attractive to ESALD transplant participants it 
evident that it needs to be medically integrated with the general transplant program. As importantly, such 
treatment of alcohol issues needs to be delivered as part of a post-transplant recovery program, and not as a 
stand-alone service.  
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The findings from this qualitative study can make an important contribution to the development of such an 
intervention, to be further outlined in the following chapter.  
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                                              CHAPTER 12                            
                    Conclusion and Recommendations  
 
 
This study by adopting both quantitative and qualitative methods, demonstrated that ESALD transplant 
patients resist alcohol treatment due to stigma, self-initiated abstinence and high abstinence self-efficacy 
and, the lack of a suitable alcohol program tailored to the needs and clinical characteristics of this patient 
population. Study 1 utilized an empirical analytical paradigm involving a case control design as means 
of isolating, defining and measuring variables commonly associated with alcohol seeking treatment. This 
study design made it possible to compare alcohol treatment seekers with ESALD transplant patients, to 
determine why alcohol treatment is considered unwarranted by transplant participants.  Study 2 used the 
interpretive paradigm using an interview-based thematic analysis study, uncovering the beliefs, 
meanings, experiences and actions of ESALD transplant participants to gain a participant’s perspective 
for treatment resistance.  
 
An examination of the findings for both the case control and in-depth interview studies revealed more 
consistencies rather than discrepancies. Both studies confirmed three main factors to treatment 
resistance, and these factors will be discussed in this chapter, along with recommendations for the design 
and implementation of alcohol intervention, to reduce the risk of relapse amongst ESALD transplant 
patients.  
 
Factors contributing to resistance to alcohol treatment   
Firstly, the majority of ESALD transplant participants are likely to reject alcohol treatment as they 
accurately perceive no need for treatment as many will have achieved a lengthy abstinence without the 
use of professional services. Yet such an approach is contingent on the presence of particular and 
significant processes that operate in the livers of transplant participants. Both studies confirmed the 
presence of cognitive and behavioural processes and tasks that are critical in the process of change and 
maintenance of abstinence. The case control study measured the stages of change from the time of 
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problematic drinking and transplant candidacy. A progressive- readiness- to- change profile marked by 
high action, was observed, suggesting that the early and latter tasks of changing addictive behaviour 
were incorporated (problem recognition, weighing pros and cons, decision making, use of cognitive-
control and suppression of competing motivational tendencies). These results provide empirical evidence 
that ESALD transplant patients make genuine change as a result of a life-threatening illness disputing 
the proposal that denial is one of the main reasons for treatment resistance.  
 
Study 2 actually described how participants achieved abstinence and how their experience was different 
to relapsers. The in-depth interview study also found participants describing many of the cognitive and 
behavioural tasks associated with initiating and maintaining abstinence. ESALD transplant participants 
revealed the use of cognitive appraisal, self-control strategies, suppression of alcohol related cues and 
substitute activities in order to maintain abstinence. This study did however highlight the positive role of 
partnership, social support, psychological wellbeing and the moral and social obligation associated with 
the contract as critical to maintaining abstinence.  The importance of self-management and self-
transcendence as participants face a life-threatening illness and how this alters attitudes, values 
and behaviour. Tentative findings of the case control study, which compared abstainers with relapsers, 
also pointed to the benefits of marriage, social support and optimal quality of life in preventing relapse. 
Health beliefs and motivation were identified by the case control study as clinical variables that changed.  
 
The second reason for resistance to alcohol treatment was stigma. Stigma was suggested in Study 1 
findings showing an embarrassment and fear of disappointing transplant staff associated with seeking 
professional help. However Study 2 provided a more in-depth understanding of the both self and 
relational factors along with the role of candidacy to a fear of self-stigma by ESALD transplant 
participants. Alcohol treatment in this setting was perceived as a social identity threat and a threat to 
candidacy, and closely associated with the negative stereotype of ‘alcoholic’. Treatment seeking was 
perceived as a failure of self-management and a sign of personal weakness. Study 2 unlike Study 1 was 
able to provide some links to stigma especially the critical role of the ‘contract’, the role of social 
interpersonal relationships including transplant staff and public opinion in relation to the gift of life. 
Unlike Study 1, the qualitative study provided the opportunity for those who had relapsed to describe 
the contextual and psychological factors contributing to relapse. Study 1 did not find depression as a 
factor while in Study 2 relapsers reported a range of psychologically distress including depression, pre-
transplant anxiety, difficulties adjusting to chronic illness.  
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Thirdly, ESALD transplant patients will reject alcohol treatment as these programs are unsuitable for 
this clinical population. The case control study clearly demonstrated a difference in the clinical profile 
and characteristics of ESALD transplant patients to those who would typically utilize alcohol treatment. 
ESALD transplant patients, unlike ATS, had a less severe form of alcoholism, less psychiatric co- 
morbidity, better quality of life and more psychosocial resources. The clinical profile of ESALD 
transplant patients is closer to natural remitters than those with alcohol use disorders who seek specialty 
treatment. While the qualitative interview–based study was not equipped to systematically measure and 
confirm the suitability of alcohol treatment based on clinical characteristics using statistical tests. It did 
reveal that ESALD transplant patients perceive specialty alcohol treatment as an external service only 
for a marginalized group and therefore potentially stigmatizing. They preferred a less direct and on-site 
alcohol interventions integrated with the liver transplant program.   
  
Alcohol treatment recommendations  
 
Current alcohol management programs used by liver transplant programs worldwide are effective, as 
over half of ESALD transplant participants maintain stable abstinence. Furthermore relapse rates are 
significantly lower than those with alcohol use disorders who complete conventional alcohol treatment. 
However, relapse to heavy alcohol use occurs for at least one third of ESALD transplant patients with 
adverse health effects. Also relapse amongst donor organ recipients can undermine public confidence in 
transplant program and organ donation rates.  
 
The results of this study suggest five key guidelines to the development, implementation and integration 
of alcohol intervention in this setting. Firstly, an on-site medically prescribed alcohol support program 
integrated with liver transplant treatment provided by experienced drug and alcohol clinician is 
suggested. Secondly, the alcohol management approach needs to support the psychosocial rehabilitative 
dimensions of transplantation. Thirdly, direct and intensive evidence-based alcohol interventions used in 
specialist settings such as motivational interviewing have not been suggested by this study for those 
who are abstinent. This is consistent with poor treatment participation and adherence found in use of 
direct alcohol interventions amongst ESALD transplant patients (Chapter 3). Fourthly, a relapse 
prevention approach needs to be integrated with the transplant program whilst still maintaining a 
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requirement for abstinence.  The large majority of ESALD transplant patients minimised their risk of 
relapse and did not have a relapse prevention plan. Relapsers did not pursue treatment and experienced 
adverse physical and psychosocial effects as a result of harmful drinking. Finally, a case 
management/case monitoring approach will be required as relapse can be difficult to predict especially 
when slips and triggers for relapse are not being closely monitored.  
The policy and goal of transplantation consisting of lifelong abstinence may need to be re-examined as 
it contributes to a fear of stigma and the lack of candour about alcohol related issues. The lack of 
candour and communication regarding alcohol issues whilst participating in the transplant program and 
difference in individual need and self-efficacy suggests that ESALD transplant population would benefit 
from the communication skills of experienced drug and alcohol professionals. Such clinicians are able 
to efficiently engage patients in a non-stigmatizing manner, assess relapse, and provide specialty alcohol 
treatment service when indicated. Interventions can be stepped up or stepped down in intensity, delivery 
and/or frequency depending on the individual’s clinical characteristics, presence of predictors for 
relapse and degree of perceived stigmatization.  
 
Program Components  
 
In order to tailor a program suitable to the needs and clinical characteristics of ESALD 
transplant patients and to minimize the potential for stigmatization, a three tiered stepped care is 
recommended (Figure 12.1).   
 
Pre-Transplant Phase 
 
The goal of pre-transplant alcohol treatment is assertive engagement and the promotion of 
treatment seeking by patients in the event of a lapse or relapse. Low intensity interventions are 
recommended such as information provided about alcohol support services in the ‘blue book’ or 
as part of transplant orientation program. Conversations between patients and their transplant 
physician regarding using alcohol services in order to maintain abstinence are also important. 
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The provision of an on-site abstinence support session with a drug and alcohol clinician for 
those being considered for candidacy and who need to enhance their abstinence self-efficacy. 
More intensive intervention is required for those who are drinking or who have relapsed.   
 
Post-Transplant Phase 
 
The aim of alcohol treatment in the post-transplant phase is to prevent relapse by addressing the 
physical, psychological, social and occupational adjustment difficulties that may be 
experienced after transplantation for some ALD patients. All ALD patients are advised to 
attend ‘Post-transplant recovery’ appointments scheduled in conjunction with outpatient 
transplant clinic appointments every 3 months during the first post-operative year to assess 
capacity to maintain abstinence and adjustment after transplantation. 
 
‘Post-transplant recovery’ intervention is recommended for those at risk of relapse and who are 
experiencing significant psychological, social and occupational difficulties associated with their 
relapse. This intervention would address active coping, illness behaviour, building social 
networks, enhancing occupational performance (employment capacity, routine, life roles) and 
maintaining abstinence.  
 
Standard on-site drug and alcohol treatment will be required for those who relapse. More 
intensive specialised intervention is required for those who relapse. Again this would involve 
assessment of relapse triggers, psychiatric co-morbidity, cognitions and motivation but also a 
more comprehensive psychosocial rehabilitation care program focusing on quality of life and 
building support network as recommended by number of key authors [1-4].Referral to suitable 
medical, drug and alcohol, mental health and community providers may be required. Programs 
may need to consider a goal of controlled drinking after liver transplantation if relapse to heavy 
drinking is difficult to alter and motivation for abstinence has changed [3]. Follow up care via 
telephone will also be required. Key caregivers or significant people in the patient’s life may 
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need to be incorporated.  Referral to specialist services would need to be considered such 
detoxification and residential rehabilitation services. A post-transplant peer based support 
group is indicated due to the special needs of those likely to experience stigma, may be 
marginalized and who lack psychosocial resources. 
 
The use of broader interventions addressing the interpersonal dimensions of transplantation, 
quality of life and wellbeing is recommended. This is consistent with the higher acceptability 
and engagement by ESALD transplant patients to the use of social network therapy (Chapter 3). 
In terms of addressing  self-stigma  there a  number of possible yet still not empirically verified 
interventions or strategies being proposed [5].  These have included psycho-education, CBT 
approach involving increasing stigma awareness, challenging stigmatizing thoughts and 
behaviours, empowering strategies such sharing personal experiences, enhancing coping skills 
increasing self esteem and finally acceptance and commitment therapy.  These approaches may 
be incorporated in the interventions program to be discussed. 
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Figure 12.1. Alcohol treatment approach for ESALD transplant patients undergoing liver 
transplantation 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         Pre-Transplant Phase  
Aim-Assertive engagement and promotion of treatment seeking focus on maintaining 
abstinence  
 Blue book 
 Transplant orientation sessions 
 Communications between patient and transplant staff regarding on-site 
abstinence support services  
 Individual assessment and alcohol treatment for  those at risk of relapse or 
who are drinking 
 
Post-Transplant Phase  
Aim- to prevent relapse by promoting physical, psychological, social and occupational 
adjustment after transplantation   
 Post-transplant recovery sessions every 3 months for the first post-operative  
year in conjunction with liver transplant clinic appointments, assessing risk 
of relapse 
 Provision of ‘post-transplant recovery’ intervention as required. 
 Intensive intervention for those who lapse/relapse using  
 On-site standard alcohol treatment  
 Referral and Liaison 
 Assertive follow- up  
 Support group 
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Conclusion 
 
High abstinence self-efficacy, the fear of stigma and the lack of suitability of specialty alcohol treatment 
were the key reasons for treatment resistance among ESALD transplant patients based on a quantitative 
and qualitative study.   On the whole ESALD transplant candidates were not opposed to the idea of 
alcohol treatment as long as they perceived the need for treatment, experience it as non-stigmatising and 
integrated with the liver transplant program. The risk or rate of relapse may be minimised by providing a 
more suitable, non-stigmatizing and efficacious intervention, at the same time maintaining the 
confidence of donor families and the general public in the integrity of the transplantation process. The 
findings from both the qualitative and quantitative study add texture and depth to prior knowledge and 
should encourage liver transplant providers to develop and implement suitable alcohol treatment 
approaches within the transplant context.   
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APPENDIX A- Models of treatment seeking  
 
Figure 1   Becker et al (1977) Adapted Health Beliefs Model Health Beliefs Model. Reprinted 
from  [220] 
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Figure 2 Goldberg and Huxley’s Pathways to Care Model. Reprinted from [34] 
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Figure 3: A Stress and Coping Model by Finney and Moos. Reprinted from [221] 
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APPENDIX B –Sydney South West Area Health Service 
Ethical Approval   
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APPENDIX C Research flyer for ESALD transplant 
participants  
Flyer for ESALD transplant participants (cases)  
 
                       
 
Recovery after Liver Transplantation – do people with a previous problem with alcohol 
benefit from additional assistance  
 
A successful liver transplant is dependent on a person’s dedication to their medical regime, regular 
checkups and abstinence from high risk behaviors such as alcohol use. Giving up alcohol is a very difficult 
thing to achieve however you have managed to do that. We are very interested to know more about how 
you have managed to achieve this, and what things have helped you maintain your abstinence over such a 
long period.  
Re-establishing a normal life after transplant surgery is quite challenging as one has to face medical and 
health issues, returning to employment or other life roles and resuming social or family activities. People 
may find themselves having cravings or thoughts about alcohol as they try to cope with these issues. Our 
concern is whether there are other things we can do to assist people’s rehabilitation and strengthen their 
coping skills during the post-transplant period.  
This study aims to determine the most effective approach to assisting patients with alcohol liver disease 
during and after liver transplantation. You will be offered the opportunity to contribute your ideas in order 
to improve our health service. 
Please contact Cathy Heyes on Ph.9515 7328   
 
If you are interested or require further information 
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               Flyer for alcohol treatment seekers (controls) 
                                                    
Would you like to participate in a alcohol treatment research 
study? 
 
We are looking for   
 Males over the age of 50 
 Good liver function   
 Who started or returned to AA  in the last month  
 
This study is being run from Royal Prince Alfred Hospital, Drug 
Health Services in Camperdown. The study aims to determine the 
most effective approach to assisting patients with alcohol related 
liver disease during and after liver transplantation. You are 
invited to participate in this study as you have sought help or 
alcohol treatment and will act as a ‘control’ participant in the 
Drug Health Services            
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study. A $20 Myers/Coles gift voucher will be provided for your 
time and contribution.  
 
Please contact Cathy Heyes on Ph.9515 7328   
 
Drug Health Services         
          
  
If you are interested or require further information 
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APPENDIX D Information for participants and consent 
form  
 
 
 
Barriers to Alcohol Treatment amongst patients with Alcohol related Liver Disease 
undergoing Liver Transplantation  
 
 
INFORMATION FOR PARTICIPANTS 
 
 
Introduction 
 
You are invited to take part in a research study to help us determine what kind of alcohol 
treatment services could be useful to patients with alcohol liver disease undergoing liver 
transplantation.  A successful liver transplant is dependent on a patient's dedication to 
their medical regime, regular checkups and abstinence from high risk behaviours such as 
alcohol use. Abstaining from alcohol can be a very difficult thing to achieve and it is easy 
to slip back into old habits especially when motivation changes.  We are concerned that 
some people can return to some kind of drinking within five years after a transplant which 
can lead to recurring liver disease, graft failure and health problems such as 
cardiovascular disease and cancer. Once the immediate demands of transplantation are 
over, people may find it difficult to maintain an abstinent lifestyle due to health problems, 
loss of employment or difficulties functioning and socializing without drinking.   
The objective is to investigate whether patients could benefit from having more 
professional support either before or after their liver transplant and what approach would 
be useful. From this study we will be better able to make recommendations regarding an 
effective intervention for patients with alcohol liver disease undergoing liver 
transplantation, thus further developing our liver transplant services. 
 
You are invited to take part in a research study because  
i) You have been diagnosed with alcohol liver disease and are either on the 
transplant waiting list or have received a transplant over six months ago 
OR  
ii) You have sought help to overcome problem drinking and will act as a ‘control’ 
participant in the study.  
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The study is being conducted within this institution by Cathy Heyes, a Drug and Alcohol 
Clinician working at Drug Health Services at Royal Prince Alfred Hospital, and will form 
the basis for the degree of Doctor of Health Science at The University of Sydney under 
the supervision of Professor Paul Haber, Medical Head, Drug Health Services, Royal 
Prince Alfred Hospital and Dr Andrew Baillie Senior Lecturer, Psychology, Macquarie 
University.  
 
 
Study Procedures 
 
If you agree to participate in this study, you will be asked to sign the Participant Consent 
Form.  You will then be asked to sign the Participant Consent Form. You will then be 
asked to complete an interview and 10 questionnaires asking about your past alcohol use, 
quality of life, personal goals, treatment motivation, mood, treatment experiences and 
stage of change. This will take around one hour to complete. If you are a liver transplant 
recipient you will be asked to complete an  interview (which will be audiotaped). If you are 
not an alcohol liver transplant recipient you will also be asked to provide a liver function 
test within the last three  months either from your general practitioner or from recent 
hospital medical records.  
In addition, the researchers would like to have access to your medical record to obtain 
information relevant to this study. 
 
 
 
Confidentiality   
 
All the information collected from you for the study will be treated confidentially, and only 
the investigators named above will have access to information on participants. No 
information provided will be reported to any staff associated with the Liver Transplant Unit 
or Drug Health Services at RPAH. A report of the study may be submitted for publication, 
but individual participants will not be identifiable in such a report. The study information 
will be coded so that you cannot be identified. The clinic will not be given any information 
about you or your study test results. 
 
 
Voluntary Participation  
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Participation in this study is entirely voluntary. You are in no way obliged to participate. If 
you do take part, you can withdraw at any time without having to give a reason. Whatever 
your decision, please be assured that it will not affect your medical treatment or the staff 
involved in your treatment.  Staff will not be directly informed about your participation or 
non-participation.    
 
Benefits  
Following on from this study, a treatment study will be conducted in which you will be 
offered the opportunity to receive further support to improve your physical and 
psychological coping mechanisms. While this study may not be of direct benefit to you in 
the short term, in the future it will further improve health services for those with alcohol 
liver disease undergoing transplantation. 
 
Costs  
Participation in this study will not cost you anything, however you will be reimbursed for 
your time to the value of $20. 
 
Further Information  
When you have read this information, Cathy Heyes will answer any questions you may 
have. If you would like to know more at any stage please feel free to contact her on 9515 
7328. 
This information sheet is for you to keep. 
 
 
 
Ethics Approval and Complaints 
 
This study has been approved by the Ethics Review Committee (RPAH Zone) of the 
Sydney South West Area Health Service.  Any person with concerns or complaints about 
the conduct of this study should contact the Executive Officer on 02 9515 6766 and quote 
protocol number X09-0080. 
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APPENDIX E Assessment Measures  
 
Demographic and Clinical Data 
 
Age:                         Gender:  
Cases: Stage of Transplant: Pre:            Post:  
Length of abstinence after being placed on the waiting list :  
Length of abstinence before being placed on waiting list:  
Hepatitis C Virus       □Yes  
 □No 
Ever IVDU        □Yes  
 □No 
 
Has there been anyone in your close or extended family who had a marked 
problem with excessive alcohol use e.g. sibling, parent, uncle or aunt, 
grandparent? 
            □Yes  □No  
 
Have you lived in stable housing for the last two years?     □Yes  
 □No 
 
 
 
319 
 
Are you married or living in a committed cohabiting partner?            
                               □Yes 
 □No 
 
Have you ever been diagnosed, received medical or psychological treatment 
or been prescribed medications for mental health problems such as 
depression, anxiety or other condition?                                     
□Yes              □No 
 
Do you believe you have a good social support network consisting of family 
and/or close friends but also people who support your abstinence or need to 
change your alcohol use?                                                            □Yes  
  □No 
 
Are you currently employed? 
                     □Yes   
 □No 
 What level of education did you reach?   ≤SC        ≤HSC          ≤ TAFE         ≤UNI 
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ALCOHOL DEPENDENCE   ALCOHOL DEPENDENCE CRITERIA 
 
 
 
 
 
 
I’d now like to ask you some 
more detailed questions thinking 
about the time your drinking was 
the most problematic or at it’s 
heaviest. Answering yes or no  
 A maladaptive pattern of  
alcohol use, leading to 
clinically significant 
impairment or distress, as 
manifested by three (or 
more) of the following 
occurring at any time in the 
same twelve month period 
 
 
? = inadequate info 
1 = absent  
2 = sub threshold 
3 = true 
 
Did find that when you started 
drinking you ended up drinking 
much more than you were 
planning to? 
 
      Did you drink for a much 
longer period of time than you 
were planning to? 
 
 (3) alcohol is often taken in 
larger amounts OR over a 
longer period than was 
intended 
 ? 1 2 3 
         No           Yes 
Did you try to cut down or stop 
drinking alcohol?   
 
IF YES: Did you ever actually stop 
drinking altogether?  
 
 (How many times did you try to 
cut down or stop altogether?) 
 
 IF NO:  Did you want to stop or 
cut down?  (Is this something 
you keep worrying about?) 
 
 (4)  there is a persistent 
desire OR unsuccessful 
efforts to cut down or 
control alcohol use 
 ? 1 2 3 
         No           Yes 
Did you spend a lot of time 
drinking, being high or tipsy, or 
hung over? 
 (5) a great deal of time is 
spent in activities necessary 
to obtain alcohol, use alcohol, 
or recover from its effects 
 ? 1 2 3 
         No           Yes 
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Did you have times when you would 
drink so often that you started to drink 
instead of working or spending time at 
hobbies or with your family or friends, 
or engaging in other important 
activities, such as sports, gardening, or 
playing music? 
 (6) important social, 
occupational, or recreational 
activities given up or 
reduced because of alcohol 
use 
 ? 1 2 3 
         No           Yes 
Did your drinking ever cause any 
psychological problems like 
making you depressed or 
anxious, making it difficult to 
sleep, or causing ‘blackouts?’ 
 
Did your drinking ever cause 
significant physical problems or 
made a physical problem worse? 
 
 IF YES TO EITHER OF ABOVE:   
Did you keep on drinking 
anyway? 
 
 (7) alcohol use is continued 
despite knowledge of having 
a persistent or recurrent 
physical or psychological 
problem that is likely to 
have been caused or 
exacerbated by alcohol (e.g., 
continued drinking despite 
recognition that an ulcer was 
made worse by alcohol 
consumption) 
 ? 1 2 3 
         No           Yes  
 
 
 
 
 
 
 
**Have you found that you 
needed to drink a lot more in 
order to get the feeling you 
wanted than you did when you 
first started drinking? 
 
  IF YES: How much more? 
 
 IF NO: What about finding that 
when you drank the same 
amount, it had much less effect 
than before? 
 
 (1)  tolerance, as defined by 
either of the following: 
 
      (a) a need for markedly  
      increased amounts of 
       alcohol  
      to achieve intoxication or  
      desired effect 
 
      (b) markedly 
diminished      effect  with 
continued use of the  
 ? 1 2 3 
         No           Yes  
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      same amount of alcohol 
Did you ever have any withdrawal 
symptoms when you cut down or 
stopped drinking like  
. . . sweating or racing heart? 
. . . hand shakes? 
. . . trouble sleeping? 
. . . feeling nauseated or      
vomiting? 
. . . feeling agitated? 
. . . or feeling anxious? 
… having a seizure  
…seeing, feeling, or hearing 
things that weren’t really there? 
 
Get description of how much 
symptoms interfered with work 
social life or relationships.  
 
(2)  withdrawal, as 
manifested by either (a) or 
(b): 
 
      (a)  at least TWO of the  
      following: 
 
      - -  autonomic 
hyperactivity  
           (e.g., sweating or 
pulse 
           rate greater than 
100) 
      - -  increased hand 
tremor 
      - -  insomnia 
      - -  nausea or vomiting 
      - -  psychomotor 
agitation 
      - -  anxiety 
      - -  grand mal seizures 
      - -  transient visual, 
tactile,  
           auditory 
hallucinations or  
           illusions 
?  1 2 3 
         No           Yes 
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IF NO: Did you ever start the day 
with a drink, or did you often 
drink or take some other drug or 
medication to keep yourself from 
getting the shakes or becoming 
sick? 
 (b) alcohol (or a substance 
from the sedative / hypnotic / 
anxiolytic class) taken to 
relieve or avoid 
withdrawal symptoms 
 
When did (Symptoms CODED ‘3’ 
on previous pages) occur?  Did 
they all happen around the same 
time? 
 AT LEAST 3 DEPENDENCE 
ITEMS CODED ‘3’ AND ITEMS 
OCCURRED WITHIN SAME 12 
MONTH PERIOD 
  NO  YES 
 
*CHRONOLOGY FOR 
DEPENDENCE* 
   
How old were you when you first 
had (list of symptoms coded 3 
above) 
 Age at onset of Alcohol 
Dependence (CODE 99 IF 
UNKNOWN) 
 
          ____  ____ 
    
During the past month, have you 
had anything at all to drink? 
Tell me more about it.   
 Has your drinking caused you 
any problems? 
 Full criteria for Alcohol 
Dependence met at any time 
in past month (or never had 
a month without symptoms 
of Dependence or Abuse 
since last onset of 
Dependence) 
CURRENT DEPENDENCE 
*** this only depends on 
symptoms not on 
abstinence 
 ? NO  YES 
 
ALCOHOL 
DEPENDENCE GO 
TO 
CHRONOLOGY 
BELOW 
Does NOT meet criteria for 
Dependence Go to abuse section of 
Questionnaire 
 
G 
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Indicate if: 
  1 -  With Physiological Dependence  (current evidence of tolerance or withdrawal) 
NOTE SEVERITY OF DEPENDENCE FOR WORST WEEK OF PAST MONTH 
(Additional questions about the effect of alcohol on social and occupational functioning may 
be necessary) 
      1   Mild:          Few, if any, symptoms in excess of those required to 
                             make the diagnosis,  and the symptoms result in no more 
                             than mild impairment in occupational functioning or in 
                             usual social activities or relationships with others (or 
                             criteria met for Dependence in the past and some current problems). 
 
      2   Moderate:  Symptoms or functional impairment between ‘mild’ and ‘severe.’ 
 
      3   Severe:      Many symptoms in excess of those required to make the 
                             diagnosis, and the symptoms markedly interfere with 
                             occupational functioning or with usual social activities 
                             or relationships with others. 
 
  2 -  Without Physiological Dependence  (no current evidence of tolerance or withdrawal 
**) 
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ALCOHOL ABUSE   ALCOHOL ABUSE 
CRITERIA 
 
 
 
Again thinking about 
the time when your 
drinking was the 
heaviest … 
 A.  A  maladaptive pattern of  
alcohol use, leading to 
clinically significant 
impairment or distress, as 
manifested by one (or more) 
of the following occurring 
within a twelve month 
period: 
? = inadequate 
info 
1 = absent  
2 = sub 
threshold 
3 = true 
 
Did you ever miss work 
or school because you 
were intoxicated, high, 
or very hung over?   
 
Did you ever do a bad 
job at work or failed 
courses  because of 
your drinking? 
 
What about not keeping 
your house clean or not 
taking proper care of 
your children because 
of your drinking?   
 
 IF YES  
How often?  (Over what 
period of time?) 
 
       (1)  Recurrent alcohol 
use  
      resulting in a failure to 
fulfill  
      major role obligations 
at  
      work, school, or home  
      (e.g., repeated absences 
or  
      poor work performance  
      related to alcohol use;  
      alcohol-related 
absences,  
      suspensions, or 
expulsions  
      from school; neglect of  
      children or household). 
 ? 1 2 3 
         No           
Yes 
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Did you ever drink in a 
situation in which it 
might have been 
dangerous to drink at 
all?  Did you ever drive 
while you were really 
too drunk to drive? 
 IF YES  
How many times?  
(When?)  
       (2)  recurrent alcohol 
use in  
      situations in which it is  
      physically hazardous 
(e.g.,  
      driving an automobile or  
      operating a machine 
when  
      impaired by alcohol use) 
 ? 1 2 3 
         No           
Yes 
Did your drinking get 
you into trouble with 
the law? 
 
 IF YES How often?  
(Over what period of 
time?) 
       (3)  recurrent alcohol-
related  
      legal problems (e.g., 
arrests  
      for alcohol-related 
disorderly  
      conduct) 
 ? 1 2 3 
         No           
Yes 
 
 
328 
 
SCID I 
CHECK FOR ABUSE CHRONOLOGY BELOW 
Did your drinking cause 
problems with other 
people, such as with 
family members, 
friends, or people at 
work? 
 
 Did you get into 
physical fights when 
you were drinking?    
 
Did you have bad 
arguments  about what 
happens, when you 
drink too much? 
 
 IF YES:  Did you keep 
on drinking anyway?   
(Over what period of  
time?) 
       (4)  continued substance  
      use despite having  
      persistent or recurrent 
social  
      or interpersonal 
problems  
      caused or exacerbated 
by  
      the effects of the 
substance  
      (e.g., arguments with 
spouse  
      about consequences of  
      intoxication, physical 
fights)  
? 1 2 3 
         No           
Yes 
 
 
 
 
 
 
 
 
 
 
 
 
  AT LEAST ONE ITEM CODED ‘3’ NO (1) YES (2) 
  
  
ALCOHOL ABUSE CHRONOLOGY  
How old were you when you first 
had (any abuse symptom coded 
‘3’)? 
  
 
Age at onset of Alcohol Abuse 
(CODE 99 IF UNKOWN) 
           
 
 ____  ____ 
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During the past month, have you 
had anything at all to drink? 
Tell me more about it.  
(Has your drinking caused you 
any problems?) 
 
  
 
Criteria for Alcohol Abuse met 
at any time in past month 
 Current Abuse 
*** this only depends on 
symptoms not on 
abstinence 
 
NO  YES 
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SIP 2-R 
INSTRUCTIONS: Here are a number of events that people sometimes 
experience.  Read each one carefully, and indicate how often each one 
happened DURING THE TIME YOUR DRINKING WAS THE MOST 
PROBLEMATIC OR HEAVIEST     (0=Never, 1=Once or a few times, etc.).  If 
an item does not apply to you, circle zero (0). 
 
During your Heaviest period of drinking   how 
often did this happen to you? 
Circle one answer: 
 
Never 
Once or 
a few 
times 
Once or 
twice a 
week 
Daily or 
almost 
daily 
1.  I was unhappy because of my drinking. 
 
0 1 2 3 
2.  Because of my drinking, I did not eat 
properly. 
 
0 1 2 3 
3.  I  failed to do what was expected of me 
because of my drinking. 
 
0 1 2 3 
4.  I felt guilty or ashamed because of my 
drinking. 
 
0 1 2 3 
5.  I took foolish risks when I had been drinking. 
 
0 1 2 3 
6.  When drinking, I did impulsive things that I 
regretted later. 
 
0 1 2 3 
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Now answer these questions about things that 
happened to you. 
During your Heaviest Drinking period  how 
often did this happen?  Circle one answer: 
 
Not at all 
 
A little 
 
Some- 
what 
 
Very 
much 
7.  My physical health was harmed by my 
drinking. 
0 1 2 3 
8.  I  had money problems because of my 
drinking. 
0 1 2 3 
9.  My physical appearance was harmed by my 
drinking. 
 
0 1 2 3 
10.  My family was hurt by my drinking. 0 1 2 3 
11.  A friendship or close relationship was 
damaged by my drinking. 
0 1 2 3 
12.  My drinking got in the way of my growth 
as a person. 
0 1 2 3 
13.  My drinking damaged my social life, 
popularity or reputation. 
0 1 2 3 
14.  I spent too much or lost a lot of money 
because of my drinking. 
0 1 2 3 
 
Has this happened to you During your 
heaviest drinking period  Circle one answer: 
 
No 
 
Almost 
 
Yes, 
once 
 
Yes, more 
than once 
15.  I had an accident while drinking or 
intoxicated.  
 
0 1 2 3 
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 SADD 
Thinking about the time when you WERE DRINKING HEAVILY, answer each 
question by placing a tick under the MOST APPRPRIATE HEADING.  
 
 
   NEVER  
 
SOMETIMES OFTEN NEARLY  
ALWAYS 
  
1 Did you find it difficult to get thoughts 
of drinking out of your mind? 
     
2 Was getting drunk more important 
than your next meal? 
  
 
   
3 Did you plan your day around when 
and where you could drink? 
     
4 Did you drink in the morning, 
afternoon and evening? 
     
5 Did you drink for the effect of alcohol 
without caring what the drink was? 
     
6 Did you drink as much as you wanted 
irrespective of what you were doing the 
next day? 
 
     
7 Given that many problems might have 
been caused by alcohol did you still 
drink too much? 
 
     
8 Did you know that you wouldn’t be able 
to stop drinking once you started? 
     
9 Did you try to control your drinking by 
giving it up completely for days or 
weeks at a time? 
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10 The morning after a heavy drinking 
session did you need to drink to get 
yourself going? 
 
     
11 The morning after a heavy drinking 
session did you wake up with a definite 
shakiness of your hands? 
 
     
12 
 
Have a heavy drinking session did you 
wake up and retch or vomit? 
     
13 The morning after a heavy drinking 
session did you go out of your way to 
avoid people? 
     
14 After a heavy drinking session did you 
see frightening things that later you 
realised were imaginary? 
 
     
15 Did you go drinking and the next day 
found that you had forgotten what 
happened the night before? 
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SOCRATES 8 A (Restrospective ) 
Instructions: Each one describes a way that you might (or might not) not) feel about your drinking. For 
each state      statement, circle one number from 1 to 5, to indicate how much you agree or disagree 
with it right now  
 
 
 
Strongly 
Disagree 
Disagree Undecided 
or Unsure  
Agree            Strong 
Agree    
1. I really wanted to make changes to my drinking 1 2 3 4 5 
2. Sometimes I wondered if I was an alcoholic. 1 2 3 4 5 
3. If I didn’t change my drinking, my problems were going to 
get worse.  
1 2 3 4 5 
4. I started making some changes to my drinking.  1 2 3 4 5 
5. I was drinking too much at that time, but I managed to 
change my drinking.  
1 2 3 4 5 
6. Sometimes I wondered if my drinking was hurting other 
people.  
1 2 3 4 5 
7. I was a problem drinker. 1 2 3 4 5 
8. I was not just thinking about changing my drinking. I was 
already doing something about it.   
1 2 3 4 5 
9. I changed my drinking and I was looking for ways to keep 
from slipping back to my old pattern.  
1 2 3 4 5 
10. I had a serious problem with drinking. 1 2 3 4 5 
11. Sometimes I wondered if I was in control of my drinking.  1 2 3 4 5 
12. My drinking was causing a lot of harm.  1 2 3 4 5 
13. I was actively doing things to cut down or to stop 
drinking.  
1 2 3 4 5 
14. I wanted help to keep myself from going back to the 
drinking problem that I had before.   
1 2 3 4 5 
15. I knew that I had a drinking problem. 1 2 3 4 5 
16. There were times when I wondered if I drank too much.  1 2 3 4 5 
17. I was an alcoholic.   1 2 3 4 5 
18. I was working hard to change my drinking.  1 2 3 4 5 
19. I made some changes in my drinking, and I wanted some 
help to keep myself from going back to the way I used to 
drink.   
 2 3 4 5 
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                                                     SOCRATES 8A (Current)      
 Strongly 
Disagree 
Disagree Undecided 
or Unsure  
Agree            Strongly 
Agree    
1. I really want to make changes in my drinking or continue 
with not drinking  
1 2 3 4 5 
2. Sometimes I wonder if I am an alcoholic. 1 2 3 4 5 
3. If I don’t change my drinking soon or remain abstinent 
my problems can get worse.  
1 2 3 4 5 
4. I have already made changes or stopped my drinking.  1 2 3 4 5 
5. I was drinking too much at one time, but I’ve managed to 
change or abstain from drinking.  
1 2 3 4 5 
6. Sometimes I wonder whether returning to drinking could 
hurt other people.  
1 2 3 4 5 
7. I am or have been a problem drinker. 1 2 3 4 5 
8. I’m not just thinking about changing my drinking, I’m 
already doing or have done something about it.    
1 2 3 4 5 
9. I have already changed my drinking. I am always 
considering ways to keep from slipping back to my old 
pattern.  
1 2 3 4 5 
10. I have or have had serious problems with drinking. 1 2 3 4 5 
11.  Sometimes I wonder if I am in control of my drinking.  1 2 3 4 5 
12. My drinking is or can cause a lot of harm.  1 2 3 4 5 
13. I am actively doing things now to cut down, stop or 
abstain from drinking.  
1 2 3 4 5 
14. I want help or will consider help to keep myself from 
going back to the drinking problem that I had before.   
1 2 3 4 5 
15. I know that I have or have had a drinking problem. 1 2 3 4 5 
16. There are times when I wonder if I drank too much.  1 2 3 4 5 
17. I am an alcoholic.   1 2 3 4 5 
18. I am working hard to change my drinking or to keep my 
abstinence. 
1 2 3 4 5 
19. I have made changes in my drinking. I will want some  
help to keep myself from going back to the way I used to 
drink.   
1 2 3 4 5 
I I       Instructions: Each one describes a way that you might (or might not) not) feel about your drinking. For each state      
statement, circle one number from 1 to 5, to indicate how much you agree or disagree with it right now  
 
 
336 
 
              HISTORY OF SUBSTANCE USE  
Code  :  0   Never used or a few times only 
1 Past non-problem 
2 Past problem 
3 Current non-problem 
4 Current problem 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Substance Code 
 
Cannabis 
 
 
Heroin 
 
 
Methadone 
 
 
Benzodiazepines 
 
 
Amphetamines 
 
 
Cocaine 
 
 
Ecstasy 
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PREVIOUS ALCOHOL TREATMENT 
1. Inpatient  Detoxification  
⁭ Nil  ⁭  1 time ⁭ 2-3 times  ⁭ 4-5  ⁭ 5+ 
2. Outpatient Detoxification  
⁭ Nil  ⁭ 1 time ⁭ 2-3 times  ⁭ 4-5  ⁭ 5+ 
3.Residential Treatment  
⁭ Nil  ⁭ 1 time ⁭ 2-3 times  ⁭ 4-5  ⁭ 5+ 
4.Day Program                
⁭ Nil  ⁭ 1 time    2-3 times  ⁭ 4-5  ⁭ 5+ 
5. Outpatient Counselling    
⁭ Nil  ⁭ 1 episode   ⁭ 2-3 times  ⁭ 4-5  ⁭ 5+ 
6.Alcoholics Anonymous or SMART   
⁭ 0  ( < 12 occasions)                       1 (More than 12 occasions)               
 
Reasons for seeking current treatment (controls):  
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HEALTH BELIEFS TREATMENT BARRIERS  QUESTIONNAIRE  
(CASES) 
 
INSTRUCTIONS: Circle the answer that shows how much you agree or disagree with each item.   
                                                               DISAGREE                                  NOT                         AGREE       
                                                                    STRONGLY ……………      … SURE …….. ……STRONGLY.    
PART 1 
1.Liver disease can be caused                      1              2             3             4              5              6          7                 
by alcohol.  
 
2. Drinking after a transplant can lead           1              2             3             4              5             6         7                 
to serious health problems 
 
3. Abstinence is essential for a healthy  
  liver.                                                            1              2             3             4              5             6          7                  
 
4. The health of my liver    
concerns me a great deal.                              1              2             3             4              5             6          7                 
 
5. It is likely that I will get sick  
if I return to drinking.                                   1              2             3             4              5             6           7                 
 
6. Not drinking is more trouble    
than it is worth.                                            1              2             3             4              5             6           7                         
 
7. Lifetime abstinence is worse than  
than liver disease.                                        1              2             3             4              5             6            7                 
 
8. Doctors have the best advice 
about alcohol and liver disease.              1              2             3             4              5             6              7                
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                                                                  DISAGREE                                  NOT                                AGREE       
                                                                   STRONGLY ……………      … SURE ….. ………STRONGLY        
9. I do not let cravings or old drinking  
behaviour  interfere with my life .              1              2             3             4              5             6              7                 
 
10. Looking after my health is one of  
my major concerns.                                     1              2             3             4              5             6              7      
 
11. I worry about returning to drinking 
after my transplant.                                      1              2             3             4              5             6              7                 
 
12. Drinking for me, can lead to health problems 
more than other people my age                   1              2             3             4              5             6              7                         
 
13. I am likely to get liver disease 
again if I return to drinking.                        1              2             3             4              5             6              7     
 
14. I would consider professional help 
if I started to drink or crave alcohol              1              2             3             4              5             6              7                         
 
15. I know how to socialize   
without drinking                                            1              2             3             4              5             6              7                         
 
16.  I am confident about coping with 
life problems without drinking                       1              2             3             4              5             6              7                         
 
17. My life is better for not drinking               1              2             3             4              5             6        7                         
     
18. Not drinking and staying well  
is largely a matter of good luck.                     1              2             3             4              5             6         7      
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19. I have replaced my drinking lifestyle 
with people and activities.                                1              2             3             4              5             6       7     
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HEALTH BELIEFS TREATMENT BARRIERS  QUESTIONNAIRE  (CONTROLS) 
 
INSTRUCTIONS: Circle the answer that shows how much you agree or disagree with each item.   
 
                                                               DISAGREE                                  NOT                              AGREE       
                                                                    STRONGLY ……………      … SURE …….. …… STRONGLY        
PART 1 
1.Liver disease can be caused                      1              2             3             4              5             6           7                 
by alcohol.  
 
2. Drinking after a liver transplant can lead               
to serious health problems                           1              2             3             4              5             6           7       
 
3. Abstinence is essential for a healthy  
  liver.                                                            1              2             3             4              5             6          7                  
 
4. The health of my liver    
concerns me a great deal.                              1              2             3             4              5             6          7                 
 
5. It is likely that I will get sick  
 if I return to drinking.                                   1              2             3             4              5             6          7                 
 
6. Not drinking is more trouble    
than it is worth.                                          1              2             3             4              5             6             7                         
 
7. Lifetime abstinence is worse than  
than liver disease.                                     1              2             3             4              5             6              7                 
 
8. Doctors have the best advice 
about alcohol and liver disease.              1              2             3             4              5             6              7              
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                                                                      DISAGREE                                  NOT                              AGREE       
                                                                         STRONGLY ……………      … SURE …….. ……          STRONGLY        
 
9. I do not let cravings or old drinking  
behaviour interfere with my life .               1              2             3             4              5             6            7                 
 
10. Looking after my health is one of  
my major concerns.                                      1              2             3             4              5             6            7      
 
11. I worry or would worry about returning  
to drinking after having been abstinent.       1              2             3             4              5             6           7                 
 
12. Drinking for me, can lead to health problems 
more than other people my age                      1              2             3             4              5             6         7                         
 
13. I am likely to get liver disease 
if I continue to drink.                                    1              2             3             4              5             6          7     
 
14. I would consider professional help 
if I started to drink or crave alcohol              1              2             3             4              5             6         7                         
 
15. I know how to socialize   
without drinking                                            1              2             3             4              5             6          7                         
 
16.  I am confident about coping with 
life problems without drinking                       1              2             3             4              5             6         7                         
 
17. My life is better for not drinking               1              2             3             4              5             6        7                         
     
18. Not drinking and staying well is largely 
a matter of good luck.                                       1              2             3             4              5             6      7                 
 
19. I have replaced my drinking lifestyle 
with people and activities.                                1              2             3             4              5             6       7                 
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DAS S 21 Name: Date: 
Please read each statement and circle a number 0, 1, 2 or 3 that indicates how much the statement applied to you 
over the past week.  There are no right or wrong answers.  Do not spend too much time on any statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
1 I found it hard to wind down 0      1      2      3 
2 I was aware of dryness of my mouth 0      1      2      3 
3 I couldn't seem to experience any positive feeling at all 0      1      2      3 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
5 I found it difficult to work up the initiative to do things 0      1      2      3 
6 I tended to over-react to situations 0      1      2      3 
7 I experienced trembling (eg, in the hands) 0      1      2      3 
8 I felt that I was using a lot of nervous energy 0      1      2      3 
9 I was worried about situations in which I might panic and make 
a fool of myself 
0      1      2      3 
10 I felt that I had nothing to look forward to 0      1      2      3 
11 I found myself getting agitated 0      1      2      3 
12 I found it difficult to relax 0      1      2      3 
13 I felt down-hearted and blue 0      1      2      3 
14 I was intolerant of anything that kept me from getting on with 
what I was doing 
0      1      2      3 
15 I felt I was close to panic 0      1      2      3 
16 I was unable to become enthusiastic about anything 0      1      2      3 
17 I felt I wasn't worth much as a person 0      1      2      3 
18 I felt that I was rather touchy 0      1      2      3 
19 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0      1      2      3 
20 I felt scared without any good reason 0      1      2      3 
21 I felt that life was meaningless 0      1      2      3 
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HIGH-RISK ALCOHOLISM RELAPSE SCALE 
 
1. Duration of heavy drinking in years   
⁭  Less than 11 years 
⁭  11-25 years 
⁭  Over 25 years 
 
 
2. Number of daily drinks when drinking 
⁭  Less than 9 standard drinks 
⁭  9-17 standard drinks 
       ⁭  More than 17  
 
3. Number of prior alcoholism inpatient treatments 
⁭  0 
⁭  1 
⁭  More than 1 
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HELP SEEKING SURVEY 
 
These questions are about your experience of counselling and medical staff at this hospital    
                                                                   DISAGREE                                  NOT                                AGREE       
                                                                           STRONGLY ……………      … SURE …….. …….   STRONGLY        
PART2  
1. I feel comfortable letting staff  
know about problems I may be having with  
drinking                                                             1              2             3             4              5             6             7 
 
2. Staff would be very disappointed if I was  
to tell them about problems with drinking.      1              2             3             4              5             6             7  
                                                                         
3. I would be embarrassed to let staff know  
about any problems with abstinence                1              2             3             4              5             6             7                               
                                                                                  
4.. If I let staff know about problems with alcohol  
they will see me as a failure.                          1              2             3             4              5             6              7 
                                                                                  
5. If  I talk about alcohol with staff it will 
affect the type of treatment I get.                    1              2             3             4              5             6              7 
 
6.Staff encourage patients to talk  
about their alcohol use.                                       1              2             3             4              5             6           7 
                                     
7. Staff have provided help and advice  
with any alcohol related problems                        1              2             3             4              5             6         7 
 
8. I want alcohol treatment   
provided by this service(or if it was                 1              2             3             4              5             6       7 
available) 
9. There is a staff member available who  
you can discuss alcohol issues with.               1              2             3             4              5             6              7 
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 MINI MENTAL STATE EXAM DATE: 
 Patient name:  
 Performed by:  
 TASK SCORE 
1 .  What is the year, season, date, day of week, and month?  
     One point for each correct answer. 
 
     /5 
2 .  Where are we? Prompt for country, state, town, building (e.g. 
Hospital/home), and floor or room.  
One point for each correct answer. 
 
     /5 
3 Name three common objects slowly and clearly, e.g. ‘apple’, ‘table’, ‘penny’. 
Ask the patient to repeat them. 
          One point for each item correctly repeated. 
 
     /3 
4 Ask the patient to count backwards from 100 by 7. Stop after five answers. ( 
Alternatively ask them to spell ‘world’ backwards.) 
          One point for each correct answer (or letter). 
 
 
     /5 
5 Ask the patient to recall the objects learned earlier. (apple, table, penny) 
          One point for each item correctly remembered. 
 
     /3 
6 .  Point to your watch and ask the patient, ‘what is this?’ Repeat with a pencil. 
          One point for each correct answer. 
 
 
     /2 
7 .   Ask the patient to repeat this phrase after you ‘No ifs, ands, or buts.’   
         One point if successful on first try. 
     /1 
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8 Give the patient a piece of paper and say: ‘Take this paper in your right hand, 
fold it in half, and put it on the floor.’ 
         One point for each correct action. 
     /3 
9 Show the patient a piece of paper with ‘CLOSE YOUR EYES’ printed on it. 
        One point if the patient’s eyes close. 
 
     /1 
10 .   Ask the patient to write a sentence. 
        One point if sentence has a subject, a verb, and makes sense. 
 
     /1 
11 Ask the patient to copy a pair of intersecting pentagons onto a piece of paper. 
       One point if the figure has ten corners and two intersecting lines.   
 
     /1 
 TOTAL      /30 
 25 – 30  Normal cognitive function  
 21 – 24  Mild cognitive impairment  
 10 – 20  Moderate cognitive impairment  
 < - 10     Severe cognitive impairment  
 
 
351 
 
APPENDIX F Interview guide and table of themes   
INTERVIEW GUIDE 
Semi- structured interview 
Q1. Abstinence  
a) What has it been like giving up drinking whilst going through liver transplantation?  
b) How did you manage to achieve abstinence?   
c) What support has been behind remaining abstinent? 
 
Q2. Transplant Staff  
a) How have transplant staff helped you with alcohol related issues?  
b) Have staff discussed alcohol related matters, provided information or referred you to 
services? 
c) How would they react if you told them you were having cravings, needing treatment  or 
that you had been drinking?   
 
Q3. Relapse 
a) What do you think causes people to relapse either before or after a transplant? 
b) If you relapsed what would you do? 
 
Q4. Preferred alcohol treatment approach  
a) What support do you think transplant staff could provide to assist people with 
maintaining long term abstinence?   
 
Q5. Possible reasons for resistance to alcohol treatment 
 
 
352 
 
a) Why do you think ALD transplant patients may refuse to attend or participate in               
alcohol treatment programs when provided by liver transplant units?  
 
In-depth semi-structured interview   
______________________________________________________ 
What has it been like going through a liver transplant and giving up drinking? 
Probing questions   
a) How difficult was it to achieve abstinence? 
b) What support was behind remaining abstinent? 
c) When has it been difficult? 
d) What prompted or motivated you to achieve abstinence?  
e) Have you been bothered by urges or cravings? 
 
Describe the relapse experience  
Probing questions   
a) Under what conditions to you think relapse is possible? 
b) What factors do you think may have influenced your lapse or relapse? 
c) Personal reaction to relapse?  
d) The reaction of others to your relapse? 
 
What has been their experience of transplant program and staff regarding alcohol and 
alcohol related problems? 
Probing questions   
a) What was your experience of how transplant staff deal with relapse? 
b) What is your view of the contract of lifelong abstinence? 
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Views regarding using alcohol treatment   
Probing questions   
a) Would you consider treatment? 
b) If yes, when would you consider treatment?     
c) What is your preferred choice of treatment?   
 
Exploratory/probing questions for more in-depth semi-structured interviews  
What has been your experience of liver transplantation? 
Can you describe that situation or experience a bit more?  
What was it like when…. 
If you could, what would you like to tell transplant staff?  
What do you think they may need to know? 
Tell me more about…… 
What are your thoughts about that? 
What do you think was influencing you when … or at that time? 
Reflect what they are saying …was that how it was…does that sound right? 
What would you tell other people who are going to go through a transplant about the risk of 
relapse? 
It seems to me that you are saying….did I get that right? Is that how it is or is there something 
I may be missing? Would you like to add more or clarify/elaborate?  
What kind of advice would you give to others? 
What will the future be like?  
Is there anything you would like to add or say before I finish the interview?  
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Table 10. 3 The number and percentages of ESALD transplant participants (abstainers, relapsers and total group) and their 
responses to the semi-structured interview questions.   
  
   Abstainers 
     (n=32) 
 
  Relapsers 
     (n=10) 
 
      Total 
Motivation for abstinence 
End-stage liver disease and wanting to live   
Including other reason 
 
 
  32 (100%) 
 
  10 (100%) 
    2 (22%) 
 
       42 (100%) 
         2 (6%) 
How abstinence was achieved and maintained    
  I weighed things up, made a decision, used my willpower                                                             
  The support of partner and family                                                                  
  By avoiding or coping with social events                                                     
  I thought about why I shouldn’t drink                                                          
  Moral obligation                                                                                           
  Transplant related epiphany                                                                             
  Relying on friends only                                                                                
  AA/NA support                                                                                             
  Relying on myself not a partner                                                                     
  Being active                                                                                         
 
 
  23 (72%) 
  21 (66%) 
21 (66%)
18 (56%)
  17 (53%) 
9 (28%)
4 (13%)
3 (9%)
4 (12%)
    2 (6%) 
  
Participants experience of transplant staff/program   
The issue of alcohol was not discussed apart from monitoring       
Staff look at your blood tests to see how you are going                  
Staff provide medical advice, information and referral      
You are asked about your drinking and encouraged not to drink      
Don’t remember getting advice, referral or information          
You are expected to comply with staff recommendations 
 
2         20 (63%)    
           15 (47%)    
           12 (38%)    
         11 (34%)    
   9 (28%)     
            5 (16%)            
 
20 (    6(60%)    
        5 (50%)              
        5 (50%)              
        7 (70%)              
        0                   
  6 (60%)            
 
20 (           26 (62%) 
              20 (48%) 
              17 (40%) 
              18 (43%) 
                   9 (21%) 
        11 (26%) 
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   Abstainers 
     (n=32) 
 
  Relapsers 
     (n=10) 
 
      Total 
 
Participant perceptions regarding staff and relapse  
   Staff would be very disappointed                                                     21 (66%)              6 (60%)                   27 (64%)   
   Staff would be supportive despite any problems                              10 (24%)              3 (33%)                   12 (32%)   
   May not get a liver or placed down the list if I report problems        2 (5%)                2 (22%)                     4 (10%)  
         Not sure                                                                                              4 (13%)              1 (11%)                     5 (12%) 
 
Participant views on reasons for relapse  
 I feel fine now I have a new liver, I can return to drinking               17 (56%)             2 (20%)                    19 (45%) 
 Personal problems, stressors, depression, or trauma                          13 (41%)            8 (80%)                     21 (50%) 
 Lack of family support                                                                         9 (28%)             6 (66%)                    15 (37%) 
Culture of social drinking                                                                      6 (19%)            5 (50%)                     11 (26%)           
Pre-transplant period-waiting (fear of death or unknown, pain)           4 (13%)            3 (33%)                      7 (17%)          
Denial (‘don’t see a problem’)                                                              3 (9%)              1 (10%)                      4 (10%) 
Severity of dependence                                                                          4 (13%)            1 (10%)                      5 (12%) 
Lack of activity                                                                                       1 (3%)             0                                 1 (2%)     
         No idea                                                                                                   3 (9%)              0                                 2 (5%) 
 
How participants would manage a relapse  
   I would tell my doctor or nursing staff                                                   14 (44%)              1(11%)                    15 (36%) 
   Handle it myself                                                                                        6 (19%)              6 (60%)                  12 (29%)    
   Go to AA/NA                                                                                            4 (13%)              3 (30%)                    7 (17%) 
   Turn to my family for help first                                                                2 (6%)                0                               2 (5%) 
   Detox/rehab                                                                                               1 (3 %)               0                               1 (2%) 
   Another health professional/counselor off-site                                         2 (6 %)               2 (20%)                    4 (10%)      
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   Abstainers 
     (n=32) 
 
  Relapsers 
     (n=10) 
 
      Total 
 
 
How participants would manage a relapse  
   I would tell my doctor or nursing staff                                                  14 (44%)             1 (10%)               15 (36%) 
   Handle it myself                                                                                       6 (19%)              6 (60%)              12 (29%)    
   Go to AA/NA                                                                                           4 (13%)              3 (30%)               7 (17%) 
   Detox/rehab                                                                                              1 (3%)                0                          1 (2%) 
   Another health professional/counselor off-site                                         2 (6 %)              2 (20%)                4 (10%)          
   Turn to my family for help first                                                                2 (6%)               0                           2 (5%) 
 
 
Possible reasons for resistance to alcohol treatment  
   I’m abstinent don’t need for treatment/I can work it out                            22 (69%)             7 (60%)             29 (69%) 
   Stigma, sense of failure, guilt about letting staff down                              18 (56%)             8 (80%)             26 (62%)     
   People may not see they have a problem with alcohol                                4 (15%)              1 (10%)              5(12%) 
   Don’t like professionals telling me what to do                                            5 (15%)              4 (13%)              5 (12%)                   
   Staff too busy                                                                                               2 (6%)                4 (44%)               6 (14%) 
   Some may be hiding their drinking                                                             3 (11%)               0                          3 (7%) 
   Don’t know where to go                                                                              1 (3%)                 0                          1 (2%) 
   Don’t want to stop my drinking                                                                   0                          1  (13%)               1 (2%) 
   Being pressured into treatment                                                                    0                          2 (25%)               2 (5%) 
 
 
